sampleID CDE_ID_3226963 _INTEGRATION _PANCAN_CNA_PANCAN_K8 _PANCAN_Cluster_Cluster_PANCAN _PANCAN_DNAMethyl_PANCAN _PANCAN_DNAMethyl_UCEC _PANCAN_RPPA_PANCAN_K8 _PANCAN_UNC_RNAseq_PANCAN_K16 _PANCAN_miRNA_PANCAN _PANCAN_mirna_UCEC _PANCAN_mutation_PANCAN _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy additional_surgery_locoregional_procedure additional_treatment_completion_success_outcome age_at_initial_pathologic_diagnosis aln_pos_ihc aln_pos_light_micro bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode birth_control_pill_history_usage_category clinical_stage colorectal_cancer days_to_additional_surgery_metastatic_procedure days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_last_known_alive days_to_new_tumor_event_additional_surgery_procedure days_to_new_tumor_event_after_initial_treatment diabetes disease_code followup_case_report_form_submission_reason form_completion_date gender height histological_type history_of_neoadjuvant_treatment horm_ther hypertension icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified init_pathology_dx_method_other initial_pathologic_diagnosis_method initial_weight is_ffpe lost_follow_up menopause_status neoplasm_histologic_grade new_neoplasm_event_occurrence_anatomic_site new_neoplasm_event_type new_neoplasm_occurrence_anatomic_site_text new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment oct_embedded other_dx pathology_report_file_name patient_id pct_tumor_invasion peritoneal_wash person_neoplasm_cancer_status pln_pos_ihc pln_pos_light_micro postoperative_rx_tx pregnancies primary_therapy_outcome_success prior_tamoxifen_administered_usage_category project_code radiation_therapy recurrence_second_surgery_neoplasm_surgical_procedure_name recurrence_second_surgery_neoplasm_surgical_procedure_name_other residual_disease_post_new_tumor_event_margin_status residual_tumor sample_type sample_type_id surgical_approach system_version targeted_molecular_therapy tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site total_aor_lnp total_aor_lnr total_pelv_lnp total_pelv_lnr tumor_tissue_site vial_number vital_status weight year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_UCEC_exp_HiSeqV2_PANCAN _GENOMIC_ID_data/public/TCGA/UCEC/miRNA_GA_gene _GENOMIC_ID_TCGA_UCEC_PDMRNAseq _GENOMIC_ID_TCGA_UCEC_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_UCEC_RPPA_RBN _GENOMIC_ID_TCGA_UCEC_RPPA _GENOMIC_ID_TCGA_UCEC_PDMarrayCNV _GENOMIC_ID_TCGA_UCEC_miRNA_GA _GENOMIC_ID_TCGA_UCEC_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_UCEC_mutation_broad_gene _GENOMIC_ID_TCGA_UCEC_mutation_wustl_gene _GENOMIC_ID_TCGA_UCEC_mutation _GENOMIC_ID_TCGA_UCEC_exp_HiSeqV2 _GENOMIC_ID_TCGA_UCEC_PDMarray _GENOMIC_ID_TCGA_UCEC_miRNA_HiSeq _GENOMIC_ID_TCGA_UCEC_exp_GAV2 _GENOMIC_ID_TCGA_UCEC_gistic2thd _GENOMIC_ID_TCGA_UCEC_G4502A_07_3 _GENOMIC_ID_TCGA_UCEC_gistic2 _GENOMIC_ID_data/public/TCGA/UCEC/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_UCEC_PDMRNAseqCNV _GENOMIC_ID_TCGA_UCEC_hMethyl450 _GENOMIC_ID_TCGA_UCEC_hMethyl27 _GENOMIC_ID_TCGA_UCEC_exp_GAV2_exon TCGA-2E-A9G8-01 Indeterminate TCGA-2E-A9G8-01 TCGA-2E-A9G8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES Partial Response 59 0 0 TCGA-2E-A9G8-F66642 TCGA-2E-A9G8 TCGA-2E-A9G8-01A Never Used Stage III NO 957 0 1249 396 NO 2014-10-21 FEMALE 157 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.3 8380/3 C54.3 YES Office Endometrial Biopsy 90 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 Other, specify Locoregional Recurrence port site YES false Yes TCGA-2E-A9G8.921E6140-A03E-4FBD-9FB8-554AE96FD16C.pdf A9G8 280 TUMOR FREE 0 0 YES 2 Progressive Disease Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES 2E 0 9 0 19 Endometrial A LIVING 71 2011 8e9f2a41-dddc-4761-8883-ca58f5934d5f TCGA-2E-A9G8-01 8e9f2a41-dddc-4761-8883-ca58f5934d5f 8e9f2a41-dddc-4761-8883-ca58f5934d5f 8e9f2a41-dddc-4761-8883-ca58f5934d5f TCGA-2E-A9G8-01 TCGA-2E-A9G8-01A-11D-A402-01 TCGA-2E-A9G8-01A-11D-A402-01 TCGA-2E-A9G8-01 TCGA-2E-A9G8-01 TCGA-2E-A9G8-01A-11D-A409-05 TCGA-4E-A92E-01 MSS TCGA-4E-A92E-01 TCGA-4E-A92E TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 54 0 0 TCGA-4E-A92E-F69233 TCGA-4E-A92E TCGA-4E-A92E-01A Never Used Stage I NO -19818 90 0 13 NO 2014-12-30 FEMALE 162 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Tumor resection 140 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-4E-A92E.BC43D6CA-235C-4217-BF72-F33B089C532B.pdf A92E negative TUMOR FREE 0 0 NO 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 YES NO 4E 0 2 0 4 Endometrial A LIVING 76 2013 87087b2e-a589-4a75-a005-2c61cb44b414 TCGA-4E-A92E-01 87087b2e-a589-4a75-a005-2c61cb44b414 9117161E-9271-495E-BC8F-26EBC10D661B 87087b2e-a589-4a75-a005-2c61cb44b414 87087b2e-a589-4a75-a005-2c61cb44b414 TCGA-4E-A92E-01 TCGA-4E-A92E-01A-11D-A37M-01 TCGA-4E-A92E-01A-11D-A37M-01 TCGA-4E-A92E-01 TCGA-4E-A92E-01 TCGA-4E-A92E-01A-11D-A37Q-05 TCGA-5B-A90C-01 MSS TCGA-5B-A90C-01 TCGA-5B-A90C TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Complete Response 69 TCGA-5B-A90C-F69362 TCGA-5B-A90C TCGA-5B-A90C-01A Stage IA NO -25518 811 0 1202 517 517 NO 2015-1-7 FEMALE 158 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 50 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 Other, specify Locoregional Recurrence right pelvic mass YES YES false No TCGA-5B-A90C.608E2698-6A3A-4673-89D2-3BE98A74EBE5.pdf A90C TUMOR FREE 0 NO 2 YES Excisional Biopsy Primary Tumor 01 Minimally Invasive 2009 NO YES 5B 0 42 Endometrial A LIVING 98 2011 4a299385-e7a5-4a82-940b-ff6e36c596c2 TCGA-5B-A90C-01 4a299385-e7a5-4a82-940b-ff6e36c596c2 4a299385-e7a5-4a82-940b-ff6e36c596c2 4a299385-e7a5-4a82-940b-ff6e36c596c2 TCGA-5B-A90C-01 TCGA-5B-A90C-01A-11D-A37M-01 TCGA-5B-A90C-01A-11D-A37M-01 TCGA-5B-A90C-01 TCGA-5B-A90C-01 TCGA-5B-A90C-01A-11D-A37Q-05 TCGA-5S-A9Q8-01 MSS TCGA-5S-A9Q8-01 TCGA-5S-A9Q8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 51 TCGA-5S-A9Q8-F64486 TCGA-5S-A9Q8 TCGA-5S-A9Q8-01A Stage IIIA NO -18785 103 0 313 YES 2014-9-4 FEMALE 162 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Excisional Biopsy 690 NO NO G2 NO true No TCGA-5S-A9Q8.3F89A501-BE16-4E08-9846-41B4BBDDFCF9.pdf A9Q8 50 0 0 YES 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO 5S 0 0 5 Endometrial A LIVING 86 2013 5eb217b7-bf79-475d-8476-a66670ad9ed2 TCGA-5S-A9Q8-01 5eb217b7-bf79-475d-8476-a66670ad9ed2 BABFB88E-883C-4766-BBBA-9EE3781212F0 5eb217b7-bf79-475d-8476-a66670ad9ed2 5eb217b7-bf79-475d-8476-a66670ad9ed2 TCGA-5S-A9Q8-01 TCGA-5S-A9Q8-01A-11D-A402-01 TCGA-5S-A9Q8-01A-11D-A402-01 TCGA-5S-A9Q8-01 TCGA-5S-A9Q8-01 TCGA-5S-A9Q8-01A-11D-A409-05 TCGA-A5-A0G1-01 MSI-H TCGA-A5-A0G1-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 14 cluster 2 TCGA-A5-A0G1 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 67 0 0 TCGA-A5-A0G1-F5839 TCGA-A5-A0G1 TCGA-A5-A0G1-01A Former User Stage IA NO -24477 5015 3251 0 NO 2011-1-7 FEMALE 168 Serous endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 190 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true No TCGA-A5-A0G1.A2EB7E85-E836-462E-ABBA-65D5110CEB1C.pdf A0G1 10 TUMOR FREE 0 0 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open NO NO YES A5 0 4 0 10 Endometrial A DECEASED 59 1996 TCGA-A5-A0G1-01 TCGA-A5-A0G1-01A-21-A162-20 CD92C224-42A7-4CC0-BBEF-FE688BE73F3E TCGA-A5-A0G1-01 c4bc1759-7de2-427c-a936-431f343ea929 TCGA-A5-A0G1-01A-11D-A120-01 TCGA-A5-A0G1-01A-11D-A120-01 TCGA-A5-A0G1-01 TCGA-A5-A0G1-01 TCGA-A5-A0G1-01A-11D-A123-05 c4bc1759-7de2-427c-a936-431f343ea929 TCGA-A5-A0G2-01 MSI-L TCGA-A5-A0G2-01 GBM C6-UCEC BRCA CIMP c7 cluster 1 BRCA basal-like c6 UCEC-like c11 miRNA cluster 13 cluster 2 TCGA-A5-A0G2 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 0 0 TCGA-A5-A0G2-F17136 TCGA-A5-A0G2 TCGA-A5-A0G2-01A Never Used Stage IIIB NO -20953 4825 0 4549 4144 NO Scheduled Follow-up Submission 2011-11-3 FEMALE 152 Serous endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 200 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A0G2.A3CD42AF-D356-415B-958D-D14D7AC52693.pdf A0G2 WITH TUMOR 0 0 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open NO NO YES A5 0 0 0 0 Endometrial A LIVING 60 1997 TCGA-A5-A0G2-01 TCGA-A5-A0G2-01 TCGA-A5-A0G2-01A-21-A162-20 F1E8AA4E-0F31-4476-8BE4-4284B284CC3A TCGA-A5-A0G2-01 TCGA-A5-A0G2-01 TCGA-A5-A0G2-01 4b998fee-a0c6-4039-824f-e5f43d5a3dbc TCGA-A5-A0G2-01A-11D-A042-01 TCGA-A5-A0G2-01A-11R-A040-07 TCGA-A5-A0G2-01A-11D-A042-01 TCGA-A5-A0G2-01 TCGA-A5-A0G2-01A-11D-A039-05 4b998fee-a0c6-4039-824f-e5f43d5a3dbc TCGA-A5-A0G3-01 MSS TCGA-A5-A0G3-01 C6-UCEC UCEC Serous c4 cluster 3 KIRC-like c1 UCEC-like c11 miRNA cluster 15 cluster 2 mutation cluster 5 TCGA-A5-A0G3 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Progressive Disease 61 2 0 TCGA-A5-A0G3-F16785 TCGA-A5-A0G3 TCGA-A5-A0G3-01A Former User Stage IIIC2 NO -22421 987 0 1428 795 NO Additional New Tumor Event 2011-10-3 FEMALE 165 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 230 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A0G3.66DEDB33-CA2C-4967-8074-1EFC1FC3CF29.pdf A0G3 50 WITH TUMOR 2 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open YES NO YES A5 2 2 2 3 Endometrial A LIVING 64 2007 TCGA-A5-A0G3-01 TCGA-A5-A0G3-01 TCGA-A5-A0G3-01A-21-A162-20 86CC5EF9-0D7D-4187-8002-CC774C70EEB1 TCGA-A5-A0G3-01 TCGA-A5-A0G3-01A-11W-A062-09 TCGA-A5-A0G3-01A-11W-A062-09 TCGA-A5-A0G3-01A-11W-A062-09 TCGA-A5-A0G3-01 cf384574-5895-4708-b29c-6906de020406 TCGA-A5-A0G3-01A-11R-A040-07 TCGA-A5-A0G3-01A-11D-A039-05 cf384574-5895-4708-b29c-6906de020406 TCGA-A5-A0G5-01 MSI-L TCGA-A5-A0G5-01 High C6-UCEC UCEC non-CIMP c3 cluster 2 BRCA basal-like c6 UCEC-like c11 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-A5-A0G5 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 73 0 0 TCGA-A5-A0G5-F17153 TCGA-A5-A0G5 TCGA-A5-A0G5-01A Never Used Stage IB NO -26827 856 0 1126 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 160 Serous endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8310/3 C54.1 YES Office Endometrial Biopsy 240 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A0G5.C7C6ABB1-32EE-4D2B-898A-91A1F596EC53.pdf A0G5 negative TUMOR FREE 0 0 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open NO NO YES A5 0 9 0 21 Endometrial A LIVING 48 2008 TCGA-A5-A0G5-01 TCGA-A5-A0G5-01 TCGA-A5-A0G5-01A-21-A162-20 105C061D-B8CC-4224-BA49-BBB94112091E TCGA-A5-A0G5-01 TCGA-A5-A0G5-01 TCGA-A5-A0G5-01A-11W-A062-09 TCGA-A5-A0G5-01A-11W-A062-09 TCGA-A5-A0G5-01A-11W-A062-09 TCGA-A5-A0G5-01 a7ed680c-2af2-47a1-846a-2169f7dd0971 TCGA-A5-A0G5-01A-11D-A042-01 TCGA-A5-A0G5-01A-11R-A040-07 TCGA-A5-A0G5-01A-11D-A042-01 TCGA-A5-A0G5-01 TCGA-A5-A0G5-01A-11D-A039-05 a7ed680c-2af2-47a1-846a-2169f7dd0971 TCGA-A5-A0G9-01 MSI-H TCGA-A5-A0G9-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-A5-A0G9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 79 0 0 TCGA-A5-A0G9-F17142 TCGA-A5-A0G9 TCGA-A5-A0G9-01A Never Used Stage IB NO -29122 2095 0 2540 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 172 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 210 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A0G9.32FB682E-B73F-4525-A845-7F240F9F40CE.pdf A0G9 70 negative TUMOR FREE 0 0 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES A5 0 5 0 7 Endometrial A LIVING 82 2004 TCGA-A5-A0G9-01 TCGA-A5-A0G9-01 TCGA-A5-A0G9-01A-21-A162-20 807AC87F-D82C-4F87-8014-4414E40D4A0B TCGA-A5-A0G9-01 TCGA-A5-A0G9-01A-11W-A062-09 TCGA-A5-A0G9-01A-11W-A062-09 TCGA-A5-A0G9-01A-11W-A062-09 4575ca5e-968c-419d-9707-4e99d55dddb7 TCGA-A5-A0G9-01A-11D-A042-01 TCGA-A5-A0G9-01A-11D-A042-01 TCGA-A5-A0G9-01 TCGA-A5-A0G9-01A-11D-A039-05 4575ca5e-968c-419d-9707-4e99d55dddb7 TCGA-A5-A0GA-01 MSI-H TCGA-A5-A0GA-01 Iq C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 4 cluster 2 mutation cluster 1 TCGA-A5-A0GA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 67 0 3 TCGA-A5-A0GA-F3146 TCGA-A5-A0GA TCGA-A5-A0GA-01A Former User Stage IIIC2 NO -24659 1312 543 0 NO 2010-9-13 FEMALE 170 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 320 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true No TCGA-A5-A0GA.36A4F391-2F46-4896-8E53-223202E42A38.pdf A0GA 46 WITH TUMOR 0 3 1 Partial Remission/Response Never Used NO R0 Primary Tumor 01 open YES NO YES A5 3 3 3 3 Endometrial A DECEASED 90 2006 TCGA-A5-A0GA-01 TCGA-A5-A0GA-01 TCGA-A5-A0GA-01A-21-A162-20 4FCEC56D-45CE-420A-868B-3726F1CC9347 TCGA-A5-A0GA-01 TCGA-A5-A0GA-01 TCGA-A5-A0GA-01A-11W-A062-09 TCGA-A5-A0GA-01A-11W-A062-09 TCGA-A5-A0GA-01A-11W-A062-09 TCGA-A5-A0GA-01 e2aee7fd-1c60-471a-931d-878805f4a443 TCGA-A5-A0GA-01A-11D-A042-01 TCGA-A5-A0GA-01A-11R-A040-07 TCGA-A5-A0GA-01A-11D-A042-01 TCGA-A5-A0GA-01 TCGA-A5-A0GA-01A-11D-A039-05 e2aee7fd-1c60-471a-931d-878805f4a443 TCGA-A5-A0GB-01 MSI-H TCGA-A5-A0GB-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 mutation cluster 11 TCGA-A5-A0GB TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 65 0 0 TCGA-A5-A0GB-F17157 TCGA-A5-A0GB TCGA-A5-A0GB-01A Never Used Stage IB NO -23883 583 0 997 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 165 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 190 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A0GB.8AC80DBE-46DE-46D5-B900-C807CBE941A6.pdf A0GB TUMOR FREE 0 0 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1995 NO NO YES A5 0 10 0 5 Endometrial A LIVING 122 2008 TCGA-A5-A0GB-01 TCGA-A5-A0GB-01A-21-A162-20 3E2E3076-D429-48E0-8EB2-4021717BEDB3 TCGA-A5-A0GB-01 TCGA-A5-A0GB-01A-11W-A062-09 TCGA-A5-A0GB-01A-11W-A062-09 TCGA-A5-A0GB-01A-11W-A062-09 TCGA-A5-A0GB-01 TCGA-A5-A0GB-01 12960b87-9d83-41e5-8980-a1ebe955fd73 TCGA-A5-A0GB-01A-11D-A042-01 TCGA-A5-A0GB-01A-11R-A040-07 TCGA-A5-A0GB-01A-11D-A042-01 TCGA-A5-A0GB-01 TCGA-A5-A0GB-01 TCGA-A5-A0GB-01A-11D-A039-05 12960b87-9d83-41e5-8980-a1ebe955fd73 TCGA-A5-A0GD-01 MSI-H TCGA-A5-A0GD-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-A5-A0GD TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 75 0 0 TCGA-A5-A0GD-F17139 TCGA-A5-A0GD TCGA-A5-A0GD-01A Never Used Stage IA NO -27399 4119 3423 0 98 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 170 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-A5-A0GD.44561792-F2F8-42F7-B697-5D7752F8430E.pdf A0GD negative TUMOR FREE 0 0 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES A5 0 3 0 9 Endometrial A DECEASED 74 1999 TCGA-A5-A0GD-01 TCGA-A5-A0GD-01 TCGA-A5-A0GD-01A-21-A162-20 F1A29822-A75F-46F5-ACAD-6A8C99D7B543 TCGA-A5-A0GD-01 TCGA-A5-A0GD-01A-11W-A062-09 TCGA-A5-A0GD-01A-11W-A062-09 TCGA-A5-A0GD-01A-11W-A062-09 7e36dab1-7cb0-42df-acfc-615f7c0bba2c TCGA-A5-A0GD-01A-11D-A042-01 TCGA-A5-A0GD-01A-11D-A042-01 TCGA-A5-A0GD-01 TCGA-A5-A0GD-01A-11D-A039-05 7e36dab1-7cb0-42df-acfc-615f7c0bba2c TCGA-A5-A0GE-01 MSS TCGA-A5-A0GE-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 14 TCGA-A5-A0GE TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 38 0 0 TCGA-A5-A0GE-F17140 TCGA-A5-A0GE TCGA-A5-A0GE-01A Never Used Stage IA NO -14170 2941 0 3205 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 155 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 200 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G2 NO true No TCGA-A5-A0GE.7686A445-554F-43EF-BE79-6EA5E5C4DB21.pdf A0GE TUMOR FREE 0 0 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open NO NO YES A5 0 5 0 3 Endometrial A LIVING 57 2002 TCGA-A5-A0GE-01 TCGA-A5-A0GE-01 TCGA-A5-A0GE-01A-21-A162-20 CFFA7BD4-5310-4035-8ADA-943D90FC2344 TCGA-A5-A0GE-01 TCGA-A5-A0GE-01 TCGA-A5-A0GE-01A-11W-A062-09 TCGA-A5-A0GE-01A-11W-A062-09 TCGA-A5-A0GE-01A-11W-A062-09 TCGA-A5-A0GE-01 34294f7a-7f80-443c-854e-5fe22b4391e0 TCGA-A5-A0GE-01A-11D-A042-01 TCGA-A5-A0GE-01A-11R-A040-07 TCGA-A5-A0GE-01A-11D-A042-01 TCGA-A5-A0GE-01 TCGA-A5-A0GE-01A-11D-A039-05 34294f7a-7f80-443c-854e-5fe22b4391e0 TCGA-A5-A0GG-01 MSI-H TCGA-A5-A0GG-01 BRCA-LUAD+ C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 TCGA-A5-A0GG TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 76 0 0 TCGA-A5-A0GG-F61693 TCGA-A5-A0GG TCGA-A5-A0GG-01A Never Used Stage IA NO -27809 2369 0 3762 NO Scheduled Follow-up Submission 2014-7-7 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 220 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-A5-A0GG.6867E576-1020-41D7-BC18-25160FE17F81.pdf A0GG 10 TUMOR FREE 0 0 NO 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO NO YES A5 0 2 0 13 Endometrial A LIVING 64 2003 TCGA-A5-A0GG-01 TCGA-A5-A0GG-01A-21-A163-20 B9DA4BE2-52B2-4824-A299-8E0D9B3E91E4 TCGA-A5-A0GG-01 88e9cdc4-bcf1-49e9-8965-7dc6b3688585 TCGA-A5-A0GG-01A-11D-A120-01 TCGA-A5-A0GG-01A-11D-A120-01 TCGA-A5-A0GG-01 TCGA-A5-A0GG-01 TCGA-A5-A0GG-01A-11D-A123-05 88e9cdc4-bcf1-49e9-8965-7dc6b3688585 TCGA-A5-A0GH-01 MSI-H TCGA-A5-A0GH-01 Quiet C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 COADREAD-like c15 miRNA cluster 13 cluster 2 mutation c1uster 10 TCGA-A5-A0GH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 0 0 TCGA-A5-A0GH-F17143 TCGA-A5-A0GH TCGA-A5-A0GH-01A Former User Stage IA NO -21090 2256 0 2254 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 163 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 230 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A0GH.8E29A939-5581-4176-B19E-14076F17726B.pdf A0GH 33 TUMOR FREE 0 0 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES A5 0 0 Endometrial A LIVING 55 2004 TCGA-A5-A0GH-01 TCGA-A5-A0GH-01 TCGA-A5-A0GH-01A-11-A162-20 0893B82F-1B83-470D-B60F-6200E66E10F7 TCGA-A5-A0GH-01 TCGA-A5-A0GH-01 TCGA-A5-A0GH-01A-21W-A062-09 TCGA-A5-A0GH-01A-21W-A062-09 TCGA-A5-A0GH-01A-21W-A062-09 TCGA-A5-A0GH-01 ec3e03af-251e-497f-8cb4-b05816df2e12 TCGA-A5-A0GH-01A-21D-A042-01 TCGA-A5-A0GH-01A-21R-A040-07 TCGA-A5-A0GH-01A-21D-A042-01 TCGA-A5-A0GH-01 TCGA-A5-A0GH-01A-21D-A039-05 ec3e03af-251e-497f-8cb4-b05816df2e12 TCGA-A5-A0GI-01 MSI-H TCGA-A5-A0GI-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 4 TCGA-A5-A0GI TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 0 0 TCGA-A5-A0GI-F53353 TCGA-A5-A0GI TCGA-A5-A0GI-01A Never Used Stage IA NO -23195 1779 0 2682 NO 2013-12-11 FEMALE 168 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 130 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true Yes TCGA-A5-A0GI.F1D23669-8247-4727-8D38-BD444C16FAAE.pdf A0GI 19 TUMOR FREE 0 0 NO 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1988 NO NO YES A5 0 1 0 6 Endometrial A LIVING 66 2005 TCGA-A5-A0GI-01 TCGA-A5-A0GI-01 TCGA-A5-A0GI-01A-21-A162-20 604B177E-903C-4CC5-AE62-6E473FF21EAF TCGA-A5-A0GI-01 TCGA-A5-A0GI-01A-11W-A062-09 TCGA-A5-A0GI-01A-11W-A062-09 ccf469e7-f403-4661-b5c4-e3ea020901b5 TCGA-A5-A0GI-01A-11D-A042-01 TCGA-A5-A0GI-01A-11D-A042-01 TCGA-A5-A0GI-01 TCGA-A5-A0GI-01A-11D-A039-05 ccf469e7-f403-4661-b5c4-e3ea020901b5 TCGA-A5-A0GJ-01 MSS TCGA-A5-A0GJ-01 High C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-A5-A0GJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO YES Complete Response 44 0 0 TCGA-A5-A0GJ-F17144 TCGA-A5-A0GJ TCGA-A5-A0GJ-01A Former User Stage IA NO 12 -16421 1708 0 2000 12 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 220 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-A5-A0GJ.83743C19-A9FF-42F0-947E-5697709151C5.pdf A0GJ 0 TUMOR FREE 0 0 1 Complete Remission/Response Never Used NO Surgical Resection R0 R0 Primary Tumor 01 open YES NO YES A5 0 3 0 4 Endometrial A LIVING 115 2005 TCGA-A5-A0GJ-01 TCGA-A5-A0GJ-01 TCGA-A5-A0GJ-01A-21-A162-20 AE211CF8-6F17-463C-9F5F-DC177FA3C373 TCGA-A5-A0GJ-01 TCGA-A5-A0GJ-01A-11W-A062-09 TCGA-A5-A0GJ-01A-11W-A062-09 TCGA-A5-A0GJ-01A-11W-A062-09 2b483617-1fc6-4809-b15c-d48d687ca3b8 TCGA-A5-A0GJ-01A-11D-A042-01 TCGA-A5-A0GJ-01A-11D-A042-01 TCGA-A5-A0GJ-01 TCGA-A5-A0GJ-01A-11D-A039-05 2b483617-1fc6-4809-b15c-d48d687ca3b8 TCGA-A5-A0GM-01 MSS TCGA-A5-A0GM-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-A5-A0GM TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 0 0 TCGA-A5-A0GM-F17150 TCGA-A5-A0GM TCGA-A5-A0GM-01A Former User Stage IA NO -19452 1518 0 1841 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 360 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true Yes TCGA-A5-A0GM.4AAFF034-45D3-4F4F-A283-262BA641D03A.pdf A0GM 49 TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES A5 0 0 0 5 Endometrial A LIVING 97 2006 TCGA-A5-A0GM-01 TCGA-A5-A0GM-01 TCGA-A5-A0GM-01A-21-A162-20 2245E2D9-A240-4577-A231-7034D705CF82 TCGA-A5-A0GM-01 TCGA-A5-A0GM-01 TCGA-A5-A0GM-01A-11W-A062-09 TCGA-A5-A0GM-01A-11W-A062-09 TCGA-A5-A0GM-01A-11W-A062-09 TCGA-A5-A0GM-01 75da1901-49d7-4a96-b195-6e38625898e5 TCGA-A5-A0GM-01A-11D-A042-01 TCGA-A5-A0GM-01A-11R-A040-07 TCGA-A5-A0GM-01A-11D-A042-01 TCGA-A5-A0GM-01 TCGA-A5-A0GM-01A-11D-A039-05 75da1901-49d7-4a96-b195-6e38625898e5 TCGA-A5-A0GN-01 MSS TCGA-A5-A0GN-01 BRCA-LUAD+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 mutation cluster 4 TCGA-A5-A0GN TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 65 0 0 TCGA-A5-A0GN-F17151 TCGA-A5-A0GN TCGA-A5-A0GN-01A Never Used Stage IB NO -24020 1354 0 1841 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 164 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 340 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-A5-A0GN.7A76BDC7-62D9-4A8D-AAEF-CECF9F819D58.pdf A0GN 56 TUMOR FREE 0 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open NO NO YES A5 0 0 0 5 Endometrial A LIVING 68 2006 TCGA-A5-A0GN-01 TCGA-A5-A0GN-01A-21-A162-20 5622D6D1-DC8D-41EC-9088-6ADA060749C4 TCGA-A5-A0GN-01A-11W-A062-09 TCGA-A5-A0GN-01A-11W-A062-09 TCGA-A5-A0GN-01A-11W-A062-09 TCGA-A5-A0GN-01 53a3dd36-866d-4c44-9b79-b9f9564996b3 TCGA-A5-A0GN-01A-11D-A042-01 TCGA-A5-A0GN-01A-11D-A042-01 TCGA-A5-A0GN-01 TCGA-A5-A0GN-01 TCGA-A5-A0GN-01A-11D-A039-05 53a3dd36-866d-4c44-9b79-b9f9564996b3 TCGA-A5-A0GP-01 MSS TCGA-A5-A0GP-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c11 miRNA cluster 13 cluster 3 mutation cluster 11 TCGA-A5-A0GP TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 0 0 TCGA-A5-A0GP-F17152 TCGA-A5-A0GP TCGA-A5-A0GP-01A Never Used Stage IA NO -21365 1030 0 1416 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 160 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-A5-A0GP.A730192C-227E-4A86-96B9-8670D3F5EF59.pdf A0GP TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES A5 0 1 0 1 Endometrial A LIVING 60 2007 TCGA-A5-A0GP-01 TCGA-A5-A0GP-01 TCGA-A5-A0GP-01 TCGA-A5-A0GP-01 TCGA-A5-A0GP-01A-11W-A062-09 TCGA-A5-A0GP-01A-11W-A062-09 TCGA-A5-A0GP-01 0ac50ce8-8c72-4b83-98c3-6efdb138d7a1 TCGA-A5-A0GP-01A-11D-A042-01 TCGA-A5-A0GP-01A-11R-A040-07 TCGA-A5-A0GP-01A-11D-A042-01 TCGA-A5-A0GP-01 TCGA-A5-A0GP-01A-11D-A039-05 0ac50ce8-8c72-4b83-98c3-6efdb138d7a1 TCGA-A5-A0GQ-01 MSS TCGA-A5-A0GQ-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 12 TCGA-A5-A0GQ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 76 TCGA-A5-A0GQ-F51570 TCGA-A5-A0GQ TCGA-A5-A0GQ-01A Never Used Stage IB NO -28078 1022 0 2247 NO 2013-11-26 FEMALE 150 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 140 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-A5-A0GQ.7B57FD81-AA42-4C76-BF65-0BA2B3451065.pdf A0GQ 50 TUMOR FREE 0 0 NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES A5 0 0 2 Endometrial A LIVING 57 2007 TCGA-A5-A0GQ-01 TCGA-A5-A0GQ-01A-21-A162-20 35256B27-92B1-4905-9571-7269212E85A6 TCGA-A5-A0GQ-01A-11D-A122-09 TCGA-A5-A0GQ-01A-11D-A122-09 TCGA-A5-A0GQ-01A-11D-A122-09 TCGA-A5-A0GQ-01 2386cca4-1d9d-490e-b188-c0e266952a5f TCGA-A5-A0GQ-01A-11D-A120-01 TCGA-A5-A0GQ-01A-11D-A120-01 TCGA-A5-A0GQ-01 TCGA-A5-A0GQ-01 TCGA-A5-A0GQ-01A-11D-A123-05 2386cca4-1d9d-490e-b188-c0e266952a5f TCGA-A5-A0GR-01 MSS TCGA-A5-A0GR-01 Squamous C6-UCEC Cluster 5 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 TCGA-A5-A0GR TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 69 0 0 TCGA-A5-A0GR-F17155 TCGA-A5-A0GR TCGA-A5-A0GR-01A Never Used Stage IA NO -25353 632 0 1120 YES Scheduled Follow-up Submission 2011-10-3 FEMALE 177 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 160 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-A5-A0GR.009B5049-74B7-49B8-8B64-28184A3ACA2B.pdf A0GR 10 TUMOR FREE 0 0 1 Complete Remission/Response Former User NO R0 Primary Tumor 01 open NO NO YES A5 0 3 0 0 Endometrial A LIVING 88 2008 TCGA-A5-A0GR-01 TCGA-A5-A0GR-01A-21-A162-20 2F6C92AF-8F69-4F30-B8DD-D752A11DF831 TCGA-A5-A0GR-01 10b2b797-1ddd-4ef8-b0e7-38f96fb06f57 TCGA-A5-A0GR-01A-11D-A120-01 TCGA-A5-A0GR-01A-11D-A120-01 TCGA-A5-A0GR-01 TCGA-A5-A0GR-01 TCGA-A5-A0GR-01A-11D-A123-05 10b2b797-1ddd-4ef8-b0e7-38f96fb06f57 TCGA-A5-A0GU-01 MSS TCGA-A5-A0GU-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 14 TCGA-A5-A0GU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 0 0 TCGA-A5-A0GU-F17158 TCGA-A5-A0GU TCGA-A5-A0GU-01A Never Used Stage IA NO -21192 471 0 860 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 190 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-A5-A0GU.B284E409-4AC1-45E5-9133-39659987D7F9.pdf A0GU 18 TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES A5 0 0 0 10 Endometrial A LIVING 95 2009 TCGA-A5-A0GU-01 TCGA-A5-A0GU-01 TCGA-A5-A0GU-01A-21-A162-20 5BD1CBD7-EF39-4774-8A6A-3BADD82989F0 TCGA-A5-A0GU-01 TCGA-A5-A0GU-01 TCGA-A5-A0GU-01A-11W-A062-09 TCGA-A5-A0GU-01A-11W-A062-09 TCGA-A5-A0GU-01A-11W-A062-09 TCGA-A5-A0GU-01 95ea81fa-025d-4338-94db-ec7024562d8f TCGA-A5-A0GU-01A-11D-A042-01 TCGA-A5-A0GU-01A-11R-A040-07 TCGA-A5-A0GU-01A-11D-A042-01 TCGA-A5-A0GU-01 TCGA-A5-A0GU-01A-11D-A039-05 95ea81fa-025d-4338-94db-ec7024562d8f TCGA-A5-A0GV-01 MSS TCGA-A5-A0GV-01 BRCA-LUAD+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 4 TCGA-A5-A0GV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES NO Complete Response 67 TCGA-A5-A0GV-F61694 TCGA-A5-A0GV TCGA-A5-A0GV-01A Former User Stage IA NO -24540 454 0 1643 304 NO Scheduled Follow-up Submission 2014-7-7 FEMALE 158 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 330 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-A5-A0GV.0E6417D3-6E95-4EEF-AE93-40D69D4F6525.pdf A0GV negative TUMOR FREE 0 0 NO 4+ Complete Remission/Response Never Used NO Other Method, Specify Below Locoregional R0 Primary Tumor 01 open 1988 NO NO YES A5 0 0 21 Endometrial A LIVING 63 2009 TCGA-A5-A0GV-01 TCGA-A5-A0GV-01 TCGA-A5-A0GV-01A-21-A162-20 C86E0866-3F2C-4364-91F3-BA8602F13866 TCGA-A5-A0GV-01 TCGA-A5-A0GV-01A-31W-A062-09 TCGA-A5-A0GV-01A-31W-A062-09 TCGA-A5-A0GV-01A-31W-A062-09 e1c80dfd-3db5-4005-9bb5-245124d4dc0f TCGA-A5-A0GV-01A-31D-A042-01 TCGA-A5-A0GV-01A-31D-A042-01 TCGA-A5-A0GV-01 TCGA-A5-A0GV-01A-31D-A039-05 e1c80dfd-3db5-4005-9bb5-245124d4dc0f TCGA-A5-A0GW-01 MSI-H TCGA-A5-A0GW-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 4 mutation cluster 2 TCGA-A5-A0GW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 46 0 0 TCGA-A5-A0GW-F17162 TCGA-A5-A0GW TCGA-A5-A0GW-01A Never Used Stage IA NO -17092 302 0 706 YES Scheduled Follow-up Submission 2011-10-3 FEMALE 142 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 160 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A0GW.0EE4FD56-D0BA-43E8-A434-CD86B21F21BF.pdf A0GW 7 TUMOR FREE 0 0 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open NO NO YES A5 0 5 0 4 Endometrial A LIVING 49 2009 TCGA-A5-A0GW-01 TCGA-A5-A0GW-01 TCGA-A5-A0GW-01A-21-A162-20 F6BCE3D4-F521-491C-AE2E-978BD90B9CAD TCGA-A5-A0GW-01 TCGA-A5-A0GW-01A-11W-A062-09 TCGA-A5-A0GW-01A-11W-A062-09 TCGA-A5-A0GW-01A-11W-A062-09 1e4969e5-6bf8-4b8d-970e-96f4424356a8 TCGA-A5-A0GW-01A-11D-A042-01 TCGA-A5-A0GW-01A-11D-A042-01 TCGA-A5-A0GW-01 TCGA-A5-A0GW-01A-11D-A039-05 1e4969e5-6bf8-4b8d-970e-96f4424356a8 TCGA-A5-A0GX-01 MSS TCGA-A5-A0GX-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 4 TCGA-A5-A0GX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 0 0 TCGA-A5-A0GX-F17145 TCGA-A5-A0GX TCGA-A5-A0GX-01A Never Used Stage IA NO -19625 1654 0 2088 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 164 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 250 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-A5-A0GX.AE5229ED-8906-4D55-9B11-4E8E214D6446.pdf A0GX 10 TUMOR FREE 0 0 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open NO NO YES A5 0 0 0 0 Endometrial A LIVING 108 2005 TCGA-A5-A0GX-01 TCGA-A5-A0GX-01 TCGA-A5-A0GX-01A-21-A162-20 8ABB876D-F6CD-4120-9949-8AA46323B51B TCGA-A5-A0GX-01 TCGA-A5-A0GX-01A-11W-A062-09 TCGA-A5-A0GX-01A-11W-A062-09 TCGA-A5-A0GX-01A-11W-A062-09 d98e99e1-ee3e-4427-90ec-24e624aa1b46 TCGA-A5-A0GX-01A-11D-A042-01 TCGA-A5-A0GX-01A-11D-A042-01 TCGA-A5-A0GX-01 TCGA-A5-A0GX-01A-11D-A039-05 d98e99e1-ee3e-4427-90ec-24e624aa1b46 TCGA-A5-A0R6-01 MSS TCGA-A5-A0R6-01 Squamous C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 2 mutation cluster 3 TCGA-A5-A0R6 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 0 TCGA-A5-A0R6-F64187 TCGA-A5-A0R6 TCGA-A5-A0R6-01A Never Used Stage IIIC1 YES -23449 259 0 1153 961 961 NO Scheduled Follow-up Submission 2014-8-27 FEMALE 157 Serous endometrial adenocarcinoma No NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 200 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify New Primary Tumor Rectum YES YES true No TCGA-A5-A0R6.2F8BAD18-8A37-4F1A-A1BA-31494035E05F.pdf A0R6 82 TUMOR FREE 0 1 YES 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO YES A5 0 3 1 17 Endometrial A LIVING 68 2009 TCGA-A5-A0R6-01 TCGA-A5-A0R6-01 TCGA-A5-A0R6-01A-21-A163-20 353D2D07-37FD-40EC-9D30-D608AB218149 TCGA-A5-A0R6-01 TCGA-A5-A0R6-01A-11D-A10B-09 TCGA-A5-A0R6-01A-11D-A10B-09 TCGA-A5-A0R6-01A-11D-A10B-09 20977188-9019-4672-a435-760abd19ee5b TCGA-A5-A0R6-01A-11D-A102-01 TCGA-A5-A0R6-01A-11D-A102-01 TCGA-A5-A0R6-01 TCGA-A5-A0R6-01A-11D-A10Q-05 20977188-9019-4672-a435-760abd19ee5b TCGA-A5-A0R7-01 MSS TCGA-A5-A0R7-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 3 TCGA-A5-A0R7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 55 0 0 TCGA-A5-A0R7-F17164 TCGA-A5-A0R7 TCGA-A5-A0R7-01A Stage IA NO -20250 173 0 535 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 290 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-A5-A0R7.3BBA7591-082A-44CE-829F-23D16A91772D.pdf A0R7 40 TUMOR FREE 0 0 0 Complete Remission/Response NO R0 Primary Tumor 01 open NO NO YES A5 0 8 0 8 Endometrial A LIVING 136 2010 TCGA-A5-A0R7-01 TCGA-A5-A0R7-01 TCGA-A5-A0R7-01A-21-A162-20 819982FF-44F4-47CA-8897-9718955ECA98 TCGA-A5-A0R7-01 TCGA-A5-A0R7-01A-31D-A10B-09 TCGA-A5-A0R7-01A-31D-A10B-09 TCGA-A5-A0R7-01A-31D-A10B-09 0824e6ac-f3f0-4b71-81a3-7ee671a256eb TCGA-A5-A0R7-01A-31D-A102-01 TCGA-A5-A0R7-01A-31D-A102-01 TCGA-A5-A0R7-01 TCGA-A5-A0R7-01A-31D-A10Q-05 0824e6ac-f3f0-4b71-81a3-7ee671a256eb TCGA-A5-A0R8-01 MSS TCGA-A5-A0R8-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-A5-A0R8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES YES Complete Response 81 0 0 TCGA-A5-A0R8-F17165 TCGA-A5-A0R8 TCGA-A5-A0R8-01A Never Used Stage IB NO 66 -29777 155 0 596 42 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 160 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 180 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-A5-A0R8.CA537524-B83F-4AC5-B721-38570E5B21BB.pdf A0R8 57 TUMOR FREE 0 0 0 Complete Remission/Response Never Used YES Surgical Resection R0 R0 Primary Tumor 01 open NO NO YES A5 0 0 0 7 Endometrial A LIVING 62 2010 TCGA-A5-A0R8-01 TCGA-A5-A0R8-01 TCGA-A5-A0R8-01A-21-A163-20 9C6EC7CC-4E83-4DE9-B194-F83829765C1D TCGA-A5-A0R8-01 TCGA-A5-A0R8-01A-11D-A10B-09 TCGA-A5-A0R8-01A-11D-A10B-09 TCGA-A5-A0R8-01A-11D-A10B-09 414c904a-29d0-44d0-bceb-ce7d024f1a58 TCGA-A5-A0R8-01A-11D-A102-01 TCGA-A5-A0R8-01A-11D-A102-01 TCGA-A5-A0R8-01 TCGA-A5-A0R8-01A-11D-A10Q-05 414c904a-29d0-44d0-bceb-ce7d024f1a58 TCGA-A5-A0R9-01 MSS TCGA-A5-A0R9-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-A5-A0R9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 51 0 0 TCGA-A5-A0R9-F17161 TCGA-A5-A0R9 TCGA-A5-A0R9-01A Never Used Stage IA NO -18982 471 0 749 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 270 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-A5-A0R9.0AAD58D4-7865-4235-AE18-8685DC5F4FE1.pdf A0R9 49 TUMOR FREE 0 0 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1995 NO NO YES A5 0 0 0 4 Endometrial A LIVING 145 2009 TCGA-A5-A0R9-01 TCGA-A5-A0R9-01 TCGA-A5-A0R9-01A-21-A163-20 3B00EFD8-7548-464C-879B-67DA5D69F15C TCGA-A5-A0R9-01 TCGA-A5-A0R9-01A-11D-A10B-09 TCGA-A5-A0R9-01A-11D-A10B-09 TCGA-A5-A0R9-01A-11D-A10B-09 d4ab800e-e0c4-40ae-8256-7271d22d1470 TCGA-A5-A0R9-01A-11D-A102-01 TCGA-A5-A0R9-01A-11D-A102-01 TCGA-A5-A0R9-01 TCGA-A5-A0R9-01A-11D-A10Q-05 d4ab800e-e0c4-40ae-8256-7271d22d1470 TCGA-A5-A0RA-01 MSS TCGA-A5-A0RA-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 mutation cluster 4 TCGA-A5-A0RA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 0 0 TCGA-A5-A0RA-F17160 TCGA-A5-A0RA TCGA-A5-A0RA-01A Never Used Stage IB NO -25060 492 0 884 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 155 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 270 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-A5-A0RA.EB6E4309-9CE1-468A-A94B-907874BDE9DE.pdf A0RA 75 TUMOR FREE 0 0 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open NO NO YES A5 0 0 0 6 Endometrial A LIVING 113 2009 TCGA-A5-A0RA-01 TCGA-A5-A0RA-01 TCGA-A5-A0RA-01A-11-A163-20 83A77885-4D57-487B-AE02-BB38572E0E44 TCGA-A5-A0RA-01 TCGA-A5-A0RA-01A-21D-A10B-09 TCGA-A5-A0RA-01A-21D-A10B-09 TCGA-A5-A0RA-01A-21D-A10B-09 7a051ecb-ad2d-4c98-8b91-96b66110a46e TCGA-A5-A0RA-01A-21D-A102-01 TCGA-A5-A0RA-01A-21D-A102-01 TCGA-A5-A0RA-01 TCGA-A5-A0RA-01A-21D-A10Q-05 7a051ecb-ad2d-4c98-8b91-96b66110a46e TCGA-A5-A0VO-01 MSS TCGA-A5-A0VO-01 C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 mutation cluster 1 TCGA-A5-A0VO TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 0 TCGA-A5-A0VO-F63925 TCGA-A5-A0VO TCGA-A5-A0VO-01A Former User Stage IB NO -23547 133 875 0 364 NO Scheduled Follow-up Submission 2014-8-21 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 320 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-A5-A0VO.6ABBA2C9-8920-4785-BFAB-40E560D2DBE6.pdf A0VO 64 TUMOR FREE 0 0 NO 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO NO YES A5 0 4 0 5 Endometrial A DECEASED 86 2010 TCGA-A5-A0VO-01 TCGA-A5-A0VO-01 TCGA-A5-A0VO-01A-11-A163-20 5D42C10D-E328-4165-961D-CF8EEE9EFBE1 TCGA-A5-A0VO-01 TCGA-A5-A0VO-01A-21D-A10G-09 TCGA-A5-A0VO-01A-21D-A10G-09 TCGA-A5-A0VO-01A-21D-A10G-09 b07b341a-32ba-4863-b202-6fae769d1dd2 TCGA-A5-A0VO-01A-21D-A10A-05 b07b341a-32ba-4863-b202-6fae769d1dd2 TCGA-A5-A0VP-01 MSI-H TCGA-A5-A0VP-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 mutation cluster 11 TCGA-A5-A0VP TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 74 0 0 TCGA-A5-A0VP-F17166 TCGA-A5-A0VP TCGA-A5-A0VP-01A Never Used Stage IA NO -27335 930 0 1288 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 163 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 210 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A0VP.960B26D6-F9BA-4099-B6F4-6D1DEA6C0F0F.pdf A0VP TUMOR FREE 0 0 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open NO NO YES A5 0 0 0 14 Endometrial A LIVING 58 2008 TCGA-A5-A0VP-01 TCGA-A5-A0VP-01 TCGA-A5-A0VP-01A-11-A163-20 82ADD7F4-FACD-40DF-A2F0-FAC4DCFEB876 TCGA-A5-A0VP-01 TCGA-A5-A0VP-01A-21D-A10B-09 TCGA-A5-A0VP-01A-21D-A10B-09 65e557db-24de-47df-827c-d8336cb099eb TCGA-A5-A0VP-01A-21D-A102-01 TCGA-A5-A0VP-01A-21D-A102-01 TCGA-A5-A0VP-01 TCGA-A5-A0VP-01A-21D-A10Q-05 65e557db-24de-47df-827c-d8336cb099eb TCGA-A5-A0VQ-01 MSI-H TCGA-A5-A0VQ-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 4 TCGA-A5-A0VQ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 62 0 0 TCGA-A5-A0VQ-F17167 TCGA-A5-A0VQ TCGA-A5-A0VQ-01A Stage IA NO -22995 133 0 485 NO Scheduled Follow-up Submission 2011-10-3 FEMALE 158 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 320 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A0VQ.6FE81DF0-D9DF-420F-8A91-40421175A12F.pdf A0VQ 36 TUMOR FREE 0 0 4+ Complete Remission/Response YES R0 Primary Tumor 01 open YES NO YES A5 0 12 0 12 Endometrial A LIVING 89 2010 TCGA-A5-A0VQ-01 TCGA-A5-A0VQ-01 TCGA-A5-A0VQ-01A-21-A163-20 9E0707C4-CBB5-4AFD-8528-FB9F95EC5A91 TCGA-A5-A0VQ-01 TCGA-A5-A0VQ-01A-11D-A10B-09 TCGA-A5-A0VQ-01A-11D-A10B-09 TCGA-A5-A0VQ-01A-11D-A10B-09 e8b8fe3e-29ff-4f1a-af7a-d12b8cd5560d TCGA-A5-A0VQ-01A-11D-A102-01 TCGA-A5-A0VQ-01A-11D-A102-01 TCGA-A5-A0VQ-01 TCGA-A5-A0VQ-01A-11D-A10Q-05 e8b8fe3e-29ff-4f1a-af7a-d12b8cd5560d TCGA-A5-A1OF-01 MSI-H TCGA-A5-A1OF-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 TCGA-A5-A1OF TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 47 0 0 TCGA-A5-A1OF-F53494 TCGA-A5-A1OF TCGA-A5-A1OF-01A Never Used Stage IA NO -17308 128 0 973 NO Scheduled Follow-up Submission 2013-12-14 FEMALE 155 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 210 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) High Grade NO true No TCGA-A5-A1OF.C0A753A3-5202-4DD2-948E-2921AFBCB3BC.pdf A1OF 13 TUMOR FREE 0 0 NO 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO YES NO A5 0 3 0 4 Endometrial A LIVING 70 2010 TCGA-A5-A1OF-01 TCGA-A5-A1OF-01A-21-A18Q-20 3992BB1A-39A7-456D-B706-8AD7048A3EFB TCGA-A5-A1OF-01 56fa9065-a4cd-435b-941b-d4507aef815b TCGA-A5-A1OF-01A-11D-A14F-01 TCGA-A5-A1OF-01A-11D-A14F-01 TCGA-A5-A1OF-01 TCGA-A5-A1OF-01 TCGA-A5-A1OF-01A-11D-A14H-05 56fa9065-a4cd-435b-941b-d4507aef815b TCGA-A5-A1OG-01 MSS TCGA-A5-A1OG-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 2 cluster 2 TCGA-A5-A1OG TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO NO Progressive Disease 65 0 4 TCGA-A5-A1OG-F51580 TCGA-A5-A1OG TCGA-A5-A1OG-01A Never Used Stage IIIC2 NO -23956 223 973 0 348 337 YES Scheduled Follow-up Submission 2013-11-22 FEMALE 158 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Dilation and curettage procedure 190 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Lung Metastatic NO true No TCGA-A5-A1OG.7BE01FDF-C4CF-471E-B395-8D7C4531CD6F.pdf A1OG 70 WITH TUMOR 0 3 YES 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES YES NO A5 4 4 3 3 Endometrial A DECEASED 64 2010 TCGA-A5-A1OG-01 TCGA-A5-A1OG-01A-21-A18Q-20 7B3713CB-8B91-4E9C-9DEF-EA02D94F9D64 TCGA-A5-A1OG-01 f501c084-03d5-48ad-b365-085773a7bd2d TCGA-A5-A1OG-01A-11D-A14F-01 TCGA-A5-A1OG-01A-11D-A14F-01 TCGA-A5-A1OG-01 TCGA-A5-A1OG-01 TCGA-A5-A1OG-01A-11D-A14H-05 f501c084-03d5-48ad-b365-085773a7bd2d TCGA-A5-A1OH-01 MSS TCGA-A5-A1OH-01 High UCEC Serous c4 KIRC-like c1 miRNA c1uster 9 TCGA-A5-A1OH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 86 0 0 TCGA-A5-A1OH-F41438 TCGA-A5-A1OH TCGA-A5-A1OH-01A Former User Stage IIIA NO -31451 358 0 1105 NO 2013-3-20 FEMALE 155 Serous endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 200 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A1OH.AAF1B591-1A0D-48D2-BF59-95B0D605950A.pdf A1OH 100 positive TUMOR FREE 0 0 YES 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO YES A5 0 0 0 0 Endometrial A LIVING 59 2010 303036f4-8c7a-484d-8458-8db4803ad6b5 TCGA-A5-A1OH-01 303036f4-8c7a-484d-8458-8db4803ad6b5 TCGA-A5-A1OH-01A-32-A23Z-20 CCB3C579-1FC7-43B1-8DAB-85F26E151F35 303036f4-8c7a-484d-8458-8db4803ad6b5 303036f4-8c7a-484d-8458-8db4803ad6b5 TCGA-A5-A1OH-01 TCGA-A5-A1OH-01A-21D-A227-01 TCGA-A5-A1OH-01A-21D-A227-01 TCGA-A5-A1OH-01 TCGA-A5-A1OH-01 TCGA-A5-A1OH-01A-21D-A22B-05 TCGA-A5-A1OJ-01 MSS TCGA-A5-A1OJ-01 Iq C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 TCGA-A5-A1OJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 31 TCGA-A5-A1OJ-F51584 TCGA-A5-A1OJ TCGA-A5-A1OJ-01A Former User Stage IA NO -11635 161 0 1006 NO Scheduled Follow-up Submission 2013-11-26 FEMALE 155 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 170 NO NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G2 NO true No TCGA-A5-A1OJ.F696BCE9-707C-4825-8A53-EFED20EBF656.pdf A1OJ 10 TUMOR FREE 0 0 NO 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO YES NO A5 0 0 17 Endometrial A LIVING 94 2010 TCGA-A5-A1OJ-01 TCGA-A5-A1OJ-01A-21-A18Q-20 F8816AD0-EFF9-40C9-9A73-0D95CA01B355 TCGA-A5-A1OJ-01 adddccb0-d276-4450-a8cf-aef663a6f45c TCGA-A5-A1OJ-01A-11D-A14F-01 TCGA-A5-A1OJ-01A-11D-A14F-01 TCGA-A5-A1OJ-01 TCGA-A5-A1OJ-01 TCGA-A5-A1OJ-01A-11D-A14H-05 adddccb0-d276-4450-a8cf-aef663a6f45c TCGA-A5-A1OK-01 MSS TCGA-A5-A1OK-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 5 cluster 4 TCGA-A5-A1OK TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 0 0 TCGA-A5-A1OK-F51587 TCGA-A5-A1OK TCGA-A5-A1OK-01A Former User Stage IIIA NO -23179 113 0 917 YES Scheduled Follow-up Submission 2013-11-26 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 250 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true Yes TCGA-A5-A1OK.1B0C95FC-7AA7-4F82-807D-85C579B6BF74.pdf A1OK 100 TUMOR FREE 0 0 YES 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES YES NO A5 0 3 0 13 Endometrial A LIVING 87 2010 TCGA-A5-A1OK-01 TCGA-A5-A1OK-01A-21-A18Q-20 89E5A639-E1A4-424B-9739-8A19067FFAE0 TCGA-A5-A1OK-01 f26a449d-f3c6-4968-a2f7-4708a5686707 TCGA-A5-A1OK-01A-11D-A14J-01 TCGA-A5-A1OK-01A-11D-A14J-01 TCGA-A5-A1OK-01 TCGA-A5-A1OK-01 TCGA-A5-A1OK-01A-11D-A14N-05 f26a449d-f3c6-4968-a2f7-4708a5686707 TCGA-A5-A2K2-01 MSS TCGA-A5-A2K2-01 Squamous UCEC non-CIMP c3 miRNA cluster 14 TCGA-A5-A2K2 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 77 TCGA-A5-A2K2-F51569 TCGA-A5-A2K2 TCGA-A5-A2K2-01A Former User Stage IA NO -28456 2812 0 3595 NO Scheduled Follow-up Submission 2013-11-26 FEMALE 155 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 70 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A2K2.D8065FA8-DC0E-4F1C-8FA4-5D8A567AC24C.pdf A2K2 49 TUMOR FREE 0 0 YES 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 YES NO YES A5 0 0 6 Endometrial A LIVING 50 2003 4341d180-bcb4-47e5-83b4-df5ecc4f7eec TCGA-A5-A2K2-01 4341d180-bcb4-47e5-83b4-df5ecc4f7eec 4341d180-bcb4-47e5-83b4-df5ecc4f7eec 4341d180-bcb4-47e5-83b4-df5ecc4f7eec TCGA-A5-A2K2-01 TCGA-A5-A2K2-01A-11D-A18N-01 TCGA-A5-A2K2-01A-11D-A18N-01 TCGA-A5-A2K2-01 TCGA-A5-A2K2-01 TCGA-A5-A2K2-01A-11D-A18O-05 TCGA-A5-A2K3-01 MSI-H TCGA-A5-A2K3-01 High BRCA CIMP c7 BRCA basal-like c6 miRNA cluster 5 TCGA-A5-A2K3 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 TCGA-A5-A2K3-F51572 TCGA-A5-A2K3 TCGA-A5-A2K3-01A Never Used Stage IA NO -24907 1431 0 2012 NO Scheduled Follow-up Submission 2013-11-22 FEMALE 160 Serous endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 120 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A2K3.D38D2FD4-78EF-4F49-976E-529055A6D9A9.pdf A2K3 0 TUMOR FREE 0 0 YES 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 YES NO YES A5 0 0 9 Endometrial A LIVING 80 2007 ef76bd16-f313-4d92-8040-44e7068958a7 TCGA-A5-A2K3-01 ef76bd16-f313-4d92-8040-44e7068958a7 TCGA-A5-A2K3-01A-21-A18Q-20 5DC692F2-49FA-4E7A-95C8-81D47EE698F1 ef76bd16-f313-4d92-8040-44e7068958a7 ef76bd16-f313-4d92-8040-44e7068958a7 TCGA-A5-A2K3-01 TCGA-A5-A2K3-01A-11D-A17U-01 TCGA-A5-A2K3-01A-11D-A17U-01 TCGA-A5-A2K3-01 TCGA-A5-A2K3-01 TCGA-A5-A2K3-01A-11D-A17Z-05 TCGA-A5-A2K4-01 MSI-L TCGA-A5-A2K4-01 Squamous UCEC Serous c4 UCEC-like c5 miRNA cluster 14 TCGA-A5-A2K4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO NO Complete Response 69 0 0 TCGA-A5-A2K4-F17269 TCGA-A5-A2K4 TCGA-A5-A2K4-01A Former User Stage IIIA NO -25270 849 871 0 528 NO Scheduled Follow-up Submission 2011-10-6 FEMALE 168 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Tumor resection 140 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Metastatic Bowel YES true No TCGA-A5-A2K4.CB29CD1C-584B-42EA-BF1D-11B6DF8EA756.pdf A2K4 53 WITH TUMOR 0 0 3 Complete Remission/Response Never Used NO R1 Primary Tumor 01 open 2009 YES NO YES A5 0 0 0 0 Endometrial A DECEASED 51 2009 586c18a6-7278-4200-9d64-20b2c7ccbc60 TCGA-A5-A2K4-01 586c18a6-7278-4200-9d64-20b2c7ccbc60 TCGA-A5-A2K4-01A-21-A23Z-20 D61371B8-56B1-44A5-85CD-EF1E560E4C1D 586c18a6-7278-4200-9d64-20b2c7ccbc60 586c18a6-7278-4200-9d64-20b2c7ccbc60 TCGA-A5-A2K4-01 TCGA-A5-A2K4-01A-11D-A18N-01 TCGA-A5-A2K4-01A-11D-A18N-01 TCGA-A5-A2K4-01 TCGA-A5-A2K4-01 TCGA-A5-A2K4-01A-11D-A18O-05 TCGA-A5-A2K5-01 MSS TCGA-A5-A2K5-01 Quiet UCEC CIMP c18 UCEC-like c5 miRNA c1uster 10 TCGA-A5-A2K5 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 76 TCGA-A5-A2K5-F51589 TCGA-A5-A2K5 TCGA-A5-A2K5-01A Never Used Stage IA NO -28057 171 0 752 YES Scheduled Follow-up Submission 2013-11-26 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 290 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A2K5.FF305857-5814-4815-90D3-B54BAA0DACB4.pdf A2K5 49 TUMOR FREE 0 0 NO 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO YES NO A5 0 0 4 Endometrial A LIVING 127 2011 98327e51-9e30-4d72-a4b1-19b62b4d3cd2 TCGA-A5-A2K5-01 98327e51-9e30-4d72-a4b1-19b62b4d3cd2 TCGA-A5-A2K5-01A-21-A18R-20 6074A3B3-E5D0-48BD-9877-8435B1314590 98327e51-9e30-4d72-a4b1-19b62b4d3cd2 98327e51-9e30-4d72-a4b1-19b62b4d3cd2 TCGA-A5-A2K5-01 TCGA-A5-A2K5-01A-11D-A17U-01 TCGA-A5-A2K5-01A-11D-A17U-01 TCGA-A5-A2K5-01 TCGA-A5-A2K5-01 TCGA-A5-A2K5-01A-11D-A17Z-05 TCGA-A5-A2K7-01 MSI-H TCGA-A5-A2K7-01 Quiet UCEC CIMP c18 UCEC-like c5 miRNA cluster 5 TCGA-A5-A2K7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 41 0 0 TCGA-A5-A2K7-F54486 TCGA-A5-A2K7 TCGA-A5-A2K7-01A Stage II NO -14980 195 0 1063 YES Scheduled Follow-up Submission 2013-12-23 FEMALE 157 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 170 NO NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 NO true No TCGA-A5-A2K7.1880F604-34C9-4B58-92DC-D67C7E656E3B.pdf A2K7 50 TUMOR FREE 0 0 YES 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES YES NO A5 0 7 0 11 Endometrial A LIVING 72 2011 7f9fd176-6826-4472-bf00-89632783b629 TCGA-A5-A2K7-01 7f9fd176-6826-4472-bf00-89632783b629 TCGA-A5-A2K7-01A-21-A18R-20 C088EF25-623E-416A-B21F-1AE65E1638A0 7f9fd176-6826-4472-bf00-89632783b629 7f9fd176-6826-4472-bf00-89632783b629 TCGA-A5-A2K7-01 TCGA-A5-A2K7-01A-11D-A17U-01 TCGA-A5-A2K7-01A-11D-A17U-01 TCGA-A5-A2K7-01 TCGA-A5-A2K7-01 TCGA-A5-A2K7-01A-11D-A17Z-05 TCGA-A5-A3LO-01 MSS TCGA-A5-A3LO-01 Squamous UCEC non-CIMP c3 squamous c3 miRNA cluster 5 TCGA-A5-A3LO TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 0 TCGA-A5-A3LO-F51590 TCGA-A5-A3LO TCGA-A5-A3LO-01A Stage IB NO -23401 182 0 776 NO Scheduled Follow-up Submission 2013-11-26 FEMALE 168 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 160 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A3LO.2AB1F28D-151D-4AFE-807A-9F98B48C51CE.pdf A3LO 65 negative TUMOR FREE 0 0 NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 YES YES NO A5 0 6 0 7 Endometrial A LIVING 103 2011 70a9e739-6f24-44b7-97cc-7197097a4f83 TCGA-A5-A3LO-01 70a9e739-6f24-44b7-97cc-7197097a4f83 TCGA-A5-A3LO-01A-21-A23Z-20 4E001E6E-EB22-4F46-BDF4-CEDD10AA9338 70a9e739-6f24-44b7-97cc-7197097a4f83 70a9e739-6f24-44b7-97cc-7197097a4f83 TCGA-A5-A3LO-01 TCGA-A5-A3LO-01A-11D-A227-01 TCGA-A5-A3LO-01A-11D-A227-01 TCGA-A5-A3LO-01 TCGA-A5-A3LO-01 TCGA-A5-A3LO-01A-11D-A22B-05 TCGA-A5-A3LP-01 MSS TCGA-A5-A3LP-01 High UCEC Serous c4 BRCA basal-like c6 miRNA cluster 4 TCGA-A5-A3LP TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 74 0 0 TCGA-A5-A3LP-F43459 TCGA-A5-A3LP TCGA-A5-A3LP-01A Former User Stage IB NO -27131 111 0 455 NO Scheduled Follow-up Submission 2013-5-22 FEMALE 159 Serous endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 150 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-A5-A3LP.A20CDB07-D90C-42B7-AE0A-254E27C6153B.pdf A3LP 90 negative TUMOR FREE 0 0 YES 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES YES NO A5 0 0 0 6 Endometrial A LIVING 46 2011 5359ca45-0d86-43b9-b318-adbee53c7381 TCGA-A5-A3LP-01 5359ca45-0d86-43b9-b318-adbee53c7381 TCGA-A5-A3LP-01A-21-A23Z-20 90E488D4-EABB-4A2B-9BA4-B669167D24A6 5359ca45-0d86-43b9-b318-adbee53c7381 5359ca45-0d86-43b9-b318-adbee53c7381 TCGA-A5-A3LP-01 TCGA-A5-A3LP-01A-11D-A227-01 TCGA-A5-A3LP-01A-11D-A227-01 TCGA-A5-A3LP-01 TCGA-A5-A3LP-01 TCGA-A5-A3LP-01A-11D-A22B-05 TCGA-A5-A7WJ-01 MSI-H TCGA-A5-A7WJ-01 TCGA-A5-A7WJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 0 TCGA-A5-A7WJ-F64296 TCGA-A5-A7WJ TCGA-A5-A7WJ-01A Never Used Stage IA NO -23723 439 0 341 NO 2014-8-28 FEMALE 170 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 140 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-A5-A7WJ.402A6ED4-B9EC-43A0-B47C-A0B95282678D.pdf A7WJ 39 negative TUMOR FREE 0 0 NO 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO A5 0 3 0 2 Endometrial A LIVING 64 2012 382f8e3e-6414-4bfd-81de-fa4260be7ede TCGA-A5-A7WJ-01 382f8e3e-6414-4bfd-81de-fa4260be7ede E76A6335-F295-4BB2-B04E-4B69A461837C 382f8e3e-6414-4bfd-81de-fa4260be7ede 382f8e3e-6414-4bfd-81de-fa4260be7ede TCGA-A5-A7WJ-01 TCGA-A5-A7WJ-01A-12D-A34P-01 TCGA-A5-A7WJ-01A-12D-A34P-01 TCGA-A5-A7WJ-01 TCGA-A5-A7WJ-01 TCGA-A5-A7WJ-01A-12D-A34S-05 TCGA-A5-A7WK-01 MSS TCGA-A5-A7WK-01 TCGA-A5-A7WK TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES Progressive Disease 71 0 0 TCGA-A5-A7WK-F63886 TCGA-A5-A7WK TCGA-A5-A7WK-01A Never Used Stage IA NO -26044 253 0 560 350 YES 2014-8-20 FEMALE 168 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 160 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Paraaortic lymph node NO YES true No TCGA-A5-A7WK.9101DD17-9216-4526-9A87-8C4E94B1F435.pdf A7WK 49 negative WITH TUMOR 0 0 YES 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO A5 0 0 0 0 Endometrial A LIVING 97 2013 e2c72ce3-f010-4f7f-832b-6277b8409f87 TCGA-A5-A7WK-01 e2c72ce3-f010-4f7f-832b-6277b8409f87 982A1758-B333-4AC0-96A8-9E4DEF8F7A97 e2c72ce3-f010-4f7f-832b-6277b8409f87 e2c72ce3-f010-4f7f-832b-6277b8409f87 TCGA-A5-A7WK-01 TCGA-A5-A7WK-01A-11D-A34P-01 TCGA-A5-A7WK-01A-11D-A34P-01 TCGA-A5-A7WK-01 TCGA-A5-A7WK-01 TCGA-A5-A7WK-01A-11D-A34S-05 TCGA-A5-AB3J-01 MSS TCGA-A5-AB3J-01 TCGA-A5-AB3J TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 52 0 0 TCGA-A5-AB3J-F71139 TCGA-A5-AB3J TCGA-A5-AB3J-01A Never Used Stage II NO -19020 126 0 512 YES 2015-3-18 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Cervical polypectomy Other method, specify: 210 NO NO Peri (6-12 months since last menstrual period) G2 NO true Yes TCGA-A5-AB3J.41CDFB48-33A6-4FCD-97CA-30C73A9E6FED.pdf AB3J 49 TUMOR FREE 0 0 YES 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO A5 0 4 0 6 Endometrial A LIVING 59 2013 8cda2390-3a6c-422e-b827-5c62c015f020 TCGA-A5-AB3J-01 8cda2390-3a6c-422e-b827-5c62c015f020 10735EAE-8427-4413-BF92-D9A29F5A3796 8cda2390-3a6c-422e-b827-5c62c015f020 8cda2390-3a6c-422e-b827-5c62c015f020 TCGA-A5-AB3J-01 TCGA-A5-AB3J-01A-11D-A402-01 TCGA-A5-AB3J-01A-11D-A402-01 TCGA-A5-AB3J-01 TCGA-A5-AB3J-01 TCGA-A5-AB3J-01A-11D-A409-05 TCGA-AJ-A23M-01 MSS TCGA-AJ-A23M-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 5 mutation cluster 3 TCGA-AJ-A23M TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO Progressive Disease 61 TCGA-AJ-A23M-F56158 TCGA-AJ-A23M TCGA-AJ-A23M-01A Never Used Stage II NO -22430 274 616 0 36 516 YES 2014-1-29 FEMALE 152 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES 90 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Abdominal Fluid NO YES false No TCGA-AJ-A23M.B9651546-290B-405B-8275-24C8A53A10A3.pdf A23M positive WITH TUMOR 0 YES 1 Stable Disease Never Used YES Primary Tumor 01 open 2009 NO YES AJ 0 4 Endometrial A DECEASED 141 2010 TCGA-AJ-A23M-01 TCGA-AJ-A23M-01A-21-A18R-20 36BE1D89-9FC1-4743-8B67-A32071FEF91E TCGA-AJ-A23M-01A-11D-A159-09 TCGA-AJ-A23M-01A-11D-A159-09 TCGA-AJ-A23M-01 9cde3009-e59c-4a08-bd85-e3f5ab521d41 TCGA-AJ-A23M-01A-11D-A160-01 TCGA-AJ-A23M-01A-11D-A160-01 TCGA-AJ-A23M-01 TCGA-AJ-A23M-01 TCGA-AJ-A23M-01A-11D-A161-05 9cde3009-e59c-4a08-bd85-e3f5ab521d41 TCGA-AJ-A23N-01 MSS TCGA-AJ-A23N-01 High UCEC Serous c4 OV-like c4 miRNA cluster 14 TCGA-AJ-A23N TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 70 TCGA-AJ-A23N-F47000 TCGA-AJ-A23N TCGA-AJ-A23N-01A Former User Stage IIIA NO -25772 84 439 0 33 NO 2013-8-21 FEMALE Serous endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8441/3 C54.1 YES Cytology (e.g. Peritoneal or pleural fluid) 130 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A23N.38EB6233-9777-4640-A896-26D16A9DBD8E.pdf A23N 27 negative WITH TUMOR YES 2 Progressive Disease Never Used YES R2 Primary Tumor 01 2009 YES NO AJ 0 0 Endometrial A DECEASED 2011 fefa50dc-29a7-4c27-a735-ab6eb500a5d5 TCGA-AJ-A23N-01 fefa50dc-29a7-4c27-a735-ab6eb500a5d5 TCGA-AJ-A23N-01A-21-A23Z-20 6EDED36B-2F9E-460F-875B-21634AC908BA fefa50dc-29a7-4c27-a735-ab6eb500a5d5 fefa50dc-29a7-4c27-a735-ab6eb500a5d5 TCGA-AJ-A23N-01 TCGA-AJ-A23N-01A-11D-A227-01 TCGA-AJ-A23N-01A-11D-A227-01 TCGA-AJ-A23N-01 TCGA-AJ-A23N-01 TCGA-AJ-A23N-01A-11D-A22B-05 TCGA-AJ-A23O-01 MSI-H TCGA-AJ-A23O-01 Iq C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 4 TCGA-AJ-A23O TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 69 0 TCGA-AJ-A23O-F22151 TCGA-AJ-A23O TCGA-AJ-A23O-01A Stage IB NO -25433 165 312 0 60 NO Scheduled Follow-up Submission 2012-2-24 FEMALE 157 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. C54.1 8380/3 C54.1 YES Dilation and curettage procedure 120 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A23O.4D477218-A4D1-4940-AEF5-D8F46931594C.pdf A23O 81 negative TUMOR FREE 0 Never Used NO R0 Primary Tumor 01 2009 NO NO YES AJ 4 15 Endometrial A DECEASED 60 2010 TCGA-AJ-A23O-01 TCGA-AJ-A23O-01A-21-A18R-20 3CB29D8C-B588-480C-9C2E-DEA19BC85744 TCGA-AJ-A23O-01 aaece63d-8d6f-4048-81e3-d4e7e3706948 TCGA-AJ-A23O-01A-11D-A160-01 TCGA-AJ-A23O-01A-11D-A160-01 TCGA-AJ-A23O-01 TCGA-AJ-A23O-01 TCGA-AJ-A23O-01A-11D-A161-05 aaece63d-8d6f-4048-81e3-d4e7e3706948 TCGA-AJ-A2QK-01 MSS TCGA-AJ-A2QK-01 Squamous C6-UCEC UCEC non-CIMP c3 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 TCGA-AJ-A2QK TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Progressive Disease 65 0 TCGA-AJ-A2QK-F43981 TCGA-AJ-A2QK TCGA-AJ-A2QK-01A Never Used Stage IA NO -23945 146 0 643 606 606 YES 2013-6-10 FEMALE 155 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 170 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Liver Distant Metastasis YES YES false No TCGA-AJ-A2QK.01A114A2-098F-4AAD-9010-54910FB89B4A.pdf A2QK 25 WITH TUMOR 0 NO Complete Remission/Response Never Used YES Other Method, Specify Below tumor debulking R2 R0 Primary Tumor 01 2009 YES NO AJ 0 6 0 18 Endometrial A LIVING 119 2011 TCGA-AJ-A2QK-01 TCGA-AJ-A2QK-01A-21-A23Z-20 B814B728-9DAC-41EC-812D-8EB841B8E96F TCGA-AJ-A2QK-01 3ec89fd3-b1fe-495c-99ef-122ab708e633 TCGA-AJ-A2QK-01A-11D-A18N-01 TCGA-AJ-A2QK-01A-11D-A18N-01 TCGA-AJ-A2QK-01 TCGA-AJ-A2QK-01 TCGA-AJ-A2QK-01A-11D-A18O-05 3ec89fd3-b1fe-495c-99ef-122ab708e633 TCGA-AJ-A2QL-01 MSS TCGA-AJ-A2QL-01 Kirc+ C6-UCEC UCEC CIMP c18 UCEC-like c5 UCEC-like c11 miRNA cluster 12 TCGA-AJ-A2QL TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 0 0 TCGA-AJ-A2QL-F43202 TCGA-AJ-A2QL TCGA-AJ-A2QL-01A Stage IIIC1 NO -22057 138 0 602 YES 2013-5-15 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 170 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A2QL.4AD4E8D1-5DA7-4134-A0C0-0AF1C3A8BCD4.pdf A2QL negative TUMOR FREE 1 0 YES Complete Remission/Response Never Used NO Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 7 1 18 Endometrial A LIVING 112 2011 TCGA-AJ-A2QL-01 TCGA-AJ-A2QL-01A-21-A23Z-20 A02B4058-B864-489A-9FAE-360F60438D12 TCGA-AJ-A2QL-01 575c927a-b846-4ef3-9644-7879d522a2cb TCGA-AJ-A2QL-01A-11D-A18N-01 TCGA-AJ-A2QL-01A-11D-A18N-01 TCGA-AJ-A2QL-01 TCGA-AJ-A2QL-01 TCGA-AJ-A2QL-01A-11D-A18O-05 575c927a-b846-4ef3-9644-7879d522a2cb TCGA-AJ-A2QL-11 MSS TCGA-AJ-A2QL-11 C6-UCEC TCGA-AJ-A2QL TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 0 0 TCGA-AJ-A2QL-F43202 TCGA-AJ-A2QL TCGA-AJ-A2QL-11A Stage IIIC1 NO -22057 138 0 602 YES 2013-5-15 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 100 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No A2QL negative TUMOR FREE 1 0 YES Complete Remission/Response Never Used NO Solid Tissue Normal 11 Minimally Invasive 2009 YES NO AJ 0 7 1 18 Endometrial A LIVING 112 2011 TCGA-AJ-A2QL-11 59022898-5d0a-4109-90fa-9f8ad89b9758 TCGA-AJ-A2QL-11 TCGA-AJ-A2QL-11A-11D-A18O-05 59022898-5d0a-4109-90fa-9f8ad89b9758 TCGA-AJ-A2QM-01 MSS TCGA-AJ-A2QM-01 High UCEC non-CIMP c3 UCEC-like c5 miRNA c1uster 10 TCGA-AJ-A2QM TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 0 0 TCGA-AJ-A2QM-F60105 TCGA-AJ-A2QM TCGA-AJ-A2QM-01A Stage II NO -24776 108 0 894 NO 2014-5-29 FEMALE 170 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 210 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes TCGA-AJ-A2QM.282D10FF-370D-4252-B1CB-3410A43C8F82.pdf A2QM negative TUMOR FREE 0 0 YES Complete Remission/Response Never Used YES Primary Tumor 01 open 2009 YES NO AJ 0 13 0 20 Endometrial A LIVING 74 2011 2bd4aa66-5a09-4bac-bfd0-fc3519d398a1 TCGA-AJ-A2QM-01 2bd4aa66-5a09-4bac-bfd0-fc3519d398a1 TCGA-AJ-A2QM-01A-21-A23Z-20 E6999DEA-FA88-4C3E-8DE5-C2DDCE73F606 2bd4aa66-5a09-4bac-bfd0-fc3519d398a1 2bd4aa66-5a09-4bac-bfd0-fc3519d398a1 TCGA-AJ-A2QM-01 TCGA-AJ-A2QM-01A-11D-A18N-01 TCGA-AJ-A2QM-01A-11D-A18N-01 TCGA-AJ-A2QM-01 TCGA-AJ-A2QM-01 TCGA-AJ-A2QM-01A-11D-A18O-05 TCGA-AJ-A2QN-01 MSS TCGA-AJ-A2QN-01 Kirc+ UCEC non-CIMP c3 UCEC-like c11 miRNA cluster 5 TCGA-AJ-A2QN TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 0 TCGA-AJ-A2QN-F58977 TCGA-AJ-A2QN TCGA-AJ-A2QN-01A Stage II NO -21915 289 0 1069 YES 2014-4-29 FEMALE 170 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 25 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A2QN.F92EF591-695A-4E48-9ACF-67497880AC20.pdf A2QN negative TUMOR FREE 0 NO 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 8 0 4 Endometrial A LIVING 132 2010 TCGA-AJ-A2QN-01 TCGA-AJ-A2QN-01 13a499dd-2bb6-4750-b24a-1c76993f5b97 TCGA-AJ-A2QN-01A-11D-A18N-01 TCGA-AJ-A2QN-01A-11D-A18N-01 TCGA-AJ-A2QN-01 TCGA-AJ-A2QN-01 TCGA-AJ-A2QN-01A-11D-A18O-05 13a499dd-2bb6-4750-b24a-1c76993f5b97 TCGA-AJ-A2QO-01 MSI-H TCGA-AJ-A2QO-01 Quiet UCEC CIMP c18 miRNA cluster 12 TCGA-AJ-A2QO TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 85 0 TCGA-AJ-A2QO-F58978 TCGA-AJ-A2QO TCGA-AJ-A2QO-01A Stage IB NO -31222 174 1045 0 92 NO 2014-4-29 FEMALE 165 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 16 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A2QO.5351BF98-9E1D-4F4D-A3EE-26A83B867D58.pdf A2QO 84 negative TUMOR FREE 0 NO 2 Complete Remission/Response Never Used NO Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 5 0 11 Endometrial A DECEASED 67 2011 0ebc7d28-128d-4842-9e10-28abb1953b72 TCGA-AJ-A2QO-01 0ebc7d28-128d-4842-9e10-28abb1953b72 0ebc7d28-128d-4842-9e10-28abb1953b72 0ebc7d28-128d-4842-9e10-28abb1953b72 TCGA-AJ-A2QO-01 TCGA-AJ-A2QO-01A-11D-A18N-01 TCGA-AJ-A2QO-01A-11D-A18N-01 TCGA-AJ-A2QO-01 TCGA-AJ-A2QO-01 TCGA-AJ-A2QO-01A-11D-A18O-05 TCGA-AJ-A3BD-01 MSS TCGA-AJ-A3BD-01 Squamous UCEC Serous c4 UCEC-like c5 miRNA c1uster 10 TCGA-AJ-A3BD TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 0 2 TCGA-AJ-A3BD-F58983 TCGA-AJ-A3BD TCGA-AJ-A3BD-01A Stage IIIC2 NO -20998 170 0 1039 NO 2014-4-29 FEMALE 152 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8460/3 C54.1 YES Office Endometrial Biopsy 200 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A3BD.8B7CB7C6-86B5-41EA-A6CB-FC496C311888.pdf A3BD negative TUMOR FREE 0 3 YES 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO AJ 2 9 3 17 Endometrial A LIVING 85 2011 b38f9ed4-266f-4b44-b42f-48396fb0be68 TCGA-AJ-A3BD-01 b38f9ed4-266f-4b44-b42f-48396fb0be68 TCGA-AJ-A3BD-01A-21-A23Z-20 EAB8433C-32F7-48FF-98B7-3DFB2D5E7E87 b38f9ed4-266f-4b44-b42f-48396fb0be68 b38f9ed4-266f-4b44-b42f-48396fb0be68 TCGA-AJ-A3BD-01 TCGA-AJ-A3BD-01A-11D-A19X-01 TCGA-AJ-A3BD-01A-11D-A19X-01 TCGA-AJ-A3BD-01 TCGA-AJ-A3BD-01 TCGA-AJ-A3BD-01A-11D-A19Z-05 TCGA-AJ-A3BF-01 MSS TCGA-AJ-A3BF-01 Squamous UCEC Serous c4 UCEC-like c5 miRNA cluster 2 TCGA-AJ-A3BF TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO Progressive Disease 65 0 6 TCGA-AJ-A3BF-F43706 TCGA-AJ-A3BF TCGA-AJ-A3BF-01A Former User Stage IIIC2 NO -23906 92 0 551 509 NO 2013-5-31 FEMALE 170 Serous endometrial adenocarcinoma No YES C54.1 8460/3 C54.1 YES Dilation and curettage procedure 150 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Distant Metastasis Supraclavicular LN NO YES false No TCGA-AJ-A3BF.3673A111-6F2E-4374-A0E7-BA436D644F0D.pdf A3BF negative TUMOR FREE 0 2 YES Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO AJ 6 14 2 43 Endometrial A LIVING 113 2011 f282d6e9-6a6a-4515-8efd-d5fff0367ee8 TCGA-AJ-A3BF-01 f282d6e9-6a6a-4515-8efd-d5fff0367ee8 TCGA-AJ-A3BF-01A-21-A23Z-20 9B9F7D60-88B6-4A7B-8FDC-6878C65E00B5 f282d6e9-6a6a-4515-8efd-d5fff0367ee8 f282d6e9-6a6a-4515-8efd-d5fff0367ee8 TCGA-AJ-A3BF-01 TCGA-AJ-A3BF-01A-11D-A20R-01 TCGA-AJ-A3BF-01A-11D-A20R-01 TCGA-AJ-A3BF-01 TCGA-AJ-A3BF-01 TCGA-AJ-A3BF-01A-11D-A212-05 TCGA-AJ-A3BG-01 MSI-H TCGA-AJ-A3BG-01 Kirc+ BRCA CIMP c7 miRNA c1uster 10 TCGA-AJ-A3BG TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Partial Response 65 0 0 TCGA-AJ-A3BG-F43755 TCGA-AJ-A3BG Stage IA NO -23861 0 550 480 NO 2013-6-3 FEMALE 163 Mixed serous and endometrioid No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Vagina NO YES Yes A3BG 33 negative WITH TUMOR 0 0 YES Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO AJ 0 4 0 13 Endometrial LIVING 66 2011 f3004f55-be95-4c2c-92f8-9ec3e96701cd TCGA-AJ-A3BG-01 f3004f55-be95-4c2c-92f8-9ec3e96701cd f3004f55-be95-4c2c-92f8-9ec3e96701cd f3004f55-be95-4c2c-92f8-9ec3e96701cd TCGA-AJ-A3BG-01 TCGA-AJ-A3BG-01A-11D-A19X-01 TCGA-AJ-A3BG-01A-11D-A19X-01 TCGA-AJ-A3BG-01 TCGA-AJ-A3BG-01 TCGA-AJ-A3BG-01A-11D-A19Z-05 TCGA-AJ-A3BH-01 MSI-H TCGA-AJ-A3BH-01 Kirc+ UCEC non-CIMP c3 UCEC-like c5 miRNA cluster 4 TCGA-AJ-A3BH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium TCGA-AJ-A3BH TCGA-AJ-A3BH-01A Stage IB 2012-2-3 FEMALE 157 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES 100 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-AJ-A3BH.469A2D52-09E6-4B67-B8D0-D6292AC22285.pdf A3BH 69 TUMOR FREE 0 R0 Primary Tumor 01 open 2009 YES NO AJ 1 Endometrial A LIVING 71 2011 9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e TCGA-AJ-A3BH-01 9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e TCGA-AJ-A3BH-01A-21-A23Z-20 44F1F9B9-348C-45D3-9E94-E3FC9BCFE9F6 9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e 9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e TCGA-AJ-A3BH-01 TCGA-AJ-A3BH-01A-11D-A19X-01 TCGA-AJ-A3BH-01A-11D-A19X-01 TCGA-AJ-A3BH-01 TCGA-AJ-A3BH-01 TCGA-AJ-A3BH-01A-11D-A19Z-05 TCGA-AJ-A3BI-01 MSS TCGA-AJ-A3BI-01 High UCEC non-CIMP c3 miRNA c1uster 10 TCGA-AJ-A3BI TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Complete Response 67 0 TCGA-AJ-A3BI-F43699 TCGA-AJ-A3BI TCGA-AJ-A3BI-01A Stage IA NO -24623 137 0 575 373 YES 2013-5-31 FEMALE 157 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 19 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Anterior Abd. Mass NO YES false No TCGA-AJ-A3BI.19B5518D-075F-40BE-A104-75C925F133A4.pdf A3BI 15 negative TUMOR FREE 0 NO Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 6 0 10 Endometrial A LIVING 100 2011 5dc20b99-8440-4d30-a803-1e10cdb29dbe TCGA-AJ-A3BI-01 5dc20b99-8440-4d30-a803-1e10cdb29dbe 5dc20b99-8440-4d30-a803-1e10cdb29dbe 5dc20b99-8440-4d30-a803-1e10cdb29dbe TCGA-AJ-A3BI-01 TCGA-AJ-A3BI-01A-11D-A20R-01 TCGA-AJ-A3BI-01A-11D-A20R-01 TCGA-AJ-A3BI-01 TCGA-AJ-A3BI-01 TCGA-AJ-A3BI-01A-11D-A212-05 TCGA-AJ-A3BK-01 MSI-L TCGA-AJ-A3BK-01 Kirc+ UCEC CIMP c18 UCEC-like c5 miRNA c1uster 10 TCGA-AJ-A3BK TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 TCGA-AJ-A3BK-F46662 TCGA-AJ-A3BK TCGA-AJ-A3BK-01A Stage IC NO -24943 547 0 1031 NO 2013-8-13 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 170 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A3BK.026350F0-3203-49E5-8CCC-9DE88B2C8625.pdf A3BK 66 negative TUMOR FREE 0 NO 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES AJ 0 0 22 Endometrial A LIVING 92 2010 18b41a91-88d1-4938-a57f-0464fc7422bc TCGA-AJ-A3BK-01 18b41a91-88d1-4938-a57f-0464fc7422bc TCGA-AJ-A3BK-01A-21-A23Z-20 07A8EC1F-8905-4DC9-94F1-EE80E3E59295 18b41a91-88d1-4938-a57f-0464fc7422bc 18b41a91-88d1-4938-a57f-0464fc7422bc TCGA-AJ-A3BK-01 TCGA-AJ-A3BK-01A-11D-A19X-01 TCGA-AJ-A3BK-01A-11D-A19X-01 TCGA-AJ-A3BK-01 TCGA-AJ-A3BK-01 TCGA-AJ-A3BK-01A-11D-A19Z-05 TCGA-AJ-A3EJ-01 MSS TCGA-AJ-A3EJ-01 High UCEC Serous c4 miRNA cluster 13 TCGA-AJ-A3EJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 74 2 TCGA-AJ-A3EJ-F43201 TCGA-AJ-A3EJ TCGA-AJ-A3EJ-01A Stage IIIC2 NO -27317 332 50 0 NO 2013-5-15 FEMALE 168 Mixed serous and endometrioid No Yes, I am currently taking menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 20 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A3EJ.FB99D237-4583-4298-844F-43B2F99F83E3.pdf A3EJ 85 negative WITH TUMOR 9 NO 4+ Never Used NO R0 Primary Tumor 01 2009 YES NO AJ 2 11 9 26 Endometrial A DECEASED 73 2010 6c10f0d4-fd7e-459e-af27-8cde9dc42860 TCGA-AJ-A3EJ-01 6c10f0d4-fd7e-459e-af27-8cde9dc42860 6c10f0d4-fd7e-459e-af27-8cde9dc42860 6c10f0d4-fd7e-459e-af27-8cde9dc42860 TCGA-AJ-A3EJ-01 TCGA-AJ-A3EJ-01A-11D-A19X-01 TCGA-AJ-A3EJ-01A-11D-A19X-01 TCGA-AJ-A3EJ-01 TCGA-AJ-A3EJ-01 TCGA-AJ-A3EJ-01A-11D-A19Z-05 TCGA-AJ-A3EK-01 MSI-H TCGA-AJ-A3EK-01 Quiet UCEC CIMP c18 UCEC-like c5 miRNA cluster 4 TCGA-AJ-A3EK TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 0 TCGA-AJ-A3EK-F45626 TCGA-AJ-A3EK TCGA-AJ-A3EK-01A Stage IA NO -19609 127 0 446 NO 2013-7-17 FEMALE 157 Endometrioid endometrial adenocarcinoma No NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 220 NO NO Peri (6-12 months since last menstrual period) G3 NO false No TCGA-AJ-A3EK.F153EAC2-7347-4CEF-916A-995C7BB8B0F1.pdf A3EK 5 negative TUMOR FREE 0 YES 3 Complete Remission/Response Never Used YES Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 9 0 10 Endometrial A LIVING 60 2011 1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4 TCGA-AJ-A3EK-01 1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4 TCGA-AJ-A3EK-01A-21-A23Z-20 5A19C935-72ED-45F3-B42D-5AC8BFDB4789 1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4 1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4 TCGA-AJ-A3EK-01 TCGA-AJ-A3EK-01A-11D-A19X-01 TCGA-AJ-A3EK-01A-11D-A19X-01 TCGA-AJ-A3EK-01 TCGA-AJ-A3EK-01 TCGA-AJ-A3EK-01A-11D-A19Z-05 TCGA-AJ-A3EL-01 MSI-L TCGA-AJ-A3EL-01 Quiet UCEC non-CIMP c3 miRNA c1uster 10 TCGA-AJ-A3EL TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 47 0 TCGA-AJ-A3EL-F46677 TCGA-AJ-A3EL Stage IA NO -17442 0 684 2013-8-13 FEMALE 155 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 NO No A3EL 6 negative TUMOR FREE 0 NO 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 13 0 15 Endometrial LIVING 57 2010 a7a5bc3b-d82d-447d-8679-47b48612834a TCGA-AJ-A3EL-01 a7a5bc3b-d82d-447d-8679-47b48612834a a7a5bc3b-d82d-447d-8679-47b48612834a a7a5bc3b-d82d-447d-8679-47b48612834a TCGA-AJ-A3EL-01 TCGA-AJ-A3EL-01A-11D-A20R-01 TCGA-AJ-A3EL-01A-11D-A20R-01 TCGA-AJ-A3EL-01 TCGA-AJ-A3EL-01 TCGA-AJ-A3EL-01A-11D-A212-05 TCGA-AJ-A3EM-01 MSS TCGA-AJ-A3EM-01 High UCEC non-CIMP c3 miRNA cluster 5 TCGA-AJ-A3EM TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 69 0 TCGA-AJ-A3EM-F46680 TCGA-AJ-A3EM TCGA-AJ-A3EM-01A Stage IB NO -25557 296 0 677 NO 2013-8-13 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 9 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A3EM.E5CE38FD-DB53-49D9-92B3-BA075BDDC5CF.pdf A3EM 3.6 negative TUMOR FREE 0 NO 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 8 0 6 Endometrial A LIVING 82 2011 4835dbe5-983f-458a-91d2-8e1d754259c3 TCGA-AJ-A3EM-01 4835dbe5-983f-458a-91d2-8e1d754259c3 4835dbe5-983f-458a-91d2-8e1d754259c3 4835dbe5-983f-458a-91d2-8e1d754259c3 TCGA-AJ-A3EM-01 TCGA-AJ-A3EM-01A-11D-A20R-01 TCGA-AJ-A3EM-01A-11D-A20R-01 TCGA-AJ-A3EM-01 TCGA-AJ-A3EM-01 TCGA-AJ-A3EM-01A-11D-A212-05 TCGA-AJ-A3I9-01 MSS TCGA-AJ-A3I9-01 Squamous UCEC non-CIMP c3 miRNA cluster 12 TCGA-AJ-A3I9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Progressive Disease 52 0 0 TCGA-AJ-A3I9-F66208 TCGA-AJ-A3I9 Former User Stage II NO -19139 519 0 39 370 NO 2014-10-3 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Bone Distant Metastasis NO YES No A3I9 WITH TUMOR 0 0 NO 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 7 0 11 Endometrial DECEASED 72 2011 e7517bb2-68d3-49c5-b298-4203845ae7db TCGA-AJ-A3I9-01 e7517bb2-68d3-49c5-b298-4203845ae7db e7517bb2-68d3-49c5-b298-4203845ae7db e7517bb2-68d3-49c5-b298-4203845ae7db TCGA-AJ-A3I9-01 TCGA-AJ-A3I9-01A-11D-A227-01 TCGA-AJ-A3I9-01A-11D-A227-01 TCGA-AJ-A3I9-01 TCGA-AJ-A3I9-01 TCGA-AJ-A3I9-01A-11D-A22B-05 TCGA-AJ-A3IA-01 MSS TCGA-AJ-A3IA-01 High OV-like c1 miRNA cluster 5 TCGA-AJ-A3IA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 77 0 0 TCGA-AJ-A3IA-F48781 TCGA-AJ-A3IA Stage IB NO -28470 0 633 NO 2013-9-20 FEMALE 157 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO Yes A3IA 88 negative TUMOR FREE 0 0 NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 9 0 17 Endometrial LIVING 58 2011 c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf TCGA-AJ-A3IA-01 c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf TCGA-AJ-A3IA-01 TCGA-AJ-A3IA-01A-11D-A20R-01 TCGA-AJ-A3IA-01A-11D-A20R-01 TCGA-AJ-A3IA-01 TCGA-AJ-A3IA-01 TCGA-AJ-A3IA-01A-11D-A212-05 TCGA-AJ-A3NC-01 MSS TCGA-AJ-A3NC-01 Iq UCEC CIMP c18 squamous c3 miRNA c1uster 10 TCGA-AJ-A3NC TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 TCGA-AJ-A3NC-F58716 TCGA-AJ-A3NC TCGA-AJ-A3NC-01A Stage IA NO -23353 282 0 1125 YES 2014-4-28 FEMALE 168 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 300 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A3NC.B6DB87F4-E88A-4209-92E2-75ADB364FB28.pdf A3NC 21 negative TUMOR FREE 0 0 NO Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 0 13 Endometrial A LIVING 110 2011 e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53 TCGA-AJ-A3NC-01 e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53 TCGA-AJ-A3NC-01A-21-A23Z-20 C156B816-181C-4A58-B620-01C7A857C8A1 e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53 e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53 TCGA-AJ-A3NC-01 TCGA-AJ-A3NC-01A-11D-A227-01 TCGA-AJ-A3NC-01A-11D-A227-01 TCGA-AJ-A3NC-01 TCGA-AJ-A3NC-01 TCGA-AJ-A3NC-01A-11D-A22B-05 TCGA-AJ-A3NC-11 MSS TCGA-AJ-A3NC-11 TCGA-AJ-A3NC TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 TCGA-AJ-A3NC-F58716 TCGA-AJ-A3NC Stage IA NO -23353 0 1125 YES 2014-4-28 FEMALE 168 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO No A3NC 21 negative TUMOR FREE 0 0 NO Complete Remission/Response Never Used NO R0 Solid Tissue Normal 11 Minimally Invasive 2009 YES NO AJ 0 0 13 Endometrial LIVING 110 2011 cd0ccc13-2ce8-408e-aceb-1b363e98584f cd0ccc13-2ce8-408e-aceb-1b363e98584f cd0ccc13-2ce8-408e-aceb-1b363e98584f cd0ccc13-2ce8-408e-aceb-1b363e98584f TCGA-AJ-A3NC-11 TCGA-AJ-A3NC-11 TCGA-AJ-A3NC-11A-11D-A22B-05 TCGA-AJ-A3NE-01 MSI-H TCGA-AJ-A3NE-01 Kirc+ UCEC non-CIMP c3 miRNA cluster 11 TCGA-AJ-A3NE TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 46 0 TCGA-AJ-A3NE-F47713 TCGA-AJ-A3NE Stage IA NO -16957 0 628 2013-8-28 FEMALE 160 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 NO No A3NE 4 negative TUMOR FREE 0 NO 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 12 0 24 Endometrial LIVING 80 2011 a133035a-7076-4fe7-b260-f866b409aba4 TCGA-AJ-A3NE-01 a133035a-7076-4fe7-b260-f866b409aba4 a133035a-7076-4fe7-b260-f866b409aba4 a133035a-7076-4fe7-b260-f866b409aba4 TCGA-AJ-A3NE-01 TCGA-AJ-A3NE-01A-11D-A227-01 TCGA-AJ-A3NE-01A-11D-A227-01 TCGA-AJ-A3NE-01 TCGA-AJ-A3NE-01 TCGA-AJ-A3NE-01A-11D-A22B-05 TCGA-AJ-A3NE-11 MSI-H TCGA-AJ-A3NE-11 TCGA-AJ-A3NE TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 46 0 TCGA-AJ-A3NE-F47713 TCGA-AJ-A3NE Stage IA NO -16957 0 628 2013-8-28 FEMALE 160 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 NO No A3NE 4 negative TUMOR FREE 0 NO 3 Complete Remission/Response Never Used NO R0 Solid Tissue Normal 11 Minimally Invasive 2009 YES NO AJ 0 12 0 24 Endometrial LIVING 80 2011 b4a85000-c0fd-4287-83f2-fc0757fe4a60 b4a85000-c0fd-4287-83f2-fc0757fe4a60 b4a85000-c0fd-4287-83f2-fc0757fe4a60 b4a85000-c0fd-4287-83f2-fc0757fe4a60 TCGA-AJ-A3NE-11 TCGA-AJ-A3NE-11 TCGA-AJ-A3NE-11A-11D-A22B-05 TCGA-AJ-A3NF-01 MSS TCGA-AJ-A3NF-01 Squamous UCEC Serous c4 miRNA cluster 5 TCGA-AJ-A3NF TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 0 0 TCGA-AJ-A3NF-F58988 TCGA-AJ-A3NF TCGA-AJ-A3NF-01A Stage IIIC NO -22210 85 0 645 NO 2014-4-29 FEMALE 160 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Dilation and curettage procedure 22 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A3NF.7003815D-F09A-46A0-8A8E-E0685A765788.pdf A3NF 54 negative TUMOR FREE 0 1 YES 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 9 1 23 Endometrial A LIVING 117 2011 5ab8bc7b-9e70-426f-8f84-d8c691440e98 TCGA-AJ-A3NF-01 5ab8bc7b-9e70-426f-8f84-d8c691440e98 5ab8bc7b-9e70-426f-8f84-d8c691440e98 5ab8bc7b-9e70-426f-8f84-d8c691440e98 TCGA-AJ-A3NF-01 TCGA-AJ-A3NF-01A-11D-A227-01 TCGA-AJ-A3NF-01A-11D-A227-01 TCGA-AJ-A3NF-01 TCGA-AJ-A3NF-01 TCGA-AJ-A3NF-01A-11D-A22B-05 TCGA-AJ-A3NG-01 MSS TCGA-AJ-A3NG-01 Kirc+ Cluster 5 squamous c3 miRNA cluster 5 TCGA-AJ-A3NG TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 83 0 TCGA-AJ-A3NG-F47019 TCGA-AJ-A3NG TCGA-AJ-A3NG-01A Stage II NO -30351 101 0 475 NO 2013-8-21 FEMALE 155 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 150 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A3NG.32C3C850-5F65-424E-894C-75B4725BBD09.pdf A3NG 60 negative TUMOR FREE 0 NO 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 7 0 10 Endometrial A LIVING 93 2011 3bf26a40-da0a-4b9f-9c8d-ef307c8f239b TCGA-AJ-A3NG-01 3bf26a40-da0a-4b9f-9c8d-ef307c8f239b TCGA-AJ-A3NG-01A-21-A23Z-20 FD29E3BB-3256-48A8-877D-E9D5CDC953BC 3bf26a40-da0a-4b9f-9c8d-ef307c8f239b 3bf26a40-da0a-4b9f-9c8d-ef307c8f239b TCGA-AJ-A3NG-01 TCGA-AJ-A3NG-01A-11D-A227-01 TCGA-AJ-A3NG-01A-11D-A227-01 TCGA-AJ-A3NG-01 TCGA-AJ-A3NG-01 TCGA-AJ-A3NG-01A-11D-A22B-05 TCGA-AJ-A3NH-01 MSS TCGA-AJ-A3NH-01 High UCEC non-CIMP c3 UCEC-like c5 miRNA c1uster 10 TCGA-AJ-A3NH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 90 TCGA-AJ-A3NH-F46995 TCGA-AJ-A3NH TCGA-AJ-A3NH-01A Never Used Stage IB NO -32871 67 310 0 23 NO 2013-8-21 FEMALE 162 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Dilation and curettage procedure 130 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes TCGA-AJ-A3NH.8FC0BB09-C917-4552-96A4-B4868FD33D27.pdf A3NH positive TUMOR FREE YES 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 0 Endometrial A DECEASED 65 2011 1b48e1cd-3c89-4508-9326-7fdd69841776 TCGA-AJ-A3NH-01 1b48e1cd-3c89-4508-9326-7fdd69841776 TCGA-AJ-A3NH-01A-21-A23Z-20 DFCB26A6-1294-4CF4-AB1F-9D6F2773C04C 1b48e1cd-3c89-4508-9326-7fdd69841776 1b48e1cd-3c89-4508-9326-7fdd69841776 TCGA-AJ-A3NH-01 TCGA-AJ-A3NH-01A-11D-A227-01 TCGA-AJ-A3NH-01A-11D-A227-01 TCGA-AJ-A3NH-01 TCGA-AJ-A3NH-01 TCGA-AJ-A3NH-01A-11D-A22B-05 TCGA-AJ-A3NH-11 MSS TCGA-AJ-A3NH-11 TCGA-AJ-A3NH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 90 TCGA-AJ-A3NH-F46995 TCGA-AJ-A3NH TCGA-AJ-A3NH-11A Never Used Stage IB NO -32871 67 310 0 23 NO 2013-8-21 FEMALE 162 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Dilation and curettage procedure 70 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes A3NH positive TUMOR FREE YES 3 Complete Remission/Response Never Used NO R0 Solid Tissue Normal 11 Minimally Invasive 2009 YES NO AJ 0 0 Endometrial A DECEASED 65 2011 1b2609b8-8c1f-4407-aba5-e47f9e83ebb1 1b2609b8-8c1f-4407-aba5-e47f9e83ebb1 1b2609b8-8c1f-4407-aba5-e47f9e83ebb1 1b2609b8-8c1f-4407-aba5-e47f9e83ebb1 TCGA-AJ-A3NH-11 TCGA-AJ-A3NH-11 TCGA-AJ-A3NH-11A-11D-A22B-05 TCGA-AJ-A3OJ-01 MSI-H TCGA-AJ-A3OJ-01 Quiet BRCA CIMP c7 UCEC-like c5 miRNA cluster 4 TCGA-AJ-A3OJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 54 0 TCGA-AJ-A3OJ-F47049 TCGA-AJ-A3OJ TCGA-AJ-A3OJ-01A Stage II NO -19826 97 0 467 NO 2013-8-21 FEMALE 157 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 260 NO NO Indeterminate (neither Pre or Postmenopausal) G3 NO false No TCGA-AJ-A3OJ.89CAF35B-187A-499C-9E01-3992A0DEBCFD.pdf A3OJ 95 negative TUMOR FREE 0 YES 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 11 0 14 Endometrial A LIVING 104 2011 f141342e-fbed-4ccf-8e4a-7299397e6e77 TCGA-AJ-A3OJ-01 f141342e-fbed-4ccf-8e4a-7299397e6e77 TCGA-AJ-A3OJ-01A-21-A23Z-20 81CF93AA-064D-43BA-AD1B-417F00852E28 f141342e-fbed-4ccf-8e4a-7299397e6e77 f141342e-fbed-4ccf-8e4a-7299397e6e77 TCGA-AJ-A3OJ-01 TCGA-AJ-A3OJ-01A-11D-A227-01 TCGA-AJ-A3OJ-01A-11D-A227-01 TCGA-AJ-A3OJ-01 TCGA-AJ-A3OJ-01 TCGA-AJ-A3OJ-01A-11D-A22B-05 TCGA-AJ-A3OK-01 MSI-L TCGA-AJ-A3OK-01 Quiet UCEC non-CIMP c3 UCEC-like c5 miRNA c1uster 10 TCGA-AJ-A3OK TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 73 0 TCGA-AJ-A3OK-F45615 TCGA-AJ-A3OK TCGA-AJ-A3OK-01A Stage IA NO -26851 162 0 485 2013-7-17 FEMALE 160 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 80 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A3OK.54D4BBBE-D458-44B2-8F7C-0185DD16D961.pdf A3OK 20 negative TUMOR FREE 0 YES 2 Complete Remission/Response YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 3 0 21 Endometrial A LIVING 75 2011 33dc8709-5c3e-4944-8e41-2bc36b26fced TCGA-AJ-A3OK-01 33dc8709-5c3e-4944-8e41-2bc36b26fced TCGA-AJ-A3OK-01A-21-A23Z-20 F7EB2D40-8596-4F8A-8AAF-D3F1A41F6AC5 33dc8709-5c3e-4944-8e41-2bc36b26fced 33dc8709-5c3e-4944-8e41-2bc36b26fced TCGA-AJ-A3OK-01 TCGA-AJ-A3OK-01A-12D-A227-01 TCGA-AJ-A3OK-01A-12D-A227-01 TCGA-AJ-A3OK-01 TCGA-AJ-A3OK-01 TCGA-AJ-A3OK-01A-12D-A22B-05 TCGA-AJ-A3OL-01 MSI-H TCGA-AJ-A3OL-01 BRCA-LUAD+ UCEC CIMP c18 UCEC-like c5 miRNA cluster 12 TCGA-AJ-A3OL TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO Progressive Disease 55 0 TCGA-AJ-A3OL-F47006 TCGA-AJ-A3OL TCGA-AJ-A3OL-01A Stage IIIA NO -20115 81 449 0 57 424 NO 2013-8-21 FEMALE 160 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 190 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Distant Metastasis Lung, Liver, and Brain NO YES false No TCGA-AJ-A3OL.B42FF342-34F0-4611-A275-B979D7658510.pdf A3OL 80 negative WITH TUMOR 0 YES 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 2009 YES NO AJ 0 6 0 9 Endometrial A DECEASED 64 2011 69fbadaa-5a9f-4fc6-b676-e938179ee830 TCGA-AJ-A3OL-01 69fbadaa-5a9f-4fc6-b676-e938179ee830 TCGA-AJ-A3OL-01A-21-A23Z-20 956AEB98-315D-492E-AFD1-F3C590EE790C 69fbadaa-5a9f-4fc6-b676-e938179ee830 69fbadaa-5a9f-4fc6-b676-e938179ee830 TCGA-AJ-A3OL-01 TCGA-AJ-A3OL-01A-11D-A227-01 TCGA-AJ-A3OL-01A-11D-A227-01 TCGA-AJ-A3OL-01 TCGA-AJ-A3OL-01 TCGA-AJ-A3OL-01A-11D-A22B-05 TCGA-AJ-A3QS-01 Indeterminate TCGA-AJ-A3QS-01 High UCEC Serous c4 miRNA cluster 5 TCGA-AJ-A3QS TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 0 TCGA-AJ-A3QS-F47011 TCGA-AJ-A3QS TCGA-AJ-A3QS-01A Stage IIIA NO -21162 129 0 513 YES 2013-8-21 FEMALE 165 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 34 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AJ-A3QS.73D1F890-5799-4166-9F9A-F9852979FD29.pdf A3QS 0 negative TUMOR FREE 1 YES 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 2009 YES NO AJ 0 6 1 1 Endometrial A LIVING 71 2011 6f0ffee6-d69f-459e-b401-f7dbcb17cb13 TCGA-AJ-A3QS-01 6f0ffee6-d69f-459e-b401-f7dbcb17cb13 6f0ffee6-d69f-459e-b401-f7dbcb17cb13 6f0ffee6-d69f-459e-b401-f7dbcb17cb13 TCGA-AJ-A3QS-01 TCGA-AJ-A3QS-01A-11D-A227-01 TCGA-AJ-A3QS-01A-11D-A227-01 TCGA-AJ-A3QS-01 TCGA-AJ-A3QS-01 TCGA-AJ-A3QS-01A-11D-A22B-05 TCGA-AJ-A3TW-01 MSS TCGA-AJ-A3TW-01 High UCEC Serous c4 BRCA basal-like c6 miRNA cluster 4 TCGA-AJ-A3TW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 78 0 TCGA-AJ-A3TW-F48779 TCGA-AJ-A3TW TCGA-AJ-A3TW-01A Stage IB NO -28559 71 0 513 NO 2013-9-20 FEMALE 160 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 230 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AJ-A3TW.1271A645-AF29-453E-BEA8-420ECCD0DFDC.pdf A3TW negative TUMOR FREE 0 NO 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 2009 YES NO AJ 0 1 0 18 Endometrial A LIVING 55 2012 a1ba7666-0fb4-4fa6-8530-242d32ca3708 TCGA-AJ-A3TW-01 a1ba7666-0fb4-4fa6-8530-242d32ca3708 TCGA-AJ-A3TW-01A-21-A23Z-20 B25EC080-F61A-41EB-85CE-40820BDCE279 a1ba7666-0fb4-4fa6-8530-242d32ca3708 a1ba7666-0fb4-4fa6-8530-242d32ca3708 TCGA-AJ-A3TW-01 TCGA-AJ-A3TW-01A-11D-A227-01 TCGA-AJ-A3TW-01A-11D-A227-01 TCGA-AJ-A3TW-01 TCGA-AJ-A3TW-01 TCGA-AJ-A3TW-01A-11D-A22B-05 TCGA-AJ-A4ZG-01 MSS TCGA-AJ-A4ZG-01 TCGA-AJ-A4ZG TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 TCGA-AJ-A4ZG-F58972 TCGA-AJ-A4ZG TCGA-AJ-A4ZG-01A Stage IVB NO -19492 57 0 498 YES 2014-4-29 FEMALE 163 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Cytology (e.g. Peritoneal or pleural fluid) 90 NO NO G3 NO false No TCGA-AJ-A4ZG.639D98FB-EFCA-4FDC-A4A0-308951C91710.pdf A4ZG 31 positive TUMOR FREE YES 1 Complete Remission/Response Never Used YES RX Primary Tumor 01 2009 YES NO AJ 0 0 Endometrial A LIVING 85 2012 9F1D2D24-2358-41C9-A2E6-D505AD6FA71E TCGA-AJ-A5DV-01 MSS TCGA-AJ-A5DV-01 TCGA-AJ-A5DV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 65 TCGA-AJ-A5DV-F64110 TCGA-AJ-A5DV Never Used Stage IA NO -23892 0 679 YES 2014-8-26 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Biopsy, NOS Other method, specify: NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO No A5DV 3 negative TUMOR FREE 0 NO 4+ Complete Remission/Response Never Used NO RX Primary Tumor 01 2009 YES NO AJ 0 0 5 Endometrial LIVING 147 2012 f9cc97ae-9b1a-46fa-ab38-c46bccf84380 TCGA-AJ-A5DV-01 f9cc97ae-9b1a-46fa-ab38-c46bccf84380 f9cc97ae-9b1a-46fa-ab38-c46bccf84380 f9cc97ae-9b1a-46fa-ab38-c46bccf84380 TCGA-AJ-A5DV-01 TCGA-AJ-A5DV-01A-11D-A27O-01 TCGA-AJ-A5DV-01A-11D-A27O-01 TCGA-AJ-A5DV-01 TCGA-AJ-A5DV-01 TCGA-AJ-A5DV-01A-11D-A27Y-05 TCGA-AJ-A5DW-01 MSS TCGA-AJ-A5DW-01 TCGA-AJ-A5DW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 0 TCGA-AJ-A5DW-F66007 TCGA-AJ-A5DW TCGA-AJ-A5DW-01A Never Used Stage IA NO -20711 133 0 390 NO 2014-10-1 FEMALE 167 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Biopsy, NOS Other method, specify: 80 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-AJ-A5DW.8B641F9B-ACF5-448B-9AC3-8C8E6B1F0724.pdf A5DW TUMOR FREE 0 0 NO 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 2009 YES NO AJ 0 13 0 12 Endometrial A LIVING 109 2012 25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd TCGA-AJ-A5DW-01 25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd D9A34298-570F-49D3-9252-7ECFA9059DB8 25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd 25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd TCGA-AJ-A5DW-01 TCGA-AJ-A5DW-01A-11D-A27O-01 TCGA-AJ-A5DW-01A-11D-A27O-01 TCGA-AJ-A5DW-01 TCGA-AJ-A5DW-01 TCGA-AJ-A5DW-01A-11D-A27Y-05 TCGA-AJ-A6NU-01 MSS TCGA-AJ-A6NU-01 TCGA-AJ-A6NU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 TCGA-AJ-A6NU-F66207 TCGA-AJ-A6NU TCGA-AJ-A6NU-01A Former User Stage II NO -23498 439 0 632 NO 2014-10-3 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 50 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-AJ-A6NU.43BA8AFC-DE95-4260-88BF-EB184430B5A4.pdf A6NU 0 negative TUMOR FREE 0 NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 0 0 10 Endometrial A LIVING 167 2012 31594ace-9586-4e98-ab81-1dfe4fb9d20e TCGA-AJ-A6NU-01 31594ace-9586-4e98-ab81-1dfe4fb9d20e 31594ace-9586-4e98-ab81-1dfe4fb9d20e 31594ace-9586-4e98-ab81-1dfe4fb9d20e TCGA-AJ-A6NU-01 TCGA-AJ-A6NU-01A-11D-A34P-01 TCGA-AJ-A6NU-01A-11D-A34P-01 TCGA-AJ-A6NU-01 TCGA-AJ-A6NU-01 TCGA-AJ-A6NU-01A-11D-A34S-05 TCGA-AJ-A8CT-01 MSI-H TCGA-AJ-A8CT-01 TCGA-AJ-A8CT TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 TCGA-AJ-A8CT-F61504 TCGA-AJ-A8CT TCGA-AJ-A8CT-01A Stage IA NO -21515 587 0 82 2014-6-30 FEMALE 165 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 60 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-AJ-A8CT.67EF8128-8F99-4B19-9B64-9C5E5BD0786F.pdf A8CT 17 negative TUMOR FREE 0 Complete Remission/Response Never Used R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 0 18 Endometrial A LIVING 115 2012 4c56a6cc-f912-4b2f-b301-d6a64f211d31 TCGA-AJ-A8CT-01 4c56a6cc-f912-4b2f-b301-d6a64f211d31 4c56a6cc-f912-4b2f-b301-d6a64f211d31 4c56a6cc-f912-4b2f-b301-d6a64f211d31 TCGA-AJ-A8CT-01 TCGA-AJ-A8CT-01A-11D-A37M-01 TCGA-AJ-A8CT-01A-11D-A37M-01 TCGA-AJ-A8CT-01 TCGA-AJ-A8CT-01 TCGA-AJ-A8CT-01A-11D-A37Q-05 TCGA-AJ-A8CV-01 MSI-H TCGA-AJ-A8CV-01 TCGA-AJ-A8CV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 TCGA-AJ-A8CV-F65831 TCGA-AJ-A8CV Stage IB NO -21336 0 1068 NO 2014-9-30 FEMALE 156 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO No A8CV 65 TUMOR FREE 0 NO 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO AJ 0 0 14 Endometrial LIVING 86 2011 ff8eb6f4-876e-4b08-8ed7-8c7930765bee TCGA-AJ-A8CV-01 ff8eb6f4-876e-4b08-8ed7-8c7930765bee ff8eb6f4-876e-4b08-8ed7-8c7930765bee ff8eb6f4-876e-4b08-8ed7-8c7930765bee TCGA-AJ-A8CV-01 TCGA-AJ-A8CV-01A-11D-A37M-01 TCGA-AJ-A8CV-01A-11D-A37M-01 TCGA-AJ-A8CV-01 TCGA-AJ-A8CV-01 TCGA-AJ-A8CV-01A-11D-A37Q-05 TCGA-AJ-A8CW-01 MSI-H TCGA-AJ-A8CW-01 TCGA-AJ-A8CW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 64 TCGA-AJ-A8CW TCGA-AJ-A8CW-01A Stage IA NO -23554 840 0 4 2014-2-27 FEMALE 168 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Tumor resection 90 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-AJ-A8CW.146E0540-B6F0-495F-ADD5-90F7564C14CA.pdf A8CW 6 negative TUMOR FREE 0 Never Used R0 Primary Tumor 01 open 2009 YES NO AJ 0 0 28 Endometrial A LIVING 134 2011 409104d7-db15-448e-96c6-e50fb7e5d67b TCGA-AJ-A8CW-01 409104d7-db15-448e-96c6-e50fb7e5d67b 409104d7-db15-448e-96c6-e50fb7e5d67b 409104d7-db15-448e-96c6-e50fb7e5d67b TCGA-AJ-A8CW-01 TCGA-AJ-A8CW-01A-11D-A37M-01 TCGA-AJ-A8CW-01A-11D-A37M-01 TCGA-AJ-A8CW-01 TCGA-AJ-A8CW-01 TCGA-AJ-A8CW-01A-11D-A37Q-05 TCGA-AP-A051-01 MSI-H TCGA-AP-A051-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 11 TCGA-AP-A051 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 69 TCGA-AP-A051-F68440 TCGA-AP-A051 TCGA-AP-A051-01A Never Used Stage IA NO -25269 2475 0 3948 NO 2014-11-17 FEMALE 159 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 430 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AP-A051.2146A2FC-99EE-4939-AD9F-086BB77D2B21.pdf A051 37 negative TUMOR FREE NO 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO NO YES AP 0 0 Endometrial A LIVING 97 2003 TCGA-AP-A051-01 TCGA-AP-A051-01 TCGA-AP-A051-01A-11-A162-20 E1F9F4C1-CBB9-49FB-BBAC-E1CA174F5FCB TCGA-AP-A051-01 TCGA-AP-A051-01 TCGA-AP-A051-01A-21W-A027-09 TCGA-AP-A051-01A-21W-A027-09 TCGA-AP-A051-01 520ac0a0-a49f-4990-8a49-dfe312361e30 TCGA-AP-A051-01A-21D-A00X-01 TCGA-AP-A051-01A-21R-A00V-07 TCGA-AP-A051-01A-21D-A00X-01 TCGA-AP-A051-01 TCGA-AP-A051-01A-21D-A00U-05 520ac0a0-a49f-4990-8a49-dfe312361e30 TCGA-AP-A052-01 MSS TCGA-AP-A052-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 mutation cluster 3 TCGA-AP-A052 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO NO Progressive Disease 59 0 0 TCGA-AP-A052-F3393 TCGA-AP-A052 TCGA-AP-A052-01A Former User Stage IVB NO -21721 2211 669 0 394 NO 2010-9-23 FEMALE 165 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Dilation and curettage procedure 500 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true No TCGA-AP-A052.830EF496-4672-4E9A-B662-DCB4678E99B0.pdf A052 0 negative WITH TUMOR 0 0 1 Complete Remission/Response Never Used NO R2 Primary Tumor 01 open YES NO YES AP 0 0 0 0 Endometrial A DECEASED 126 2004 TCGA-AP-A052-01 TCGA-AP-A052-01A-21-A162-20 48950750-AF24-4930-A739-4D029A0D5B2D TCGA-AP-A052-01 TCGA-AP-A052-01A-11W-A027-09 TCGA-AP-A052-01A-11W-A027-09 TCGA-AP-A052-01A-11W-A027-09 TCGA-AP-A052-01 2b64fee1-6e95-417d-b9b7-25bad9db4dc3 TCGA-AP-A052-01A-11D-A00X-01 TCGA-AP-A052-01A-11R-A00V-07 TCGA-AP-A052-01A-11D-A00X-01 TCGA-AP-A052-01 TCGA-AP-A052-01A-11D-A00U-05 2b64fee1-6e95-417d-b9b7-25bad9db4dc3 TCGA-AP-A053-01 MSS TCGA-AP-A053-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 3 TCGA-AP-A053 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 90 0 0 TCGA-AP-A053-F68441 TCGA-AP-A053 TCGA-AP-A053-01A Never Used Stage IA NO -32872 2163 3365 0 18 YES 2014-11-17 FEMALE 156 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 220 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true Yes TCGA-AP-A053.6179478F-93BE-4C03-9F65-D74E66AFE449.pdf A053 25 negative TUMOR FREE 0 0 NO 2 Complete Remission/Response Former User YES R0 Primary Tumor 01 open 2009 NO NO YES AP 0 3 0 12 Endometrial A DECEASED 48 2004 TCGA-AP-A053-01 TCGA-AP-A053-01A-11-A162-20 C6D00B82-9791-4C99-AC08-263A2BC2E33E TCGA-AP-A053-01 TCGA-AP-A053-01A-21W-A027-09 TCGA-AP-A053-01A-21W-A027-09 TCGA-AP-A053-01A-21W-A027-09 TCGA-AP-A053-01 bd558781-2e3b-4fb0-aeb8-a8cefbf3272d TCGA-AP-A053-01A-21D-A00X-01 TCGA-AP-A053-01A-21R-A00V-07 TCGA-AP-A053-01A-21D-A00X-01 TCGA-AP-A053-01 TCGA-AP-A053-01A-21D-A00U-05 bd558781-2e3b-4fb0-aeb8-a8cefbf3272d TCGA-AP-A054-01 MSI-H TCGA-AP-A054-01 Iq C11-small-various UCEC CIMP c18 cluster 1 OV-like c4 GBM-like c6 miRNA cluster 12 cluster 5 mutation cluster 8 TCGA-AP-A054 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO YES Progressive Disease 64 0 0 TCGA-AP-A054-F3409 TCGA-AP-A054 TCGA-AP-A054-01A Never Used Stage IIIC1 NO 604 -23404 2086 709 0 566 NO 2010-9-23 FEMALE 167 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 410 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true No TCGA-AP-A054.72028DF7-DAD0-487E-914B-C3AA69A1E6C4.pdf A054 100 positive WITH TUMOR 0 1 2 Complete Remission/Response Never Used NO Other Method, Specify Below Metastatic R0 R1 Primary Tumor 01 open YES NO YES AP 0 4 1 22 Endometrial A DECEASED 75 2004 TCGA-AP-A054-01 TCGA-AP-A054-01 TCGA-AP-A054-01A-21-A162-20 566C65B2-4775-4AC8-B63D-21ED246B0523 TCGA-AP-A054-01 TCGA-AP-A054-01 TCGA-AP-A054-01A-11W-A062-09 TCGA-AP-A054-01A-11W-A062-09 TCGA-AP-A054-01 2fc92e79-f56f-46b9-b378-a242dd7642d6 TCGA-AP-A054-01A-11D-A042-01 TCGA-AP-A054-01A-11R-A040-07 TCGA-AP-A054-01A-11D-A042-01 TCGA-AP-A054-01 TCGA-AP-A054-01A-11D-A039-05 2fc92e79-f56f-46b9-b378-a242dd7642d6 TCGA-AP-A056-01 MSI-L TCGA-AP-A056-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 mutation cluster 11 TCGA-AP-A056 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 0 TCGA-AP-A056-F29046 TCGA-AP-A056 TCGA-AP-A056-01A Stage II NO -23707 2017 0 2618 2096 NO 2012-3-6 FEMALE 151 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Pap Smear Other method, specify: 400 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AP-A056.008786AD-6CA8-488D-A5AC-BA558985E765.pdf A056 96 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES AP 0 18 0 20 Endometrial A LIVING 56 2004 TCGA-AP-A056-01 TCGA-AP-A056-01A-21-A162-20 7940CC0D-31A6-4780-9516-A7DDF53EEBBF TCGA-AP-A056-01 TCGA-AP-A056-01A-11W-A027-09 TCGA-AP-A056-01A-11W-A027-09 TCGA-AP-A056-01 833990d5-5a6c-4d68-b15b-f2cc2309c611 TCGA-AP-A056-01A-11D-A00X-01 TCGA-AP-A056-01A-11R-A00V-07 TCGA-AP-A056-01A-11D-A00X-01 TCGA-AP-A056-01 TCGA-AP-A056-01A-11D-A00U-05 833990d5-5a6c-4d68-b15b-f2cc2309c611 TCGA-AP-A059-01 MSI-H TCGA-AP-A059-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 5 cluster 4 mutation cluster 11 TCGA-AP-A059 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 69 0 0 TCGA-AP-A059-F68482 TCGA-AP-A059 TCGA-AP-A059-01A Never Used Stage IA NO -25311 1476 0 1461 NO 2014-11-19 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 230 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true No TCGA-AP-A059.29A150D3-D5F0-4222-B082-6ABE35A2BB46.pdf A059 12 negative TUMOR FREE 0 0 NO 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO NO YES AP 0 6 0 13 Endometrial A LIVING 99 2006 TCGA-AP-A059-01 TCGA-AP-A059-01A-11-A162-20 F2B96570-CB63-4102-95C8-A42A6F59F620 TCGA-AP-A059-01A-21D-A122-09 TCGA-AP-A059-01A-21D-A122-09 TCGA-AP-A059-01 1d8b3e3b-590d-4087-9506-d6b0b2bab9a9 TCGA-AP-A059-01A-21D-A120-01 TCGA-AP-A059-01A-21D-A120-01 TCGA-AP-A059-01 TCGA-AP-A059-01 TCGA-AP-A059-01A-21D-A123-05 1d8b3e3b-590d-4087-9506-d6b0b2bab9a9 TCGA-AP-A05A-01 MSS TCGA-AP-A05A-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 mutation cluster 5 TCGA-AP-A05A TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 81 0 0 TCGA-AP-A05A-F29051 TCGA-AP-A05A TCGA-AP-A05A-01A Stage II NO -29914 1479 1944 0 1199 1634 YES 2012-3-6 FEMALE Serous endometrial adenocarcinoma No NO C54.1 8441/3 C54.1 YES Dilation and curettage procedure 260 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AP-A05A.1DAE9968-7D20-45A9-B2BC-5F32F6EC7A08.pdf A05A 91 negative TUMOR FREE 0 0 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES AP 0 0 0 6 Endometrial A DECEASED 2006 TCGA-AP-A05A-01 TCGA-AP-A05A-01A-21-A162-20 4DB12D27-16C1-4BE7-B060-977F3F5CAA30 TCGA-AP-A05A-01 TCGA-AP-A05A-01A-11W-A027-09 TCGA-AP-A05A-01A-11W-A027-09 TCGA-AP-A05A-01A-11W-A027-09 TCGA-AP-A05A-01 02528092-3a7a-4ddf-8801-e47a48fdeafe TCGA-AP-A05A-01A-11D-A00X-01 TCGA-AP-A05A-01A-11R-A00V-07 TCGA-AP-A05A-01A-11D-A00X-01 TCGA-AP-A05A-01 TCGA-AP-A05A-01A-11D-A00U-05 02528092-3a7a-4ddf-8801-e47a48fdeafe TCGA-AP-A05D-01 MSS TCGA-AP-A05D-01 COAD-READ C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 mutation cluster 3 TCGA-AP-A05D TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 0 1 TCGA-AP-A05D-F29055 TCGA-AP-A05D TCGA-AP-A05D-01A Never Used Stage IIIC2 YES -24597 1063 0 1758 NO 2012-3-6 FEMALE 161 Serous endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 190 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true Yes TCGA-AP-A05D.3312F531-00A3-4104-8C9C-8734C32C89C0.pdf A05D 73 negative TUMOR FREE 0 1 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES AP 1 8 1 29 Endometrial A LIVING 98 2007 TCGA-AP-A05D-01 TCGA-AP-A05D-01A-21-A162-20 8949703E-7677-4A5F-9DE7-19C9EDBCF894 TCGA-AP-A05D-01 TCGA-AP-A05D-01A-11W-A027-09 TCGA-AP-A05D-01A-11W-A027-09 TCGA-AP-A05D-01A-11W-A027-09 TCGA-AP-A05D-01 c60df680-5bd6-48cc-a112-985f73d9092c TCGA-AP-A05D-01A-11D-A00X-01 TCGA-AP-A05D-01A-11R-A00V-07 TCGA-AP-A05D-01A-11D-A00X-01 TCGA-AP-A05D-01 TCGA-AP-A05D-01A-11D-A00U-05 c60df680-5bd6-48cc-a112-985f73d9092c TCGA-AP-A05H-01 MSS TCGA-AP-A05H-01 High C6-UCEC OV-like c1 cluster 3 UCEC-like c5 UCEC-like c11 mutation cluster 13 TCGA-AP-A05H TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 75 0 0 TCGA-AP-A05H-F29059 TCGA-AP-A05H TCGA-AP-A05H-01A Stage IB NO -27744 706 0 1385 863 NO 2012-3-6 FEMALE 153 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES Dilation and curettage procedure 210 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AP-A05H.805B997D-9755-4AC1-8695-294806148F25.pdf A05H 61 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive NO NO YES AP 0 7 0 24 Endometrial A LIVING 89 2008 TCGA-AP-A05H-01 TCGA-AP-A05H-01A-21-A162-20 9E9C27A1-EBEF-41DC-891A-7256F805297F TCGA-AP-A05H-01 TCGA-AP-A05H-01A-11W-A027-09 TCGA-AP-A05H-01A-11W-A027-09 TCGA-AP-A05H-01A-11W-A027-09 TCGA-AP-A05H-01 b3516570-4a66-418f-87e1-32829d67ec1c TCGA-AP-A05H-01A-11D-A00X-01 TCGA-AP-A05H-01A-11R-A00V-07 TCGA-AP-A05H-01A-11D-A00X-01 TCGA-AP-A05H-01 TCGA-AP-A05H-01A-11D-A00U-05 b3516570-4a66-418f-87e1-32829d67ec1c TCGA-AP-A05J-01 MSS TCGA-AP-A05J-01 COAD-READ C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 mutation cluster 5 TCGA-AP-A05J TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 66 0 0 TCGA-AP-A05J-F29060 TCGA-AP-A05J TCGA-AP-A05J-01A Stage II NO -24119 566 0 1122 729 NO 2012-3-6 FEMALE 168 Serous endometrial adenocarcinoma No NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 170 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AP-A05J.C6426DA0-86C5-49CC-9983-A0002DA0D4F2.pdf A05J 0 negative TUMOR FREE 0 0 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES AP 0 1 0 14 Endometrial A LIVING 79 2008 TCGA-AP-A05J-01 TCGA-AP-A05J-01A-21-A162-20 7B9D2566-40DC-4A4F-A4BE-A5CD1E56BFA2 TCGA-AP-A05J-01 TCGA-AP-A05J-01A-11W-A027-09 TCGA-AP-A05J-01A-11W-A027-09 TCGA-AP-A05J-01A-11W-A027-09 TCGA-AP-A05J-01 dbe07c69-fd67-4dcd-b69d-6bdc4a85110c TCGA-AP-A05J-01A-11D-A00X-01 TCGA-AP-A05J-01A-11R-A00V-07 TCGA-AP-A05J-01A-11D-A00X-01 TCGA-AP-A05J-01 TCGA-AP-A05J-01A-11D-A00U-05 dbe07c69-fd67-4dcd-b69d-6bdc4a85110c TCGA-AP-A05N-01 MSI-H TCGA-AP-A05N-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 mutation cluster 14 TCGA-AP-A05N TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 0 0 TCGA-AP-A05N-F16693 TCGA-AP-A05N TCGA-AP-A05N-01A Former User Stage IA NO -21254 232 726 0 239 394 NO Scheduled Follow-up Submission 2011-9-23 FEMALE 162 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 350 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G1 NO true No TCGA-AP-A05N.E4FF43F2-5CBD-4B68-9CD5-BE4E84AD67D5.pdf A05N 23 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive NO NO YES AP 0 0 0 2 Endometrial A DECEASED 123 2009 TCGA-AP-A05N-01 TCGA-AP-A05N-01A-21-A162-20 E5EB1353-69A4-4A11-BB90-B4C98225B1DA TCGA-AP-A05N-01 TCGA-AP-A05N-01A-11W-A027-09 TCGA-AP-A05N-01A-11W-A027-09 TCGA-AP-A05N-01A-11W-A027-09 TCGA-AP-A05N-01 63ba785b-9345-4cc3-b0af-a1a1d45b59b3 TCGA-AP-A05N-01A-11D-A00X-01 TCGA-AP-A05N-01A-11R-A00V-07 TCGA-AP-A05N-01A-11D-A00X-01 TCGA-AP-A05N-01 TCGA-AP-A05N-01A-11D-A00U-05 63ba785b-9345-4cc3-b0af-a1a1d45b59b3 TCGA-AP-A05O-01 MSI-H TCGA-AP-A05O-01 Iq C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 5 cluster 4 TCGA-AP-A05O TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES Complete Response 68 TCGA-AP-A05O-F68484 TCGA-AP-A05O TCGA-AP-A05O-01A Never Used Stage IB NO 344 -24978 209 0 384 340 YES 2014-11-19 FEMALE 158 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 270 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 YES true No TCGA-AP-A05O.9C8BD34A-DC49-4547-850A-80DCD2D073F8.pdf A05O 80 negative TUMOR FREE 0 0 YES 3 Complete Remission/Response Never Used YES Surgical Resection RX R0 Primary Tumor 01 Minimally Invasive 2009 YES NO YES AP 0 0 23 Endometrial A LIVING 103 2009 TCGA-AP-A05O-01 TCGA-AP-A05O-01A-21-A162-20 FA95D970-8B04-40E4-B2DF-1A2E9E2910E7 TCGA-AP-A05O-01 00186124-cecf-4580-9dca-cef7c09f741c TCGA-AP-A05O-01A-12D-A120-01 TCGA-AP-A05O-01A-12D-A120-01 TCGA-AP-A05O-01 TCGA-AP-A05O-01 TCGA-AP-A05O-01A-12D-A123-05 00186124-cecf-4580-9dca-cef7c09f741c TCGA-AP-A05P-01 MSS TCGA-AP-A05P-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 mutation cluster 7 TCGA-AP-A05P TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 54 0 0 TCGA-AP-A05P-F16694 TCGA-AP-A05P TCGA-AP-A05P-01A Never Used Stage IA NO -20017 203 0 636 NO Scheduled Follow-up Submission 2011-9-23 FEMALE 161 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 170 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G1 NO true No TCGA-AP-A05P.5BA23C70-805A-4356-B739-AFBAFD29D7FC.pdf A05P 0 negative TUMOR FREE 0 0 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive NO NO YES AP 0 0 0 4 Endometrial A LIVING 74 2009 TCGA-AP-A05P-01 TCGA-AP-A05P-01 TCGA-AP-A05P-01A-21-A162-20 7E58EFEF-758A-4B54-A989-7E76AD97D014 TCGA-AP-A05P-01 TCGA-AP-A05P-01 TCGA-AP-A05P-01A-11W-A062-09 TCGA-AP-A05P-01A-11W-A062-09 TCGA-AP-A05P-01A-11W-A062-09 TCGA-AP-A05P-01 167b2ac1-034d-4eac-982e-b96f65bedfb2 TCGA-AP-A05P-01A-11D-A042-01 TCGA-AP-A05P-01A-11R-A040-07 TCGA-AP-A05P-01A-11D-A042-01 TCGA-AP-A05P-01 TCGA-AP-A05P-01A-11D-A039-05 167b2ac1-034d-4eac-982e-b96f65bedfb2 TCGA-AP-A0L8-01 MSS TCGA-AP-A0L8-01 High C6-UCEC UCEC Serous c4 cluster 4 UCEC-like c11 miRNA cluster 13 cluster 6 mutation cluster 5 TCGA-AP-A0L8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES NO Progressive Disease 70 0 1 TCGA-AP-A0L8-F3824 TCGA-AP-A0L8 Never Used Stage IIIC2 NO -25733 1484 0 1453 NO 2010-9-23 FEMALE Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 No A0L8 87 negative WITH TUMOR 0 0 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open NO NO YES AP 1 6 0 6 Endometrial DECEASED 61 2000 TCGA-AP-A0L8-01 TCGA-AP-A0L8-01 TCGA-AP-A0L8-01 TCGA-AP-A0L8-01 TCGA-AP-A0L8-01A-11W-A062-09 TCGA-AP-A0L8-01A-11W-A062-09 TCGA-AP-A0L8-01A-11W-A062-09 TCGA-AP-A0L8-01 ca1e32b0-7daf-403e-a3b2-7cfd3948cedf TCGA-AP-A0L8-01A-11D-A042-01 TCGA-AP-A0L8-01A-11R-A040-07 TCGA-AP-A0L8-01A-11D-A042-01 TCGA-AP-A0L8-01 TCGA-AP-A0L8-01A-11D-A039-05 ca1e32b0-7daf-403e-a3b2-7cfd3948cedf TCGA-AP-A0L9-01 MSS TCGA-AP-A0L9-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 3 TCGA-AP-A0L9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 71 0 0 TCGA-AP-A0L9-F29042 TCGA-AP-A0L9 TCGA-AP-A0L9-01A Stage IA NO -26185 3402 0 3815 3456 NO 2012-3-6 FEMALE 152 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 140 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AP-A0L9.62E44C56-838D-4318-B8F7-80476A148C03.pdf A0L9 0 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES AP 0 2 0 12 Endometrial A LIVING 60 2001 TCGA-AP-A0L9-01 TCGA-AP-A0L9-01 TCGA-AP-A0L9-01 TCGA-AP-A0L9-01 TCGA-AP-A0L9-01A-11W-A062-09 TCGA-AP-A0L9-01A-11W-A062-09 TCGA-AP-A0L9-01A-11W-A062-09 TCGA-AP-A0L9-01 43abe272-41cb-4b54-b6f6-50a27c670e46 TCGA-AP-A0L9-01A-11D-A042-01 TCGA-AP-A0L9-01A-11R-A040-07 TCGA-AP-A0L9-01A-11D-A042-01 TCGA-AP-A0L9-01 TCGA-AP-A0L9-01A-11D-A039-05 43abe272-41cb-4b54-b6f6-50a27c670e46 TCGA-AP-A0LD-01 MSI-H TCGA-AP-A0LD-01 BRCA-LUAD+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 4 mutation cluster 1 TCGA-AP-A0LD TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 0 0 TCGA-AP-A0LD-F29043 TCGA-AP-A0LD TCGA-AP-A0LD-01A Never Used Stage IB NO -23216 2993 0 3589 3083 YES 2012-3-6 FEMALE 158 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 230 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AP-A0LD.10B9E917-C1FB-480D-9DB2-8E93FA446ADC.pdf A0LD 87 negative TUMOR FREE 0 0 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES AP 0 12 0 20 Endometrial A LIVING 68 2002 TCGA-AP-A0LD-01 TCGA-AP-A0LD-01 TCGA-AP-A0LD-01A-21-A162-20 833628B6-91CA-4896-9796-6D9F0F57DCF1 TCGA-AP-A0LD-01 TCGA-AP-A0LD-01 TCGA-AP-A0LD-01A-11W-A062-09 TCGA-AP-A0LD-01A-11W-A062-09 TCGA-AP-A0LD-01A-11W-A062-09 TCGA-AP-A0LD-01 c094698b-0de5-4f14-9b3e-7f2deedde428 TCGA-AP-A0LD-01A-11D-A042-01 TCGA-AP-A0LD-01A-11R-A040-07 TCGA-AP-A0LD-01A-11D-A042-01 TCGA-AP-A0LD-01 TCGA-AP-A0LD-01A-11D-A039-05 c094698b-0de5-4f14-9b3e-7f2deedde428 TCGA-AP-A0LE-01 MSI-H TCGA-AP-A0LE-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 1 TCGA-AP-A0LE TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 0 0 TCGA-AP-A0LE-F29044 TCGA-AP-A0LE TCGA-AP-A0LE-01A Former User Stage IA NO -20967 2988 0 3357 YES 2012-3-6 FEMALE 160 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 170 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AP-A0LE.3EA84930-6B34-43B8-A5A8-3D2B3754155F.pdf A0LE 5 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES AP 0 5 0 19 Endometrial A LIVING 75 2002 TCGA-AP-A0LE-01 TCGA-AP-A0LE-01 TCGA-AP-A0LE-01A-21-A162-20 164F62FF-A3BE-465D-B511-EBA500C9E7FA TCGA-AP-A0LE-01 TCGA-AP-A0LE-01A-11D-A127-09 TCGA-AP-A0LE-01A-11D-A127-09 TCGA-AP-A0LE-01A-11D-A127-09 3701ff8a-afd6-4a3d-aae4-735325390d1f TCGA-AP-A0LE-01A-11D-A102-01 TCGA-AP-A0LE-01A-11D-A102-01 TCGA-AP-A0LE-01 TCGA-AP-A0LE-01A-11D-A10Q-05 3701ff8a-afd6-4a3d-aae4-735325390d1f TCGA-AP-A0LF-01 MSS TCGA-AP-A0LF-01 High C6-UCEC UCEC Serous c4 cluster 4 BRCA basal-like c6 UCEC-like c11 miRNA cluster 13 cluster 2 mutation cluster 13 TCGA-AP-A0LF TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 82 0 0 TCGA-AP-A0LF-F68473 TCGA-AP-A0LF TCGA-AP-A0LF-01A Never Used Stage IVB NO -30027 2891 0 2859 NO 2014-11-19 FEMALE 161 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 240 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true Yes TCGA-AP-A0LF.7112CE75-9EFD-4989-9F2A-4D0F517B8EDE.pdf A0LF 17 WITH TUMOR 0 14 2 Never Used NO R2 Primary Tumor 01 open 2009 NO NO YES AP 0 10 14 32 Endometrial A LIVING 72 2002 TCGA-AP-A0LF-01 TCGA-AP-A0LF-01A-21-A162-20 4F747B8B-48BD-4672-AD42-B142645B56F5 TCGA-AP-A0LF-01A-11D-A122-09 TCGA-AP-A0LF-01A-11D-A122-09 TCGA-AP-A0LF-01A-11D-A122-09 TCGA-AP-A0LF-01 2c5d86e0-2e3d-4259-97e9-023df54c8c56 TCGA-AP-A0LF-01A-11D-A120-01 TCGA-AP-A0LF-01A-11D-A120-01 TCGA-AP-A0LF-01 TCGA-AP-A0LF-01 TCGA-AP-A0LF-01A-11D-A123-05 2c5d86e0-2e3d-4259-97e9-023df54c8c56 TCGA-AP-A0LG-01 MSI-H TCGA-AP-A0LG-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 1 TCGA-AP-A0LG TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 54 0 0 TCGA-AP-A0LG-F68442 TCGA-AP-A0LG TCGA-AP-A0LG-01A Never Used Stage IA NO -20047 2833 0 2015 NO 2014-11-17 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 360 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true No TCGA-AP-A0LG.7343A9B5-276E-4EE1-AC06-27835D63B0E2.pdf A0LG 18 negative TUMOR FREE 0 0 NO 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES AP 0 2 0 3 Endometrial A LIVING 76 2002 TCGA-AP-A0LG-01 TCGA-AP-A0LG-01 TCGA-AP-A0LG-01A-21-A162-20 7058B69A-0F87-471D-A36D-E355BC950F3E TCGA-AP-A0LG-01 TCGA-AP-A0LG-01 TCGA-AP-A0LG-01A-11W-A062-09 TCGA-AP-A0LG-01A-11W-A062-09 TCGA-AP-A0LG-01A-11W-A062-09 TCGA-AP-A0LG-01 e4db21b5-9a76-47c1-b838-10f49d2696d0 TCGA-AP-A0LG-01A-11D-A042-01 TCGA-AP-A0LG-01A-11R-A040-07 TCGA-AP-A0LG-01A-11D-A042-01 TCGA-AP-A0LG-01 TCGA-AP-A0LG-01A-11D-A039-05 e4db21b5-9a76-47c1-b838-10f49d2696d0 TCGA-AP-A0LH-01 MSS TCGA-AP-A0LH-01 High C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 COADREAD-like c15 miRNA c1uster 10 cluster 2 mutation cluster 3 TCGA-AP-A0LH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO NO Progressive Disease 60 0 0 TCGA-AP-A0LH-F3950 TCGA-AP-A0LH TCGA-AP-A0LH-01A Never Used Stage IA NO -22169 2772 1106 0 302 NO 2010-9-23 FEMALE 164 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Dilation and curettage procedure 210 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true No TCGA-AP-A0LH.78E73020-1173-45DA-BDBA-DFB1CF7BCB41.pdf A0LH 0 positive WITH TUMOR 0 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open YES NO YES AP 0 14 0 17 Endometrial A DECEASED 83 2002 TCGA-AP-A0LH-01 TCGA-AP-A0LH-01 TCGA-AP-A0LH-01A-21-A162-20 186CD641-E906-4F42-B3CE-8CF9B361AE3A TCGA-AP-A0LH-01 TCGA-AP-A0LH-01 TCGA-AP-A0LH-01A-11W-A062-09 TCGA-AP-A0LH-01A-11W-A062-09 TCGA-AP-A0LH-01A-11W-A062-09 TCGA-AP-A0LH-01 39dbc57b-dd7d-4ebe-a905-47b500adef88 TCGA-AP-A0LH-01A-11D-A042-01 TCGA-AP-A0LH-01A-11R-A040-07 TCGA-AP-A0LH-01A-11D-A042-01 TCGA-AP-A0LH-01 TCGA-AP-A0LH-01A-11D-A039-05 39dbc57b-dd7d-4ebe-a905-47b500adef88 TCGA-AP-A0LI-01 MSS TCGA-AP-A0LI-01 High C6-UCEC UCEC non-CIMP c3 cluster 4 BRCA basal-like c6 UCEC-like c11 miRNA cluster 14 cluster 2 mutation cluster 13 TCGA-AP-A0LI TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 0 2 TCGA-AP-A0LI-F29045 TCGA-AP-A0LI TCGA-AP-A0LI-01A Never Used Stage IIIC2 NO -24573 2567 0 2972 NO 2012-3-6 FEMALE 161 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Cervical biopsy Other method, specify: 180 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AP-A0LI.EFEA05D7-E720-4FE4-977C-6A6369B1BA2E.pdf A0LI 83 negative TUMOR FREE 0 4+ Complete Remission/Response Never Used NO R2 Primary Tumor 01 open NO NO YES AP 2 3 26 Endometrial A LIVING 86 2003 TCGA-AP-A0LI-01 TCGA-AP-A0LI-01 TCGA-AP-A0LI-01A-21-A162-20 7625DF56-46C8-401F-9FE3-D95D692BC04A TCGA-AP-A0LI-01 TCGA-AP-A0LI-01A-11W-A062-09 TCGA-AP-A0LI-01A-11W-A062-09 TCGA-AP-A0LI-01A-11W-A062-09 0fd52e18-275a-4c3d-8c8d-9e27859a5482 TCGA-AP-A0LI-01A-11D-A042-01 TCGA-AP-A0LI-01A-11D-A042-01 TCGA-AP-A0LI-01 TCGA-AP-A0LI-01A-11D-A039-05 0fd52e18-275a-4c3d-8c8d-9e27859a5482 TCGA-AP-A0LJ-01 MSS TCGA-AP-A0LJ-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 2 mutation cluster 4 TCGA-AP-A0LJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 42 0 0 TCGA-AP-A0LJ-F68468 TCGA-AP-A0LJ TCGA-AP-A0LJ-01A Never Used Stage IA NO -15577 2290 0 1421 NO 2014-11-19 FEMALE 152 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 680 NO YES Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G1 true No TCGA-AP-A0LJ.859CBF70-D72E-4843-B3AA-6226B707AA2B.pdf A0LJ 0 negative TUMOR FREE 0 0 NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES AP 0 6 0 14 Endometrial A LIVING 80 2004 TCGA-AP-A0LJ-01 TCGA-AP-A0LJ-01 TCGA-AP-A0LJ-01A-21-A162-20 FE469D1C-3900-4649-A36E-562F8047F8E0 TCGA-AP-A0LJ-01 TCGA-AP-A0LJ-01 TCGA-AP-A0LJ-01A-11W-A062-09 TCGA-AP-A0LJ-01A-11W-A062-09 TCGA-AP-A0LJ-01A-11W-A062-09 TCGA-AP-A0LJ-01 db3d4b8a-6ef3-4bb9-acca-2cbc4cf5f8c6 TCGA-AP-A0LJ-01A-11D-A042-01 TCGA-AP-A0LJ-01A-11R-A040-07 TCGA-AP-A0LJ-01A-11D-A042-01 TCGA-AP-A0LJ-01 TCGA-AP-A0LJ-01A-11D-A039-05 db3d4b8a-6ef3-4bb9-acca-2cbc4cf5f8c6 TCGA-AP-A0LL-01 MSS TCGA-AP-A0LL-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation c1uster 9 TCGA-AP-A0LL TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO YES Complete Response 56 0 0 TCGA-AP-A0LL-F29047 TCGA-AP-A0LL TCGA-AP-A0LL-01A Stage IA NO 792 -20700 2066 0 2554 790 NO 2012-3-6 FEMALE 161 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 160 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-AP-A0LL.B4A6F5DE-E477-48FD-ADA1-EAE436FBC576.pdf A0LL 8 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO Other Method, Specify Below LOCOREGIOL R0 R0 Primary Tumor 01 open NO NO YES AP 0 8 0 29 Endometrial A LIVING 72 2004 TCGA-AP-A0LL-01 TCGA-AP-A0LL-01 TCGA-AP-A0LL-01A-21-A162-20 5B026F34-12B6-4DCC-838A-E65120AED9C7 TCGA-AP-A0LL-01 TCGA-AP-A0LL-01A-12D-A127-09 TCGA-AP-A0LL-01A-12D-A127-09 TCGA-AP-A0LL-01A-12D-A127-09 96756b4d-0e43-404d-a819-dc6da126eef8 TCGA-AP-A0LL-01A-12D-A102-01 TCGA-AP-A0LL-01A-12D-A102-01 TCGA-AP-A0LL-01 TCGA-AP-A0LL-01A-12D-A10Q-05 96756b4d-0e43-404d-a819-dc6da126eef8 TCGA-AP-A0LM-01 MSS TCGA-AP-A0LM-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 5 cluster 4 mutation cluster 11 TCGA-AP-A0LM TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 33 0 1 TCGA-AP-A0LM-F6990 TCGA-AP-A0LM TCGA-AP-A0LM-01A Stage IIIC2 NO -12309 2019 0 825 NO 2011-2-1 FEMALE 166 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 200 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 true No TCGA-AP-A0LM.BF380986-0279-41FC-AAE8-BA9772456CE6.pdf A0LM 71 negative TUMOR FREE 0 0 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open YES NO YES AP 1 13 0 40 Endometrial A LIVING 100 2004 TCGA-AP-A0LM-01 TCGA-AP-A0LM-01A-21-A162-20 11FA828B-C9E3-4BD4-B7C6-35F19EBEAA9A TCGA-AP-A0LM-01A-11D-A122-09 TCGA-AP-A0LM-01A-11D-A122-09 TCGA-AP-A0LM-01 db91880d-1e53-4852-8a94-dd40e2b9aa6c TCGA-AP-A0LM-01A-11D-A120-01 TCGA-AP-A0LM-01A-11D-A120-01 TCGA-AP-A0LM-01 TCGA-AP-A0LM-01 TCGA-AP-A0LM-01A-11D-A123-05 db91880d-1e53-4852-8a94-dd40e2b9aa6c TCGA-AP-A0LN-01 MSS TCGA-AP-A0LN-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-AP-A0LN TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 TCGA-AP-A0LN-F29048 TCGA-AP-A0LN TCGA-AP-A0LN-01A Stage IA NO -20704 1907 0 2510 NO Scheduled Follow-up Submission 2012-3-6 FEMALE 166 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 250 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-AP-A0LN.D50C7207-D840-48A2-8D73-E1C71FFA73E1.pdf A0LN 0 negative TUMOR FREE 0 0 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES AP 0 0 36 Endometrial A LIVING 119 2005 TCGA-AP-A0LN-01 TCGA-AP-A0LN-01 TCGA-AP-A0LN-01A-21-A162-20 DC2D620E-E811-473A-8780-61287FC2F992 TCGA-AP-A0LN-01 TCGA-AP-A0LN-01 TCGA-AP-A0LN-01A-11W-A062-09 TCGA-AP-A0LN-01A-11W-A062-09 TCGA-AP-A0LN-01A-11W-A062-09 TCGA-AP-A0LN-01 cc57fe2e-2370-4697-828f-eee51aacbe0b TCGA-AP-A0LN-01A-11D-A042-01 TCGA-AP-A0LN-01A-11R-A040-07 TCGA-AP-A0LN-01A-11D-A042-01 TCGA-AP-A0LN-01 TCGA-AP-A0LN-01A-11D-A039-05 cc57fe2e-2370-4697-828f-eee51aacbe0b TCGA-AP-A0LO-01 MSS TCGA-AP-A0LO-01 BRCA-LUAD+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c11 mutation cluster 4 TCGA-AP-A0LO TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES YES Complete Response 45 0 0 TCGA-AP-A0LO-F4021 TCGA-AP-A0LO Former User Stage IA NO 585 -16493 1016 0 516 YES 2010-9-23 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G2 No A0LO 0 negative WITH TUMOR 0 0 3 Complete Remission/Response Never Used NO Other Method, Specify Below LOCOREGIOL R2 R0 Primary Tumor 01 Minimally Invasive NO NO YES AP 0 6 0 15 Endometrial DECEASED 67 2005 TCGA-AP-A0LO-01 TCGA-AP-A0LO-01A-11W-A062-09 TCGA-AP-A0LO-01A-11W-A062-09 TCGA-AP-A0LO-01A-11W-A062-09 TCGA-AP-A0LO-01 e563cfb5-6904-45c6-acbb-ac96bfb9770b TCGA-AP-A0LO-01A-11D-A042-01 TCGA-AP-A0LO-01A-11D-A042-01 TCGA-AP-A0LO-01 TCGA-AP-A0LO-01 TCGA-AP-A0LO-01A-11D-A039-05 e563cfb5-6904-45c6-acbb-ac96bfb9770b TCGA-AP-A0LP-01 MSI-H TCGA-AP-A0LP-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 14 TCGA-AP-A0LP TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 76 0 0 TCGA-AP-A0LP-F4030 TCGA-AP-A0LP TCGA-AP-A0LP-01A Never Used Stage IA NO -27898 1884 0 1875 NO 2010-9-23 FEMALE 167 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 150 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 true No TCGA-AP-A0LP.ECA6E3D1-141B-4DB1-90B6-FE6A2E355AD3.pdf A0LP 12 positive TUMOR FREE 0 0 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open YES NO YES AP 0 10 0 17 Endometrial A LIVING 60 2005 TCGA-AP-A0LP-01 TCGA-AP-A0LP-01 TCGA-AP-A0LP-01A-21-A162-20 1A47B25B-E5B8-4D98-900B-F0D2D0ABB3A8 TCGA-AP-A0LP-01 TCGA-AP-A0LP-01A-12D-A10B-09 TCGA-AP-A0LP-01A-12D-A10B-09 TCGA-AP-A0LP-01A-12D-A10B-09 1fea8c9c-7f1f-40d9-944a-f542b91c16b5 TCGA-AP-A0LP-01A-12D-A102-01 TCGA-AP-A0LP-01A-12D-A102-01 TCGA-AP-A0LP-01 TCGA-AP-A0LP-01A-12D-A10Q-05 1fea8c9c-7f1f-40d9-944a-f542b91c16b5 TCGA-AP-A0LQ-01 MSS TCGA-AP-A0LQ-01 Kirc+ UCEC non-CIMP c3 cluster 4 miRNA cluster 11 cluster 2 mutation cluster 4 TCGA-AP-A0LQ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 59 0 0 TCGA-AP-A0LQ-F29049 TCGA-AP-A0LQ Stage IA NO -21629 0 2457 NO 2012-3-6 FEMALE 163 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO No A0LQ 5 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES AP 0 6 0 33 Endometrial LIVING 95 2005 TCGA-AP-A0LQ-01 TCGA-AP-A0LQ-01 TCGA-AP-A0LQ-01A-12D-A10B-09 TCGA-AP-A0LQ-01A-12D-A10B-09 TCGA-AP-A0LQ-01A-12D-A10B-09 TCGA-AP-A0LQ-01A-12D-A102-01 TCGA-AP-A0LQ-01A-12D-A102-01 TCGA-AP-A0LQ-01A-12D-A10Q-05 TCGA-AP-A0LS-01 MSI-H TCGA-AP-A0LS-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-AP-A0LS TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 TCGA-AP-A0LS-F68432 TCGA-AP-A0LS TCGA-AP-A0LS-01A Stage IA -23126 1421 0 2904 2014-11-17 FEMALE 169 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 200 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true Yes TCGA-AP-A0LS.E802CEF6-BC3F-4C35-85E8-2B37531571CD.pdf A0LS 21 TUMOR FREE 0 0 NO YES R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES AP 0 0 14 Endometrial A LIVING 81 2006 TCGA-AP-A0LS-01 TCGA-AP-A0LS-01A-21-A18Q-20 86FD0DBA-0947-4AC8-B145-E8799F8C335C TCGA-AP-A0LS-01 929006f8-5f5c-4215-80a9-0ff6a91ef1d6 TCGA-AP-A0LS-01A-11D-A14F-01 TCGA-AP-A0LS-01A-11D-A14F-01 TCGA-AP-A0LS-01 TCGA-AP-A0LS-01 TCGA-AP-A0LS-01A-11D-A14H-05 929006f8-5f5c-4215-80a9-0ff6a91ef1d6 TCGA-AP-A0LT-01 MSI-H TCGA-AP-A0LT-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 11 TCGA-AP-A0LT TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 0 0 TCGA-AP-A0LT-F29053 TCGA-AP-A0LT TCGA-AP-A0LT-01A Former User Stage II NO -21107 1404 0 1497 NO 2012-3-6 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 200 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-AP-A0LT.4A25211C-354E-4FC8-B81B-29766B7962D4.pdf A0LT 38 negative TUMOR FREE 0 0 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive NO NO YES AP 0 0 0 16 Endometrial A LIVING 91 2006 TCGA-AP-A0LT-01 TCGA-AP-A0LT-01 TCGA-AP-A0LT-01A-21-A162-20 D535B5D0-490A-41CE-8FBF-9D6B01DD164A TCGA-AP-A0LT-01 TCGA-AP-A0LT-01 TCGA-AP-A0LT-01A-11W-A062-09 TCGA-AP-A0LT-01A-11W-A062-09 TCGA-AP-A0LT-01A-11W-A062-09 TCGA-AP-A0LT-01 cda60e53-f917-454b-b1f5-d1f0f8b8f130 TCGA-AP-A0LT-01A-11D-A042-01 TCGA-AP-A0LT-01A-11R-A040-07 TCGA-AP-A0LT-01A-11D-A042-01 TCGA-AP-A0LT-01 TCGA-AP-A0LT-01A-11D-A039-05 cda60e53-f917-454b-b1f5-d1f0f8b8f130 TCGA-AP-A0LV-01 MSS TCGA-AP-A0LV-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 4 TCGA-AP-A0LV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 39 0 0 TCGA-AP-A0LV-F29062 TCGA-AP-A0LV TCGA-AP-A0LV-01A Former User Stage IA NO -14556 341 0 763 NO 2012-3-6 FEMALE 152 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 280 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G1 NO true No TCGA-AP-A0LV.75767B04-9FDF-4EE9-8DFF-350B60AF281C.pdf A0LV 36 negative TUMOR FREE 0 0 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES AP 0 0 0 16 Endometrial A LIVING 76 2009 TCGA-AP-A0LV-01 TCGA-AP-A0LV-01 TCGA-AP-A0LV-01A-21-A162-20 F9285FF1-70D2-4E1C-B8EE-9CCDE52D9D46 TCGA-AP-A0LV-01 TCGA-AP-A0LV-01 TCGA-AP-A0LV-01A-11W-A062-09 TCGA-AP-A0LV-01A-11W-A062-09 TCGA-AP-A0LV-01A-11W-A062-09 TCGA-AP-A0LV-01 0d04e718-95ff-4eb9-b56f-99c0ee5970d2 TCGA-AP-A0LV-01A-11D-A042-01 TCGA-AP-A0LV-01A-11R-A040-07 TCGA-AP-A0LV-01A-11D-A042-01 TCGA-AP-A0LV-01 TCGA-AP-A0LV-01A-11D-A039-05 0d04e718-95ff-4eb9-b56f-99c0ee5970d2 TCGA-AP-A1DH-01 TCGA-AP-A1DH-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 TCGA-AP-A1DH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 62 0 0 TCGA-AP-A1DH-F29050 TCGA-AP-A1DH TCGA-AP-A1DH-01A Stage IA -22652 1843 0 2180 2012-3-6 FEMALE 168 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 150 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AP-A1DH.B77EE1CD-716C-4441-B4A9-CCCC37BD1379.pdf A1DH 41 negative TUMOR FREE 0 0 NO R0 Primary Tumor 01 open 2009 NO NO YES AP 0 0 0 25 Endometrial A LIVING 127 2005 TCGA-AP-A1DH-01 TCGA-AP-A1DH-01A-21-A18Q-20 BF108ABC-32D7-4B1C-8B19-2ADEDB1F178A TCGA-AP-A1DH-01 c5d7f9d3-70d3-469d-8588-5a125a24efa3 TCGA-AP-A1DH-01A-31D-A134-01 TCGA-AP-A1DH-01A-31D-A134-01 TCGA-AP-A1DH-01 TCGA-AP-A1DH-01 TCGA-AP-A1DH-01A-31D-A138-05 c5d7f9d3-70d3-469d-8588-5a125a24efa3 TCGA-AP-A1DK-01 MSI-H TCGA-AP-A1DK-01 Quiet UCEC Serous c4 cluster 3 UCEC-like c11 miRNA cluster 13 cluster 4 TCGA-AP-A1DK TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 0 0 TCGA-AP-A1DK-F68435 TCGA-AP-A1DK TCGA-AP-A1DK-01A Stage IA -19509 1541 0 2767 2014-11-17 FEMALE 160 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 70 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AP-A1DK.9A3BB88B-F16F-4773-8912-CF519B847354.pdf A1DK 36 negative TUMOR FREE 0 0 NO YES R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES AP 0 7 0 20 Endometrial A LIVING 56 2006 TCGA-AP-A1DK-01 TCGA-AP-A1DK-01 13096ff9-ae2d-4ccb-8127-8e4238cef4d3 TCGA-AP-A1DK-01A-11D-A134-01 TCGA-AP-A1DK-01A-11D-A134-01 TCGA-AP-A1DK-01 TCGA-AP-A1DK-01 TCGA-AP-A1DK-01A-11D-A138-05 13096ff9-ae2d-4ccb-8127-8e4238cef4d3 TCGA-AP-A1DM-01 MSI-H TCGA-AP-A1DM-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 TCGA-AP-A1DM TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 0 0 TCGA-AP-A1DM-F29056 TCGA-AP-A1DM TCGA-AP-A1DM-01A Stage IA -22239 1309 0 1700 2012-3-6 FEMALE 159 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 110 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-AP-A1DM.E25BA7AD-5C24-4953-B9C3-7509AE6E9F4C.pdf A1DM 23 negative TUMOR FREE 0 0 NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES AP 0 4 0 22 Endometrial A LIVING 92 2007 TCGA-AP-A1DM-01 TCGA-AP-A1DM-01A-11-A18Q-20 2DA765F6-6546-491B-A2A8-07FCB86B94D0 TCGA-AP-A1DM-01 631c96e1-7e11-4c0f-a6ea-49cd942f4390 TCGA-AP-A1DM-01A-21D-A134-01 TCGA-AP-A1DM-01A-21D-A134-01 TCGA-AP-A1DM-01 TCGA-AP-A1DM-01 TCGA-AP-A1DM-01A-21D-A138-05 631c96e1-7e11-4c0f-a6ea-49cd942f4390 TCGA-AP-A1DO-01 MSI-H TCGA-AP-A1DO-01 Iq C6-UCEC BRCA CIMP c7 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 1 TCGA-AP-A1DO TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 62 0 0 TCGA-AP-A1DO-F13624 TCGA-AP-A1DO TCGA-AP-A1DO-01A Never Used Stage IA NO -22787 1210 0 952 NO Scheduled Follow-up Submission 2011-9-23 FEMALE 156 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 220 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-AP-A1DO.EAC1A113-68BB-4D45-AB57-E59E392029BC.pdf A1DO 24 negative TUMOR FREE 0 0 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES AP 0 9 0 17 Endometrial A LIVING 80 2007 TCGA-AP-A1DO-01 TCGA-AP-A1DO-01A-21-A18Q-20 88B9B7C3-CFE9-4AC9-9B91-110B626EBA6E TCGA-AP-A1DO-01 6ff22866-1896-4200-bef2-f05724bf15a3 TCGA-AP-A1DO-01A-11D-A134-01 TCGA-AP-A1DO-01A-11D-A134-01 TCGA-AP-A1DO-01 TCGA-AP-A1DO-01 TCGA-AP-A1DO-01A-11D-A138-05 6ff22866-1896-4200-bef2-f05724bf15a3 TCGA-AP-A1DP-01 MSI-H TCGA-AP-A1DP-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 1 TCGA-AP-A1DP TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO NO Progressive Disease 70 0 0 TCGA-AP-A1DP-F13648 TCGA-AP-A1DP TCGA-AP-A1DP-01A Never Used Stage IA NO -25601 1105 1081 0 831 YES Scheduled Follow-up Submission 2011-9-23 FEMALE 158 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8441/3 C54.1 YES Dilation and curettage procedure 230 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 Other, specify Metastatic Lung, liver, lymph nodes YES true No TCGA-AP-A1DP.20EEB047-0185-4B65-9A6A-43D6C97307C8.pdf A1DP 46 negative WITH TUMOR 0 0 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO NO YES AP 0 7 0 17 Endometrial A DECEASED 83 2008 TCGA-AP-A1DP-01 TCGA-AP-A1DP-01A-21-A18Q-20 4F1CABB5-0907-49C7-80CC-AE14712D3DCA TCGA-AP-A1DP-01 97b9cac2-2c23-4759-b558-24f7b90fe787 TCGA-AP-A1DP-01A-11D-A134-01 TCGA-AP-A1DP-01A-11D-A134-01 TCGA-AP-A1DP-01 TCGA-AP-A1DP-01 TCGA-AP-A1DP-01A-11D-A138-05 97b9cac2-2c23-4759-b558-24f7b90fe787 TCGA-AP-A1DQ-01 MSS TCGA-AP-A1DQ-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 2 mutation cluster 3 TCGA-AP-A1DQ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 76 0 0 TCGA-AP-A1DQ-F29057 TCGA-AP-A1DQ TCGA-AP-A1DQ-01A Stage IIIC1 -27815 1074 1423 0 1185 2012-3-6 FEMALE 163 Serous endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 100 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) High Grade NO true No TCGA-AP-A1DQ.F5983E58-F466-42CF-8905-B942D2BDF702.pdf A1DQ 82 negative WITH TUMOR 0 6 NO R0 Primary Tumor 01 open 2009 NO NO YES AP 0 1 6 20 Endometrial A DECEASED 60 2008 TCGA-AP-A1DQ-01 TCGA-AP-A1DQ-01A-21-A18Q-20 903A7E22-F05E-40BC-A40B-7833FC342F07 TCGA-AP-A1DQ-01A-11D-A135-09 TCGA-AP-A1DQ-01A-11D-A135-09 TCGA-AP-A1DQ-01 19d3602e-79e6-467f-b49d-c2fa216418ed TCGA-AP-A1DQ-01A-11D-A134-01 TCGA-AP-A1DQ-01A-11D-A134-01 TCGA-AP-A1DQ-01 TCGA-AP-A1DQ-01 TCGA-AP-A1DQ-01A-11D-A138-05 19d3602e-79e6-467f-b49d-c2fa216418ed TCGA-AP-A1DR-01 MSI-H TCGA-AP-A1DR-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 1 TCGA-AP-A1DR TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 59 0 0 TCGA-AP-A1DR-F29058 TCGA-AP-A1DR TCGA-AP-A1DR-01A Stage IIIC1 -21904 1095 0 1495 2012-3-6 FEMALE 160 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 270 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-AP-A1DR.75A10A08-04CB-49C2-8086-5F7B1D57524E.pdf A1DR 27 negative TUMOR FREE 2 0 NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES AP 0 0 2 18 Endometrial A LIVING 109 2008 TCGA-AP-A1DR-01 TCGA-AP-A1DR-01A-21-A18Q-20 F10639F4-19FB-4548-ADC6-F6E92B342732 TCGA-AP-A1DR-01 2aacc974-7ee5-4be2-b511-1543745df0bf TCGA-AP-A1DR-01A-11D-A134-01 TCGA-AP-A1DR-01A-11D-A134-01 TCGA-AP-A1DR-01 TCGA-AP-A1DR-01 TCGA-AP-A1DR-01A-11D-A138-05 2aacc974-7ee5-4be2-b511-1543745df0bf TCGA-AP-A1DV-01 MSI-L TCGA-AP-A1DV-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-AP-A1DV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 59 0 0 TCGA-AP-A1DV-F13635 TCGA-AP-A1DV TCGA-AP-A1DV-01A Former User Stage II NO -21901 876 0 204 NO Scheduled Follow-up Submission 2011-9-23 FEMALE 147 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 170 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AP-A1DV.F3163501-DD37-4C13-A921-3C2A74928BA7.pdf A1DV 94 negative TUMOR FREE 0 0 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO NO YES AP 0 5 0 21 Endometrial A LIVING 46 2008 TCGA-AP-A1DV-01 TCGA-AP-A1DV-01A-11-A18Q-20 CA09409F-45A8-4006-BA8A-23FC3847BFD0 TCGA-AP-A1DV-01 ca0261c0-0935-450b-9e9c-db02f92ecb0e TCGA-AP-A1DV-01A-21D-A134-01 TCGA-AP-A1DV-01A-21D-A134-01 TCGA-AP-A1DV-01 TCGA-AP-A1DV-01 TCGA-AP-A1DV-01A-21D-A138-05 ca0261c0-0935-450b-9e9c-db02f92ecb0e TCGA-AP-A1E0-01 MSI-L TCGA-AP-A1E0-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 TCGA-AP-A1E0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 40 0 1 TCGA-AP-A1E0-F68436 TCGA-AP-A1E0 TCGA-AP-A1E0-01A Stage IIIC2 -14653 582 0 1832 2014-11-17 FEMALE 158 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 110 NO NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G2 NO true No TCGA-AP-A1E0.700FD29A-69DC-4B34-B841-FFFA7E76A5AF.pdf A1E0 35 positive TUMOR FREE 0 0 YES NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO YES AP 1 9 0 3 Endometrial A LIVING 59 2009 TCGA-AP-A1E0-01 TCGA-AP-A1E0-01A-21-A18Q-20 D70F0543-7F46-409A-B78E-FB4C215FB336 TCGA-AP-A1E0-01 d2b4e23b-6cfa-4831-b0ea-8d15f2a55e61 TCGA-AP-A1E0-01A-11D-A134-01 TCGA-AP-A1E0-01A-11D-A134-01 TCGA-AP-A1E0-01 TCGA-AP-A1E0-01 TCGA-AP-A1E0-01A-11D-A138-05 d2b4e23b-6cfa-4831-b0ea-8d15f2a55e61 TCGA-AP-A1E1-01 MSI-H TCGA-AP-A1E1-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 TCGA-AP-A1E1 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 74 0 0 TCGA-AP-A1E1-F68437 TCGA-AP-A1E1 TCGA-AP-A1E1-01A Stage IA NO -27072 470 0 1395 NO Scheduled Follow-up Submission 2014-11-17 FEMALE 160 Endometrioid endometrial adenocarcinoma No Yes, I am currently taking menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 260 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-AP-A1E1.E8873536-294D-4E41-9165-EE403A11B439.pdf A1E1 10 negative TUMOR FREE 0 0 NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES AP 0 0 0 2 Endometrial A LIVING 73 2009 TCGA-AP-A1E1-01 TCGA-AP-A1E1-01A-21-A18Q-20 601B63EA-312B-4BFF-A107-2DC549F295C2 TCGA-AP-A1E1-01 2e11f69d-8c0d-484e-8f22-1ad97f26c78d TCGA-AP-A1E1-01A-11D-A134-01 TCGA-AP-A1E1-01A-11D-A134-01 TCGA-AP-A1E1-01 TCGA-AP-A1E1-01 TCGA-AP-A1E1-01A-11D-A138-05 2e11f69d-8c0d-484e-8f22-1ad97f26c78d TCGA-AP-A1E3-01 MSS TCGA-AP-A1E3-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 5 cluster 4 TCGA-AP-A1E3 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Stable Disease 45 0 0 TCGA-AP-A1E3-F29063 TCGA-AP-A1E3 TCGA-AP-A1E3-01A Stage IIIC1 -16544 440 0 847 2012-3-6 FEMALE 163 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 350 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 NO true No TCGA-AP-A1E3.FDA2C217-5267-41CC-AC07-CBACFF8E7B8D.pdf A1E3 77 negative WITH TUMOR 0 1 NO R0 Primary Tumor 01 open 2009 NO NO YES AP 0 0 1 1 Endometrial A LIVING 130 2009 TCGA-AP-A1E3-01 TCGA-AP-A1E3-01A-21-A18Q-20 CD1D4130-E1BC-4829-934D-67ACF926D474 TCGA-AP-A1E3-01 0aa199cd-4fa0-4773-9659-1a246e42ad88 TCGA-AP-A1E3-01A-11D-A134-01 TCGA-AP-A1E3-01A-11D-A134-01 TCGA-AP-A1E3-01 TCGA-AP-A1E3-01 TCGA-AP-A1E3-01A-11D-A138-05 0aa199cd-4fa0-4773-9659-1a246e42ad88 TCGA-AP-A1E4-01 MSS TCGA-AP-A1E4-01 Iq C6-UCEC OV-like c1 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 TCGA-AP-A1E4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 54 0 0 TCGA-AP-A1E4-F68438 TCGA-AP-A1E4 TCGA-AP-A1E4-01A Stage IB -19814 154 0 1555 158 2014-11-17 FEMALE 163 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 90 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 YES true No TCGA-AP-A1E4.1E33ABA3-0B55-4021-A370-DB8E2CA4C022.pdf A1E4 58 negative WITH TUMOR 0 0 NO YES R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES AP 0 0 0 3 Endometrial A LIVING 54 2010 TCGA-AP-A1E4-01 TCGA-AP-A1E4-01A-21-A18Q-20 50B326F9-9A74-4C1D-A08D-46B5DDDFACDF TCGA-AP-A1E4-01 2a549626-7bc3-4ba9-9822-35af631afd0c TCGA-AP-A1E4-01A-12D-A134-01 TCGA-AP-A1E4-01A-12D-A134-01 TCGA-AP-A1E4-01 TCGA-AP-A1E4-01 TCGA-AP-A1E4-01A-12D-A138-05 2a549626-7bc3-4ba9-9822-35af631afd0c TCGA-AP-A3K1-01 MSI-L TCGA-AP-A3K1-01 High UCEC Serous c4 UCEC-like c5 miRNA cluster 13 TCGA-AP-A3K1 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Progressive Disease 56 0 12 TCGA-AP-A3K1-F38425 TCGA-AP-A3K1 TCGA-AP-A3K1-01A Never Used Stage IVB NO -20594 450 666 0 555 198 NO 2012-12-14 FEMALE 157 Serous endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8441/3 C54.1 YES Cytology (e.g. Peritoneal or pleural fluid) 190 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) High Grade Other, specify Locoregional Recurrence Paracolic gutter NO YES true No TCGA-AP-A3K1.A2E4C9FE-F82D-440E-AA52-88379EBC2442.pdf A3K1 58.8 positive WITH TUMOR 0 3 YES 0 Progressive Disease Never Used NO RX Primary Tumor 01 open 2009 NO YES AP 12 29 3 34 Endometrial A DECEASED 60 2010 c6b592eb-d131-4344-9135-7d9964143c28 TCGA-AP-A3K1-01 c6b592eb-d131-4344-9135-7d9964143c28 TCGA-AP-A3K1-01A-21-A23Z-20 B8160651-765E-4FDD-A02A-1612113DA755 c6b592eb-d131-4344-9135-7d9964143c28 c6b592eb-d131-4344-9135-7d9964143c28 TCGA-AP-A3K1-01 TCGA-AP-A3K1-01A-11D-A20R-01 TCGA-AP-A3K1-01A-11D-A20R-01 TCGA-AP-A3K1-01 TCGA-AP-A3K1-01 TCGA-AP-A3K1-01A-11D-A212-05 TCGA-AP-A5FX-01 MSS TCGA-AP-A5FX-01 TCGA-AP-A5FX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 68 0 0 TCGA-AP-A5FX-F58067 TCGA-AP-A5FX TCGA-AP-A5FX-01A Never Used Stage IIIC1 NO -25063 878 1099 0 1026 YES 2014-3-31 FEMALE 168 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. YES C54.1 8255/3 C54.1 YES Dilation and curettage procedure 300 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-AP-A5FX.AF38CD86-2F5A-46A3-903A-81A8067F2456.pdf A5FX 96 positive WITH TUMOR 0 4 YES 4+ Complete Remission/Response Never Used YES RX Primary Tumor 01 open 2009 NO YES AP 0 0 4 4 Endometrial A DECEASED 80 2010 e55857c5-0581-471c-ba7a-cd9b83afbc14 TCGA-AP-A5FX-01 e55857c5-0581-471c-ba7a-cd9b83afbc14 383E90E4-0DD9-4887-B3F5-B7FF175F3A99 e55857c5-0581-471c-ba7a-cd9b83afbc14 e55857c5-0581-471c-ba7a-cd9b83afbc14 TCGA-AP-A5FX-01 TCGA-AP-A5FX-01A-11D-A27O-01 TCGA-AP-A5FX-01A-11D-A27O-01 TCGA-AP-A5FX-01 TCGA-AP-A5FX-01 TCGA-AP-A5FX-01A-11D-A27Y-05 TCGA-AW-A1PO-01 MSS TCGA-AW-A1PO-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 TCGA-AW-A1PO TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 66 0 0 TCGA-AW-A1PO-F68990 TCGA-AW-A1PO TCGA-AW-A1PO-01A Stage IIIA -24225 331 0 17 2014-12-24 FEMALE 162 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Tumor resection 190 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true No TCGA-AW-A1PO.B5351001-32B2-4BA9-998D-F6631F6BE705.pdf A1PO 70 TUMOR FREE 0 0 NO NO R0 Primary Tumor 01 open 2009 NO YES AW 0 0 0 7 Endometrial A LIVING 58 2010 TCGA-AW-A1PO-01 TCGA-AW-A1PO-01A-21-A18Q-20 BC4CAC82-65CC-46C9-880A-C933FEBEB7DE TCGA-AW-A1PO-01 c9bdd9d8-f0f6-4abb-aca8-11d274f90995 TCGA-AW-A1PO-01A-12D-A160-01 TCGA-AW-A1PO-01A-12D-A160-01 TCGA-AW-A1PO-01 TCGA-AW-A1PO-01 TCGA-AW-A1PO-01A-12D-A161-05 c9bdd9d8-f0f6-4abb-aca8-11d274f90995 TCGA-AX-A05S-01 MSI-H TCGA-AX-A05S-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 2 mutation cluster 4 TCGA-AX-A05S TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO 81 0 TCGA-AX-A05S-F5583 TCGA-AX-A05S TCGA-AX-A05S-01A Stage IIIC NO -29928 507 413 0 338 NO 2011-5-23 FEMALE 152 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 230 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-AX-A05S.571B1EC2-3698-4FF2-89DD-7C5A8A048660.pdf A05S 50 negative WITH TUMOR 5 3 Progressive Disease YES R2 Primary Tumor 01 open 1988 YES NO YES AX 0 4 5 18 Endometrial A DECEASED 48 2008 TCGA-AX-A05S-01 TCGA-AX-A05S-01 TCGA-AX-A05S-01A-21-A162-20 51E13F14-0AA7-4DF2-A28C-9B20734EEC2E TCGA-AX-A05S-01 TCGA-AX-A05S-01 TCGA-AX-A05S-01A-11W-A027-09 TCGA-AX-A05S-01A-11W-A027-09 TCGA-AX-A05S-01A-11W-A027-09 TCGA-AX-A05S-01 f9533750-9b2f-44a2-8b4e-941fe0c53acb TCGA-AX-A05S-01A-11D-A00X-01 TCGA-AX-A05S-01A-11R-A00V-07 TCGA-AX-A05S-01A-11D-A00X-01 TCGA-AX-A05S-01 TCGA-AX-A05S-01A-11D-A00U-05 f9533750-9b2f-44a2-8b4e-941fe0c53acb TCGA-AX-A05T-01 MSS TCGA-AX-A05T-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 4 TCGA-AX-A05T TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 82 0 TCGA-AX-A05T-F62985 TCGA-AX-A05T TCGA-AX-A05T-01A Stage IB NO -30137 310 0 1010 2014-7-29 FEMALE 161 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 160 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-AX-A05T.85F75553-6E10-4AF5-9BDF-DAB52D00615B.pdf A05T 50 negative TUMOR FREE 0 NO 4+ Complete Remission/Response NO R0 Primary Tumor 01 Minimally Invasive 1988 NO NO YES AX 0 7 0 14 Endometrial A LIVING 61 2009 TCGA-AX-A05T-01 TCGA-AX-A05T-01 TCGA-AX-A05T-01A-21-A162-20 92B1BAEC-3052-4773-AB10-466CFB9CCE84 TCGA-AX-A05T-01 TCGA-AX-A05T-01 TCGA-AX-A05T-01A-11W-A027-09 TCGA-AX-A05T-01A-11W-A027-09 TCGA-AX-A05T-01A-11W-A027-09 TCGA-AX-A05T-01 8cfdaa7a-34fe-4b0f-9916-60e7158c893e TCGA-AX-A05T-01A-11D-A00X-01 TCGA-AX-A05T-01A-11R-A00V-07 TCGA-AX-A05T-01A-11D-A00X-01 TCGA-AX-A05T-01 TCGA-AX-A05T-01A-11D-A00U-05 8cfdaa7a-34fe-4b0f-9916-60e7158c893e TCGA-AX-A05U-01 MSS TCGA-AX-A05U-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-AX-A05U TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 56 0 TCGA-AX-A05U-F5579 TCGA-AX-A05U TCGA-AX-A05U-01A Stage IB NO -20533 500 0 903 YES 2011-5-23 FEMALE 155 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 180 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 false No TCGA-AX-A05U.1F51E982-37A1-40C6-BFAC-782B93D9967F.pdf A05U 50 negative TUMOR FREE 0 4+ Complete Remission/Response NO R0 Primary Tumor 01 Minimally Invasive 1988 NO NO YES AX 0 11 0 12 Endometrial A LIVING 62 2008 TCGA-AX-A05U-01 TCGA-AX-A05U-01 TCGA-AX-A05U-01A-21-A162-20 83BDFCC6-9E1F-4683-AD35-D6978DA1A959 TCGA-AX-A05U-01 TCGA-AX-A05U-01 TCGA-AX-A05U-01A-11W-A027-09 TCGA-AX-A05U-01A-11W-A027-09 TCGA-AX-A05U-01A-11W-A027-09 TCGA-AX-A05U-01 cadb8d53-b172-421d-ac3e-1583f5e55049 TCGA-AX-A05U-01A-11D-A00X-01 TCGA-AX-A05U-01A-11R-A00V-07 TCGA-AX-A05U-01A-11D-A00X-01 TCGA-AX-A05U-01 TCGA-AX-A05U-01A-11D-A00U-05 cadb8d53-b172-421d-ac3e-1583f5e55049 TCGA-AX-A05W-01 MSS TCGA-AX-A05W-01 BRCA-LUAD+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 miRNA cluster 4 cluster 2 mutation cluster 1 TCGA-AX-A05W TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 60 0 TCGA-AX-A05W-F65206 TCGA-AX-A05W TCGA-AX-A05W-01A Stage IIB NO -22200 1935 0 2450 2014-9-19 FEMALE 161 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 210 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-AX-A05W.4C960E79-D109-4C4C-B99F-F73D4DD73B40.pdf A05W 50 negative TUMOR FREE 0 NO 2 Complete Remission/Response NO R0 Primary Tumor 01 open 1988 NO NO YES AX 0 6 0 15 Endometrial A LIVING 74 2004 ceba19ee-6da0-4917-a4ba-e9bd20ad7f10 TCGA-AX-A05W-01 TCGA-AX-A05W-01 ceba19ee-6da0-4917-a4ba-e9bd20ad7f10 TCGA-AX-A05W-01A-11-A162-20 2DDFA76D-9935-4B66-BAC4-051E44960A93 TCGA-AX-A05W-01 TCGA-AX-A05W-01 ceba19ee-6da0-4917-a4ba-e9bd20ad7f10 TCGA-AX-A05W-01A-21W-A027-09 TCGA-AX-A05W-01A-21W-A027-09 TCGA-AX-A05W-01A-21W-A027-09 ceba19ee-6da0-4917-a4ba-e9bd20ad7f10 TCGA-AX-A05W-01 TCGA-AX-A05W-01A-21D-A00X-01 TCGA-AX-A05W-01A-21R-A00V-07 TCGA-AX-A05W-01A-21D-A00X-01 TCGA-AX-A05W-01 TCGA-AX-A05W-01A-21D-A00U-05 TCGA-AX-A05Y-01 MSI-H TCGA-AX-A05Y-01 Iq C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-AX-A05Y TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO YES 57 0 TCGA-AX-A05Y-F65207 TCGA-AX-A05Y TCGA-AX-A05Y-01A Stage IB NO -20904 1967 0 2684 194 YES 2014-9-19 FEMALE 166 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 230 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-AX-A05Y.7E7D9403-AA77-4F14-9017-3B69F66D8EBC.pdf A05Y 50 negative TUMOR FREE 0 NO 4+ Complete Remission/Response NO Other Method, Specify Below Whipple Procedure R0 Primary Tumor 01 open 1988 NO NO YES AX 0 6 0 24 Endometrial A LIVING 92 2004 TCGA-AX-A05Y-01 TCGA-AX-A05Y-01 TCGA-AX-A05Y-01A-21-A162-20 52EF3E35-2A73-4880-91BE-E768E8DD7D08 TCGA-AX-A05Y-01 TCGA-AX-A05Y-01 TCGA-AX-A05Y-01A-11W-A027-09 TCGA-AX-A05Y-01A-11W-A027-09 TCGA-AX-A05Y-01A-11W-A027-09 TCGA-AX-A05Y-01 153cecfe-8963-4b96-8cc3-d2870ce8e584 TCGA-AX-A05Y-01A-11D-A00X-01 TCGA-AX-A05Y-01A-11R-A00V-07 TCGA-AX-A05Y-01A-11D-A00X-01 TCGA-AX-A05Y-01 TCGA-AX-A05Y-01A-11D-A00U-05 153cecfe-8963-4b96-8cc3-d2870ce8e584 TCGA-AX-A05Y-11 MSI-H TCGA-AX-A05Y-11 C6-UCEC mutation cluster 4 TCGA-AX-A05Y TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO YES 57 0 TCGA-AX-A05Y-F65207 TCGA-AX-A05Y TCGA-AX-A05Y-11A Stage IB NO -20904 2391 0 2684 194 YES 2014-9-19 FEMALE 166 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 140 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No A05Y 50 negative TUMOR FREE 0 NO 4+ Complete Remission/Response NO Other Method, Specify Below Whipple Procedure R0 Solid Tissue Normal 11 open 1988 NO NO YES AX 0 6 0 24 Endometrial A LIVING 92 2004 1011cb92-17a6-48b0-95ab-da22acddfb5a 1011cb92-17a6-48b0-95ab-da22acddfb5a 1011cb92-17a6-48b0-95ab-da22acddfb5a 1011cb92-17a6-48b0-95ab-da22acddfb5a TCGA-AX-A05Y-11 TCGA-AX-A05Y-11 TCGA-AX-A05Y-11A-11D-A27Y-05 TCGA-AX-A05Z-01 MSS TCGA-AX-A05Z-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 2 mutation cluster 11 TCGA-AX-A05Z TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 37 0 TCGA-AX-A05Z-F65208 TCGA-AX-A05Z TCGA-AX-A05Z-01A Stage IIIA NO -13529 1416 0 2175 2014-9-19 FEMALE 150 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 180 NO NO Indeterminate (neither Pre or Postmenopausal) G2 NO false No TCGA-AX-A05Z.5938A010-17E7-41FB-9F4D-8B4F1A3C0F2F.pdf A05Z 50 negative TUMOR FREE 0 NO Complete Remission/Response NO R1 Primary Tumor 01 Minimally Invasive 1988 YES NO YES AX 0 7 0 13 Endometrial A LIVING 66 2006 TCGA-AX-A05Z-01 TCGA-AX-A05Z-01 TCGA-AX-A05Z-01A-21-A162-20 5ADB0EFC-74E1-4C20-8516-88D70CB851A0 TCGA-AX-A05Z-01 TCGA-AX-A05Z-01 TCGA-AX-A05Z-01A-11W-A027-09 TCGA-AX-A05Z-01A-11W-A027-09 TCGA-AX-A05Z-01 5e6246e7-35a3-4ce5-b234-b4dec034a6a8 TCGA-AX-A05Z-01A-11D-A00X-01 TCGA-AX-A05Z-01A-11R-A00V-07 TCGA-AX-A05Z-01A-11D-A00X-01 TCGA-AX-A05Z-01 TCGA-AX-A05Z-01A-11D-A00U-05 5e6246e7-35a3-4ce5-b234-b4dec034a6a8 TCGA-AX-A060-01 MSI-H TCGA-AX-A060-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 2 TCGA-AX-A060 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 77 0 TCGA-AX-A060-F5558 TCGA-AX-A060 TCGA-AX-A060-01A Stage IC NO -28472 1033 0 1075 2011-5-24 FEMALE 163 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 170 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-AX-A060.9086A79B-F764-42D4-BD9A-4C4F9F65C92B.pdf A060 50 negative TUMOR FREE 0 4+ Complete Remission/Response YES R1 Primary Tumor 01 open 1988 YES NO YES AX 0 6 0 17 Endometrial A LIVING 87 2007 TCGA-AX-A060-01 TCGA-AX-A060-01 TCGA-AX-A060-01A-21-A162-20 97D25271-925A-4D51-95D3-AE0C5B584BB3 TCGA-AX-A060-01 TCGA-AX-A060-01 TCGA-AX-A060-01A-11W-A027-09 TCGA-AX-A060-01A-11W-A027-09 TCGA-AX-A060-01A-11W-A027-09 TCGA-AX-A060-01 3289fb8a-7268-4669-8d0c-471fc24a8607 TCGA-AX-A060-01A-11D-A00X-01 TCGA-AX-A060-01A-11R-A00V-07 TCGA-AX-A060-01A-11D-A00X-01 TCGA-AX-A060-01 TCGA-AX-A060-01A-11D-A00U-05 3289fb8a-7268-4669-8d0c-471fc24a8607 TCGA-AX-A062-01 MSS TCGA-AX-A062-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 2 mutation cluster 4 TCGA-AX-A062 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 53 0 TCGA-AX-A062-F5504 TCGA-AX-A062 TCGA-AX-A062-01A Stage IB NO -19643 1610 0 1399 2011-5-24 FEMALE 173 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 200 NO Indeterminate (neither Pre or Postmenopausal) G1 false No TCGA-AX-A062.FAAFB078-A6DF-4E1B-BD5F-A3B30E45BE1E.pdf A062 50 negative TUMOR FREE 0 1 Complete Remission/Response NO R0 Primary Tumor 01 open 1988 NO NO YES AX 0 8 0 25 Endometrial A LIVING 122 2005 TCGA-AX-A062-01 TCGA-AX-A062-01 TCGA-AX-A062-01A-21-A162-20 DEC72ADB-614C-4E2A-A8DC-DB9FDABA89A6 TCGA-AX-A062-01 TCGA-AX-A062-01 TCGA-AX-A062-01A-11W-A027-09 TCGA-AX-A062-01A-11W-A027-09 TCGA-AX-A062-01A-11W-A027-09 TCGA-AX-A062-01 cfa7827b-f6bb-4714-ba9f-17e4adfdf3a9 TCGA-AX-A062-01A-11D-A00X-01 TCGA-AX-A062-01A-11R-A00V-07 TCGA-AX-A062-01A-11D-A00X-01 TCGA-AX-A062-01 TCGA-AX-A062-01A-11D-A00U-05 cfa7827b-f6bb-4714-ba9f-17e4adfdf3a9 TCGA-AX-A063-01 MSI-H TCGA-AX-A063-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 3 TCGA-AX-A063 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 63 0 TCGA-AX-A063-F65210 TCGA-AX-A063 TCGA-AX-A063-01A Stage IB NO -23045 1950 0 2417 2014-9-19 FEMALE 160 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 190 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-AX-A063.E911408A-8447-4CB8-8A3F-B2C24875ACF0.pdf A063 50 negative TUMOR FREE 0 NO 4+ Complete Remission/Response NO R0 Primary Tumor 01 open 1988 NO NO YES AX 0 3 0 19 Endometrial A LIVING 88 2004 TCGA-AX-A063-01 TCGA-AX-A063-01 TCGA-AX-A063-01A-21-A162-20 C40DB171-2B0B-48BD-AA20-C787378D57D3 TCGA-AX-A063-01 TCGA-AX-A063-01 TCGA-AX-A063-01A-11W-A027-09 TCGA-AX-A063-01A-11W-A027-09 TCGA-AX-A063-01 4c101954-7344-4cf7-a1bd-4cfcf472e05d TCGA-AX-A063-01A-11D-A00X-01 TCGA-AX-A063-01A-11R-A00V-07 TCGA-AX-A063-01A-11D-A00X-01 TCGA-AX-A063-01 TCGA-AX-A063-01A-11D-A00U-05 4c101954-7344-4cf7-a1bd-4cfcf472e05d TCGA-AX-A064-01 MSI-H TCGA-AX-A064-01 Iq C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 mutation cluster 4 TCGA-AX-A064 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 81 0 TCGA-AX-A064-F65211 TCGA-AX-A064 TCGA-AX-A064-01A Stage IIA NO -29625 1024 0 1517 2014-9-19 FEMALE 154 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 180 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-AX-A064.F760DFF2-7A11-4465-8581-397ABAA76BE4.pdf A064 50 negative TUMOR FREE 0 NO Complete Remission/Response NO Primary Tumor 01 open 1988 NO NO YES AX 0 5 0 29 Endometrial A LIVING 48 2007 TCGA-AX-A064-01 TCGA-AX-A064-01A-21-A162-20 146A3777-8123-40F5-91E7-117DD9CE360B TCGA-AX-A064-01 TCGA-AX-A064-01A-11W-A027-09 TCGA-AX-A064-01A-11W-A027-09 TCGA-AX-A064-01A-11W-A027-09 TCGA-AX-A064-01 TCGA-AX-A064-01 91340f00-f5e1-496d-b7d5-08c2ccf57292 TCGA-AX-A064-01A-11D-A00X-01 TCGA-AX-A064-01A-11R-A00V-07 TCGA-AX-A064-01A-11D-A00X-01 TCGA-AX-A064-01 TCGA-AX-A064-01 TCGA-AX-A064-01A-11D-A00U-05 91340f00-f5e1-496d-b7d5-08c2ccf57292 TCGA-AX-A06B-01 MSS TCGA-AX-A06B-01 High C6-UCEC UCEC Serous c4 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 5 cluster 4 mutation cluster 3 TCGA-AX-A06B TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 72 TCGA-AX-A06B-F65213 TCGA-AX-A06B TCGA-AX-A06B-01A Stage IIA NO -26348 1563 0 2058 2014-9-19 FEMALE 151 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 210 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes TCGA-AX-A06B.394E8BCD-1BE6-44C4-BDAC-D251A6C08E2B.pdf A06B 50 negative TUMOR FREE 0 NO 3 Complete Remission/Response NO R0 Primary Tumor 01 open 1988 NO NO YES AX 0 8 0 13 Endometrial A LIVING 93 2005 TCGA-AX-A06B-01 TCGA-AX-A06B-01 TCGA-AX-A06B-01A-21-A162-20 3A631688-46E7-40E7-BABA-DAA439DA508D TCGA-AX-A06B-01 TCGA-AX-A06B-01 TCGA-AX-A06B-01A-11W-A027-09 TCGA-AX-A06B-01A-11W-A027-09 TCGA-AX-A06B-01A-11W-A027-09 TCGA-AX-A06B-01 e62793b0-8fb2-4c91-9f64-c0eae21571a7 TCGA-AX-A06B-01A-11D-A00X-01 TCGA-AX-A06B-01A-11R-A00V-07 TCGA-AX-A06B-01A-11D-A00X-01 TCGA-AX-A06B-01 TCGA-AX-A06B-01A-11D-A00U-05 e62793b0-8fb2-4c91-9f64-c0eae21571a7 TCGA-AX-A06D-01 MSS TCGA-AX-A06D-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 TCGA-AX-A06D TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO NO 82 0 TCGA-AX-A06D-F9718 TCGA-AX-A06D TCGA-AX-A06D-01A Stage IIIA NO -30024 1066 373 0 253 YES 2011-5-13 FEMALE 160 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 190 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 false Yes TCGA-AX-A06D.B523C3E8-6FE7-4D6A-B6CE-7DEA1C32D33F.pdf A06D 50 positive WITH TUMOR 0 Progressive Disease Former User NO R1 Primary Tumor 01 Minimally Invasive 1988 YES NO YES AX 0 3 0 7 Endometrial A DECEASED 91 2007 TCGA-AX-A06D-01 TCGA-AX-A06D-01A-21-A162-20 5269E40A-C8F6-4F21-BAEF-CD506B1D8493 f29cd33b-c1eb-4c17-b2b0-5cf553beb2a9 TCGA-AX-A06D-01A-11D-A120-01 TCGA-AX-A06D-01A-11D-A120-01 TCGA-AX-A06D-01 TCGA-AX-A06D-01A-11D-A123-05 f29cd33b-c1eb-4c17-b2b0-5cf553beb2a9 TCGA-AX-A06F-01 MSI-L TCGA-AX-A06F-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 TCGA-AX-A06F TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 59 0 TCGA-AX-A06F-F62986 TCGA-AX-A06F TCGA-AX-A06F-01A Stage IVA YES -21624 1267 0 1748 2014-7-29 FEMALE 165 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 210 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-AX-A06F.4904C404-B17E-4471-AA2F-6DC705E4FBF2.pdf A06F 50 TUMOR FREE 2 YES 2 Complete Remission/Response NO R0 Primary Tumor 01 open 1988 YES NO YES AX 0 1 2 16 Endometrial A LIVING 84 2006 TCGA-AX-A06F-01 TCGA-AX-A06F-01 TCGA-AX-A06F-01A-21-A162-20 7C89DB66-FE87-47CA-B4CF-7A851F36F37F TCGA-AX-A06F-01 TCGA-AX-A06F-01 TCGA-AX-A06F-01 6eb1ae77-4d92-4823-ad9e-2a15cae95db2 TCGA-AX-A06F-01A-11D-A00X-01 TCGA-AX-A06F-01A-11R-A00V-07 TCGA-AX-A06F-01A-11D-A00X-01 TCGA-AX-A06F-01 TCGA-AX-A06F-01A-11D-A00U-05 6eb1ae77-4d92-4823-ad9e-2a15cae95db2 TCGA-AX-A06H-01 MSI-H TCGA-AX-A06H-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 6 TCGA-AX-A06H TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 60 0 TCGA-AX-A06H-F29312 TCGA-AX-A06H Stage IIIA NO -22270 0 833 Scheduled Follow-up Submission 2011-5-17 FEMALE 160 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO No A06H 50 negative WITH TUMOR 0 1 Complete Remission/Response NO R1 Primary Tumor 01 Minimally Invasive 1988 YES NO YES AX 0 4 0 20 Endometrial LIVING 98 2008 TCGA-AX-A06H-01 TCGA-AX-A06H-01A-11D-A122-09 TCGA-AX-A06H-01A-11D-A122-09 TCGA-AX-A06H-01A-11D-A122-09 TCGA-AX-A06H-01 fb8cfa19-3dfb-4ad5-a64e-7f51837e56cf TCGA-AX-A06H-01A-11D-A120-01 TCGA-AX-A06H-01A-11D-A120-01 TCGA-AX-A06H-01 TCGA-AX-A06H-01 TCGA-AX-A06H-01A-11D-A123-05 fb8cfa19-3dfb-4ad5-a64e-7f51837e56cf TCGA-AX-A06J-01 MSS TCGA-AX-A06J-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 TCGA-AX-A06J TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 71 0 TCGA-AX-A06J-F5542 TCGA-AX-A06J TCGA-AX-A06J-01A Stage IB NO -26000 662 0 913 2011-5-26 FEMALE 161 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 200 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-AX-A06J.553324CE-44B8-416F-B965-074CE5FF9834.pdf A06J 50 negative TUMOR FREE 0 3 Complete Remission/Response YES R0 Primary Tumor 01 Minimally Invasive 1988 YES NO YES AX 0 10 0 15 Endometrial A LIVING 119 2008 TCGA-AX-A06J-01 TCGA-AX-A06J-01 TCGA-AX-A06J-01A-21-A162-20 06500A95-B79C-47B8-8777-34E5DB32AB3C TCGA-AX-A06J-01 TCGA-AX-A06J-01 TCGA-AX-A06J-01 3d4e6413-b717-45c2-8531-118ed3a593a0 TCGA-AX-A06J-01A-11D-A00X-01 TCGA-AX-A06J-01A-11R-A00V-07 TCGA-AX-A06J-01A-11D-A00X-01 TCGA-AX-A06J-01 TCGA-AX-A06J-01A-11D-A00U-05 3d4e6413-b717-45c2-8531-118ed3a593a0 TCGA-AX-A06L-01 MSS TCGA-AX-A06L-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 3 mutation cluster 4 TCGA-AX-A06L TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 63 0 TCGA-AX-A06L-F9726 TCGA-AX-A06L TCGA-AX-A06L-01A Stage IB NO -23294 1499 0 1845 2011-5-17 FEMALE 161 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 250 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 false No TCGA-AX-A06L.926937F8-6057-4D39-BB3B-0115B0ACFE1A.pdf A06L 50 negative TUMOR FREE 0 Complete Remission/Response NO R1 Primary Tumor 01 open 1988 NO NO YES AX 0 4 0 21 Endometrial A LIVING 112 2006 TCGA-AX-A06L-01 TCGA-AX-A06L-01A-21-A162-20 BF44A950-E005-4031-8F27-52901F8E5963 TCGA-AX-A06L-01A-11D-A122-09 TCGA-AX-A06L-01A-11D-A122-09 TCGA-AX-A06L-01 06ee29fc-036c-4c36-b62b-f304c6ccad50 TCGA-AX-A06L-01A-11D-A120-01 TCGA-AX-A06L-01A-11D-A120-01 TCGA-AX-A06L-01 TCGA-AX-A06L-01 TCGA-AX-A06L-01A-11D-A123-05 06ee29fc-036c-4c36-b62b-f304c6ccad50 TCGA-AX-A0IS-01 MSS TCGA-AX-A0IS-01 Iq C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 1 mutation cluster 4 TCGA-AX-A0IS TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO 52 0 TCGA-AX-A0IS-F72576 TCGA-AX-A0IS TCGA-AX-A0IS-01A Stage IC NO -19173 805 1858 0 1065 448 YES 2015-7-27 FEMALE 168 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Endocervical Biopsy Other method, specify: 90 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 false No TCGA-AX-A0IS.35606B48-9820-4F59-8090-1F8D448DB9FB.pdf A0IS 50 negative WITH TUMOR 0 [Discrepancy] Complete Remission/Response NO R1 Primary Tumor 01 Minimally Invasive 1988 YES NO YES AX 0 4 0 10 Endometrial A DECEASED 132 2008 TCGA-AX-A0IS-01 TCGA-AX-A0IS-01 TCGA-AX-A0IS-01A-21-A162-20 BD9FE914-A8A6-4F03-9C96-557466D03CAC TCGA-AX-A0IS-01 TCGA-AX-A0IS-01A-12D-A10M-09 TCGA-AX-A0IS-01A-12D-A10M-09 TCGA-AX-A0IS-01A-12D-A10M-09 0cbb432d-fbb9-4c0e-b126-3bb862ab8602 TCGA-AX-A0IS-01A-12D-A10L-01 TCGA-AX-A0IS-01A-12D-A10L-01 TCGA-AX-A0IS-01 TCGA-AX-A0IS-01A-12D-A10N-05 0cbb432d-fbb9-4c0e-b126-3bb862ab8602 TCGA-AX-A0IU-01 MSS TCGA-AX-A0IU-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 5 TCGA-AX-A0IU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 79 1 TCGA-AX-A0IU-F62988 TCGA-AX-A0IU Stage IIIC NO -29063 0 1087 YES 2014-7-29 FEMALE 158 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 No A0IU 50 negative TUMOR FREE 1 Complete Remission/Response NO R0 Primary Tumor 01 open 1988 YES NO YES AX 1 6 1 7 Endometrial LIVING 76 2008 TCGA-AX-A0IU-01 TCGA-AX-A0IU-01 TCGA-AX-A0IU-01 TCGA-AX-A0IU-01A-11D-A10B-09 TCGA-AX-A0IU-01A-11D-A10B-09 TCGA-AX-A0IU-01A-11D-A10B-09 fb355c45-282b-4eff-8d06-074d9acf1ea5 TCGA-AX-A0IU-01A-11D-A102-01 TCGA-AX-A0IU-01A-11D-A102-01 TCGA-AX-A0IU-01 TCGA-AX-A0IU-01A-11D-A10Q-05 fb355c45-282b-4eff-8d06-074d9acf1ea5 TCGA-AX-A0IW-01 MSI-L TCGA-AX-A0IW-01 High C6-UCEC OV-like c1 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 5 TCGA-AX-A0IW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 67 0 TCGA-AX-A0IW-F5518 TCGA-AX-A0IW TCGA-AX-A0IW-01A Stage IIIA NO -24488 854 0 1149 2011-5-23 FEMALE 163 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 190 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-AX-A0IW.DE971C2D-31E8-42AC-A943-29E76FCD8F68.pdf A0IW 50 negative TUMOR FREE 0 3 Complete Remission/Response NO R0 Primary Tumor 01 open 1988 YES NO YES AX 0 9 0 24 Endometrial A LIVING 61 2008 TCGA-AX-A0IW-01 TCGA-AX-A0IW-01 TCGA-AX-A0IW-01A-21-A162-20 1619E238-C173-4981-A0BD-8F7138F26FDD TCGA-AX-A0IW-01 TCGA-AX-A0IW-01 TCGA-AX-A0IW-01A-11W-A062-09 TCGA-AX-A0IW-01A-11W-A062-09 TCGA-AX-A0IW-01A-11W-A062-09 TCGA-AX-A0IW-01 60bb00e3-9ac9-4c61-bb38-b85b27bff865 TCGA-AX-A0IW-01A-11D-A042-01 TCGA-AX-A0IW-01A-11R-A040-07 TCGA-AX-A0IW-01A-11D-A042-01 TCGA-AX-A0IW-01 TCGA-AX-A0IW-01A-11D-A039-05 60bb00e3-9ac9-4c61-bb38-b85b27bff865 TCGA-AX-A0IZ-01 MSI-H TCGA-AX-A0IZ-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 5 cluster 4 TCGA-AX-A0IZ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 0 TCGA-AX-A0IZ-F62989 TCGA-AX-A0IZ TCGA-AX-A0IZ-01A Stage IB NO -19364 1114 0 1333 2014-7-29 FEMALE 160 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 200 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-AX-A0IZ.1DEA7C0C-3280-4E11-B0A4-13562DDF307B.pdf A0IZ 50 negative TUMOR FREE 0 2 Complete Remission/Response NO R0 Primary Tumor 01 open 1988 NO NO YES AX 0 3 0 21 Endometrial A LIVING 60 2007 TCGA-AX-A0IZ-01 TCGA-AX-A0IZ-01A-21-A162-20 9AADB315-ED0B-44AB-9391-6E3E04B0B4FA TCGA-AX-A0IZ-01 e76c4434-3eaf-4ab2-a994-6c27237d344d TCGA-AX-A0IZ-01A-11D-A120-01 TCGA-AX-A0IZ-01A-11D-A120-01 TCGA-AX-A0IZ-01 TCGA-AX-A0IZ-01 TCGA-AX-A0IZ-01A-11D-A123-05 e76c4434-3eaf-4ab2-a994-6c27237d344d TCGA-AX-A0IZ-11 MSI-H TCGA-AX-A0IZ-11 C6-UCEC TCGA-AX-A0IZ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 0 TCGA-AX-A0IZ-F62989 TCGA-AX-A0IZ TCGA-AX-A0IZ-11A Stage IB NO -19364 1485 0 1333 2014-7-29 FEMALE 160 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 160 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No A0IZ 50 negative TUMOR FREE 0 2 Complete Remission/Response NO R0 Solid Tissue Normal 11 open 1988 NO NO YES AX 0 3 0 21 Endometrial A LIVING 60 2007 9d6c70ea-ec88-4b78-a495-cd31cc048ece 9d6c70ea-ec88-4b78-a495-cd31cc048ece 9d6c70ea-ec88-4b78-a495-cd31cc048ece 9d6c70ea-ec88-4b78-a495-cd31cc048ece TCGA-AX-A0IZ-11 TCGA-AX-A0IZ-11 TCGA-AX-A0IZ-11A-11D-A27Y-05 TCGA-AX-A0J0-01 MSI-L TCGA-AX-A0J0-01 Quiet C6-UCEC UCEC Serous c4 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 11 TCGA-AX-A0J0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 47 0 TCGA-AX-A0J0-F5464 TCGA-AX-A0J0 TCGA-AX-A0J0-01A Stage IB NO -17466 1581 0 1220 2011-5-23 FEMALE 163 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 180 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 false No TCGA-AX-A0J0.EC377A34-B219-4A4F-95DB-DF6E0050A63A.pdf A0J0 50 negative TUMOR FREE 0 2 Complete Remission/Response NO R0 Primary Tumor 01 open 1988 NO NO YES AX 0 3 0 26 Endometrial A LIVING 53 2006 TCGA-AX-A0J0-01 TCGA-AX-A0J0-01 TCGA-AX-A0J0-01A-21-A162-20 2B44D365-A7F6-4A4E-99C5-019A2BDC6384 TCGA-AX-A0J0-01 TCGA-AX-A0J0-01A-11D-A117-09 TCGA-AX-A0J0-01A-11D-A117-09 cb236783-68e6-4522-8618-ea19fd0b8ab5 TCGA-AX-A0J0-01A-11D-A107-01 TCGA-AX-A0J0-01A-11D-A107-01 TCGA-AX-A0J0-01 TCGA-AX-A0J0-01A-11D-A10A-05 cb236783-68e6-4522-8618-ea19fd0b8ab5 TCGA-AX-A0J0-11 MSI-L TCGA-AX-A0J0-11 C6-UCEC mutation cluster 11 TCGA-AX-A0J0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 47 0 TCGA-AX-A0J0-F5464 TCGA-AX-A0J0 Stage IB NO -17466 0 1220 2011-5-23 FEMALE 163 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 No A0J0 50 negative TUMOR FREE 0 2 Complete Remission/Response NO R0 Solid Tissue Normal 11 open 1988 NO NO YES AX 0 3 0 26 Endometrial LIVING 53 2006 bdb31196-8bc4-4c2a-bbcf-641e1916733f bdb31196-8bc4-4c2a-bbcf-641e1916733f bdb31196-8bc4-4c2a-bbcf-641e1916733f bdb31196-8bc4-4c2a-bbcf-641e1916733f TCGA-AX-A0J0-11 TCGA-AX-A0J0-11 TCGA-AX-A0J0-11A-11D-A27Y-05 TCGA-AX-A0J1-01 MSI-H TCGA-AX-A0J1-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 mutation cluster 11 TCGA-AX-A0J1 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 80 0 TCGA-AX-A0J1-F65220 TCGA-AX-A0J1 TCGA-AX-A0J1-01A Stage IB NO -29501 1721 0 2354 2014-9-19 FEMALE 160 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 220 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-AX-A0J1.38FCBC4A-2CAB-46EF-805D-121BEF85912E.pdf A0J1 50 negative TUMOR FREE 0 NO Complete Remission/Response NO R0 Primary Tumor 01 open 1988 NO NO YES AX 0 7 0 15 Endometrial A LIVING 57 2005 TCGA-AX-A0J1-01 TCGA-AX-A0J1-01 TCGA-AX-A0J1-01A-21-A162-20 2EE962C0-8925-47C7-8AEA-9AE3B1375A6B TCGA-AX-A0J1-01 TCGA-AX-A0J1-01 TCGA-AX-A0J1-01A-11W-A062-09 TCGA-AX-A0J1-01A-11W-A062-09 TCGA-AX-A0J1-01 20b8dd9b-c6b1-4a16-aeeb-e5aa49e62247 TCGA-AX-A0J1-01A-11D-A042-01 TCGA-AX-A0J1-01A-11R-A040-07 TCGA-AX-A0J1-01A-11D-A042-01 TCGA-AX-A0J1-01 TCGA-AX-A0J1-01A-11D-A039-05 20b8dd9b-c6b1-4a16-aeeb-e5aa49e62247 TCGA-AX-A1C4-01 MSI-H TCGA-AX-A1C4-01 Kirc+ UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA cluster 7 cluster 1 TCGA-AX-A1C4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 52 0 TCGA-AX-A1C4-F10395 TCGA-AX-A1C4 TCGA-AX-A1C4-01A Stage IB NO -19209 575 0 404 YES 2011-5-12 FEMALE 178 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 120 NO Indeterminate (neither Pre or Postmenopausal) G2 false No TCGA-AX-A1C4.81C6DDE6-ACC3-4659-91EC-D986671B592A.pdf A1C4 50 negative TUMOR FREE 0 0 YES R1 Primary Tumor 01 open 1988 NO NO YES AX 0 8 0 13 Endometrial A LIVING 115 2009 TCGA-AX-A1C4-01 TCGA-AX-A1C4-01 58623d8a-f51b-470a-bde3-f31e91f9bd80 TCGA-AX-A1C4-01A-11D-A134-01 TCGA-AX-A1C4-01A-11D-A134-01 TCGA-AX-A1C4-01 TCGA-AX-A1C4-01 TCGA-AX-A1C4-01A-11D-A138-05 58623d8a-f51b-470a-bde3-f31e91f9bd80 TCGA-AX-A1C5-01 MSI-H TCGA-AX-A1C5-01 Kirc+ UCEC non-CIMP c3 cluster 2 UCEC-like c11 miRNA cluster 12 cluster 5 TCGA-AX-A1C5 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 47 1 TCGA-AX-A1C5-F65223 TCGA-AX-A1C5 TCGA-AX-A1C5-01A Stage IIIC NO -17383 517 0 1001 404 YES 2014-9-19 FEMALE 160 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 130 NO NO Indeterminate (neither Pre or Postmenopausal) G3 NO false No TCGA-AX-A1C5.6F79B83A-90B4-45DF-8542-A6BC2F93470D.pdf A1C5 50 negative WITH TUMOR 1 YES Complete Remission/Response YES R2 Primary Tumor 01 open 1988 YES NO YES AX 1 1 1 2 Endometrial A LIVING 107 2009 TCGA-AX-A1C5-01 TCGA-AX-A1C5-01 1bce2d6c-cbe9-4191-b23c-a3bb815ec5e1 TCGA-AX-A1C5-01A-11D-A134-01 TCGA-AX-A1C5-01A-11D-A134-01 TCGA-AX-A1C5-01 TCGA-AX-A1C5-01 TCGA-AX-A1C5-01A-11D-A138-05 1bce2d6c-cbe9-4191-b23c-a3bb815ec5e1 TCGA-AX-A1C7-01 MSS TCGA-AX-A1C7-01 COAD-READ C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c11 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-AX-A1C7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO NO 77 0 TCGA-AX-A1C7-F65224 TCGA-AX-A1C7 TCGA-AX-A1C7-01A Stage IB -28198 423 0 1054 390 2014-9-19 FEMALE 152 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 90 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AX-A1C7.10458026-49D7-40EC-BC7B-0D6A381FB025.pdf A1C7 50 negative 0 YES NO R0 Primary Tumor 01 open 1988 YES NO YES AX 0 9 0 24 Endometrial A LIVING 60 2009 284f6163-92f2-4e21-8649-45dcfce6634f TCGA-AX-A1C7-01 284f6163-92f2-4e21-8649-45dcfce6634f 284f6163-92f2-4e21-8649-45dcfce6634f TCGA-AX-A1C7-01A-11D-A135-09 TCGA-AX-A1C7-01A-11D-A135-09 284f6163-92f2-4e21-8649-45dcfce6634f TCGA-AX-A1C7-01 284f6163-92f2-4e21-8649-45dcfce6634f TCGA-AX-A1C7-01A-11D-A134-01 TCGA-AX-A1C7-01A-11D-A134-01 TCGA-AX-A1C7-01 TCGA-AX-A1C7-01 TCGA-AX-A1C7-01A-11D-A138-05 284f6163-92f2-4e21-8649-45dcfce6634f TCGA-AX-A1C8-01 MSS TCGA-AX-A1C8-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c11 miRNA cluster 13 cluster 2 mutation cluster 13 TCGA-AX-A1C8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 77 0 TCGA-AX-A1C8-F65226 TCGA-AX-A1C8 TCGA-AX-A1C8-01A Stage IIIC NO -28452 475 0 776 2014-9-19 FEMALE 156 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 100 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AX-A1C8.5F0E78BA-B827-4DB6-99EB-5FA3D3598793.pdf A1C8 50 negative 1 YES 4+ NO R1 Primary Tumor 01 Minimally Invasive 1988 YES NO YES AX 0 3 1 12 Endometrial A LIVING 66 2009 TCGA-AX-A1C8-01 TCGA-AX-A1C8-01A-11D-A135-09 TCGA-AX-A1C8-01A-11D-A135-09 TCGA-AX-A1C8-01A-11D-A135-09 TCGA-AX-A1C8-01 34149234-2d6a-46ac-b7e0-52787cf2c49a TCGA-AX-A1C8-01A-11D-A134-01 TCGA-AX-A1C8-01A-11D-A134-01 TCGA-AX-A1C8-01 TCGA-AX-A1C8-01 TCGA-AX-A1C8-01A-11D-A138-05 34149234-2d6a-46ac-b7e0-52787cf2c49a TCGA-AX-A1C9-01 MSI-H TCGA-AX-A1C9-01 Kirc+ UCEC non-CIMP c3 cluster 2 UCEC-like c11 miRNA cluster 13 cluster 6 TCGA-AX-A1C9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 73 0 TCGA-AX-A1C9-F65227 TCGA-AX-A1C9 Stage IB NO -26903 0 802 YES 2014-9-19 FEMALE 152 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO No A1C9 50 negative TUMOR FREE 0 NO NO R0 Primary Tumor 01 Minimally Invasive 1988 NO NO YES AX 0 3 0 17 Endometrial LIVING 73 2009 TCGA-AX-A1C9-01 TCGA-AX-A1C9-01 a5a45936-135b-499e-a0bb-7c2d992ef962 TCGA-AX-A1C9-01A-11D-A134-01 TCGA-AX-A1C9-01A-11D-A134-01 TCGA-AX-A1C9-01 TCGA-AX-A1C9-01 TCGA-AX-A1C9-01A-11D-A138-05 a5a45936-135b-499e-a0bb-7c2d992ef962 TCGA-AX-A1CA-01 Indeterminate TCGA-AX-A1CA-01 High UCEC Serous c4 cluster 3 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-AX-A1CA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 70 0 TCGA-AX-A1CA-F63035 TCGA-AX-A1CA Stage IB NO -25817 0 974 2014-7-30 FEMALE 157 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy NO G3 NO No A1CA 50 negative TUMOR FREE 0 YES NO R1 Primary Tumor 01 open 1988 YES NO YES AX 0 4 0 10 Endometrial LIVING 77 2009 TCGA-AX-A1CA-01 TCGA-AX-A1CA-01 cadf8449-cd8e-4581-ad35-37a0aa2f7a9b TCGA-AX-A1CA-01A-12D-A134-01 TCGA-AX-A1CA-01A-12D-A134-01 TCGA-AX-A1CA-01 TCGA-AX-A1CA-01 TCGA-AX-A1CA-01A-12D-A138-05 cadf8449-cd8e-4581-ad35-37a0aa2f7a9b TCGA-AX-A1CC-01 MSI-L TCGA-AX-A1CC-01 COAD-READ Low purity c2 cluster 3 UCEC-like c11 miRNA cluster 13 cluster 6 TCGA-AX-A1CC TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 65 0 TCGA-AX-A1CC-F62990 TCGA-AX-A1CC Stage IC NO -23795 0 788 NO 2014-7-29 FEMALE 156 Serous endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO No A1CC 50 negative TUMOR FREE 0 YES 2 NO R0 Primary Tumor 01 open 1988 YES NO YES AX 0 9 0 11 Endometrial LIVING 99 2010 TCGA-AX-A1CC-01 TCGA-AX-A1CC-01 ac3b86dc-2dd8-41e8-832a-5625f5cd5a27 TCGA-AX-A1CC-01A-11D-A134-01 TCGA-AX-A1CC-01A-11D-A134-01 TCGA-AX-A1CC-01 TCGA-AX-A1CC-01 TCGA-AX-A1CC-01A-11D-A138-05 ac3b86dc-2dd8-41e8-832a-5625f5cd5a27 TCGA-AX-A1CE-01 MSI-H TCGA-AX-A1CE-01 Quiet UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-AX-A1CE TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES Complete Response 60 0 TCGA-AX-A1CE-F65229 TCGA-AX-A1CE TCGA-AX-A1CE-01A Stage IB NO -21969 504 0 1037 2014-9-19 FEMALE 160 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Total hysterectomy, bilateral salpingo-oophorectomy with pelvic and para-aortic lymph node dissection Other method, specify: 130 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AX-A1CE.79482353-F9A0-4A36-97B3-F270241B2B50.pdf A1CE 50 negative TUMOR FREE 0 YES 3 YES R0 R0 Primary Tumor 01 Minimally Invasive 1988 YES NO YES AX 0 5 0 12 Endometrial A LIVING 58 2009 TCGA-AX-A1CE-01 TCGA-AX-A1CE-01 2a9c8cdb-71bc-480d-b9d5-c6b8c0198daf TCGA-AX-A1CE-01A-11D-A134-01 TCGA-AX-A1CE-01A-11D-A134-01 TCGA-AX-A1CE-01 TCGA-AX-A1CE-01 TCGA-AX-A1CE-01A-11D-A138-05 2a9c8cdb-71bc-480d-b9d5-c6b8c0198daf TCGA-AX-A1CF-01 MSS TCGA-AX-A1CF-01 Squamous OV-like c1 cluster 3 UCEC-like c11 miRNA c1uster 10 cluster 2 TCGA-AX-A1CF TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES NO 69 0 TCGA-AX-A1CF-F10338 TCGA-AX-A1CF Stage IVB NO -25300 0 2337 875 2011-5-10 FEMALE 150 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy G3 No A1CF 50 positive WITH TUMOR Progressive Disease Former User YES R2 Primary Tumor 01 open 1988 YES NO YES AX 0 7 0 0 Endometrial LIVING 79 2004 TCGA-AX-A1CF-01 TCGA-AX-A1CF-01 ee60f261-392f-4583-8ddb-b29f07f20e6e TCGA-AX-A1CF-01A-11D-A134-01 TCGA-AX-A1CF-01A-11D-A134-01 TCGA-AX-A1CF-01 TCGA-AX-A1CF-01 TCGA-AX-A1CF-01A-11D-A138-05 ee60f261-392f-4583-8ddb-b29f07f20e6e TCGA-AX-A1CF-11 MSS TCGA-AX-A1CF-11 TCGA-AX-A1CF TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES NO 69 0 TCGA-AX-A1CF-F10338 TCGA-AX-A1CF Stage IVB NO -25300 0 2337 875 2011-5-10 FEMALE 150 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy G3 No A1CF 50 positive WITH TUMOR Progressive Disease Former User YES R2 Solid Tissue Normal 11 open 1988 YES NO YES AX 0 7 0 0 Endometrial LIVING 79 2004 TCGA-AX-A1CF-11 c588b29f-0abf-47c6-bff2-d0589ea506ee TCGA-AX-A1CF-11 TCGA-AX-A1CF-11A-11D-A138-05 c588b29f-0abf-47c6-bff2-d0589ea506ee TCGA-AX-A1CI-01 MSS TCGA-AX-A1CI-01 Iq UCEC CIMP c18 cluster 2 UCEC-like c11 miRNA cluster 13 cluster 6 TCGA-AX-A1CI TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 61 0 TCGA-AX-A1CI-F65231 TCGA-AX-A1CI Stage IB NO -22582 0 2600 2014-9-19 FEMALE 164 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO No A1CI 50 negative TUMOR FREE 0 NO NO R0 Primary Tumor 01 open 1988 NO NO YES AX 0 3 0 13 Endometrial LIVING 74 2004 TCGA-AX-A1CI-01 TCGA-AX-A1CI-01 e54b7e44-82a3-4016-bc32-129799097b4c TCGA-AX-A1CI-01A-11D-A134-01 TCGA-AX-A1CI-01A-11D-A134-01 TCGA-AX-A1CI-01 TCGA-AX-A1CI-01 TCGA-AX-A1CI-01A-11D-A138-05 e54b7e44-82a3-4016-bc32-129799097b4c TCGA-AX-A1CI-11 MSS TCGA-AX-A1CI-11 TCGA-AX-A1CI TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 61 0 TCGA-AX-A1CI-F65231 TCGA-AX-A1CI Stage IB NO -22582 0 2600 2014-9-19 FEMALE 164 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO No A1CI 50 negative TUMOR FREE 0 NO NO R0 Solid Tissue Normal 11 open 1988 NO NO YES AX 0 3 0 13 Endometrial LIVING 74 2004 TCGA-AX-A1CI-11 ce5b0ba0-2777-4c92-ac50-483174cc5dca TCGA-AX-A1CI-11 TCGA-AX-A1CI-11A-11D-A138-05 ce5b0ba0-2777-4c92-ac50-483174cc5dca TCGA-AX-A1CJ-01 Indeterminate TCGA-AX-A1CJ-01 Iq UCEC non-CIMP c3 cluster 4 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-AX-A1CJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 59 TCGA-AX-A1CJ-F65232 TCGA-AX-A1CJ TCGA-AX-A1CJ-01A Stage IC NO -21655 1758 0 2233 2014-9-19 FEMALE 163 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 90 NO NO Indeterminate (neither Pre or Postmenopausal) G2 NO false No TCGA-AX-A1CJ.AC9C3BB1-9B41-4B1F-BCEA-F6A0C68921B3.pdf A1CJ 50 negative TUMOR FREE NO YES R0 Primary Tumor 01 open 1988 NO NO YES AX 0 0 0 0 Endometrial A LIVING 115 2006 TCGA-AX-A1CJ-01 TCGA-AX-A1CJ-01 87d95a5d-174b-4f13-a00f-85a28bfd1fb7 TCGA-AX-A1CJ-01A-11D-A134-01 TCGA-AX-A1CJ-01A-11D-A134-01 TCGA-AX-A1CJ-01 TCGA-AX-A1CJ-01 TCGA-AX-A1CJ-01A-11D-A138-05 87d95a5d-174b-4f13-a00f-85a28bfd1fb7 TCGA-AX-A1CJ-11 Indeterminate TCGA-AX-A1CJ-11 TCGA-AX-A1CJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 59 TCGA-AX-A1CJ-F65232 TCGA-AX-A1CJ TCGA-AX-A1CJ-11A Stage IC NO -21655 1758 0 2233 2014-9-19 FEMALE 163 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 120 NO NO Indeterminate (neither Pre or Postmenopausal) G2 NO false No A1CJ 50 negative TUMOR FREE NO YES R0 Solid Tissue Normal 11 open 1988 NO NO YES AX 0 0 0 0 Endometrial A LIVING 115 2006 TCGA-AX-A1CJ-11A-11D-A138-05 TCGA-AX-A1CK-01 MSS TCGA-AX-A1CK-01 BRCA-LUAD+ UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA cluster 12 cluster 5 TCGA-AX-A1CK TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO YES 58 0 TCGA-AX-A1CK-F65233 TCGA-AX-A1CK TCGA-AX-A1CK-01A Stage IB NO 1027 -21200 2115 0 2441 NO 2014-9-25 FEMALE 163 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 100 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-AX-A1CK.5810919B-7778-4566-A024-2D70BDE9A4F5.pdf A1CK 50 negative WITH TUMOR 0 NO NO Surgical Resection R0 Primary Tumor 01 open 1988 NO NO YES AX 0 3 0 14 Endometrial A LIVING 72 2005 TCGA-AX-A1CK-01 TCGA-AX-A1CK-01 5755caa5-b187-498f-a7a9-22e8ddcd2830 TCGA-AX-A1CK-01A-11D-A134-01 TCGA-AX-A1CK-01A-11D-A134-01 TCGA-AX-A1CK-01 TCGA-AX-A1CK-01 TCGA-AX-A1CK-01A-11D-A138-05 5755caa5-b187-498f-a7a9-22e8ddcd2830 TCGA-AX-A1CK-11 MSS TCGA-AX-A1CK-11 TCGA-AX-A1CK TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO YES 58 0 TCGA-AX-A1CK-F65233 TCGA-AX-A1CK TCGA-AX-A1CK-11A Stage IB NO 1027 -21200 2115 0 2441 NO 2014-9-25 FEMALE 163 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 100 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No A1CK 50 negative WITH TUMOR 0 NO NO Surgical Resection R0 Solid Tissue Normal 11 open 1988 NO NO YES AX 0 3 0 14 Endometrial A LIVING 72 2005 TCGA-AX-A1CK-11 3aba63fa-86d2-4ca9-b064-fe782a749161 TCGA-AX-A1CK-11 TCGA-AX-A1CK-11A-11D-A138-05 3aba63fa-86d2-4ca9-b064-fe782a749161 TCGA-AX-A1CN-01 MSI-L TCGA-AX-A1CN-01 Kirc+ OV-like c1 cluster 3 RNA cluster 3 miRNA cluster 12 cluster 5 TCGA-AX-A1CN TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 54 0 TCGA-AX-A1CN-F65235 TCGA-AX-A1CN TCGA-AX-A1CN-01A Stage IIB NO -19860 701 0 1143 1105 2014-9-19 FEMALE 175 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 110 NO NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 Lung New Primary Tumor YES false No TCGA-AX-A1CN.D0FB2179-60D4-4B3C-9D88-B07D802F772E.pdf A1CN 50 negative WITH TUMOR 0 YES 1 YES R0 Primary Tumor 01 open 1988 YES NO YES AX 0 5 0 13 Endometrial A LIVING 146 2009 TCGA-AX-A1CN-01 TCGA-AX-A1CN-01 222512dc-7088-4c86-a82c-99c2e4cd427c TCGA-AX-A1CN-01A-11D-A134-01 TCGA-AX-A1CN-01A-11D-A134-01 TCGA-AX-A1CN-01 TCGA-AX-A1CN-01 TCGA-AX-A1CN-01A-11D-A138-05 222512dc-7088-4c86-a82c-99c2e4cd427c TCGA-AX-A1CP-01 MSS TCGA-AX-A1CP-01 Squamous C6-UCEC OV-like c1 cluster 3 UCEC-like c11 miRNA cluster 13 cluster 6 mutation cluster 3 TCGA-AX-A1CP TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO 84 0 TCGA-AX-A1CP-F9828 TCGA-AX-A1CP Stage IA NO -30737 0 1107 722 YES 2011-5-12 FEMALE 156 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Yes A1CP 0 negative 0 NO R1 Primary Tumor 01 Minimally Invasive 1988 YES NO YES AX 0 5 0 11 Endometrial LIVING 55 2008 TCGA-AX-A1CP-01 TCGA-AX-A1CP-01A-11D-A135-09 TCGA-AX-A1CP-01A-11D-A135-09 TCGA-AX-A1CP-01A-11D-A135-09 da204d4a-922e-4501-9db6-8034ae6b8177 TCGA-AX-A1CP-01A-11D-A134-01 TCGA-AX-A1CP-01A-11D-A134-01 TCGA-AX-A1CP-01 TCGA-AX-A1CP-01A-11D-A138-05 da204d4a-922e-4501-9db6-8034ae6b8177 TCGA-AX-A1CR-01 MSS TCGA-AX-A1CR-01 High UCEC Serous c4 cluster 3 UCEC-like c11 miRNA cluster 4 cluster 2 TCGA-AX-A1CR TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 70 TCGA-AX-A1CR-F65236 TCGA-AX-A1CR Stage IIB NO -25812 0 701 2014-9-19 FEMALE 165 Mixed serous and endometrioid No YES C54.1 8441/3 C54.1 YES Dilation and curettage procedure NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO Yes A1CR 50 negative TUMOR FREE YES 0 NO R1 Primary Tumor 01 open 1988 YES NO YES AX 0 12 0 17 Endometrial LIVING 97 2010 TCGA-AX-A1CR-01 d979abda-1498-41e5-848c-8dc20d6c7eee TCGA-AX-A1CR-01A-12D-A134-01 TCGA-AX-A1CR-01A-12D-A134-01 TCGA-AX-A1CR-01 TCGA-AX-A1CR-01A-12D-A138-05 d979abda-1498-41e5-848c-8dc20d6c7eee TCGA-AX-A2H2-01 MSS TCGA-AX-A2H2-01 High C6-UCEC UCEC Serous c4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 TCGA-AX-A2H2 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 86 TCGA-AX-A2H2-F31588 TCGA-AX-A2H2 TCGA-AX-A2H2-01A Stage IIA NO -31524 1079 145 0 YES Scheduled Follow-up Submission 2012-5-7 FEMALE 162 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 160 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AX-A2H2.1BDF6880-A5E1-4DD8-A7E5-1E91BBCF8F60.pdf A2H2 negative TUMOR FREE 4+ Complete Remission/Response NO R0 Primary Tumor 01 open 1988 NO NO YES AX 0 0 0 5 Endometrial A DECEASED 65 2008 TCGA-AX-A2H2-01 TCGA-AX-A2H2-01A-21-A18R-20 17E73B0A-942F-4EA2-95E5-F1A0618240B3 TCGA-AX-A2H2-01 245e65eb-ec7a-4a85-a524-194afbdf67ef TCGA-AX-A2H2-01A-11D-A17U-01 TCGA-AX-A2H2-01A-11D-A17U-01 TCGA-AX-A2H2-01 TCGA-AX-A2H2-01 TCGA-AX-A2H2-01A-11D-A17Z-05 245e65eb-ec7a-4a85-a524-194afbdf67ef TCGA-AX-A2H4-01 MSS TCGA-AX-A2H4-01 Squamous UCEC non-CIMP c3 miRNA cluster 14 TCGA-AX-A2H4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO Progressive Disease 66 TCGA-AX-A2H4-F31597 TCGA-AX-A2H4 TCGA-AX-A2H4-01A Stage IIIA NO -24234 1981 916 0 520 YES Scheduled Follow-up Submission 2012-5-7 FEMALE 157 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 120 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Disease Vaginal cuff, iliac YES false No TCGA-AX-A2H4.5230A27B-4AA6-4ED9-90BB-98C6671E0B2E.pdf A2H4 negative WITH TUMOR Complete Remission/Response NO R2 Primary Tumor 01 open 1988 NO NO YES AX 0 0 0 0 Endometrial A DECEASED 84 2006 46eaeac0-bacb-4c76-b86d-5bd912229f69 TCGA-AX-A2H4-01 46eaeac0-bacb-4c76-b86d-5bd912229f69 46eaeac0-bacb-4c76-b86d-5bd912229f69 46eaeac0-bacb-4c76-b86d-5bd912229f69 TCGA-AX-A2H4-01 TCGA-AX-A2H4-01A-21D-A18N-01 TCGA-AX-A2H4-01A-21D-A18N-01 TCGA-AX-A2H4-01 TCGA-AX-A2H4-01 TCGA-AX-A2H4-01A-21D-A18O-05 TCGA-AX-A2H4-11 MSS TCGA-AX-A2H4-11 TCGA-AX-A2H4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO Progressive Disease 66 TCGA-AX-A2H4-F31597 TCGA-AX-A2H4 TCGA-AX-A2H4-11A Stage IIIA NO -24234 1981 916 0 520 YES Scheduled Follow-up Submission 2012-5-7 FEMALE 157 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 180 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Disease Vaginal cuff, iliac YES false No A2H4 negative WITH TUMOR Complete Remission/Response NO R2 Solid Tissue Normal 11 open 1988 NO NO YES AX 0 0 0 0 Endometrial A DECEASED 84 2006 TCGA-AX-A2H4-11A-11D-A18O-05 TCGA-AX-A2H5-01 MSS TCGA-AX-A2H5-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 2 TCGA-AX-A2H5 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 TCGA-AX-A2H5-F31616 TCGA-AX-A2H5 TCGA-AX-A2H5-01A Stage IIIC NO -24757 2206 0 2167 Scheduled Follow-up Submission 2012-5-7 FEMALE 161 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 100 NO G3 NO false No TCGA-AX-A2H5.BF4BE7F8-7D37-4CB2-B340-FAE14155F257.pdf A2H5 negative TUMOR FREE Complete Remission/Response YES R1 Primary Tumor 01 open 1988 YES NO YES AX 3 5 9 13 Endometrial A LIVING 87 2005 TCGA-AX-A2H5-01 TCGA-AX-A2H5-01A-21-A18R-20 5298E5E5-5AAF-46F4-8D91-AA10FAB8F2B2 TCGA-AX-A2H5-01A-11D-A17D-09 TCGA-AX-A2H5-01A-11D-A17D-09 TCGA-AX-A2H5-01A-11D-A17D-09 TCGA-AX-A2H5-01 2f712e62-f400-4922-bdc5-d5d06276101d TCGA-AX-A2H5-01A-11D-A17C-01 TCGA-AX-A2H5-01A-11D-A17C-01 TCGA-AX-A2H5-01 TCGA-AX-A2H5-01 TCGA-AX-A2H5-01A-11D-A17F-05 2f712e62-f400-4922-bdc5-d5d06276101d TCGA-AX-A2H5-11 MSS TCGA-AX-A2H5-11 C6-UCEC mutation cluster 2 TCGA-AX-A2H5 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 TCGA-AX-A2H5-F31616 TCGA-AX-A2H5 TCGA-AX-A2H5-11A Stage IIIC NO -24757 2206 0 2167 Scheduled Follow-up Submission 2012-5-7 FEMALE 161 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 130 NO G3 NO false No A2H5 negative TUMOR FREE Complete Remission/Response YES R1 Solid Tissue Normal 11 open 1988 YES NO YES AX 3 5 9 13 Endometrial A LIVING 87 2005 TCGA-AX-A2H5-11A-11D-A17F-05 TCGA-AX-A2H7-01 MSS TCGA-AX-A2H7-01 BRCA-LUAD+ C6-UCEC UCEC non-CIMP c3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 TCGA-AX-A2H7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO NO Progressive Disease 87 TCGA-AX-A2H7-F31704 TCGA-AX-A2H7 TCGA-AX-A2H7-01A Stage IC NO -32100 951 1241 0 1020 684 YES Scheduled Follow-up Submission 2012-5-8 FEMALE 151 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 160 NO G3 Lung Metastatic YES false No TCGA-AX-A2H7.76630DF8-2D08-4CF8-8B07-ACCE872B3ED1.pdf A2H7 negative WITH TUMOR 4+ Complete Remission/Response YES R0 Primary Tumor 01 open 1988 NO NO YES AX 0 3 0 12 Endometrial A DECEASED 60 2008 TCGA-AX-A2H7-01 TCGA-AX-A2H7-01A-21-A23Z-20 808DF04C-E181-48B1-A9C5-0EB8617CC26F TCGA-AX-A2H7-01 25dd0765-735c-4146-9551-cdfdd9213593 TCGA-AX-A2H7-01A-12D-A18N-01 TCGA-AX-A2H7-01A-12D-A18N-01 TCGA-AX-A2H7-01 TCGA-AX-A2H7-01 TCGA-AX-A2H7-01A-12D-A18O-05 25dd0765-735c-4146-9551-cdfdd9213593 TCGA-AX-A2H7-11 MSS TCGA-AX-A2H7-11 C6-UCEC TCGA-AX-A2H7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO NO Progressive Disease 87 TCGA-AX-A2H7-F31704 TCGA-AX-A2H7 TCGA-AX-A2H7-11A Stage IC NO -32100 951 1241 0 1020 684 YES Scheduled Follow-up Submission 2012-5-8 FEMALE 151 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 140 NO G3 Lung Metastatic YES false No A2H7 negative WITH TUMOR 4+ Complete Remission/Response YES R0 Solid Tissue Normal 11 open 1988 NO NO YES AX 0 3 0 12 Endometrial A DECEASED 60 2008 TCGA-AX-A2H7-11A-11D-A18O-05 TCGA-AX-A2H8-01 MSI-L TCGA-AX-A2H8-01 High C6-UCEC UCEC non-CIMP c3 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 TCGA-AX-A2H8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 TCGA-AX-A2H8-F31709 TCGA-AX-A2H8 TCGA-AX-A2H8-01A Stage IB NO -23448 1974 0 1861 Scheduled Follow-up Submission 2012-5-8 FEMALE 160 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 150 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes TCGA-AX-A2H8.1D1AF737-8A5A-4274-B9AD-2F4BA3127DDD.pdf A2H8 negative TUMOR FREE 3 Complete Remission/Response YES R0 Primary Tumor 01 open 1988 NO NO YES AX 0 17 0 22 Endometrial A LIVING 113 2006 TCGA-AX-A2H8-01 TCGA-AX-A2H8-01A-21-A18R-20 EB4C8FF0-F085-401B-A1D7-B37B1DEEE592 99d5ea34-d803-41f1-a7bc-3d9e0fb3dbda TCGA-AX-A2H8-01A-11D-A17C-01 TCGA-AX-A2H8-01A-11D-A17C-01 TCGA-AX-A2H8-01 TCGA-AX-A2H8-01A-11D-A17F-05 99d5ea34-d803-41f1-a7bc-3d9e0fb3dbda TCGA-AX-A2H8-11 MSI-L TCGA-AX-A2H8-11 C6-UCEC TCGA-AX-A2H8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 TCGA-AX-A2H8-F31709 TCGA-AX-A2H8 TCGA-AX-A2H8-11A Stage IB NO -23448 1974 0 1861 Scheduled Follow-up Submission 2012-5-8 FEMALE 160 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 140 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes A2H8 negative TUMOR FREE 3 Complete Remission/Response YES R0 Solid Tissue Normal 11 open 1988 NO NO YES AX 0 17 0 22 Endometrial A LIVING 113 2006 8e59d005-8361-457f-9316-04c989d0b74f TCGA-AX-A2H8-11A-11D-A17F-05 8e59d005-8361-457f-9316-04c989d0b74f TCGA-AX-A2HA-01 MSI-H TCGA-AX-A2HA-01 Iq C6-UCEC UCEC CIMP c18 UCEC-like c5 UCEC-like c11 miRNA cluster 12 TCGA-AX-A2HA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 35 TCGA-AX-A2HA-F31721 TCGA-AX-A2HA TCGA-AX-A2HA-01A Former User Stage IB NO -13142 2188 0 2475 NO Scheduled Follow-up Submission 2012-5-8 FEMALE 167 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 100 NO G3 NO false No TCGA-AX-A2HA.E44408C9-53DE-4FF7-8D8E-6BFAB24302C3.pdf A2HA negative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 open 1988 NO NO YES AX 0 3 0 24 Endometrial A LIVING 60 2005 TCGA-AX-A2HA-01 TCGA-AX-A2HA-01A-21-A23Z-20 91D657B3-74C5-4978-81F8-249127F92199 TCGA-AX-A2HA-01 3df718d2-9089-4055-8190-adc218fd3216 TCGA-AX-A2HA-01A-12D-A18N-01 TCGA-AX-A2HA-01A-12D-A18N-01 TCGA-AX-A2HA-01 TCGA-AX-A2HA-01 TCGA-AX-A2HA-01A-12D-A18O-05 3df718d2-9089-4055-8190-adc218fd3216 TCGA-AX-A2HA-11 MSI-H TCGA-AX-A2HA-11 C6-UCEC TCGA-AX-A2HA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 35 TCGA-AX-A2HA-F31721 TCGA-AX-A2HA TCGA-AX-A2HA-11A Former User Stage IB NO -13142 2188 0 2475 NO Scheduled Follow-up Submission 2012-5-8 FEMALE 167 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 100 NO G3 NO false No A2HA negative TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 open 1988 NO NO YES AX 0 3 0 24 Endometrial A LIVING 60 2005 TCGA-AX-A2HA-11 0f659732-62d9-4b13-b4c4-cd6b231bdedb TCGA-AX-A2HA-11 TCGA-AX-A2HA-11A-11D-A18O-05 0f659732-62d9-4b13-b4c4-cd6b231bdedb TCGA-AX-A2HC-01 MSI-H TCGA-AX-A2HC-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 GBM-like c6 miRNA cluster 12 cluster 5 TCGA-AX-A2HC TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES NO Progressive Disease 53 TCGA-AX-A2HC-F31735 TCGA-AX-A2HC TCGA-AX-A2HC-01A Stage IIIC NO -19485 1786 0 1044 756 Scheduled Follow-up Submission 2012-5-8 FEMALE 158 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 120 NO G3 Other, specify Metastatic Abdomen YES false No TCGA-AX-A2HC.90DC9BBA-4666-4702-8BA1-F57253E43CDD.pdf A2HC negative WITH TUMOR 2 Complete Remission/Response NO R0 Primary Tumor 01 open 1988 YES NO YES AX 1 1 3 20 Endometrial A LIVING 118 2006 TCGA-AX-A2HC-01 TCGA-AX-A2HC-01A-21-A18R-20 76DDEA74-3A3A-4604-A8F6-954228149A76 TCGA-AX-A2HC-01 3e40a983-aba5-4454-88df-a271c296ada6 TCGA-AX-A2HC-01A-11D-A17C-01 TCGA-AX-A2HC-01A-11D-A17C-01 TCGA-AX-A2HC-01 TCGA-AX-A2HC-01 TCGA-AX-A2HC-01A-11D-A17F-05 3e40a983-aba5-4454-88df-a271c296ada6 TCGA-AX-A2HC-11 MSI-H TCGA-AX-A2HC-11 C6-UCEC TCGA-AX-A2HC TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES NO Progressive Disease 53 TCGA-AX-A2HC-F31735 TCGA-AX-A2HC TCGA-AX-A2HC-11A Stage IIIC NO -19485 1786 0 1044 756 Scheduled Follow-up Submission 2012-5-8 FEMALE 158 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 120 NO G3 Other, specify Metastatic Abdomen YES false No A2HC negative WITH TUMOR 2 Complete Remission/Response NO R0 Solid Tissue Normal 11 open 1988 YES NO YES AX 1 1 3 20 Endometrial A LIVING 118 2006 0959be20-00aa-4736-9cf1-41b3c1d5c5b4 0959be20-00aa-4736-9cf1-41b3c1d5c5b4 0959be20-00aa-4736-9cf1-41b3c1d5c5b4 0959be20-00aa-4736-9cf1-41b3c1d5c5b4 TCGA-AX-A2HC-11 TCGA-AX-A2HC-11 TCGA-AX-A2HC-11A-11D-A17F-05 TCGA-AX-A2HD-01 MSI-H TCGA-AX-A2HD-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 TCGA-AX-A2HD TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Partial Response 69 TCGA-AX-A2HD-F31844 TCGA-AX-A2HD TCGA-AX-A2HD-01A Stage IIIA NO -25499 1175 0 1414 Scheduled Follow-up Submission 2012-5-9 FEMALE 149 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 100 NO G3 NO false No TCGA-AX-A2HD.83BDA3FE-254F-4F99-B41E-FC1F8C128906.pdf A2HD positive WITH TUMOR 4+ Partial Remission/Response NO R1 Primary Tumor 01 open 1988 NO NO YES AX 0 5 0 21 Endometrial A LIVING 51 2008 TCGA-AX-A2HD-01 TCGA-AX-A2HD-01A-11-A18R-20 6BD35FAB-31F7-42F9-BD81-F8083DF351AC TCGA-AX-A2HD-01 03141105-bc66-4e89-ad97-c54fcf189468 TCGA-AX-A2HD-01A-21D-A17C-01 TCGA-AX-A2HD-01A-21D-A17C-01 TCGA-AX-A2HD-01 TCGA-AX-A2HD-01 TCGA-AX-A2HD-01A-21D-A17F-05 03141105-bc66-4e89-ad97-c54fcf189468 TCGA-AX-A2HD-11 MSI-H TCGA-AX-A2HD-11 C6-UCEC TCGA-AX-A2HD TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Partial Response 69 TCGA-AX-A2HD-F31844 TCGA-AX-A2HD TCGA-AX-A2HD-11A Stage IIIA NO -25499 1175 0 1414 Scheduled Follow-up Submission 2012-5-9 FEMALE 149 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 110 NO G3 NO false No A2HD positive WITH TUMOR 4+ Partial Remission/Response NO R1 Solid Tissue Normal 11 open 1988 NO NO YES AX 0 5 0 21 Endometrial A LIVING 51 2008 773d237c-995c-4e0b-aaf1-3b78763ae704 773d237c-995c-4e0b-aaf1-3b78763ae704 773d237c-995c-4e0b-aaf1-3b78763ae704 773d237c-995c-4e0b-aaf1-3b78763ae704 TCGA-AX-A2HD-11 TCGA-AX-A2HD-11 TCGA-AX-A2HD-11A-11D-A17F-05 TCGA-AX-A2HF-01 MSS TCGA-AX-A2HF-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 3 TCGA-AX-A2HF TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 TCGA-AX-A2HF-F65239 TCGA-AX-A2HF TCGA-AX-A2HF-01A Stage IB -24689 440 0 848 YES Scheduled Follow-up Submission 2014-9-19 FEMALE 157 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 140 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes TCGA-AX-A2HF.5454BF58-3D26-4D61-B0A8-30A06ECD0E60.pdf A2HF negative WITH TUMOR YES Complete Remission/Response YES R0 Primary Tumor 01 open 1988 YES NO YES AX 0 9 0 27 Endometrial A LIVING 70 2010 TCGA-AX-A2HF-01 TCGA-AX-A2HF-01A-21-A18R-20 84A10878-AFC0-4880-A277-D06ACFDFCA8C TCGA-AX-A2HF-01A-11D-A17D-09 TCGA-AX-A2HF-01A-11D-A17D-09 TCGA-AX-A2HF-01A-11D-A17D-09 2ffda10e-5941-4c80-9291-a5ebbe0d5a2a TCGA-AX-A2HF-01A-11D-A17C-01 TCGA-AX-A2HF-01A-11D-A17C-01 TCGA-AX-A2HF-01 TCGA-AX-A2HF-01A-11D-A17F-05 2ffda10e-5941-4c80-9291-a5ebbe0d5a2a TCGA-AX-A2HG-01 MSI-H TCGA-AX-A2HG-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 TCGA-AX-A2HG TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 TCGA-AX-A2HG-F62992 TCGA-AX-A2HG TCGA-AX-A2HG-01A Stage IC NO -20771 582 0 1163 NO Scheduled Follow-up Submission 2014-7-29 FEMALE 157 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 150 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AX-A2HG.EF863B73-4C80-42E6-8AAF-2EF72559212A.pdf A2HG 67 TUMOR FREE NO Complete Remission/Response YES R1 Primary Tumor 01 open 1988 NO NO YES AX 0 2 0 27 Endometrial A LIVING 115 2009 TCGA-AX-A2HG-01 TCGA-AX-A2HG-01A-21-A18R-20 C506AB11-CE52-4097-B686-C7962D68B9B5 TCGA-AX-A2HG-01 8d2b2907-863e-4db9-8d4b-ce877e562531 TCGA-AX-A2HG-01A-11D-A17C-01 TCGA-AX-A2HG-01A-11D-A17C-01 TCGA-AX-A2HG-01 TCGA-AX-A2HG-01 TCGA-AX-A2HG-01A-11D-A17F-05 8d2b2907-863e-4db9-8d4b-ce877e562531 TCGA-AX-A2HH-01 MSS TCGA-AX-A2HH-01 Kirc+ UCEC CIMP c18 cluster 2 UCEC-like c5 miRNA cluster 13 cluster 6 TCGA-AX-A2HH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Partial Response 60 TCGA-AX-A2HH-F31851 TCGA-AX-A2HH TCGA-AX-A2HH-01A Stage IA NO -21924 462 0 540 Scheduled Follow-up Submission 2012-5-9 FEMALE 155 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 150 NO G3 NO false No TCGA-AX-A2HH.2EE7245F-7069-456A-A215-41E59D9FE606.pdf A2HH negative WITH TUMOR Partial Remission/Response NO R1 Primary Tumor 01 open 1988 NO NO YES AX 0 4 0 18 Endometrial A LIVING 65 2010 9cfe7287-c1aa-4fc0-8d4f-dc72655b2810 TCGA-AX-A2HH-01 9cfe7287-c1aa-4fc0-8d4f-dc72655b2810 TCGA-AX-A2HH-01A-21-A18R-20 E63D7EF7-EE98-4738-9BA6-D2BB407CBBCA 9cfe7287-c1aa-4fc0-8d4f-dc72655b2810 9cfe7287-c1aa-4fc0-8d4f-dc72655b2810 TCGA-AX-A2HH-01 TCGA-AX-A2HH-01A-11D-A17C-01 TCGA-AX-A2HH-01A-11D-A17C-01 TCGA-AX-A2HH-01 TCGA-AX-A2HH-01 TCGA-AX-A2HH-01A-11D-A17F-05 TCGA-AX-A2HJ-01 MSI-H TCGA-AX-A2HJ-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 TCGA-AX-A2HJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 35 TCGA-AX-A2HJ-F31575 TCGA-AX-A2HJ TCGA-AX-A2HJ-01A Stage IC NO -13112 779 0 935 Scheduled Follow-up Submission 2012-5-7 FEMALE 152 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 140 NO G3 NO false No TCGA-AX-A2HJ.84FF1AB9-47F4-4884-9345-43878BDEF379.pdf A2HJ 80 negative TUMOR FREE 0 Complete Remission/Response YES R0 Primary Tumor 01 open 1988 YES NO YES AX 0 11 0 7 Endometrial A LIVING 56 2009 TCGA-AX-A2HJ-01 TCGA-AX-A2HJ-01A-21-A18R-20 4E7CA333-8EC4-4C6D-A98F-554F67D74087 TCGA-AX-A2HJ-01 b3b47f11-3e7c-475e-8f39-cefb8db8fa35 TCGA-AX-A2HJ-01A-11D-A17C-01 TCGA-AX-A2HJ-01A-11D-A17C-01 TCGA-AX-A2HJ-01 TCGA-AX-A2HJ-01 TCGA-AX-A2HJ-01A-11D-A17F-05 b3b47f11-3e7c-475e-8f39-cefb8db8fa35 TCGA-AX-A2HK-01 MSS TCGA-AX-A2HK-01 High C6-UCEC UCEC Serous c4 cluster 3 KIRC-like c1 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-AX-A2HK TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 77 TCGA-AX-A2HK-F31847 TCGA-AX-A2HK TCGA-AX-A2HK-01A Stage IIIC NO -28316 2045 90 0 Scheduled Follow-up Submission 2012-5-9 FEMALE 154 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 240 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-AX-A2HK.DBC5CE66-3BC0-4A86-A53C-06DEF90A752B.pdf A2HK 84 negative WITH TUMOR 4+ Complete Remission/Response NO R0 Primary Tumor 01 open 1988 NO NO YES AX 2 6 3 25 Endometrial A DECEASED 73 2005 TCGA-AX-A2HK-01 TCGA-AX-A2HK-01A-21-A18R-20 494C2E2E-C337-420E-BBBE-3981C02497AA TCGA-AX-A2HK-01 28e3b0f0-29e2-4726-8e28-c6f5a2275fff TCGA-AX-A2HK-01A-11D-A17C-01 TCGA-AX-A2HK-01A-11D-A17C-01 TCGA-AX-A2HK-01 TCGA-AX-A2HK-01 TCGA-AX-A2HK-01A-11D-A17F-05 28e3b0f0-29e2-4726-8e28-c6f5a2275fff TCGA-AX-A2IN-01 MSI-H TCGA-AX-A2IN-01 Iq UCEC CIMP c18 miRNA cluster 6 cluster 1 TCGA-AX-A2IN TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 63 TCGA-AX-A2IN-F58273 TCGA-AX-A2IN Stage IC -23275 947 0 358 2014-4-3 FEMALE 157 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Brain Distant Metastasis YES No A2IN 85 negative WITH TUMOR NO YES R0 Primary Tumor 01 open 1988 NO YES AX 0 4 0 21 Endometrial DECEASED 100 2007 af153b10-b6c0-4345-b242-9ad4c676e6c4 TCGA-AX-A2IN-01 af153b10-b6c0-4345-b242-9ad4c676e6c4 af153b10-b6c0-4345-b242-9ad4c676e6c4 af153b10-b6c0-4345-b242-9ad4c676e6c4 TCGA-AX-A2IN-01 TCGA-AX-A2IN-01A-12D-A17U-01 TCGA-AX-A2IN-01A-12D-A17U-01 TCGA-AX-A2IN-01 TCGA-AX-A2IN-01 TCGA-AX-A2IN-01A-12D-A17Z-05 TCGA-AX-A2IO-01 MSS TCGA-AX-A2IO-01 High UCEC Serous c4 UCEC-like c11 miRNA cluster 5 cluster 4 TCGA-AX-A2IO TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Stable Disease 83 TCGA-AX-A2IO-F58276 TCGA-AX-A2IO Stage IIA -30539 0 1975 2014-4-3 FEMALE 162 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO No A2IO negative TUMOR FREE YES YES R1 Primary Tumor 01 open 1988 NO YES AX 0 3 0 7 Endometrial LIVING 64 2008 TCGA-AX-A2IO-01 TCGA-AX-A2IO-01 e216a53d-5300-45af-985d-9d397e990acf TCGA-AX-A2IO-01A-11D-A17U-01 TCGA-AX-A2IO-01A-11D-A17U-01 TCGA-AX-A2IO-01 TCGA-AX-A2IO-01 TCGA-AX-A2IO-01A-11D-A17Z-05 e216a53d-5300-45af-985d-9d397e990acf TCGA-AX-A3FS-01 MSI-H TCGA-AX-A3FS-01 Kirc+ UCEC CIMP c18 BRCA basal-like c6 miRNA cluster 5 TCGA-AX-A3FS TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 82 TCGA-AX-A3FS-F58279 TCGA-AX-A3FS TCGA-AX-A3FS-01A Stage IA -30102 609 0 1 2014-4-3 FEMALE 139 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Laparoscopy, robotic-assisted lysis of adhesions, robotic-assisted lysis total hysterectomy, bso, bilateral pelvic lymphadenectomy and cystoscopy Other method, specify: 80 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-AX-A3FS.1AEA9AC0-3B22-4819-9542-1F6A6AD474BC.pdf A3FS negative Primary Tumor 01 open 1988 NO YES AX 0 0 16 Endometrial A LIVING 98 2010 2db9f19e-4614-44f9-a9f5-7541d6a20369 TCGA-AX-A3FS-01 2db9f19e-4614-44f9-a9f5-7541d6a20369 TCGA-AX-A3FS-01A-21-A23Z-20 07244A31-9016-4B5E-B95C-E2EC48438634 2db9f19e-4614-44f9-a9f5-7541d6a20369 2db9f19e-4614-44f9-a9f5-7541d6a20369 TCGA-AX-A3FS-01 TCGA-AX-A3FS-01A-11D-A227-01 TCGA-AX-A3FS-01A-11D-A227-01 TCGA-AX-A3FS-01 TCGA-AX-A3FS-01 TCGA-AX-A3FS-01A-11D-A22B-05 TCGA-AX-A3FT-01 MSI-H TCGA-AX-A3FT-01 Kirc+ BRCA CIMP c7 UCEC-like c5 miRNA cluster 13 TCGA-AX-A3FT TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 64 TCGA-AX-A3FT-F58280 TCGA-AX-A3FT TCGA-AX-A3FT-01A Stage IB -23543 524 0 6 2014-4-3 FEMALE 161 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Exploratory Laparotomy, TAH, BSO, Pelvic and pariaortic LND. Other method, specify: 110 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-AX-A3FT.EF16D53F-14A2-4127-B5F7-F318EC60C5C0.pdf A3FT Primary Tumor 01 open 1988 NO YES AX 0 4 0 21 Endometrial A LIVING 82 2010 9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b TCGA-AX-A3FT-01 9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b TCGA-AX-A3FT-01A-21-A23Z-20 3F2A36E1-DC43-4EB6-B0C0-F7D255496FB0 9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b 9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b TCGA-AX-A3FT-01 TCGA-AX-A3FT-01A-11D-A227-01 TCGA-AX-A3FT-01A-11D-A227-01 TCGA-AX-A3FT-01 TCGA-AX-A3FT-01 TCGA-AX-A3FT-01A-11D-A22B-05 TCGA-AX-A3FV-01 MSS TCGA-AX-A3FV-01 High Cluster 13 (HNSC-LUSC) BRCA basal-like c6 miRNA cluster 12 TCGA-AX-A3FV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 62 TCGA-AX-A3FV-F58281 TCGA-AX-A3FV TCGA-AX-A3FV-01A Stage IIIA -22752 799 0 -6 2014-4-3 FEMALE 152 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 100 NO YES G3 false No TCGA-AX-A3FV.0D1601D0-E0F4-4DBA-91EA-62092FE8621F.pdf A3FV Primary Tumor 01 open 1988 NO YES AX 0 0 Endometrial A LIVING 113 2009 3f24dcf1-9ec6-4ec4-9379-f9051151c639 TCGA-AX-A3FV-01 3f24dcf1-9ec6-4ec4-9379-f9051151c639 TCGA-AX-A3FV-01A-21-A23Z-20 C39A1125-5A35-4983-B5F7-290CBA28EE1A 3f24dcf1-9ec6-4ec4-9379-f9051151c639 3f24dcf1-9ec6-4ec4-9379-f9051151c639 TCGA-AX-A3FV-01 TCGA-AX-A3FV-01A-11D-A227-01 TCGA-AX-A3FV-01A-11D-A227-01 TCGA-AX-A3FV-01 TCGA-AX-A3FV-01 TCGA-AX-A3FV-01A-11D-A22B-05 TCGA-AX-A3FW-01 MSS TCGA-AX-A3FW-01 Squamous UCEC non-CIMP c3 UCEC-like c5 miRNA c1uster 10 TCGA-AX-A3FW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 66 TCGA-AX-A3FW-F58282 TCGA-AX-A3FW TCGA-AX-A3FW-01A Stage IB -24419 723 0 17 2014-4-3 FEMALE 167 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Robotic hysterectomy with Lymph Node Dissection Other method, specify: 90 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-AX-A3FW.AAB4F0FC-D6D5-4D5F-B36C-E4D4869E1A15.pdf A3FW 27 Primary Tumor 01 open 1988 NO YES AX 0 0 12 Endometrial A LIVING 84 2009 bbf7786d-0996-47fc-8af9-482d2087ccb1 TCGA-AX-A3FW-01 bbf7786d-0996-47fc-8af9-482d2087ccb1 TCGA-AX-A3FW-01A-21-A23Z-20 21B45816-6F8E-4657-9E16-9953FD234D09 bbf7786d-0996-47fc-8af9-482d2087ccb1 bbf7786d-0996-47fc-8af9-482d2087ccb1 TCGA-AX-A3FW-01 TCGA-AX-A3FW-01A-11D-A227-01 TCGA-AX-A3FW-01A-11D-A227-01 TCGA-AX-A3FW-01 TCGA-AX-A3FW-01 TCGA-AX-A3FW-01A-11D-A22B-05 TCGA-AX-A3FX-01 MSS TCGA-AX-A3FX-01 Squamous UCEC non-CIMP c3 UCEC-like c5 miRNA cluster 12 TCGA-AX-A3FX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES Progressive Disease 69 TCGA-AX-A3FX-F58283 TCGA-AX-A3FX TCGA-AX-A3FX-01A Stage IIB -25260 736 1333 0 4 938 2014-4-3 FEMALE 149 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES TAH/BSO/LND/Panniculectomy Other method, specify: 100 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Chest YES false No TCGA-AX-A3FX.B3326BA1-71E3-4207-9727-B157A3E195E7.pdf A3FX YES NO Primary Tumor 01 open 1988 NO YES AX 0 2 0 24 Endometrial A DECEASED 85 2009 73d3142f-9060-488c-9108-3b1abd12f323 TCGA-AX-A3FX-01 73d3142f-9060-488c-9108-3b1abd12f323 TCGA-AX-A3FX-01A-21-A23Z-20 8BB9A436-20C4-45D9-98BD-FFCAF66C9C8B 73d3142f-9060-488c-9108-3b1abd12f323 73d3142f-9060-488c-9108-3b1abd12f323 TCGA-AX-A3FX-01 TCGA-AX-A3FX-01A-11D-A227-01 TCGA-AX-A3FX-01A-11D-A227-01 TCGA-AX-A3FX-01 TCGA-AX-A3FX-01 TCGA-AX-A3FX-01A-11D-A22B-05 TCGA-AX-A3FZ-01 MSS TCGA-AX-A3FZ-01 High UCEC non-CIMP c3 KIRC-like c1 miRNA cluster 15 TCGA-AX-A3FZ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 33 TCGA-AX-A3FZ-F58286 TCGA-AX-A3FZ TCGA-AX-A3FZ-01A Stage IIIB -12331 658 0 2 2014-4-3 FEMALE 152 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Exploratory laparotomy, total abdominal hysterectomy, bso, major debulking, omentectomy, appendectomy, bilateral pelvic lymphadenectomy, segmental small bowel resection, cystoscopy Other method, specify: 100 NO YES G3 false No TCGA-AX-A3FZ.4989F66F-57F8-4B1C-97DD-69F3036EB0BA.pdf A3FZ positive Primary Tumor 01 open 1988 NO YES AX 0 0 9 Endometrial A LIVING 113 2010 da84a25d-fd15-40ff-80c1-e3f2d2b2b301 TCGA-AX-A3FZ-01 da84a25d-fd15-40ff-80c1-e3f2d2b2b301 TCGA-AX-A3FZ-01A-21-A23Z-20 A6279404-9822-4FE1-A21E-949EAAF4A31F da84a25d-fd15-40ff-80c1-e3f2d2b2b301 da84a25d-fd15-40ff-80c1-e3f2d2b2b301 TCGA-AX-A3FZ-01 TCGA-AX-A3FZ-01A-11D-A227-01 TCGA-AX-A3FZ-01A-11D-A227-01 TCGA-AX-A3FZ-01 TCGA-AX-A3FZ-01 TCGA-AX-A3FZ-01A-11D-A22B-05 TCGA-AX-A3G1-01 MSS TCGA-AX-A3G1-01 Squamous UCEC non-CIMP c3 miRNA cluster 12 TCGA-AX-A3G1 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 84 TCGA-AX-A3G1-F21258 TCGA-AX-A3G1 Stage IC NO -31037 624 0 Scheduled Follow-up Submission 2012-2-7 FEMALE 160 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Total abdominal hysterectomy with bso Other method, specify: Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO No A3G1 4+ NO Primary Tumor 01 open 1988 NO NO YES AX 0 6 0 21 Endometrial DECEASED 61 2009 b774f929-57f2-4f5a-9080-82b390a7a7f9 TCGA-AX-A3G1-01 b774f929-57f2-4f5a-9080-82b390a7a7f9 b774f929-57f2-4f5a-9080-82b390a7a7f9 b774f929-57f2-4f5a-9080-82b390a7a7f9 TCGA-AX-A3G1-01 TCGA-AX-A3G1-01A-11D-A227-01 TCGA-AX-A3G1-01A-11D-A227-01 TCGA-AX-A3G1-01 TCGA-AX-A3G1-01 TCGA-AX-A3G1-01A-11D-A22B-05 TCGA-AX-A3G3-01 MSS TCGA-AX-A3G3-01 High OV-like c1 UCEC-like c5 miRNA cluster 4 TCGA-AX-A3G3 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 58 TCGA-AX-A3G3-F58287 TCGA-AX-A3G3 TCGA-AX-A3G3-01A Stage IIIA -21308 713 0 42 2014-4-3 FEMALE 167 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES total laparascopic hysterectomy, bso, bilateral pelvic and obturator lymphadenectomy, omentectomy and staging biopsies Other method, specify: 140 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false Yes TCGA-AX-A3G3.3D86258F-2C9B-4DF2-86C5-E12B3FCB480D.pdf A3G3 Primary Tumor 01 open 1988 NO YES AX 0 3 0 14 Endometrial A LIVING 55 2009 11e82091-a9fb-4b7b-b0a2-7908e50e2c60 TCGA-AX-A3G3-01 11e82091-a9fb-4b7b-b0a2-7908e50e2c60 TCGA-AX-A3G3-01A-21-A23Z-20 8FBE82B9-42A9-4451-A36F-9DE16D55BEB3 11e82091-a9fb-4b7b-b0a2-7908e50e2c60 11e82091-a9fb-4b7b-b0a2-7908e50e2c60 TCGA-AX-A3G3-01A-11D-A20R-01 TCGA-AX-A3G3-01A-11D-A20R-01 TCGA-AX-A3G3-01 TCGA-AX-A3G3-01A-11D-A212-05 TCGA-AX-A3G4-01 MSS TCGA-AX-A3G4-01 BRCA-LUAD+ UCEC Serous c4 UCEC-like c5 miRNA cluster 5 TCGA-AX-A3G4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 60 TCGA-AX-A3G4-F58288 TCGA-AX-A3G4 TCGA-AX-A3G4-01A Stage IIIC -22099 463 0 9 2014-4-3 FEMALE 167 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES TAH, BSO, bilateral pelvic and periaortic lymphadenectomy and omentecomy. Other method, specify: 130 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-AX-A3G4.7E8857D6-4347-4BC5-8655-40AAD7197789.pdf A3G4 Primary Tumor 01 open 1988 NO YES AX 2 4 2 Endometrial A LIVING 107 2010 a598aef0-10a2-41bb-b755-4b2788b32e10 TCGA-AX-A3G4-01 a598aef0-10a2-41bb-b755-4b2788b32e10 TCGA-AX-A3G4-01A-21-A23Z-20 AC600CA3-2BAC-46B1-A370-C17D6BB200DE a598aef0-10a2-41bb-b755-4b2788b32e10 a598aef0-10a2-41bb-b755-4b2788b32e10 TCGA-AX-A3G4-01 TCGA-AX-A3G4-01A-11D-A20R-01 TCGA-AX-A3G4-01A-11D-A20R-01 TCGA-AX-A3G4-01 TCGA-AX-A3G4-01 TCGA-AX-A3G4-01A-11D-A212-05 TCGA-AX-A3G6-01 MSS TCGA-AX-A3G6-01 Squamous UCEC non-CIMP c3 miRNA cluster 12 TCGA-AX-A3G6 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 67 TCGA-AX-A3G6-F58289 TCGA-AX-A3G6 TCGA-AX-A3G6-01A Stage IA -24681 456 0 8 2014-4-3 FEMALE 167 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES TAH, BSO, bilateral pelvic lymphadenectomy, periaortic node dissection Other method, specify: 50 NO YES G2 false No TCGA-AX-A3G6.53586ED5-5C68-4517-8543-7508AF37F68C.pdf A3G6 Primary Tumor 01 open 1988 NO YES AX 0 5 0 11 Endometrial A LIVING 60 2010 99e76a2e-9162-4345-9155-cc7267c0325b TCGA-AX-A3G6-01 99e76a2e-9162-4345-9155-cc7267c0325b 99e76a2e-9162-4345-9155-cc7267c0325b 99e76a2e-9162-4345-9155-cc7267c0325b TCGA-AX-A3G6-01 TCGA-AX-A3G6-01A-11D-A20R-01 TCGA-AX-A3G6-01A-11D-A20R-01 TCGA-AX-A3G6-01 TCGA-AX-A3G6-01 TCGA-AX-A3G6-01A-11D-A212-05 TCGA-AX-A3G7-01 MSS TCGA-AX-A3G7-01 Squamous UCEC Serous c4 TCGA-AX-A3G7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 71 TCGA-AX-A3G7-F58290 TCGA-AX-A3G7 TCGA-AX-A3G7-01A Stage IVB -26187 520 0 9 2014-4-3 FEMALE 154 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Exploratory laparotomy, TAH, BSO, radical optimal tumor debulking with gastrocolic omentectomy Other method, specify: 50 NO YES G3 false No TCGA-AX-A3G7.81608C78-6495-4FC7-9210-1132E9335D01.pdf A3G7 Primary Tumor 01 open 1988 NO YES AX 0 0 Endometrial A LIVING 74 2010 8d020165-5475-4257-87c3-c98fc2d201d2 TCGA-AX-A3G7-01 8d020165-5475-4257-87c3-c98fc2d201d2 8d020165-5475-4257-87c3-c98fc2d201d2 8d020165-5475-4257-87c3-c98fc2d201d2 TCGA-AX-A3G7-01 TCGA-AX-A3G7-01A-12D-A20R-01 TCGA-AX-A3G7-01A-12D-A20R-01 TCGA-AX-A3G7-01 TCGA-AX-A3G7-01 TCGA-AX-A3G7-01A-12D-A212-05 TCGA-AX-A3G8-01 MSI-H TCGA-AX-A3G8-01 Iq UCEC CIMP c18 UCEC-like c5 miRNA cluster 13 TCGA-AX-A3G8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 76 TCGA-AX-A3G8-F58291 TCGA-AX-A3G8 TCGA-AX-A3G8-01A Stage IA -27899 350 0 30 2014-4-3 FEMALE 157 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 110 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-AX-A3G8.FD22A233-9333-4DA2-A913-4DBA90600247.pdf A3G8 negative Primary Tumor 01 open 1988 NO YES AX 0 2 0 30 Endometrial A LIVING 62 2010 9c949f30-455e-48a6-ae31-73f26c609ffd TCGA-AX-A3G8-01 9c949f30-455e-48a6-ae31-73f26c609ffd TCGA-AX-A3G8-01A-21-A23Z-20 208B07DB-EF6D-4B9E-9E76-1F24126FFD67 9c949f30-455e-48a6-ae31-73f26c609ffd 9c949f30-455e-48a6-ae31-73f26c609ffd TCGA-AX-A3G8-01 TCGA-AX-A3G8-01A-11D-A227-01 TCGA-AX-A3G8-01A-11D-A227-01 TCGA-AX-A3G8-01 TCGA-AX-A3G8-01 TCGA-AX-A3G8-01A-11D-A22B-05 TCGA-AX-A3G9-01 MSI-H TCGA-AX-A3G9-01 Quiet UCEC CIMP c18 UCEC-like c5 miRNA cluster 4 TCGA-AX-A3G9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 63 TCGA-AX-A3G9-F21262 TCGA-AX-A3G9 TCGA-AX-A3G9-01A Stage IIIC -23361 560 0 558 Scheduled Follow-up Submission 2012-2-7 FEMALE 154 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Robotic laparoscopic hysterectomy, BSO, pelvic and periaortic LND Other method, specify: 110 NO G3 NO false No TCGA-AX-A3G9.FADFF649-7518-4EFB-B96C-9390DD308DBD.pdf A3G9 negative 2 YES R1 Primary Tumor 01 open 1988 YES NO YES AX 0 1 1 4 Endometrial A LIVING 60 2010 f31b5e70-af25-4f1a-b7e3-13f17998e7e2 TCGA-AX-A3G9-01 f31b5e70-af25-4f1a-b7e3-13f17998e7e2 TCGA-AX-A3G9-01A-21-A23Z-20 AD5918E9-5828-4266-95F1-38E5C9F20F80 f31b5e70-af25-4f1a-b7e3-13f17998e7e2 f31b5e70-af25-4f1a-b7e3-13f17998e7e2 TCGA-AX-A3G9-01 TCGA-AX-A3G9-01A-11D-A227-01 TCGA-AX-A3G9-01A-11D-A227-01 TCGA-AX-A3G9-01 TCGA-AX-A3G9-01 TCGA-AX-A3G9-01A-11D-A22B-05 TCGA-AX-A3GB-01 MSS TCGA-AX-A3GB-01 Iq UCEC CIMP c18 miRNA c1uster 9 TCGA-AX-A3GB TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 73 TCGA-AX-A3GB-F21266 TCGA-AX-A3GB Stage IB NO -26724 0 440 Scheduled Follow-up Submission 2012-2-7 FEMALE 158 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES TAH, BSO, pelvic and paraaortic LND, intracolic omentectomy Other method, specify: Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO No A3GB negative NO R0 Primary Tumor 01 open 1988 YES NO YES AX 0 6 0 19 Endometrial LIVING 87 2010 ba01a4cb-d7cd-4a9a-ae28-978262154683 TCGA-AX-A3GB-01 ba01a4cb-d7cd-4a9a-ae28-978262154683 ba01a4cb-d7cd-4a9a-ae28-978262154683 ba01a4cb-d7cd-4a9a-ae28-978262154683 TCGA-AX-A3GB-01 TCGA-AX-A3GB-01A-11D-A227-01 TCGA-AX-A3GB-01A-11D-A227-01 TCGA-AX-A3GB-01 TCGA-AX-A3GB-01 TCGA-AX-A3GB-01A-11D-A22B-05 TCGA-AX-A3GI-01 Indeterminate TCGA-AX-A3GI-01 Squamous UCEC Serous c4 UCEC-like c5 miRNA c1uster 10 TCGA-AX-A3GI TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 66 TCGA-AX-A3GI-F58292 TCGA-AX-A3GI TCGA-AX-A3GI-01A Stage IIIC -24388 300 0 12 2014-4-3 FEMALE 167 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Exploratory Laparotomy, TAH, BSO, bilateral pelvic and periaortic LND. Other method, specify: 110 NO YES G3 false No TCGA-AX-A3GI.A803E376-399C-4841-A6AE-E82B99CD57B7.pdf A3GI Primary Tumor 01 open 1988 NO YES AX 3 4 4 4 Endometrial A LIVING 87 2011 9d42a9c4-305b-4e25-a260-82805d6b059a TCGA-AX-A3GI-01 9d42a9c4-305b-4e25-a260-82805d6b059a TCGA-AX-A3GI-01A-21-A23Z-20 4E4812F1-7DB6-4475-BBE6-DE4A4AEB82E1 9d42a9c4-305b-4e25-a260-82805d6b059a 9d42a9c4-305b-4e25-a260-82805d6b059a TCGA-AX-A3GI-01 TCGA-AX-A3GI-01A-11D-A20R-01 TCGA-AX-A3GI-01A-11D-A20R-01 TCGA-AX-A3GI-01 TCGA-AX-A3GI-01 TCGA-AX-A3GI-01A-11D-A212-05 TCGA-B5-A0JN-01 MSI-L TCGA-B5-A0JN-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 miRNA c1uster 10 cluster 2 mutation cluster 3 TCGA-B5-A0JN TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 84 0 0 TCGA-B5-A0JN-F11873 TCGA-B5-A0JN TCGA-B5-A0JN-01A Stage IVB NO -30933 2164 0 2445 NO 2011-5-18 FEMALE 154 Serous endometrial adenocarcinoma Yes No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Tumor resection 440 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true Yes TCGA-B5-A0JN.A22F4C33-7630-4595-8415-24C87949B211.pdf A0JN 0 positive TUMOR FREE 0 0 0 Complete Remission/Response Former User NO Primary Tumor 01 open 1988 YES NO YES B5 0 0 0 0 Endometrial A LIVING 58 2004 cbd18c2a-4544-4a90-904e-533c3f776f32 TCGA-B5-A0JN-01 TCGA-B5-A0JN-01 cbd18c2a-4544-4a90-904e-533c3f776f32 TCGA-B5-A0JN-01A-21-A163-20 90FFCFFB-C276-438C-AD00-0DA5CABA8596 TCGA-B5-A0JN-01 cbd18c2a-4544-4a90-904e-533c3f776f32 TCGA-B5-A0JN-01A-11D-A10B-09 TCGA-B5-A0JN-01A-11D-A10B-09 TCGA-B5-A0JN-01A-11D-A10B-09 cbd18c2a-4544-4a90-904e-533c3f776f32 TCGA-B5-A0JN-01A-11D-A102-01 TCGA-B5-A0JN-01A-11D-A102-01 TCGA-B5-A0JN-01 TCGA-B5-A0JN-01A-11D-A10Q-05 TCGA-B5-A0JR-01 MSI-H TCGA-B5-A0JR-01 BRCA-LUAD+ UCEC CIMP c18 cluster 1 mutation cluster 7 TCGA-B5-A0JR TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 73 0 0 TCGA-B5-A0JR-F12807 TCGA-B5-A0JR Stage IB NO -26814 0 1731 NO Scheduled Follow-up Submission 2011-6-8 FEMALE 161 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO No A0JR 71 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO Primary Tumor 01 Minimally Invasive 1988 NO NO YES B5 0 6 0 32 Endometrial LIVING 105 2006 a67adcd5-7f63-44f2-a127-568569c9a357 TCGA-B5-A0JR-01 a67adcd5-7f63-44f2-a127-568569c9a357 TCGA-B5-A0JR-01 a67adcd5-7f63-44f2-a127-568569c9a357 TCGA-B5-A0JR-01A-13W-A062-09 TCGA-B5-A0JR-01A-13W-A062-09 TCGA-B5-A0JR-01A-13W-A062-09 a67adcd5-7f63-44f2-a127-568569c9a357 TCGA-B5-A0JR-01 TCGA-B5-A0JR-01 TCGA-B5-A0JR-01A-13D-A042-01 TCGA-B5-A0JR-01A-13R-A040-07 TCGA-B5-A0JR-01A-13D-A042-01 TCGA-B5-A0JR-01 TCGA-B5-A0JR-01 TCGA-B5-A0JR-01A-13D-A039-05 TCGA-B5-A0JS-01 MSS TCGA-B5-A0JS-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 1 TCGA-B5-A0JS TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 54 TCGA-B5-A0JS-F72215 TCGA-B5-A0JS Stage IA NO -19995 0 2627 NO Scheduled Follow-up Submission 2015-4-29 FEMALE 170 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO No A0JS 11 negative TUMOR FREE 0 0 NO 2 Complete Remission/Response Never Used NO Primary Tumor 01 Minimally Invasive 1988 NO NO YES B5 0 0 28 Endometrial LIVING 110 2007 TCGA-B5-A0JS-01 TCGA-B5-A0JS-01 TCGA-B5-A0JS-01 TCGA-B5-A0JS-01A-11D-A10B-09 TCGA-B5-A0JS-01A-11D-A10B-09 TCGA-B5-A0JS-01A-11D-A10B-09 a18fa5ae-5c28-426a-a7ae-d0c0b223991f TCGA-B5-A0JS-01A-11D-A102-01 TCGA-B5-A0JS-01A-11D-A102-01 TCGA-B5-A0JS-01 TCGA-B5-A0JS-01A-11D-A10Q-05 a18fa5ae-5c28-426a-a7ae-d0c0b223991f TCGA-B5-A0JT-01 MSS TCGA-B5-A0JT-01 BRCA-LUAD+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 4 mutation cluster 4 TCGA-B5-A0JT TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 TCGA-B5-A0JT-F32680 TCGA-B5-A0JT TCGA-B5-A0JT-01A Former User Stage IIIA -23041 1128 0 1682 Scheduled Follow-up Submission 2012-6-7 FEMALE 168 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 750 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-B5-A0JT.CC6EE5B1-5548-4DE7-873F-332DBF81710F.pdf A0JT 12 positive TUMOR FREE 0 NO Primary Tumor 01 Minimally Invasive 1988 YES NO YES B5 0 0 0 14 Endometrial A LIVING 119 2007 TCGA-B5-A0JT-01 TCGA-B5-A0JT-01A-11-A162-20 4E93B9DF-D389-4EDB-B2D5-CFD48CEBB426 TCGA-B5-A0JT-01A-21D-A122-09 TCGA-B5-A0JT-01A-21D-A122-09 TCGA-B5-A0JT-01 b3e039bf-945c-4974-a4ec-8e3b177aef8d TCGA-B5-A0JT-01A-21D-A120-01 TCGA-B5-A0JT-01A-21D-A120-01 TCGA-B5-A0JT-01 TCGA-B5-A0JT-01 TCGA-B5-A0JT-01A-21D-A123-05 b3e039bf-945c-4974-a4ec-8e3b177aef8d TCGA-B5-A0JU-01 MSI-H TCGA-B5-A0JU-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 1 TCGA-B5-A0JU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 TCGA-B5-A0JU-F32684 TCGA-B5-A0JU TCGA-B5-A0JU-01B Former User Stage IB -21159 1345 0 1802 Scheduled Follow-up Submission 2012-6-7 FEMALE 158 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 300 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-B5-A0JU.1EB80878-50FF-4E79-AF16-E809E6EE7DEC.pdf A0JU 19 negative TUMOR FREE 2 NO Primary Tumor 01 Minimally Invasive 1988 NO NO YES B5 0 0 0 17 Endometrial B LIVING 137 2007 TCGA-B5-A0JU-01 TCGA-B5-A0JU-01B-21-A18Q-20 7899C98B-FB71-4CE0-993B-FCBEA706104B TCGA-B5-A0JU-01 26ef4a16-ddf1-4585-949b-14057cc8a5bf TCGA-B5-A0JU-01B-11D-A14F-01 TCGA-B5-A0JU-01B-11D-A14F-01 TCGA-B5-A0JU-01 TCGA-B5-A0JU-01 TCGA-B5-A0JU-01B-11D-A14H-05 26ef4a16-ddf1-4585-949b-14057cc8a5bf TCGA-B5-A0JV-01 MSI-H TCGA-B5-A0JV-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA cluster 13 cluster 6 mutation cluster 1 TCGA-B5-A0JV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO YES Complete Response 63 0 0 TCGA-B5-A0JV-F72216 TCGA-B5-A0JV TCGA-B5-A0JV-01A Stage IA NO 728 -23295 1001 0 2616 698 Scheduled Follow-up Submission 2015-4-29 FEMALE 166 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 40 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 Other, specify Locoregional Disease vaginal wall NO true No TCGA-B5-A0JV.71A1DE5B-7CE5-4884-A91E-3BE753036E4F.pdf A0JV 26 negative TUMOR FREE 0 0 NO 2 Complete Remission/Response YES Surgical Resection R0 Primary Tumor 01 Minimally Invasive 1988 NO NO YES B5 0 2 0 16 Endometrial A LIVING 94 2007 TCGA-B5-A0JV-01 TCGA-B5-A0JV-01 TCGA-B5-A0JV-01 TCGA-B5-A0JV-01A-11D-A10B-09 TCGA-B5-A0JV-01A-11D-A10B-09 TCGA-B5-A0JV-01A-11D-A10B-09 39b1ee4d-b57a-44d5-8b14-20b02f878123 TCGA-B5-A0JV-01A-11D-A102-01 TCGA-B5-A0JV-01A-11D-A102-01 TCGA-B5-A0JV-01 TCGA-B5-A0JV-01A-11D-A10Q-05 39b1ee4d-b57a-44d5-8b14-20b02f878123 TCGA-B5-A0JX-01 MSS TCGA-B5-A0JX-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 TCGA-B5-A0JX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 62 TCGA-B5-A0JX-F72217 TCGA-B5-A0JX TCGA-B5-A0JX-01A Never Used Stage IB -22834 952 0 1787 Scheduled Follow-up Submission 2015-4-29 FEMALE 168 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 170 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-B5-A0JX.E511CFF9-9687-4134-B85D-37C037B71643.pdf A0JX 23 negative TUMOR FREE NO 1 Complete Remission/Response NO Primary Tumor 01 Minimally Invasive 1988 NO NO YES B5 0 2 0 40 Endometrial A LIVING 113 2007 TCGA-B5-A0JX-01 TCGA-B5-A0JX-01A-11-A18Q-20 FD2FA120-9178-48CD-A4EF-B93D243FF172 TCGA-B5-A0JX-01 093be209-e5ac-4129-83b2-5f79f6a5c15f TCGA-B5-A0JX-01A-21D-A14J-01 TCGA-B5-A0JX-01A-21D-A14J-01 TCGA-B5-A0JX-01 TCGA-B5-A0JX-01 TCGA-B5-A0JX-01A-21D-A14N-05 093be209-e5ac-4129-83b2-5f79f6a5c15f TCGA-B5-A0JY-01 MSS TCGA-B5-A0JY-01 Quiet C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 11 TCGA-B5-A0JY TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 50 TCGA-B5-A0JY-F72218 TCGA-B5-A0JY TCGA-B5-A0JY-01A Stage IIIC1 NO -18475 632 0 2107 NO Scheduled Follow-up Submission 2015-4-29 FEMALE 168 Endometrioid endometrial adenocarcinoma No NO C54.1 8020/3 C54.1 YES Dilation and curettage procedure 1170 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-B5-A0JY.9708BE95-175D-458B-8BA1-02D9C488225D.pdf A0JY 100 negative TUMOR FREE YES 2 Complete Remission/Response NO Primary Tumor 01 open 1988 YES NO YES B5 0 2 17 Endometrial A LIVING 67 2008 TCGA-B5-A0JY-01 TCGA-B5-A0JY-01 TCGA-B5-A0JY-01A-21-A162-20 67F7ACE8-BFC1-4162-B334-D70ADF7A75EF TCGA-B5-A0JY-01 TCGA-B5-A0JY-01A-11D-A10B-09 TCGA-B5-A0JY-01A-11D-A10B-09 bbc76639-b9f4-4e9f-afa2-e319eee91b48 TCGA-B5-A0JY-01A-11D-A102-01 TCGA-B5-A0JY-01A-11D-A102-01 TCGA-B5-A0JY-01 TCGA-B5-A0JY-01A-11D-A10Q-05 bbc76639-b9f4-4e9f-afa2-e319eee91b48 TCGA-B5-A0JZ-01 MSI-H TCGA-B5-A0JZ-01 Quiet C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 6 cluster 1 mutation cluster 6 TCGA-B5-A0JZ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES YES Complete Response 60 TCGA-B5-A0JZ-F72219 TCGA-B5-A0JZ TCGA-B5-A0JZ-01A Never Used Stage IIIC1 NO 356 -22106 642 0 2173 356 NO Scheduled Follow-up Submission 2015-4-29 FEMALE 162 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 400 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Metastatic inguinal lymph node NO true No TCGA-B5-A0JZ.B275A085-067D-42ED-8E41-8461D5183A6E.pdf A0JZ 61 negative TUMOR FREE YES 0 Progressive Disease YES Other Method, Specify Below lymph node dissection Primary Tumor 01 open 1988 YES NO YES B5 0 8 1 19 Endometrial A LIVING 87 2008 TCGA-B5-A0JZ-01 TCGA-B5-A0JZ-01 TCGA-B5-A0JZ-01A-21-A162-20 D30AC09F-6CFC-4660-A8BF-6C5538C8456D TCGA-B5-A0JZ-01 TCGA-B5-A0JZ-01 TCGA-B5-A0JZ-01A-11W-A062-09 TCGA-B5-A0JZ-01A-11W-A062-09 TCGA-B5-A0JZ-01A-11W-A062-09 TCGA-B5-A0JZ-01 3bc43656-d16a-4ec6-9fde-aab0446c6e50 TCGA-B5-A0JZ-01A-11D-A042-01 TCGA-B5-A0JZ-01A-11R-A040-07 TCGA-B5-A0JZ-01A-11D-A042-01 TCGA-B5-A0JZ-01 TCGA-B5-A0JZ-01A-11D-A039-05 3bc43656-d16a-4ec6-9fde-aab0446c6e50 TCGA-B5-A0K0-01 MSS TCGA-B5-A0K0-01 BRCA-LUAD+ C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 4 TCGA-B5-A0K0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 48 TCGA-B5-A0K0-F72220 TCGA-B5-A0K0 TCGA-B5-A0K0-01A Former User Stage IA NO -17810 615 0 1478 YES Scheduled Follow-up Submission 2015-4-29 FEMALE 168 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 440 NO NO Indeterminate (neither Pre or Postmenopausal) G1 NO true No TCGA-B5-A0K0.6284E0A9-FACB-4297-ABC6-308715ABAFCD.pdf A0K0 0 negative TUMOR FREE NO 3 Complete Remission/Response NO Primary Tumor 01 Minimally Invasive 1988 NO NO YES B5 0 0 15 Endometrial A LIVING 140 2008 TCGA-B5-A0K0-01 TCGA-B5-A0K0-01 TCGA-B5-A0K0-01A-21-A162-20 712B8668-113A-4AE1-92C6-8D3104282749 TCGA-B5-A0K0-01 TCGA-B5-A0K0-01 TCGA-B5-A0K0-01A-11W-A062-09 TCGA-B5-A0K0-01A-11W-A062-09 TCGA-B5-A0K0-01A-11W-A062-09 TCGA-B5-A0K0-01 2df1abb0-b25b-4486-a5ed-728964eb0a1b TCGA-B5-A0K0-01A-11D-A042-01 TCGA-B5-A0K0-01A-11R-A040-07 TCGA-B5-A0K0-01A-11D-A042-01 TCGA-B5-A0K0-01 TCGA-B5-A0K0-01A-11D-A039-05 2df1abb0-b25b-4486-a5ed-728964eb0a1b TCGA-B5-A0K1-01 MSS TCGA-B5-A0K1-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-B5-A0K1 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 69 TCGA-B5-A0K1-F72221 TCGA-B5-A0K1 TCGA-B5-A0K1-01A Stage IA NO -25291 636 0 1110 YES Scheduled Follow-up Submission 2015-4-29 FEMALE 174 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 180 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-B5-A0K1.826BF8E6-F928-4962-9322-78FA74F9FB0E.pdf A0K1 45 negative TUMOR FREE NO 4+ Complete Remission/Response NO Primary Tumor 01 open 1988 NO NO YES B5 0 0 22 Endometrial A LIVING 117 2008 TCGA-B5-A0K1-01 TCGA-B5-A0K1-01 TCGA-B5-A0K1-01A-21-A162-20 6E5666F2-50BE-4591-878C-723948CDF9C8 TCGA-B5-A0K1-01 TCGA-B5-A0K1-01 TCGA-B5-A0K1-01A-11W-A062-09 TCGA-B5-A0K1-01A-11W-A062-09 TCGA-B5-A0K1-01A-11W-A062-09 TCGA-B5-A0K1-01 bacdb0de-d29b-4ac1-a163-35376a7b2b9b TCGA-B5-A0K1-01A-11D-A042-01 TCGA-B5-A0K1-01A-11R-A040-07 TCGA-B5-A0K1-01A-11D-A042-01 TCGA-B5-A0K1-01 TCGA-B5-A0K1-01A-11D-A039-05 bacdb0de-d29b-4ac1-a163-35376a7b2b9b TCGA-B5-A0K2-01 MSI-H TCGA-B5-A0K2-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 mutation cluster 1 TCGA-B5-A0K2 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 54 TCGA-B5-A0K2-F72222 TCGA-B5-A0K2 TCGA-B5-A0K2-01A Never Used Stage IIIA NO -20080 534 0 2209 NO Scheduled Follow-up Submission 2015-4-29 FEMALE 159 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 270 NO NO Indeterminate (neither Pre or Postmenopausal) G1 NO true No TCGA-B5-A0K2.5D780459-F4E6-4BB8-939D-5FDFD9BF7073.pdf A0K2 0 positive TUMOR FREE YES 2 Complete Remission/Response NO Primary Tumor 01 Minimally Invasive 1988 YES NO YES B5 0 0 25 Endometrial A LIVING 84 2008 TCGA-B5-A0K2-01 TCGA-B5-A0K2-01 TCGA-B5-A0K2-01A-21-A162-20 A0DA1E80-290C-4AF2-AE26-9492B418C580 TCGA-B5-A0K2-01 TCGA-B5-A0K2-01A-12W-A10C-09 TCGA-B5-A0K2-01A-12W-A10C-09 TCGA-B5-A0K2-01A-12W-A10C-09 c30924bd-cb0b-43ee-832e-1b470ec39d21 TCGA-B5-A0K2-01A-12D-A102-01 TCGA-B5-A0K2-01A-12D-A102-01 TCGA-B5-A0K2-01 TCGA-B5-A0K2-01A-12D-A10Q-05 c30924bd-cb0b-43ee-832e-1b470ec39d21 TCGA-B5-A0K3-01 MSS TCGA-B5-A0K3-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 2 mutation cluster 2 TCGA-B5-A0K3 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO YES 62 TCGA-B5-A0K3-F13268 TCGA-B5-A0K3 TCGA-B5-A0K3-01A Stage IA 150 -22664 523 0 700 529 Additional New Tumor Event 2011-6-22 FEMALE 164 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 390 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Disease diffuse carcinomatosis YES true No TCGA-B5-A0K3.2D78431C-7385-4BD3-B597-85E613D89BF6.pdf A0K3 10 negative WITH TUMOR Surgical Resection Primary Tumor 01 Minimally Invasive 2009 NO YES B5 0 11 0 27 Endometrial A LIVING 88 2009 TCGA-B5-A0K3-01 TCGA-B5-A0K3-01 TCGA-B5-A0K3-01A-21-A162-20 7854E580-34CD-4714-A5FF-58219FDC22BE TCGA-B5-A0K3-01 TCGA-B5-A0K3-01A-11W-A062-09 TCGA-B5-A0K3-01A-11W-A062-09 TCGA-B5-A0K3-01A-11W-A062-09 a2d46b53-d9bd-4c19-9a0a-fecb48d3c06a TCGA-B5-A0K3-01A-11D-A042-01 TCGA-B5-A0K3-01A-11D-A042-01 TCGA-B5-A0K3-01 TCGA-B5-A0K3-01A-11D-A039-05 a2d46b53-d9bd-4c19-9a0a-fecb48d3c06a TCGA-B5-A0K4-01 MSS TCGA-B5-A0K4-01 BRCA-LUAD+ C6-UCEC UCEC non-CIMP c3 cluster 4 squamous c3 UCEC-like c11 miRNA cluster 12 cluster 3 mutation c1uster 10 TCGA-B5-A0K4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 51 TCGA-B5-A0K4-F72223 TCGA-B5-A0K4 TCGA-B5-A0K4-01A Never Used Stage IB NO -18631 264 0 1757 Scheduled Follow-up Submission 2015-4-29 FEMALE 162 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 280 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-B5-A0K4.80DE2981-089A-47A2-B221-F7C28ECAF3F2.pdf A0K4 87 negative TUMOR FREE YES 0 Complete Remission/Response YES Primary Tumor 01 Minimally Invasive 2009 YES NO YES B5 0 3 0 23 Endometrial A LIVING 75 2009 TCGA-B5-A0K4-01 TCGA-B5-A0K4-01 TCGA-B5-A0K4-01A-21-A162-20 AB1E33D6-97E4-43CA-BAC8-612E767BE9EF TCGA-B5-A0K4-01 TCGA-B5-A0K4-01 TCGA-B5-A0K4-01A-11W-A062-09 TCGA-B5-A0K4-01A-11W-A062-09 TCGA-B5-A0K4-01A-11W-A062-09 TCGA-B5-A0K4-01 73e01a38-164c-44ce-ab36-ed429af8af44 TCGA-B5-A0K4-01A-11D-A042-01 TCGA-B5-A0K4-01A-11R-A040-07 TCGA-B5-A0K4-01A-11D-A042-01 TCGA-B5-A0K4-01 TCGA-B5-A0K4-01A-11D-A039-05 73e01a38-164c-44ce-ab36-ed429af8af44 TCGA-B5-A0K6-01 MSI-H TCGA-B5-A0K6-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA cluster 13 cluster 1 mutation cluster 1 TCGA-B5-A0K6 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 TCGA-B5-A0K6-F72224 TCGA-B5-A0K6 TCGA-B5-A0K6-01A Stage IA NO -21515 206 0 1953 YES Scheduled Follow-up Submission 2015-4-29 FEMALE 167 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 110 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-B5-A0K6.B7F34F79-DB7F-4C98-B1B3-80C3187AE91C.pdf A0K6 7 negative TUMOR FREE NO 0 Complete Remission/Response NO Primary Tumor 01 Minimally Invasive 2009 NO NO YES B5 0 0 Endometrial A LIVING 132 2009 TCGA-B5-A0K6-01 TCGA-B5-A0K6-01 TCGA-B5-A0K6-01 TCGA-B5-A0K6-01A-11W-A062-09 TCGA-B5-A0K6-01A-11W-A062-09 TCGA-B5-A0K6-01A-11W-A062-09 4534628b-5eb9-4123-b56b-b00447ee730b TCGA-B5-A0K6-01A-11D-A042-01 TCGA-B5-A0K6-01A-11D-A042-01 TCGA-B5-A0K6-01 TCGA-B5-A0K6-01A-11D-A039-05 4534628b-5eb9-4123-b56b-b00447ee730b TCGA-B5-A0K7-01 MSS TCGA-B5-A0K7-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 1 mutation cluster 4 TCGA-B5-A0K7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES NO Complete Response 64 TCGA-B5-A0K7-F72225 TCGA-B5-A0K7 TCGA-B5-A0K7-01A Stage IA NO -23429 184 0 1933 322 Scheduled Follow-up Submission 2015-4-29 FEMALE 168 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 1160 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 Other, specify Metastatic vagina NO true No TCGA-B5-A0K7.5C3818CE-5DA9-403E-B895-61DEA4BBFA57.pdf A0K7 0 negative TUMOR FREE NO 2 Complete Remission/Response NO Primary Tumor 01 Minimally Invasive 2009 NO NO YES B5 0 0 6 Endometrial A LIVING 61 2009 TCGA-B5-A0K7-01 TCGA-B5-A0K7-01 TCGA-B5-A0K7-01A-21-A162-20 4CC6CB63-CD6A-4683-B5C9-4C9F9FBF09C8 TCGA-B5-A0K7-01 TCGA-B5-A0K7-01A-11W-A10C-09 TCGA-B5-A0K7-01A-11W-A10C-09 TCGA-B5-A0K7-01A-11W-A10C-09 444a9114-2e40-4e7c-979a-624bc95d4c47 TCGA-B5-A0K7-01A-11D-A102-01 TCGA-B5-A0K7-01A-11D-A102-01 TCGA-B5-A0K7-01 TCGA-B5-A0K7-01A-11D-A10Q-05 444a9114-2e40-4e7c-979a-624bc95d4c47 TCGA-B5-A0K8-01 MSS TCGA-B5-A0K8-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation c1uster 9 TCGA-B5-A0K8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 71 TCGA-B5-A0K8-F32705 TCGA-B5-A0K8 TCGA-B5-A0K8-01A Stage IB -25992 191 0 847 Scheduled Follow-up Submission 2012-6-7 FEMALE 160 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 260 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-B5-A0K8.1E7C9CA2-73AA-4443-A125-D5588F93BEF9.pdf A0K8 5 negative TUMOR FREE 4+ Complete Remission/Response NO Primary Tumor 01 Minimally Invasive 2009 YES NO YES B5 0 0 12 Endometrial A LIVING 61 2009 TCGA-B5-A0K8-01 TCGA-B5-A0K8-01A-21-A18Q-20 FDF53DCD-50F1-4C8A-83A2-FA68972DDA16 TCGA-B5-A0K8-01A-11D-A14K-09 TCGA-B5-A0K8-01A-11D-A14K-09 TCGA-B5-A0K8-01A-11D-A14K-09 TCGA-B5-A0K8-01 71cdc7a1-4bbb-461c-ab98-34cad8c3a767 TCGA-B5-A0K8-01A-11D-A14J-01 TCGA-B5-A0K8-01A-11D-A14J-01 TCGA-B5-A0K8-01 TCGA-B5-A0K8-01 TCGA-B5-A0K8-01A-11D-A14N-05 71cdc7a1-4bbb-461c-ab98-34cad8c3a767 TCGA-B5-A0K9-01 MSI-H TCGA-B5-A0K9-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 miRNA cluster 13 cluster 6 mutation cluster 6 TCGA-B5-A0K9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 88 TCGA-B5-A0K9-F71992 TCGA-B5-A0K9 TCGA-B5-A0K9-01A Never Used Stage II NO -32289 182 409 0 335 YES Scheduled Follow-up Submission 2015-4-1 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 600 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-B5-A0K9.8278F457-C0A5-4441-9105-3FC015E3F0EF.pdf A0K9 87 negative TUMOR FREE NO 3 Complete Remission/Response YES Primary Tumor 01 Minimally Invasive 2009 NO NO YES B5 0 0 Endometrial A DECEASED 65 2009 ac3970c9-575a-4d72-a2b3-45f1ab671bbb TCGA-B5-A0K9-01 TCGA-B5-A0K9-01 ac3970c9-575a-4d72-a2b3-45f1ab671bbb TCGA-B5-A0K9-01A-11-A162-20 BFE971A5-CADC-45EE-8CE3-991809A3479E TCGA-B5-A0K9-01 ac3970c9-575a-4d72-a2b3-45f1ab671bbb TCGA-B5-A0K9-01A-21D-A10O-09 TCGA-B5-A0K9-01A-21D-A10O-09 TCGA-B5-A0K9-01A-21D-A10O-09 ac3970c9-575a-4d72-a2b3-45f1ab671bbb TCGA-B5-A0K9-01A-21D-A102-01 TCGA-B5-A0K9-01A-21D-A102-01 TCGA-B5-A0K9-01 TCGA-B5-A0K9-01A-21D-A10Q-05 TCGA-B5-A0KB-01 MSS TCGA-B5-A0KB-01 Squamous C6-UCEC UCEC Serous c4 cluster 4 squamous c3 UCEC-like c11 miRNA c1uster 10 cluster 2 TCGA-B5-A0KB TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO NO Progressive Disease 62 TCGA-B5-A0KB-F32711 TCGA-B5-A0KB TCGA-B5-A0KB-01B Stage IB -22669 368 0 824 689 Scheduled Follow-up Submission 2012-6-7 FEMALE 161 Endometrioid endometrial adenocarcinoma Yes C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 430 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Disease cul de sac mass YES true Yes TCGA-B5-A0KB.2C744545-8FF8-4A07-A8F2-A47D28B2A8E2.pdf A0KB 72 negative WITH TUMOR 1 Complete Remission/Response YES Primary Tumor 01 Minimally Invasive 2009 YES NO YES B5 0 0 0 0 Endometrial B LIVING 76 2010 TCGA-B5-A0KB-01 TCGA-B5-A0KB-01B-21-A18Q-20 FDAB5E26-83C0-46A6-859F-18727FBB2B21 b5ee1a9b-caca-4abf-9317-d6bf673b8e65 TCGA-B5-A0KB-01B-11D-A14F-01 TCGA-B5-A0KB-01B-11D-A14F-01 TCGA-B5-A0KB-01 TCGA-B5-A0KB-01B-11D-A14H-05 b5ee1a9b-caca-4abf-9317-d6bf673b8e65 TCGA-B5-A11E-01 MSI-L TCGA-B5-A11E-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 11 TCGA-B5-A11E TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 TCGA-B5-A11E-F72226 TCGA-B5-A11E TCGA-B5-A11E-01A Stage IB NO -19458 198 0 1820 Scheduled Follow-up Submission 2015-4-29 FEMALE 165 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 890 NO NO Peri (6-12 months since last menstrual period) G3 NO true No TCGA-B5-A11E.2058131C-09EA-4DC7-A84A-EB055A68F1B6.pdf A11E 69 negative TUMOR FREE NO 2 Complete Remission/Response NO Primary Tumor 01 Minimally Invasive 2009 NO NO YES B5 0 4 0 20 Endometrial A LIVING 52 2010 TCGA-B5-A11E-01 TCGA-B5-A11E-01 TCGA-B5-A11E-01A-21-A163-20 E4F73CB4-DF3F-467F-BE19-6037F9871CCE TCGA-B5-A11E-01 TCGA-B5-A11E-01A-11D-A10M-09 TCGA-B5-A11E-01A-11D-A10M-09 7e923dc8-9920-4f06-a98b-085a5935b29c TCGA-B5-A11E-01A-11D-A10L-01 TCGA-B5-A11E-01A-11D-A10L-01 TCGA-B5-A11E-01 TCGA-B5-A11E-01A-11D-A10N-05 7e923dc8-9920-4f06-a98b-085a5935b29c TCGA-B5-A11F-01 MSS TCGA-B5-A11F-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 3 mutation cluster 4 TCGA-B5-A11F TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES NO Complete Response 55 TCGA-B5-A11F-F17642 TCGA-B5-A11F TCGA-B5-A11F-01A Stage IA NO -20171 5482 0 5651 1610 NO Scheduled Follow-up Submission 2011-10-20 FEMALE Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 380 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 Bone Metastatic YES true No TCGA-B5-A11F.228E437D-FB45-452B-A5A0-299C125F4CC4.pdf A11F 7 negative TUMOR FREE Complete Remission/Response YES Other Method, Specify Below CT guided thin needle aspirate Primary Tumor 01 Minimally Invasive 1988 YES NO YES B5 0 0 0 13 Endometrial A LIVING 1995 TCGA-B5-A11F-01 TCGA-B5-A11F-01 TCGA-B5-A11F-01A-21-A163-20 8C6D529C-DAD0-4264-A2FD-D7250A73C825 TCGA-B5-A11F-01 TCGA-B5-A11F-01A-11D-A10M-09 TCGA-B5-A11F-01A-11D-A10M-09 TCGA-B5-A11F-01A-11D-A10M-09 fb1c341a-34f7-482c-a954-de07652990b1 TCGA-B5-A11F-01A-11D-A10L-01 TCGA-B5-A11F-01A-11D-A10L-01 TCGA-B5-A11F-01 TCGA-B5-A11F-01A-11D-A10N-05 fb1c341a-34f7-482c-a954-de07652990b1 TCGA-B5-A11G-01 MSI-H TCGA-B5-A11G-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 6 cluster 1 mutation cluster 11 TCGA-B5-A11G TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 71 TCGA-B5-A11G-F17657 TCGA-B5-A11G TCGA-B5-A11G-01A Stage IA NO -25995 3248 0 3448 NO Scheduled Follow-up Submission 2011-5-23 FEMALE 160 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 180 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-B5-A11G.7021DC28-67C3-4BB6-9C8B-0FE7EFBCA1E1.pdf A11G 0 negative TUMOR FREE 2 Complete Remission/Response NO Primary Tumor 01 open 1988 NO NO YES B5 0 0 0 10 Endometrial A LIVING 77 2001 TCGA-B5-A11G-01 TCGA-B5-A11G-01A-21-A163-20 A166DDC1-C6D9-4125-81AE-7CA62778D347 TCGA-B5-A11G-01A-13D-A122-09 TCGA-B5-A11G-01A-13D-A122-09 TCGA-B5-A11G-01 b213f9e2-4253-41db-9a05-e91791f4ec7e TCGA-B5-A11G-01A-13D-A120-01 TCGA-B5-A11G-01A-13D-A120-01 TCGA-B5-A11G-01 TCGA-B5-A11G-01 TCGA-B5-A11G-01A-13D-A123-05 b213f9e2-4253-41db-9a05-e91791f4ec7e TCGA-B5-A11H-01 MSI-H TCGA-B5-A11H-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 1 TCGA-B5-A11H TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 TCGA-B5-A11H-F17659 TCGA-B5-A11H TCGA-B5-A11H-01A Stage IIIA NO -24556 2324 0 2687 YES Scheduled Follow-up Submission 2011-10-20 FEMALE Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 620 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-B5-A11H.40813C61-4B78-4677-89A4-4B9488613F57.pdf A11H 0 positive TUMOR FREE Complete Remission/Response NO Primary Tumor 01 open 1988 YES NO YES B5 0 0 0 15 Endometrial A LIVING 101 2004 TCGA-B5-A11H-01 TCGA-B5-A11H-01A-21-A163-20 84A856DF-6E1C-48D8-AF42-3430608432F1 TCGA-B5-A11H-01A-11D-A122-09 TCGA-B5-A11H-01A-11D-A122-09 TCGA-B5-A11H-01 c0294497-87d4-481f-864a-e4fa9baab8c5 TCGA-B5-A11H-01A-11D-A120-01 TCGA-B5-A11H-01A-11D-A120-01 TCGA-B5-A11H-01 TCGA-B5-A11H-01 TCGA-B5-A11H-01A-11D-A123-05 c0294497-87d4-481f-864a-e4fa9baab8c5 TCGA-B5-A11I-01 MSS TCGA-B5-A11I-01 High C6-UCEC UCEC Serous c4 cluster 3 squamous c3 UCEC-like c11 miRNA cluster 4 cluster 2 mutation cluster 3 TCGA-B5-A11I TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Stable Disease 65 TCGA-B5-A11I-F17675 TCGA-B5-A11I TCGA-B5-A11I-01A Stage IVB NO -23857 1974 0 2303 1940 YES Additional New Tumor Event 2011-10-21 FEMALE 159 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8140/3 C54.1 YES Office Endometrial Biopsy 970 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Lung Metastatic YES true No TCGA-B5-A11I.850EFCC5-484B-4E09-801A-2FAFB4CFD72B.pdf A11I 8 negative TUMOR FREE 0 Complete Remission/Response Current User YES Excisional Biopsy Primary Tumor 01 open 1988 YES NO YES B5 0 7 0 6 Endometrial A LIVING 124 2005 TCGA-B5-A11I-01 TCGA-B5-A11I-01 TCGA-B5-A11I-01A-21-A163-20 354106A1-BA91-416A-B95C-05ACAE0EC86B TCGA-B5-A11I-01 TCGA-B5-A11I-01A-11D-A10M-09 TCGA-B5-A11I-01A-11D-A10M-09 TCGA-B5-A11I-01A-11D-A10M-09 5706f1b9-2c2c-4906-a9fb-64ba5a57d47e TCGA-B5-A11I-01A-11D-A10L-01 TCGA-B5-A11I-01A-11D-A10L-01 TCGA-B5-A11I-01 TCGA-B5-A11I-01A-11D-A10N-05 5706f1b9-2c2c-4906-a9fb-64ba5a57d47e TCGA-B5-A11J-01 MSI-H TCGA-B5-A11J-01 Quiet C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 2 TCGA-B5-A11J TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 TCGA-B5-A11J-F17687 TCGA-B5-A11J TCGA-B5-A11J-01A Stage IA NO -23485 1536 0 1656 YES Scheduled Follow-up Submission 2011-10-21 FEMALE Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 90 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-B5-A11J.1F9E7FAB-ADA0-4EFF-8A86-F5344357ADED.pdf A11J 9 negative TUMOR FREE 1 Complete Remission/Response NO Primary Tumor 01 open 1988 NO NO YES B5 0 0 0 17 Endometrial A LIVING 134 2006 TCGA-B5-A11J-01 TCGA-B5-A11J-01A-11D-A122-09 TCGA-B5-A11J-01A-11D-A122-09 TCGA-B5-A11J-01 4f3e68ae-cf3c-491d-a3ed-0fc30261ead3 TCGA-B5-A11J-01A-11D-A120-01 TCGA-B5-A11J-01A-11D-A120-01 TCGA-B5-A11J-01 TCGA-B5-A11J-01 TCGA-B5-A11J-01A-11D-A123-05 4f3e68ae-cf3c-491d-a3ed-0fc30261ead3 TCGA-B5-A11L-01 MSS TCGA-B5-A11L-01 COAD-READ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 5 cluster 4 TCGA-B5-A11L TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 71 0 TCGA-B5-A11L-F37005 TCGA-B5-A11L TCGA-B5-A11L-01B Stage IC -26120 1297 2240 0 1396 131 2012-11-21 FEMALE 163 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 90 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 Other, specify Locoregional Recurrence Vaginal Apex NO YES true No TCGA-B5-A11L.ABA26FE8-0C80-459A-9DF8-537D1A08A92E.pdf A11L 85 negative TUMOR FREE NO Complete Remission/Response YES Other Method, Specify Below Whole Pelvic Radiation Primary Tumor 01 Minimally Invasive 1988 NO YES B5 0 0 9 Endometrial B DECEASED 92 2007 TCGA-B5-A11L-01 TCGA-B5-A11L-01B-11-A18Q-20 8D1A88C2-9AD4-4A1B-80CE-864D78A2089A TCGA-B5-A11L-01 d262b256-5452-4df1-9526-9a1b11da775f TCGA-B5-A11L-01B-21D-A13J-01 TCGA-B5-A11L-01B-21D-A13J-01 TCGA-B5-A11L-01 TCGA-B5-A11L-01 TCGA-B5-A11L-01B-21D-A13K-05 d262b256-5452-4df1-9526-9a1b11da775f TCGA-B5-A11M-01 MSS TCGA-B5-A11M-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 3 UCEC-like c11 miRNA cluster 13 cluster 6 mutation cluster 1 TCGA-B5-A11M TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 43 TCGA-B5-A11M-F17720 TCGA-B5-A11M Former User Stage IA NO -16063 0 1362 YES Scheduled Follow-up Submission 2011-10-24 FEMALE 153 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G1 NO No A11M 4 negative TUMOR FREE 0 Complete Remission/Response NO Primary Tumor 01 open 1988 NO NO YES B5 0 0 0 0 Endometrial LIVING 139 2007 TCGA-B5-A11M-01 TCGA-B5-A11M-01A-11D-A122-09 TCGA-B5-A11M-01A-11D-A122-09 TCGA-B5-A11M-01A-11D-A122-09 TCGA-B5-A11M-01 aefe6191-1196-4614-b319-4ce263d3cc90 TCGA-B5-A11M-01 TCGA-B5-A11M-01A-11D-A123-05 aefe6191-1196-4614-b319-4ce263d3cc90 TCGA-B5-A11N-01 MSI-L TCGA-B5-A11N-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 11 TCGA-B5-A11N TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 69 TCGA-B5-A11N-F72227 TCGA-B5-A11N TCGA-B5-A11N-01A Stage IA NO -25442 1140 0 1876 Scheduled Follow-up Submission 2015-4-29 FEMALE 174 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 370 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-B5-A11N.A4C1DE15-A45A-4D31-B363-C6652370C09C.pdf A11N 5 negative TUMOR FREE NO 3 Complete Remission/Response NO Primary Tumor 01 Minimally Invasive 1988 NO NO YES B5 0 0 46 Endometrial A LIVING 90 2007 TCGA-B5-A11N-01 TCGA-B5-A11N-01A-21-A163-20 0DA12AA8-1686-4705-90CD-B50DB7F41C24 TCGA-B5-A11N-01A-11D-A122-09 TCGA-B5-A11N-01A-11D-A122-09 TCGA-B5-A11N-01 823aed7c-3bf3-4ace-b17d-dc4f8a4e0e2f TCGA-B5-A11N-01A-11D-A120-01 TCGA-B5-A11N-01A-11D-A120-01 TCGA-B5-A11N-01 TCGA-B5-A11N-01 TCGA-B5-A11N-01A-11D-A123-05 823aed7c-3bf3-4ace-b17d-dc4f8a4e0e2f TCGA-B5-A11O-01 MSI-L TCGA-B5-A11O-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c11 miRNA cluster 13 cluster 2 mutation cluster 1 TCGA-B5-A11O TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES Complete Response 62 TCGA-B5-A11O-F72228 TCGA-B5-A11O TCGA-B5-A11O-01A Stage IA NO -22720 993 0 2609 2111 1924 YES Scheduled Follow-up Submission 2015-4-29 FEMALE 177 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 130 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 Other, specify New Primary Tumor Right Breast YES YES true No TCGA-B5-A11O.078AA8A2-E812-4603-9084-8414937B88E1.pdf A11O 13 negative TUMOR FREE YES 2 Complete Remission/Response YES Surgical Resection Primary Tumor 01 Minimally Invasive 1988 NO NO YES B5 0 0 0 18 Endometrial A LIVING 114 2008 TCGA-B5-A11O-01 TCGA-B5-A11O-01A-11D-A122-09 TCGA-B5-A11O-01A-11D-A122-09 TCGA-B5-A11O-01A-11D-A122-09 TCGA-B5-A11O-01 7e3666db-df81-4413-b742-c475e786772e TCGA-B5-A11O-01A-11D-A120-01 TCGA-B5-A11O-01A-11D-A120-01 TCGA-B5-A11O-01 TCGA-B5-A11O-01 TCGA-B5-A11O-01A-11D-A123-05 7e3666db-df81-4413-b742-c475e786772e TCGA-B5-A11P-01 MSI-L TCGA-B5-A11P-01 Squamous C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-B5-A11P TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 87 TCGA-B5-A11P-F37003 TCGA-B5-A11P TCGA-B5-A11P-01B Never Used Stage IB NO -32047 979 0 1583 NO 2012-11-21 FEMALE Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 120 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-B5-A11P.77639636-9C18-4C81-9FCF-04BA2D92110E.pdf A11P 20 TUMOR FREE NO 4+ Never Used NO Primary Tumor 01 Minimally Invasive 1988 NO YES B5 Endometrial B LIVING 74 2008 TCGA-B5-A11P-01 TCGA-B5-A11P-01B-21-A18Q-20 4DB77D5F-8FE5-4079-B786-AC15D556A530 TCGA-B5-A11P-01 2d49f9b3-88bc-4e99-a2ea-ba900713563d TCGA-B5-A11P-01B-11D-A14F-01 TCGA-B5-A11P-01B-11D-A14F-01 TCGA-B5-A11P-01 TCGA-B5-A11P-01 TCGA-B5-A11P-01B-11D-A14H-05 2d49f9b3-88bc-4e99-a2ea-ba900713563d TCGA-B5-A11Q-01 MSS TCGA-B5-A11Q-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation c1uster 9 TCGA-B5-A11Q TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 TCGA-B5-A11Q-F17770 TCGA-B5-A11Q TCGA-B5-A11Q-01A Former User Stage IIIA NO -23538 702 0 976 Scheduled Follow-up Submission 2011-10-25 FEMALE 161 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 120 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-B5-A11Q.5117F490-9CE1-465F-BDF7-7B545B314703.pdf A11Q 34 negative TUMOR FREE 0 Complete Remission/Response YES Primary Tumor 01 Minimally Invasive 1988 YES NO YES B5 0 0 8 Endometrial A LIVING 88 2008 TCGA-B5-A11Q-01 TCGA-B5-A11Q-01A-21-A163-20 418EAA98-126B-4B44-B332-944D38386927 TCGA-B5-A11Q-01A-11D-A122-09 TCGA-B5-A11Q-01A-11D-A122-09 TCGA-B5-A11Q-01 3b8301c9-646f-43e7-9b8c-7690294d0356 TCGA-B5-A11Q-01A-11D-A120-01 TCGA-B5-A11Q-01A-11D-A120-01 TCGA-B5-A11Q-01 TCGA-B5-A11Q-01 TCGA-B5-A11Q-01A-11D-A123-05 3b8301c9-646f-43e7-9b8c-7690294d0356 TCGA-B5-A11R-01 MSS TCGA-B5-A11R-01 Iq UCEC CIMP c18 cluster 2 miRNA cluster 12 cluster 5 mutation cluster 1 TCGA-B5-A11R TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 51 TCGA-B5-A11R-F72229 TCGA-B5-A11R TCGA-B5-A11R-01A Stage II NO -18878 734 0 2349 Scheduled Follow-up Submission 2015-4-29 FEMALE 168 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 100 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-B5-A11R.0AC5670B-7EA6-438C-9326-843BB7A6A81C.pdf A11R 60 negative TUMOR FREE YES 2 Complete Remission/Response YES Primary Tumor 01 Minimally Invasive 1988 YES NO YES B5 0 12 0 6 Endometrial A LIVING 89 2008 6152d141-ed7d-4c03-9af9-4647dc455c4f TCGA-B5-A11R-01 6152d141-ed7d-4c03-9af9-4647dc455c4f 6152d141-ed7d-4c03-9af9-4647dc455c4f TCGA-B5-A11R-01A-11D-A122-09 TCGA-B5-A11R-01A-11D-A122-09 6152d141-ed7d-4c03-9af9-4647dc455c4f TCGA-B5-A11R-01 TCGA-B5-A11R-01A-11D-A120-01 TCGA-B5-A11R-01A-11D-A120-01 TCGA-B5-A11R-01 TCGA-B5-A11R-01 TCGA-B5-A11R-01A-11D-A123-05 TCGA-B5-A11S-01 MSS TCGA-B5-A11S-01 BRCA-LUAD+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-B5-A11S TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES Complete Response 63 TCGA-B5-A11S-F72230 TCGA-B5-A11S TCGA-B5-A11S-01A Never Used Stage IA NO 68 -23085 615 0 2229 41 Scheduled Follow-up Submission 2015-4-29 FEMALE 157 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. C54.1 8380/3 C54.1 YES Dilation and curettage procedure 200 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 Other, specify New Primary Tumor Breast NO true No TCGA-B5-A11S.A1E96BA3-7DFB-4E3C-A6CF-B0B99D4C44FA.pdf A11S 17 negative TUMOR FREE NO 2 Complete Remission/Response NO Surgical Resection Primary Tumor 01 Minimally Invasive 2009 NO NO YES B5 0 2 0 28 Endometrial A LIVING 118 2009 TCGA-B5-A11S-01 TCGA-B5-A11S-01A-21-A163-20 69621795-517F-4376-81BC-4450BE17F9EF TCGA-B5-A11S-01A-11D-A122-09 TCGA-B5-A11S-01A-11D-A122-09 TCGA-B5-A11S-01A-11D-A122-09 TCGA-B5-A11S-01 eb6cac23-997e-4d0b-82cf-f74fd5fb57d2 TCGA-B5-A11S-01A-11D-A120-01 TCGA-B5-A11S-01A-11D-A120-01 TCGA-B5-A11S-01 TCGA-B5-A11S-01 TCGA-B5-A11S-01A-11D-A123-05 eb6cac23-997e-4d0b-82cf-f74fd5fb57d2 TCGA-B5-A11U-01 MSI-H TCGA-B5-A11U-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 5 cluster 4 mutation cluster 13 TCGA-B5-A11U TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 74 TCGA-B5-A11U-F17774 TCGA-B5-A11U TCGA-B5-A11U-01A Stage IVB NO -27160 371 0 509 YES Scheduled Follow-up Submission 2011-10-25 FEMALE 152 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 220 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-B5-A11U.1EF2CB28-A515-4E9D-9148-CC1A2DF77F60.pdf A11U 23 TUMOR FREE 2 Complete Remission/Response YES Primary Tumor 01 Minimally Invasive 2009 NO NO YES B5 0 Endometrial A LIVING 61 2009 TCGA-B5-A11U-01 TCGA-B5-A11U-01A-21-A163-20 73AE6942-57B1-4104-8D42-3D5BA79480B2 TCGA-B5-A11U-01A-11D-A122-09 TCGA-B5-A11U-01A-11D-A122-09 TCGA-B5-A11U-01 714254dd-834a-4b70-8f88-c48bc7b4fdb8 TCGA-B5-A11U-01A-11D-A120-01 TCGA-B5-A11U-01A-11D-A120-01 TCGA-B5-A11U-01 TCGA-B5-A11U-01 TCGA-B5-A11U-01A-11D-A123-05 714254dd-834a-4b70-8f88-c48bc7b4fdb8 TCGA-B5-A11V-01 MSS TCGA-B5-A11V-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 1 mutation cluster 4 TCGA-B5-A11V TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 TCGA-B5-A11V-F17776 TCGA-B5-A11V TCGA-B5-A11V-01A Stage IA NO -23630 294 0 595 YES Scheduled Follow-up Submission 2011-10-25 FEMALE 157 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 760 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-B5-A11V.E1B5A941-5EEB-4207-84DC-F3BF22D5FC29.pdf A11V 29 positive TUMOR FREE 0 Complete Remission/Response NO Primary Tumor 01 Minimally Invasive 2009 NO NO YES B5 0 0 0 3 Endometrial A LIVING 71 2010 TCGA-B5-A11V-01 TCGA-B5-A11V-01 TCGA-B5-A11V-01A-21-A163-20 597AAFA9-8552-4364-ABB2-2B013C305A8B TCGA-B5-A11V-01 TCGA-B5-A11V-01A-11D-A10M-09 TCGA-B5-A11V-01A-11D-A10M-09 TCGA-B5-A11V-01A-11D-A10M-09 986bddf6-4dde-4bfb-94c3-123674a4ca45 TCGA-B5-A11V-01A-11D-A10L-01 TCGA-B5-A11V-01A-11D-A10L-01 TCGA-B5-A11V-01 TCGA-B5-A11V-01A-11D-A10N-05 986bddf6-4dde-4bfb-94c3-123674a4ca45 TCGA-B5-A11W-01 MSS TCGA-B5-A11W-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 7 TCGA-B5-A11W TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 61 TCGA-B5-A11W-F17779 TCGA-B5-A11W TCGA-B5-A11W-01A Never Used Stage IB -22365 258 0 593 YES Scheduled Follow-up Submission 2011-10-25 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 310 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-B5-A11W.C5762F7C-AB69-40D0-A9D0-71A6281F30AF.pdf A11W 52 positive TUMOR FREE 1 Complete Remission/Response YES Primary Tumor 01 Minimally Invasive 2009 NO NO YES B5 0 0 0 17 Endometrial A LIVING 102 2010 TCGA-B5-A11W-01 TCGA-B5-A11W-01A-21-A163-20 2868A3E3-9D6E-4F91-8E5D-EBDF6893272D TCGA-B5-A11W-01A-12D-A122-09 TCGA-B5-A11W-01A-12D-A122-09 TCGA-B5-A11W-01 168116db-99c5-4d7a-9e9f-3858e1824298 TCGA-B5-A11W-01A-12D-A120-01 TCGA-B5-A11W-01A-12D-A120-01 TCGA-B5-A11W-01 TCGA-B5-A11W-01 TCGA-B5-A11W-01A-12D-A123-05 168116db-99c5-4d7a-9e9f-3858e1824298 TCGA-B5-A11X-01 MSI-L TCGA-B5-A11X-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 BRCA basal-like c6 RNA cluster 3 miRNA cluster 12 cluster 5 mutation cluster 4 TCGA-B5-A11X TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Complete Response 66 TCGA-B5-A11X-F17790 TCGA-B5-A11X TCGA-B5-A11X-01A Stage IIIC2 NO -24217 246 0 596 397 Scheduled Follow-up Submission 2011-10-25 FEMALE 160 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8020/3 C54.1 YES Dilation and curettage procedure 530 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Metastatic lymph nodes YES true No TCGA-B5-A11X.89C9704E-F43C-440C-970F-872835910268.pdf A11X 100 negative TUMOR FREE 2 NO Primary Tumor 01 open 2009 YES NO YES B5 5 5 1 5 Endometrial A LIVING 71 2010 TCGA-B5-A11X-01 TCGA-B5-A11X-01 TCGA-B5-A11X-01A-21-A163-20 C94E9FFC-592E-41B8-9552-BAC7AE2F7404 TCGA-B5-A11X-01 TCGA-B5-A11X-01A-11D-A10M-09 TCGA-B5-A11X-01A-11D-A10M-09 TCGA-B5-A11X-01A-11D-A10M-09 bca7a3e6-57e9-44e6-b33f-a5e62011884d TCGA-B5-A11X-01A-11D-A10N-05 bca7a3e6-57e9-44e6-b33f-a5e62011884d TCGA-B5-A11Y-01 MSI-L TCGA-B5-A11Y-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 mutation cluster 6 TCGA-B5-A11Y TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 59 TCGA-B5-A11Y-F17795 TCGA-B5-A11Y TCGA-B5-A11Y-01A Former User Stage IB NO -21860 244 0 560 Scheduled Follow-up Submission 2011-10-25 FEMALE 162 Endometrioid endometrial adenocarcinoma No C54.1 8382/3 C54.1 YES Office Endometrial Biopsy 580 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-B5-A11Y.4FA7876E-EF1B-4EBA-99F9-1D26099B2CA1.pdf A11Y 54 negative TUMOR FREE 1 Complete Remission/Response NO Primary Tumor 01 Minimally Invasive 2009 NO NO YES B5 0 8 Endometrial A LIVING 63 2010 TCGA-B5-A11Y-01 TCGA-B5-A11Y-01 TCGA-B5-A11Y-01A-31-A163-20 016DB1F0-DE63-48F1-9C2A-1C77E23306ED TCGA-B5-A11Y-01 TCGA-B5-A11Y-01A-21D-A10M-09 TCGA-B5-A11Y-01A-21D-A10M-09 f192adcd-d613-400e-9737-725083638ee4 TCGA-B5-A11Y-01A-21D-A10L-01 TCGA-B5-A11Y-01A-21D-A10L-01 TCGA-B5-A11Y-01 TCGA-B5-A11Y-01A-21D-A10N-05 f192adcd-d613-400e-9737-725083638ee4 TCGA-B5-A11Z-01 MSS TCGA-B5-A11Z-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 4 TCGA-B5-A11Z TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 61 TCGA-B5-A11Z-F17833 TCGA-B5-A11Z TCGA-B5-A11Z-01A Stage IA NO -22505 213 0 528 NO Scheduled Follow-up Submission 2011-10-26 FEMALE 172 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 340 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-B5-A11Z.62C170A9-710F-45C0-B6BB-3F491A86A7E4.pdf A11Z 0 negative TUMOR FREE 3 Complete Remission/Response NO Primary Tumor 01 Minimally Invasive 2009 NO NO YES B5 0 0 Endometrial A LIVING 84 2010 TCGA-B5-A11Z-01 TCGA-B5-A11Z-01A-21-A163-20 6CEE54D4-5FA9-4D01-82BF-C5B6A6341AB3 TCGA-B5-A11Z-01A-11D-A10M-09 TCGA-B5-A11Z-01A-11D-A10M-09 TCGA-B5-A11Z-01A-11D-A10M-09 TCGA-B5-A11Z-01 640190cd-cd16-4a1a-8e63-9e41db6c3f89 TCGA-B5-A11Z-01A-11D-A10L-01 TCGA-B5-A11Z-01A-11D-A10L-01 TCGA-B5-A11Z-01 TCGA-B5-A11Z-01 TCGA-B5-A11Z-01A-11D-A10N-05 640190cd-cd16-4a1a-8e63-9e41db6c3f89 TCGA-B5-A121-01 MSS TCGA-B5-A121-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 mutation c1uster 9 TCGA-B5-A121 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 TCGA-B5-A121-F17838 TCGA-B5-A121 TCGA-B5-A121-01A Stage IIIA NO -21018 188 0 504 Scheduled Follow-up Submission 2011-10-26 FEMALE 165 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 280 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-B5-A121.82B20A1F-99AC-4CC8-BAF2-B7132809D4F2.pdf A121 48 negative TUMOR FREE 2 Complete Remission/Response YES Primary Tumor 01 Minimally Invasive 2009 NO NO YES B5 0 0 0 0 Endometrial A LIVING 80 2010 TCGA-B5-A121-01 TCGA-B5-A121-01A-21-A163-20 A4DA0446-B32E-4A47-8D1D-F4934D134F1D TCGA-B5-A121-01A-31D-A122-09 TCGA-B5-A121-01A-31D-A122-09 TCGA-B5-A121-01 3e0f0d9d-31cc-4e48-b4ca-d53deec9b7d3 TCGA-B5-A121-01A-31D-A120-01 TCGA-B5-A121-01A-31D-A120-01 TCGA-B5-A121-01 TCGA-B5-A121-01 TCGA-B5-A121-01A-31D-A123-05 3e0f0d9d-31cc-4e48-b4ca-d53deec9b7d3 TCGA-B5-A1MR-01 MSS TCGA-B5-A1MR-01 Kirc+ UCEC non-CIMP c3 cluster 2 LAML-like c13 miRNA cluster 4 cluster 2 TCGA-B5-A1MR TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 65 TCGA-B5-A1MR-F72232 TCGA-B5-A1MR Stage IIIA NO -24017 0 6859 NO Scheduled Follow-up Submission 2015-4-29 FEMALE Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO No A1MR 4 negative TUMOR FREE NO 3 Complete Remission/Response Never Used YES Primary Tumor 01 open 1988 NO NO YES B5 0 7 0 15 Endometrial LIVING 58 1995 TCGA-B5-A1MR-01 TCGA-B5-A1MR-01 a644742b-ae08-41e3-810e-800bf0eef8fe TCGA-B5-A1MR-01A-31D-A14F-01 TCGA-B5-A1MR-01A-31D-A14F-01 TCGA-B5-A1MR-01 TCGA-B5-A1MR-01 TCGA-B5-A1MR-01A-31D-A14H-05 a644742b-ae08-41e3-810e-800bf0eef8fe TCGA-B5-A1MS-01 MSS TCGA-B5-A1MS-01 BRCA-LUAD+ UCEC Serous c4 UCEC-like c5 miRNA cluster 14 TCGA-B5-A1MS TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES Progressive Disease 60 TCGA-B5-A1MS-F44649 TCGA-B5-A1MS TCGA-B5-A1MS-01B Stage IC NO -22068 3117 3112 0 2706 NO 2013-8-20 FEMALE 166 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Dilation and curettage procedure 440 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Supraclavicular Fossa NO YES true No TCGA-B5-A1MS.5FF9FC65-FBCD-40E8-8382-DDD0B8EFD22B.pdf A1MS 55 negative WITH TUMOR NO 4+ Partial Remission/Response Never Used NO RX Primary Tumor 01 Minimally Invasive 1988 NO YES B5 0 4 0 25 Endometrial B DECEASED 74 2003 6acf7672-ec9d-4765-85db-43c311d5f124 TCGA-B5-A1MS-01 6acf7672-ec9d-4765-85db-43c311d5f124 TCGA-B5-A1MS-01B-21-A23Z-20 02AB5130-5982-4EFB-9CA0-BE933CB5D453 6acf7672-ec9d-4765-85db-43c311d5f124 6acf7672-ec9d-4765-85db-43c311d5f124 TCGA-B5-A1MS-01 TCGA-B5-A1MS-01B-11D-A227-01 TCGA-B5-A1MS-01B-11D-A227-01 TCGA-B5-A1MS-01 TCGA-B5-A1MS-01 TCGA-B5-A1MS-01B-11D-A22B-05 TCGA-B5-A1MU-01 MSS TCGA-B5-A1MU-01 BRCA-LUAD+ C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 5 cluster 4 mutation cluster 3 TCGA-B5-A1MU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO YES Progressive Disease 79 TCGA-B5-A1MU-F19109 TCGA-B5-A1MU TCGA-B5-A1MU-01A Stage IVB NO 1374 -29027 1834 1548 0 1365 NO Scheduled Follow-up Submission 2011-12-2 FEMALE 147 Serous endometrial adenocarcinoma No NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 260 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify New Primary Tumor Breast YES true No TCGA-B5-A1MU.FC3D9B79-4CAD-4F62-892C-C830B24E50DD.pdf A1MU 100 positive WITH TUMOR 3 Complete Remission/Response Former User NO Surgical Resection Primary Tumor 01 open 1988 NO NO YES B5 0 0 Endometrial A DECEASED 44 2006 TCGA-B5-A1MU-01 TCGA-B5-A1MU-01A-21-A18Q-20 25E51246-A434-4281-90CE-E2577B8DC786 TCGA-B5-A1MU-01A-11D-A13L-09 TCGA-B5-A1MU-01A-11D-A13L-09 TCGA-B5-A1MU-01A-11D-A13L-09 TCGA-B5-A1MU-01 5afaa343-65f0-4499-a44d-c3c87106443a TCGA-B5-A1MU-01A-11D-A13J-01 TCGA-B5-A1MU-01A-11D-A13J-01 TCGA-B5-A1MU-01 TCGA-B5-A1MU-01 TCGA-B5-A1MU-01A-11D-A13K-05 5afaa343-65f0-4499-a44d-c3c87106443a TCGA-B5-A1MV-01 MSI-L TCGA-B5-A1MV-01 BRCA-LUAD+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 4 TCGA-B5-A1MV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 84 TCGA-B5-A1MV-F72234 TCGA-B5-A1MV TCGA-B5-A1MV-01A Former User Stage IA NO -30926 226 0 1565 Scheduled Follow-up Submission 2015-4-29 FEMALE 151 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 470 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-B5-A1MV.E536759E-F47A-4EE9-B855-AFEC6BCF5EE0.pdf A1MV 47 negative TUMOR FREE NO 2 Complete Remission/Response NO Primary Tumor 01 open 2009 NO NO YES B5 0 7 0 19 Endometrial A LIVING 72 2010 TCGA-B5-A1MV-01 TCGA-B5-A1MV-01A-41-A18Q-20 F062FF19-5D49-4994-9952-F263FDB3B0B6 TCGA-B5-A1MV-01 ef62242e-872b-4bd3-ac3d-a6645f771020 TCGA-B5-A1MV-01A-31D-A14F-01 TCGA-B5-A1MV-01A-31D-A14F-01 TCGA-B5-A1MV-01 TCGA-B5-A1MV-01 TCGA-B5-A1MV-01A-31D-A14H-05 ef62242e-872b-4bd3-ac3d-a6645f771020 TCGA-B5-A1MW-01 MSI-H TCGA-B5-A1MW-01 Kirc+ UCEC non-CIMP c3 cluster 2 UCEC-like c5 miRNA cluster 7 cluster 1 TCGA-B5-A1MW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES Complete Response 55 TCGA-B5-A1MW-F21619 TCGA-B5-A1MW TCGA-B5-A1MW-01A Former User Stage IA NO -20183 148 0 447 311 Scheduled Follow-up Submission 2012-2-16 FEMALE 163 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 340 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Disease vaginal cuff YES true No TCGA-B5-A1MW.870882D8-D89A-4A89-B516-DADAB95BE285.pdf A1MW 31 negative TUMOR FREE 1 Complete Remission/Response YES Primary Tumor 01 Minimally Invasive 2009 NO NO YES B5 0 8 0 31 Endometrial A LIVING 62 2010 7ad9720d-18e2-472f-a267-525f191a23ca TCGA-B5-A1MW-01 7ad9720d-18e2-472f-a267-525f191a23ca TCGA-B5-A1MW-01A-21-A18Q-20 ED0D19FF-3919-4938-943F-EF1CDB803193 7ad9720d-18e2-472f-a267-525f191a23ca 7ad9720d-18e2-472f-a267-525f191a23ca TCGA-B5-A1MW-01 TCGA-B5-A1MW-01A-11D-A17C-01 TCGA-B5-A1MW-01A-11D-A17C-01 TCGA-B5-A1MW-01 TCGA-B5-A1MW-01 TCGA-B5-A1MW-01A-11D-A17F-05 TCGA-B5-A1MX-01 MSI-H TCGA-B5-A1MX-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 TCGA-B5-A1MX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 47 TCGA-B5-A1MX-F72235 TCGA-B5-A1MX TCGA-B5-A1MX-01A Never Used Stage IB NO -17320 103 0 1473 Scheduled Follow-up Submission 2015-4-29 FEMALE 152 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Tumor resection 560 NO NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 NO true No TCGA-B5-A1MX.C8962646-1A09-4EAA-8864-2539A0CCEC4C.pdf A1MX 100 TUMOR FREE YES 4+ Complete Remission/Response YES Primary Tumor 01 Minimally Invasive 2009 YES NO YES B5 0 2 0 14 Endometrial A LIVING 58 2010 TCGA-B5-A1MX-01 TCGA-B5-A1MX-01A-21-A18Q-20 FB207C5A-C3BE-44FF-85C1-9757F354DA68 TCGA-B5-A1MX-01 1cb61aae-c6d4-4afc-889e-4060d109c83e TCGA-B5-A1MX-01A-11D-A141-01 TCGA-B5-A1MX-01A-11D-A141-01 TCGA-B5-A1MX-01 TCGA-B5-A1MX-01 TCGA-B5-A1MX-01A-11D-A145-05 1cb61aae-c6d4-4afc-889e-4060d109c83e TCGA-B5-A1MY-01 MSS TCGA-B5-A1MY-01 High C6-UCEC UCEC Serous c4 cluster 3 BRCA basal-like c6 UCEC-like c11 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-B5-A1MY TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO NO Progressive Disease 62 TCGA-B5-A1MY-F22095 TCGA-B5-A1MY TCGA-B5-A1MY-01A Stage IIIC2 NO -22805 128 361 0 333 Scheduled Follow-up Submission 2012-2-23 FEMALE 146 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 360 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Disease peritoneum YES true No TCGA-B5-A1MY.A5328E25-1433-4331-83B8-148780F6A6DA.pdf A1MY 100 negative WITH TUMOR 4+ YES Primary Tumor 01 Minimally Invasive 2009 YES NO YES B5 2 5 0 Endometrial A DECEASED 67 2010 TCGA-B5-A1MY-01 TCGA-B5-A1MY-01A-21-A18Q-20 2CA50913-5945-4E8E-B67B-96BA996A7737 TCGA-B5-A1MY-01A-11D-A142-09 TCGA-B5-A1MY-01A-11D-A142-09 TCGA-B5-A1MY-01A-11D-A142-09 TCGA-B5-A1MY-01 fcb43e1a-3b34-4ff1-8d3e-849fbf901877 TCGA-B5-A1MY-01A-11D-A141-01 TCGA-B5-A1MY-01A-11D-A141-01 TCGA-B5-A1MY-01 TCGA-B5-A1MY-01 TCGA-B5-A1MY-01A-11D-A145-05 fcb43e1a-3b34-4ff1-8d3e-849fbf901877 TCGA-B5-A1MZ-01 MSI-L TCGA-B5-A1MZ-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 1 TCGA-B5-A1MZ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES Complete Response 54 TCGA-B5-A1MZ-F72236 TCGA-B5-A1MZ TCGA-B5-A1MZ-01A Stage IA NO -19955 114 0 1598 613 Scheduled Follow-up Submission 2015-4-29 FEMALE 166 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 130 NO NO Indeterminate (neither Pre or Postmenopausal) G1 Other, specify Locoregional Recurrence Vagina NO YES true No TCGA-B5-A1MZ.071A53F9-6E40-4402-8353-BB963AFE5C33.pdf A1MZ 31 negative TUMOR FREE NO 1 Complete Remission/Response YES Primary Tumor 01 Minimally Invasive 2009 NO NO YES B5 0 32 Endometrial A LIVING 114 2010 TCGA-B5-A1MZ-01 TCGA-B5-A1MZ-01A-21-A18Q-20 96829880-88C7-4AC5-B779-1C3E985309FD TCGA-B5-A1MZ-01 770fd2b7-24cf-432b-829d-39364a11277d TCGA-B5-A1MZ-01A-11D-A141-01 TCGA-B5-A1MZ-01A-11D-A141-01 TCGA-B5-A1MZ-01 TCGA-B5-A1MZ-01 TCGA-B5-A1MZ-01A-11D-A145-05 770fd2b7-24cf-432b-829d-39364a11277d TCGA-B5-A1N2-01 MSS TCGA-B5-A1N2-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 5 cluster 4 TCGA-B5-A1N2 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES Progressive Disease 70 TCGA-B5-A1N2-F72237 TCGA-B5-A1N2 TCGA-B5-A1N2-01A Former User Stage IIIC1 NO -25612 93 954 0 389 804 YES Scheduled Follow-up Submission 2015-4-29 FEMALE 168 Serous endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 540 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Brain Distant Metastasis YES true No TCGA-B5-A1N2.CB8D6955-D74A-4A05-ACC3-F0DE49CC60A9.pdf A1N2 12.5 positive WITH TUMOR YES 4+ Complete Remission/Response YES Primary Tumor 01 Minimally Invasive 2009 YES NO YES B5 1 1 Endometrial A DECEASED 114 2010 TCGA-B5-A1N2-01 TCGA-B5-A1N2-01A-11-A18Q-20 C3866F58-D26C-4DF1-A522-125C0A4D12CE TCGA-B5-A1N2-01 c45110ae-6ba6-44d7-8bff-5fa16c45d962 TCGA-B5-A1N2-01A-21D-A141-01 TCGA-B5-A1N2-01A-21D-A141-01 TCGA-B5-A1N2-01 TCGA-B5-A1N2-01 TCGA-B5-A1N2-01A-21D-A145-05 c45110ae-6ba6-44d7-8bff-5fa16c45d962 TCGA-B5-A3F9-01 MSS TCGA-B5-A3F9-01 Squamous UCEC non-CIMP c3 miRNA c1uster 10 TCGA-B5-A3F9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 TCGA-B5-A3F9-F63391 TCGA-B5-A3F9 TCGA-B5-A3F9-01A Stage IB -20523 3159 0 4155 2014-8-7 FEMALE 166 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 110 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-B5-A3F9.E4AD1574-653C-444D-BB43-B4DE701B109F.pdf A3F9 6 TUMOR FREE NO NO Primary Tumor 01 Minimally Invasive 1988 NO YES B5 0 0 Endometrial A LIVING 155 2003 654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd TCGA-B5-A3F9-01 654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd 654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd 654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd TCGA-B5-A3F9-01 TCGA-B5-A3F9-01A-21D-A227-01 TCGA-B5-A3F9-01A-21D-A227-01 TCGA-B5-A3F9-01 TCGA-B5-A3F9-01 TCGA-B5-A3F9-01A-21D-A22B-05 TCGA-B5-A3FA-01 MSI-L TCGA-B5-A3FA-01 Quiet UCEC Serous c4 UCEC-like c5 miRNA cluster 13 TCGA-B5-A3FA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 73 TCGA-B5-A3FA-F37049 TCGA-B5-A3FA TCGA-B5-A3FA-01A Stage IC -26850 2679 0 2929 2012-11-21 FEMALE 158 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 510 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-B5-A3FA.1CA1DEC3-AD70-40F7-859B-24A27F47C904.pdf A3FA 52 negative TUMOR FREE NO 4+ NO Primary Tumor 01 Minimally Invasive 1988 NO YES B5 0 2 0 11 Endometrial A LIVING 74 2004 ae424bbe-6970-4afc-aa3b-7ae842f9a9d9 TCGA-B5-A3FA-01 ae424bbe-6970-4afc-aa3b-7ae842f9a9d9 TCGA-B5-A3FA-01A-21-A23Z-20 B51FC044-B48F-43F6-B592-04C89D59A355 ae424bbe-6970-4afc-aa3b-7ae842f9a9d9 ae424bbe-6970-4afc-aa3b-7ae842f9a9d9 TCGA-B5-A3FA-01 TCGA-B5-A3FA-01A-11D-A19X-01 TCGA-B5-A3FA-01A-11D-A19X-01 TCGA-B5-A3FA-01 TCGA-B5-A3FA-01 TCGA-B5-A3FA-01A-11D-A19Z-05 TCGA-B5-A3FB-01 MSS TCGA-B5-A3FB-01 Kirc+ UCEC Serous c4 squamous c3 miRNA cluster 12 TCGA-B5-A3FB TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 73 TCGA-B5-A3FB-F63408 TCGA-B5-A3FB TCGA-B5-A3FB-01A Stage IB -26779 2066 0 2844 2014-8-8 FEMALE 170 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 350 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-B5-A3FB.FA278AFC-C294-48A5-BE7B-B26F4AE3FC5B.pdf A3FB 4 negative TUMOR FREE NO NO Primary Tumor 01 Minimally Invasive 1988 NO YES B5 0 0 33 Endometrial A LIVING 115 2006 0421d738-8236-46c5-8b98-6b261defb294 TCGA-B5-A3FB-01 0421d738-8236-46c5-8b98-6b261defb294 TCGA-B5-A3FB-01A-21-A23Z-20 296D37E4-A844-4792-869D-B1639FF420BE 0421d738-8236-46c5-8b98-6b261defb294 0421d738-8236-46c5-8b98-6b261defb294 TCGA-B5-A3FB-01 TCGA-B5-A3FB-01A-11D-A19X-01 TCGA-B5-A3FB-01A-11D-A19X-01 TCGA-B5-A3FB-01 TCGA-B5-A3FB-01 TCGA-B5-A3FB-01A-11D-A19Z-05 TCGA-B5-A3FC-01 MSI-H TCGA-B5-A3FC-01 Quiet UCEC CIMP c18 UCEC-like c5 miRNA c1uster 10 TCGA-B5-A3FC TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 TCGA-B5-A3FC-F37051 TCGA-B5-A3FC TCGA-B5-A3FC-01A Stage II -19422 1814 0 2185 2012-11-21 FEMALE 169 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 150 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-B5-A3FC.4A63436E-BBC1-4F02-9B72-7ED4CC2AC1CD.pdf A3FC 0 negative TUMOR FREE NO NO Primary Tumor 01 open 1988 NO YES B5 0 0 Endometrial A LIVING 76 2006 cfc3065f-652c-458b-926f-24092edb803f TCGA-B5-A3FC-01 cfc3065f-652c-458b-926f-24092edb803f TCGA-B5-A3FC-01A-21-A23Z-20 17669455-F951-4491-992D-E8D3748C7A22 cfc3065f-652c-458b-926f-24092edb803f cfc3065f-652c-458b-926f-24092edb803f TCGA-B5-A3FC-01 TCGA-B5-A3FC-01A-11D-A227-01 TCGA-B5-A3FC-01A-11D-A227-01 TCGA-B5-A3FC-01 TCGA-B5-A3FC-01 TCGA-B5-A3FC-01A-11D-A22B-05 TCGA-B5-A3FD-01 Indeterminate TCGA-B5-A3FD-01 Kirc+ UCEC Serous c4 UCEC-like c5 miRNA c1uster 10 TCGA-B5-A3FD TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO Progressive Disease 70 TCGA-B5-A3FD-F63409 TCGA-B5-A3FD TCGA-B5-A3FD-01A Stage IA -25813 679 1197 0 796 992 2014-8-8 FEMALE 174 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 370 NO NO Indeterminate (neither Pre or Postmenopausal) G3 Other, specify Locoregional Recurrence peritoneum NO YES true No TCGA-B5-A3FD.7AC30D60-097A-4FED-A928-7A4BCAFB6C8D.pdf A3FD 30 negative TUMOR FREE YES NO Other Method, Specify Below thoracentesis Primary Tumor 01 Minimally Invasive 2009 NO YES B5 0 7 0 34 Endometrial A DECEASED 115 2009 6fbe6214-bdfd-4688-bae3-d12a931f9989 TCGA-B5-A3FD-01 6fbe6214-bdfd-4688-bae3-d12a931f9989 TCGA-B5-A3FD-01A-21-A23Z-20 4DCFD79E-47D9-4223-B907-DA116D0015D8 6fbe6214-bdfd-4688-bae3-d12a931f9989 6fbe6214-bdfd-4688-bae3-d12a931f9989 TCGA-B5-A3FD-01 TCGA-B5-A3FD-01A-11D-A19X-01 TCGA-B5-A3FD-01A-11D-A19X-01 TCGA-B5-A3FD-01 TCGA-B5-A3FD-01 TCGA-B5-A3FD-01A-11D-A19Z-05 TCGA-B5-A3FH-01 MSI-L TCGA-B5-A3FH-01 Iq UCEC non-CIMP c3 UCEC-like c5 miRNA c1uster 10 TCGA-B5-A3FH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 74 TCGA-B5-A3FH-F63411 TCGA-B5-A3FH TCGA-B5-A3FH-01A Stage IA -27221 97 0 841 NO 2014-8-8 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 480 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-B5-A3FH.05AD8EE1-E2F8-42F7-8E6A-380A8EE4770E.pdf A3FH 6 negative TUMOR FREE NO 3 Complete Remission/Response NO Primary Tumor 01 Minimally Invasive 2009 NO YES B5 0 9 0 17 Endometrial A LIVING 85 2011 2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7 TCGA-B5-A3FH-01 2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7 TCGA-B5-A3FH-01A-21-A23Z-20 6FCB4E7F-DE11-4F45-8BEB-5D60942D06B7 2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7 2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7 TCGA-B5-A3FH-01 TCGA-B5-A3FH-01A-11D-A19X-01 TCGA-B5-A3FH-01A-11D-A19X-01 TCGA-B5-A3FH-01 TCGA-B5-A3FH-01 TCGA-B5-A3FH-01A-11D-A19Z-05 TCGA-B5-A3S1-01 MSS TCGA-B5-A3S1-01 High UCEC non-CIMP c3 UCEC-like c5 miRNA cluster 4 TCGA-B5-A3S1 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 71 TCGA-B5-A3S1-F59469 TCGA-B5-A3S1 TCGA-B5-A3S1-01A Former User Stage IIIC1 NO -26031 127 0 902 NO 2014-5-13 FEMALE 155 Serous endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 140 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-B5-A3S1.72F97A0D-1245-4C80-B2D2-B7B217BEC06B.pdf A3S1 87.6 negative WITH TUMOR YES 1 Complete Remission/Response Never Used YES Primary Tumor 01 Minimally Invasive 2009 NO YES B5 0 7 3 24 Endometrial A LIVING 68 2011 77db73b5-24ef-47a3-b54b-4457ae62d562 TCGA-B5-A3S1-01 77db73b5-24ef-47a3-b54b-4457ae62d562 TCGA-B5-A3S1-01A-21-A23Z-20 2F5C90A3-2306-4D8D-A5F3-DDAFD7B6E298 77db73b5-24ef-47a3-b54b-4457ae62d562 77db73b5-24ef-47a3-b54b-4457ae62d562 TCGA-B5-A3S1-01 TCGA-B5-A3S1-01A-11D-A227-01 TCGA-B5-A3S1-01A-11D-A227-01 TCGA-B5-A3S1-01 TCGA-B5-A3S1-01 TCGA-B5-A3S1-01A-11D-A22B-05 TCGA-B5-A5OC-01 MSI-H TCGA-B5-A5OC-01 TCGA-B5-A5OC TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 71 TCGA-B5-A5OC-F59471 TCGA-B5-A5OC TCGA-B5-A5OC-01A Never Used Stage IIIB NO -26109 732 0 1249 YES 2014-5-13 FEMALE Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES 750 NO NO G3 NO true No TCGA-B5-A5OC.2B1515A6-001A-46AF-952C-D393944DE57F.pdf A5OC TUMOR FREE YES 3 Never Used YES R2 Primary Tumor 01 2009 YES NO B5 Endometrial A LIVING 2011 12be39a5-bbae-439a-84a9-28b790e89aa9 TCGA-B5-A5OC-01 12be39a5-bbae-439a-84a9-28b790e89aa9 22D396FC-0D94-4E2A-AFD0-4D2CCFB3872F 12be39a5-bbae-439a-84a9-28b790e89aa9 12be39a5-bbae-439a-84a9-28b790e89aa9 TCGA-B5-A5OC-01 TCGA-B5-A5OC-01A-21D-A27O-01 TCGA-B5-A5OC-01A-21D-A27O-01 TCGA-B5-A5OC-01 TCGA-B5-A5OC-01 TCGA-B5-A5OC-01A-21D-A27Y-05 TCGA-B5-A5OD-01 MSS TCGA-B5-A5OD-01 TCGA-B5-A5OD TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 TCGA-B5-A5OD-F59472 TCGA-B5-A5OD TCGA-B5-A5OD-01A Stage IIIC NO -24775 662 0 1038 NO 2014-5-13 FEMALE Serous endometrial adenocarcinoma No NO C54.1 8441/3 C54.1 YES 370 NO NO G3 NO true No TCGA-B5-A5OD.8A0B9737-98D2-4A61-95FF-18842056A6DE.pdf A5OD TUMOR FREE YES 0 Never Used YES Primary Tumor 01 2009 YES NO B5 Endometrial A LIVING 2011 0dfc3298-73ab-4c7b-b4f5-1314a5713c92 TCGA-B5-A5OD-01 0dfc3298-73ab-4c7b-b4f5-1314a5713c92 16DD0C81-5825-4E38-8230-090E6783721B 0dfc3298-73ab-4c7b-b4f5-1314a5713c92 0dfc3298-73ab-4c7b-b4f5-1314a5713c92 TCGA-B5-A5OD-01 TCGA-B5-A5OD-01A-11D-A31T-01 TCGA-B5-A5OD-01A-11D-A31T-01 TCGA-B5-A5OD-01 TCGA-B5-A5OD-01 TCGA-B5-A5OD-01A-11D-A31V-05 TCGA-B5-A5OE-01 MSS TCGA-B5-A5OE-01 TCGA-B5-A5OE TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 TCGA-B5-A5OE-F59473 TCGA-B5-A5OE TCGA-B5-A5OE-01A Stage IIIC2 NO -24905 609 0 1063 NO 2014-5-14 FEMALE Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES 1540 NO NO G3 NO true No TCGA-B5-A5OE.82A668E5-6B89-4C94-BEED-F4FF227BD0B1.pdf A5OE TUMOR FREE YES 4+ NO Primary Tumor 01 2009 YES NO B5 Endometrial A LIVING 2011 0595a9e2-f382-4f97-8d0e-69af86b9fb78 TCGA-B5-A5OE-01 0595a9e2-f382-4f97-8d0e-69af86b9fb78 300974AA-5FA7-4658-A7BD-95F64E650DCC 0595a9e2-f382-4f97-8d0e-69af86b9fb78 0595a9e2-f382-4f97-8d0e-69af86b9fb78 TCGA-B5-A5OE-01 TCGA-B5-A5OE-01A-11D-A31T-01 TCGA-B5-A5OE-01A-11D-A31T-01 TCGA-B5-A5OE-01 TCGA-B5-A5OE-01 TCGA-B5-A5OE-01A-11D-A31V-05 TCGA-BG-A0LW-01 MSS TCGA-BG-A0LW-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation c1uster 9 TCGA-BG-A0LW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 47 TCGA-BG-A0LW-F19329 TCGA-BG-A0LW TCGA-BG-A0LW-01A Never Used Stage IA -17369 107 0 566 Scheduled Follow-up Submission 2011-12-8 FEMALE 157 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 190 NO Indeterminate (neither Pre or Postmenopausal) G2 NO true No TCGA-BG-A0LW.75A97BED-AB64-46CC-AE6B-59860673D53E.pdf A0LW 5 negative TUMOR FREE 0 0 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES BG 0 0 6 Endometrial A LIVING 141 2010 TCGA-BG-A0LW-01 TCGA-BG-A0LW-01 TCGA-BG-A0LW-01A-21-A163-20 1AF915C6-7503-4190-9013-EA95D556D6D2 TCGA-BG-A0LW-01 TCGA-BG-A0LW-01 TCGA-BG-A0LW-01A-11W-A062-09 TCGA-BG-A0LW-01A-11W-A062-09 TCGA-BG-A0LW-01A-11W-A062-09 TCGA-BG-A0LW-01 e91d204d-8790-4438-add0-52f520fa532b TCGA-BG-A0LW-01A-11D-A042-01 TCGA-BG-A0LW-01A-11R-A040-07 TCGA-BG-A0LW-01A-11D-A042-01 TCGA-BG-A0LW-01 TCGA-BG-A0LW-01A-11D-A039-05 e91d204d-8790-4438-add0-52f520fa532b TCGA-BG-A0LX-01 MSI-H TCGA-BG-A0LX-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 6 TCGA-BG-A0LX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 0 0 TCGA-BG-A0LX-F19323 TCGA-BG-A0LX TCGA-BG-A0LX-01A Never Used Stage IB -20928 120 0 614 NO Scheduled Follow-up Submission 2011-12-8 FEMALE 170 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 250 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-BG-A0LX.4306E592-FA36-4AB9-BF84-7232CC599A64.pdf A0LX 90 TUMOR FREE 0 0 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO NO YES BG 0 7 0 15 Endometrial A LIVING 96 2010 TCGA-BG-A0LX-01 TCGA-BG-A0LX-01 TCGA-BG-A0LX-01A-21-A163-20 5F4E9178-6219-44BF-A4A2-D02F0AB33AD8 TCGA-BG-A0LX-01 TCGA-BG-A0LX-01A-11W-A062-09 TCGA-BG-A0LX-01A-11W-A062-09 TCGA-BG-A0LX-01A-11W-A062-09 7961370a-641d-4dc9-a530-99789e7d0036 TCGA-BG-A0LX-01A-11D-A042-01 TCGA-BG-A0LX-01A-11D-A042-01 TCGA-BG-A0LX-01 TCGA-BG-A0LX-01A-11D-A039-05 7961370a-641d-4dc9-a530-99789e7d0036 TCGA-BG-A0M0-01 MSI-H TCGA-BG-A0M0-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-BG-A0M0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 66 TCGA-BG-A0M0-F19320 TCGA-BG-A0M0 TCGA-BG-A0M0-01A Never Used Stage IA -24427 147 0 588 NO Scheduled Follow-up Submission 2011-12-8 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 800 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-BG-A0M0.BDDACDFC-E3D4-4EA7-9591-DB6371713E8E.pdf A0M0 6 negative TUMOR FREE 0 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES BG 0 0 1 Endometrial A LIVING 117 2010 TCGA-BG-A0M0-01 TCGA-BG-A0M0-01 TCGA-BG-A0M0-01A-21-A163-20 5007B1AB-8651-4B64-8777-885393A6A284 TCGA-BG-A0M0-01 TCGA-BG-A0M0-01A-11W-A10C-09 TCGA-BG-A0M0-01A-11W-A10C-09 TCGA-BG-A0M0-01A-11W-A10C-09 5343a292-c0ee-4764-8051-ee24716cf79d TCGA-BG-A0M0-01A-11D-A102-01 TCGA-BG-A0M0-01A-11D-A102-01 TCGA-BG-A0M0-01 TCGA-BG-A0M0-01A-11D-A10Q-05 5343a292-c0ee-4764-8051-ee24716cf79d TCGA-BG-A0M2-01 MSS TCGA-BG-A0M2-01 BRCA-LUAD+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation c1uster 9 TCGA-BG-A0M2 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 62 0 0 TCGA-BG-A0M2-F19319 TCGA-BG-A0M2 TCGA-BG-A0M2-01A Never Used Stage IB -22822 185 0 637 NO Scheduled Follow-up Submission 2011-12-8 FEMALE 168 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 510 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-BG-A0M2.A0087300-81E9-4733-8497-95E0F95575B4.pdf A0M2 59 negative TUMOR FREE 0 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES BG 0 1 0 8 Endometrial A LIVING 76 2009 TCGA-BG-A0M2-01 TCGA-BG-A0M2-01 TCGA-BG-A0M2-01A-21-A163-20 DD52C56D-2806-4F0F-906C-7518B5CC058F TCGA-BG-A0M2-01 TCGA-BG-A0M2-01A-11D-A10O-09 TCGA-BG-A0M2-01A-11D-A10O-09 TCGA-BG-A0M2-01A-11D-A10O-09 4487eb24-a67d-4406-9a1f-b2c2fde39787 TCGA-BG-A0M2-01A-11D-A102-01 TCGA-BG-A0M2-01A-11D-A102-01 TCGA-BG-A0M2-01 TCGA-BG-A0M2-01A-11D-A10Q-05 4487eb24-a67d-4406-9a1f-b2c2fde39787 TCGA-BG-A0M3-01 MSS TCGA-BG-A0M3-01 BRCA-LUAD+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 1 mutation cluster 4 TCGA-BG-A0M3 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 74 0 0 TCGA-BG-A0M3-F19332 TCGA-BG-A0M3 TCGA-BG-A0M3-01A Never Used Stage IB -27183 597 0 1071 NO Scheduled Follow-up Submission 2011-12-8 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 100 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-BG-A0M3.19AABBD8-3DC5-418E-9B62-37CF7500F174.pdf A0M3 53 positive TUMOR FREE 0 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1988 NO NO YES BG 0 5 0 12 Endometrial A LIVING 75 2008 TCGA-BG-A0M3-01 TCGA-BG-A0M3-01 TCGA-BG-A0M3-01A-21-A163-20 00F34C1B-8B1B-47D2-9D64-12591734FAA1 TCGA-BG-A0M3-01 TCGA-BG-A0M3-01A-11W-A10C-09 TCGA-BG-A0M3-01A-11W-A10C-09 TCGA-BG-A0M3-01A-11W-A10C-09 e5b97796-bf64-458e-8ed8-246c2b303ce7 TCGA-BG-A0M3-01A-11D-A102-01 TCGA-BG-A0M3-01A-11D-A102-01 TCGA-BG-A0M3-01 TCGA-BG-A0M3-01A-11D-A10Q-05 e5b97796-bf64-458e-8ed8-246c2b303ce7 TCGA-BG-A0M4-01 MSI-H TCGA-BG-A0M4-01 BRCA-LUAD+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 4 cluster 2 mutation cluster 6 TCGA-BG-A0M4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 0 0 TCGA-BG-A0M4-F71768 TCGA-BG-A0M4 TCGA-BG-A0M4-01A Never Used Stage IA -22090 643 0 2167 Scheduled Follow-up Submission 2015-3-30 FEMALE 178 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. C54.1 8380/3 C54.1 YES Dilation and curettage procedure 240 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-BG-A0M4.95002D96-C9D8-43BE-ADD1-072E93994194.pdf A0M4 5 negative TUMOR FREE 0 0 YES Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 1988 YES YES NO BG 0 3 0 14 Endometrial A LIVING 97 2008 TCGA-BG-A0M4-01 TCGA-BG-A0M4-01 TCGA-BG-A0M4-01A-21-A163-20 57311FA8-C83F-4B62-8310-BE9A12E10B2E TCGA-BG-A0M4-01 TCGA-BG-A0M4-01A-11W-A10C-09 TCGA-BG-A0M4-01A-11W-A10C-09 TCGA-BG-A0M4-01A-11W-A10C-09 174acfe1-d3ab-4912-9d05-7aa598ae1add TCGA-BG-A0M4-01A-11D-A102-01 TCGA-BG-A0M4-01A-11D-A102-01 TCGA-BG-A0M4-01 TCGA-BG-A0M4-01A-11D-A10Q-05 174acfe1-d3ab-4912-9d05-7aa598ae1add TCGA-BG-A0M6-01 MSS TCGA-BG-A0M6-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 2 mutation cluster 3 TCGA-BG-A0M6 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 73 0 3 TCGA-BG-A0M6-F19331 TCGA-BG-A0M6 TCGA-BG-A0M6-01A Never Used Stage IIIC2 -26666 618 671 0 241 NO Scheduled Follow-up Submission 2011-12-8 FEMALE 152 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Tumor resection 320 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true Yes TCGA-BG-A0M6.39EC3673-5B31-403B-8328-9DEA5FF7CD1A.pdf A0M6 100 positive TUMOR FREE 0 5 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1988 YES NO YES BG 3 5 5 16 Endometrial A DECEASED 55 2008 TCGA-BG-A0M6-01 TCGA-BG-A0M6-01 TCGA-BG-A0M6-01A-21-A163-20 61AE62D3-8662-47BB-B2A1-FE0A5D787E24 TCGA-BG-A0M6-01 TCGA-BG-A0M6-01A-31D-A10B-09 TCGA-BG-A0M6-01A-31D-A10B-09 TCGA-BG-A0M6-01A-31D-A10B-09 989bcd83-f8c2-4027-a10c-19ce3b67e348 TCGA-BG-A0M6-01A-31D-A102-01 TCGA-BG-A0M6-01A-31D-A102-01 TCGA-BG-A0M6-01 TCGA-BG-A0M6-01A-31D-A10Q-05 989bcd83-f8c2-4027-a10c-19ce3b67e348 TCGA-BG-A0M7-01 MSS TCGA-BG-A0M7-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 mutation cluster 2 TCGA-BG-A0M7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 TCGA-BG-A0M7-F71767 TCGA-BG-A0M7 TCGA-BG-A0M7-01A Stage IIIC1 -22096 659 0 1937 Scheduled Follow-up Submission 2015-3-30 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. C54.1 8380/3 C54.1 YES Dilation and curettage procedure 260 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-BG-A0M7.F9128DAE-F3D0-4738-AC20-E665F22DDC63.pdf A0M7 75 negative TUMOR FREE YES Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1988 YES NO YES BG Endometrial A LIVING 102 2008 TCGA-BG-A0M7-01 TCGA-BG-A0M7-01 TCGA-BG-A0M7-01A-21-A163-20 7CEAF55F-FB25-46A2-B3B8-24CA17F2477D TCGA-BG-A0M7-01 TCGA-BG-A0M7-01A-11W-A062-09 TCGA-BG-A0M7-01A-11W-A062-09 TCGA-BG-A0M7-01A-11W-A062-09 a832a6a6-1998-41c2-9dab-87076a1f11cf TCGA-BG-A0M7-01A-11D-A042-01 TCGA-BG-A0M7-01A-11D-A042-01 TCGA-BG-A0M7-01 TCGA-BG-A0M7-01A-11D-A039-05 a832a6a6-1998-41c2-9dab-87076a1f11cf TCGA-BG-A0M8-01 MSS TCGA-BG-A0M8-01 High C6-UCEC OV-like c1 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 2 TCGA-BG-A0M8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 50 TCGA-BG-A0M8-F71766 TCGA-BG-A0M8 TCGA-BG-A0M8-01A Never Used Stage IA -18308 734 0 2020 NO Scheduled Follow-up Submission 2015-3-30 FEMALE 160 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 630 NO NO Indeterminate (neither Pre or Postmenopausal) G3 NO true Yes TCGA-BG-A0M8.42DBC6F7-E413-41A6-994E-1391099818A0.pdf A0M8 50 negative TUMOR FREE NO Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BG 0 0 Endometrial A LIVING 209 2008 TCGA-BG-A0M8-01 TCGA-BG-A0M8-01A-21-A163-20 E01A90AC-A64F-4AD2-8C5B-374D2F9FBF75 TCGA-BG-A0M8-01A-12D-A10B-09 TCGA-BG-A0M8-01A-12D-A10B-09 TCGA-BG-A0M8-01A-12D-A10B-09 90962783-12b4-434d-9b27-6c6f8f3b8d10 TCGA-BG-A0M8-01A-12D-A102-01 TCGA-BG-A0M8-01A-12D-A102-01 TCGA-BG-A0M8-01 TCGA-BG-A0M8-01A-12D-A10Q-05 90962783-12b4-434d-9b27-6c6f8f3b8d10 TCGA-BG-A0M9-01 MSS TCGA-BG-A0M9-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 3 mutation cluster 1 TCGA-BG-A0M9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 73 0 0 TCGA-BG-A0M9-F71764 TCGA-BG-A0M9 TCGA-BG-A0M9-01A Never Used Stage IB -26708 772 0 2270 NO Scheduled Follow-up Submission 2015-3-30 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 220 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-BG-A0M9.08D832C7-9B5F-4B6E-9C3E-2F3E58305016.pdf A0M9 75 negative TUMOR FREE 0 0 NO Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BG 0 4 0 5 Endometrial A LIVING 93 2008 TCGA-BG-A0M9-01 TCGA-BG-A0M9-01 TCGA-BG-A0M9-01A-11-A163-20 6AF1C2FB-89E2-4FCC-9774-858ED6CAC492 TCGA-BG-A0M9-01 TCGA-BG-A0M9-01A-21W-A10C-09 TCGA-BG-A0M9-01A-21W-A10C-09 TCGA-BG-A0M9-01A-21W-A10C-09 55874b54-441d-4a28-b2a7-a90e96774ff9 TCGA-BG-A0M9-01A-21D-A102-01 TCGA-BG-A0M9-01A-21D-A102-01 TCGA-BG-A0M9-01 TCGA-BG-A0M9-01A-21D-A10Q-05 55874b54-441d-4a28-b2a7-a90e96774ff9 TCGA-BG-A0MA-01 MSS TCGA-BG-A0MA-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-BG-A0MA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO Progressive Disease 60 0 0 TCGA-BG-A0MA-F72174 TCGA-BG-A0MA TCGA-BG-A0MA-01A Stage IB -22036 805 326 0 70 Scheduled Follow-up Submission 2015-4-22 FEMALE 170 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 130 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Liver Distant Metastasis lung YES true No TCGA-BG-A0MA.E5908692-5B04-407B-818A-D202756DD880.pdf A0MA 78 negative WITH TUMOR 0 0 NO 0 Progressive Disease NO R0 Primary Tumor 01 open 1988 NO NO YES BG 0 6 0 10 Endometrial A DECEASED 111 2008 TCGA-BG-A0MA-01 TCGA-BG-A0MA-01A-21-A18Q-20 26F8155B-BC23-4D3E-AE18-B9B538437680 TCGA-BG-A0MA-01 e93ac169-2fab-4312-9239-a9141d347763 TCGA-BG-A0MA-01A-11D-A17C-01 TCGA-BG-A0MA-01A-11D-A17C-01 TCGA-BG-A0MA-01 TCGA-BG-A0MA-01 TCGA-BG-A0MA-01A-11D-A17F-05 e93ac169-2fab-4312-9239-a9141d347763 TCGA-BG-A0MA-11 MSS TCGA-BG-A0MA-11 C6-UCEC TCGA-BG-A0MA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO Progressive Disease 60 0 0 TCGA-BG-A0MA-F72174 TCGA-BG-A0MA TCGA-BG-A0MA-11A Stage IB -22036 1134 326 0 70 Scheduled Follow-up Submission 2015-4-22 FEMALE 170 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 120 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Liver Distant Metastasis lung YES true No A0MA 78 negative WITH TUMOR 0 0 NO 0 Progressive Disease NO R0 Solid Tissue Normal 11 open 1988 NO NO YES BG 0 6 0 10 Endometrial A DECEASED 111 2008 TCGA-BG-A0MA-11A-11D-A17F-05 TCGA-BG-A0MC-01 MSS TCGA-BG-A0MC-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 1 TCGA-BG-A0MC TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 74 TCGA-BG-A0MC-F19280 TCGA-BG-A0MC TCGA-BG-A0MC-01A Never Used Stage IA -27136 779 0 1263 YES Scheduled Follow-up Submission 2011-12-7 FEMALE 155 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Tumor resection 630 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-BG-A0MC.100F4900-491A-438B-9704-51D4E016B325.pdf A0MC 0 negative TUMOR FREE Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 1988 NO NO YES BG 0 0 Endometrial A LIVING 135 2008 TCGA-BG-A0MC-01 TCGA-BG-A0MC-01 TCGA-BG-A0MC-01A-11-A163-20 27EBFA46-C09D-471B-A9D5-B3BA90EE832E TCGA-BG-A0MC-01 TCGA-BG-A0MC-01A-21W-A062-09 TCGA-BG-A0MC-01A-21W-A062-09 TCGA-BG-A0MC-01A-21W-A062-09 1ad1a4dc-b34a-4f34-990b-05c2c14fb4c9 TCGA-BG-A0MC-01A-21D-A042-01 TCGA-BG-A0MC-01A-21D-A042-01 TCGA-BG-A0MC-01 TCGA-BG-A0MC-01A-21D-A039-05 1ad1a4dc-b34a-4f34-990b-05c2c14fb4c9 TCGA-BG-A0MG-01 MSS TCGA-BG-A0MG-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 mutation cluster 4 TCGA-BG-A0MG TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 73 0 0 TCGA-BG-A0MG-F19272 TCGA-BG-A0MG TCGA-BG-A0MG-01A Never Used Stage IA NO -26957 980 0 1477 NO Scheduled Follow-up Submission 2011-12-6 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 240 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-BG-A0MG.65A0B84A-72AD-42E2-B0DB-DA8D2BD54E9B.pdf A0MG 36 negative TUMOR FREE 0 0 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BG 0 2 0 5 Endometrial A LIVING 61 2007 TCGA-BG-A0MG-01 TCGA-BG-A0MG-01 TCGA-BG-A0MG-01A-11-A163-20 107D6429-EC36-4D65-9820-23FF2EACE5E9 TCGA-BG-A0MG-01 TCGA-BG-A0MG-01A-21D-A10B-09 TCGA-BG-A0MG-01A-21D-A10B-09 TCGA-BG-A0MG-01A-21D-A10B-09 a21894d9-a459-4dbd-b9de-6c39f6fc61c2 TCGA-BG-A0MG-01A-21D-A102-01 TCGA-BG-A0MG-01A-21D-A102-01 TCGA-BG-A0MG-01 TCGA-BG-A0MG-01A-21D-A10Q-05 a21894d9-a459-4dbd-b9de-6c39f6fc61c2 TCGA-BG-A0MH-01 MSS TCGA-BG-A0MH-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 1 TCGA-BG-A0MH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 61 TCGA-BG-A0MH-F49548 TCGA-BG-A0MH TCGA-BG-A0MH-01A Stage IC -22475 1000 0 1930 2013-10-3 FEMALE 154 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 790 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-BG-A0MH.F641C526-7A0D-46C3-92EE-CD9CB0D13960.pdf A0MH 90 TUMOR FREE 0 NO Complete Remission/Response YES Primary Tumor 01 open 1988 NO YES BG 8 Endometrial A LIVING 136 2007 TCGA-BG-A0MH-01 TCGA-BG-A0MH-01A-21-A163-20 61CC9B5C-C646-4D6C-92FF-CEC57CD68FB7 TCGA-BG-A0MH-01 f73e7e5b-239b-4ac9-861e-c8f42e68188e TCGA-BG-A0MH-01 TCGA-BG-A0MH-01A-11D-A123-05 f73e7e5b-239b-4ac9-861e-c8f42e68188e TCGA-BG-A0MI-01 MSS TCGA-BG-A0MI-01 Quiet C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 4 TCGA-BG-A0MI TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 83 0 0 TCGA-BG-A0MI-F17205 TCGA-BG-A0MI Never Used Stage IA NO -30334 714 0 NO Scheduled Follow-up Submission 2011-10-4 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO No A0MI 13 negative TUMOR FREE 0 0 3 Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BG 0 2 0 13 Endometrial DECEASED 101 2007 TCGA-BG-A0MI-01 TCGA-BG-A0MI-01 TCGA-BG-A0MI-01 TCGA-BG-A0MI-01 TCGA-BG-A0MI-01A-11W-A062-09 TCGA-BG-A0MI-01A-11W-A062-09 TCGA-BG-A0MI-01A-11W-A062-09 TCGA-BG-A0MI-01 c199bab3-c6e3-4123-811c-2c50e8d44fae TCGA-BG-A0MI-01A-11D-A042-01 TCGA-BG-A0MI-01A-11R-A040-07 TCGA-BG-A0MI-01A-11D-A042-01 TCGA-BG-A0MI-01 TCGA-BG-A0MI-01A-11D-A039-05 c199bab3-c6e3-4123-811c-2c50e8d44fae TCGA-BG-A0MK-01 Indeterminate TCGA-BG-A0MK-01 Quiet UCEC CIMP c18 squamous c3 miRNA c1uster 10 TCGA-BG-A0MK TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 52 TCGA-BG-A0MK-F39617 TCGA-BG-A0MK TCGA-BG-A0MK-01A Stage IIB -19034 1399 1317 0 2013-1-28 FEMALE Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 1100 NO NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 NO true No TCGA-BG-A0MK.9D631FCB-78A9-4CA9-A033-D66CB78D8CA3.pdf A0MK negative WITH TUMOR NO Progressive Disease YES R0 Primary Tumor 01 Minimally Invasive 1995 YES NO BG Endometrial A DECEASED 2006 1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3 TCGA-BG-A0MK-01 1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3 TCGA-BG-A0MK-01A-41-A23Z-20 4B3EF3BA-BF09-4B60-B976-73C9307C8D61 1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3 1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3 TCGA-BG-A0MK-01 TCGA-BG-A0MK-01A-51D-A19X-01 TCGA-BG-A0MK-01A-51D-A19X-01 TCGA-BG-A0MK-01 TCGA-BG-A0MK-01 TCGA-BG-A0MK-01A-51D-A19Z-05 TCGA-BG-A0MO-01 MSS TCGA-BG-A0MO-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c11 miRNA c1uster 10 cluster 1 mutation c1uster 9 TCGA-BG-A0MO TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 TCGA-BG-A0MO-F19273 TCGA-BG-A0MO TCGA-BG-A0MO-01A Never Used Stage IA NO -23287 854 0 1309 NO Scheduled Follow-up Submission 2011-12-6 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 100 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-BG-A0MO.C120AC98-36D2-49AD-84A1-6EA168D2A2BA.pdf A0MO 35.7 negative TUMOR FREE Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1988 NO NO YES BG Endometrial A LIVING 83 2008 TCGA-BG-A0MO-01 TCGA-BG-A0MO-01 TCGA-BG-A0MO-01 TCGA-BG-A0MO-01A-11W-A062-09 TCGA-BG-A0MO-01A-11W-A062-09 TCGA-BG-A0MO-01A-11W-A062-09 7fc96ce5-b529-4d89-8b27-5f8ba4e301e9 TCGA-BG-A0MO-01A-11D-A042-01 TCGA-BG-A0MO-01A-11D-A042-01 TCGA-BG-A0MO-01 TCGA-BG-A0MO-01A-11D-A039-05 7fc96ce5-b529-4d89-8b27-5f8ba4e301e9 TCGA-BG-A0MQ-01 MSI-H TCGA-BG-A0MQ-01 BRCA-LUAD+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 6 TCGA-BG-A0MQ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Stable Disease 71 TCGA-BG-A0MQ-F71765 TCGA-BG-A0MQ TCGA-BG-A0MQ-01A Never Used Stage IA -26284 692 0 1817 YES Scheduled Follow-up Submission 2015-3-30 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 120 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-BG-A0MQ.3252AEB3-3B0D-4066-B18E-31096F928D63.pdf A0MQ 25 negative WITH TUMOR NO Stable Disease Never Used YES R0 Primary Tumor 01 open 1988 NO NO YES BG Endometrial A LIVING 101 2008 TCGA-BG-A0MQ-01 TCGA-BG-A0MQ-01 TCGA-BG-A0MQ-01 TCGA-BG-A0MQ-01A-11D-A10B-09 TCGA-BG-A0MQ-01A-11D-A10B-09 TCGA-BG-A0MQ-01A-11D-A10B-09 37d2da87-d591-440d-87d3-a34a038bef5b TCGA-BG-A0MQ-01A-11D-A102-01 TCGA-BG-A0MQ-01A-11D-A102-01 TCGA-BG-A0MQ-01 TCGA-BG-A0MQ-01A-11D-A10Q-05 37d2da87-d591-440d-87d3-a34a038bef5b TCGA-BG-A0MS-01 MSS TCGA-BG-A0MS-01 BRCA-LUAD+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 4 TCGA-BG-A0MS TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 TCGA-BG-A0MS-F71770 TCGA-BG-A0MS TCGA-BG-A0MS-01A Never Used Stage IIIC1 -19547 420 0 1882 NO Scheduled Follow-up Submission 2015-3-30 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 560 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true Yes TCGA-BG-A0MS.7BE89F2D-74E5-4D9E-8270-A216D79ADCD7.pdf A0MS 44 negative TUMOR FREE YES Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO YES BG Endometrial A LIVING 65 2009 TCGA-BG-A0MS-01 TCGA-BG-A0MS-01A-21-A163-20 C7A57035-FAC8-466B-B969-37A70C4D246F TCGA-BG-A0MS-01A-11D-A10B-09 TCGA-BG-A0MS-01A-11D-A10B-09 TCGA-BG-A0MS-01A-11D-A10B-09 09b4aa83-d8e7-4615-bfad-da877df4fe7d TCGA-BG-A0MS-01A-11D-A102-01 TCGA-BG-A0MS-01A-11D-A102-01 TCGA-BG-A0MS-01 TCGA-BG-A0MS-01A-11D-A10Q-05 09b4aa83-d8e7-4615-bfad-da877df4fe7d TCGA-BG-A0MT-01 MSS TCGA-BG-A0MT-01 BRCA-LUAD+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation c1uster 10 TCGA-BG-A0MT TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES Partial Response 64 TCGA-BG-A0MT-F19318 TCGA-BG-A0MT TCGA-BG-A0MT-01A Never Used Stage IA -23574 344 0 644 565 NO Scheduled Follow-up Submission 2011-12-8 FEMALE 168 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 820 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 Other, specify Locoregional Disease locally in the endometrium YES true No TCGA-BG-A0MT.89610F48-AC0D-431D-8A9E-FC9E51CF8FC0.pdf A0MT 25 negative TUMOR FREE Partial Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES BG Endometrial A LIVING 73 2009 TCGA-BG-A0MT-01 TCGA-BG-A0MT-01 TCGA-BG-A0MT-01A-21-A163-20 9170FA52-8CC4-465C-8DE7-94199FF1E4E4 TCGA-BG-A0MT-01 TCGA-BG-A0MT-01A-11D-A10B-09 TCGA-BG-A0MT-01A-11D-A10B-09 TCGA-BG-A0MT-01A-11D-A10B-09 578f3ec4-17e0-4cf9-bfa8-56624d174374 TCGA-BG-A0MT-01A-11D-A102-01 TCGA-BG-A0MT-01A-11D-A102-01 TCGA-BG-A0MT-01 TCGA-BG-A0MT-01A-11D-A10Q-05 578f3ec4-17e0-4cf9-bfa8-56624d174374 TCGA-BG-A0MU-01 MSS TCGA-BG-A0MU-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 1 mutation cluster 4 TCGA-BG-A0MU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 78 0 0 TCGA-BG-A0MU-F19322 TCGA-BG-A0MU TCGA-BG-A0MU-01A Never Used Stage IIIA -28621 121 0 617 NO Scheduled Follow-up Submission 2011-12-8 FEMALE 152 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Tumor resection 860 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-BG-A0MU.7162F7A7-7295-4736-B721-B13DAE006092.pdf A0MU 76.9 negative TUMOR FREE 0 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO YES BG 0 1 0 8 Endometrial A LIVING 68 2010 TCGA-BG-A0MU-01 TCGA-BG-A0MU-01 TCGA-BG-A0MU-01A-21-A163-20 2220B369-D1D5-48E1-8F1D-2BF17726A5C9 TCGA-BG-A0MU-01 TCGA-BG-A0MU-01A-11D-A10B-09 TCGA-BG-A0MU-01A-11D-A10B-09 TCGA-BG-A0MU-01A-11D-A10B-09 06c39fc6-9167-4913-bf84-4fde036869a2 TCGA-BG-A0MU-01A-11D-A102-01 TCGA-BG-A0MU-01A-11D-A102-01 TCGA-BG-A0MU-01 TCGA-BG-A0MU-01A-11D-A10Q-05 06c39fc6-9167-4913-bf84-4fde036869a2 TCGA-BG-A0RY-01 MSS TCGA-BG-A0RY-01 BRCA-LUAD+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 1 mutation cluster 4 TCGA-BG-A0RY TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 0 0 TCGA-BG-A0RY-F19333 TCGA-BG-A0RY TCGA-BG-A0RY-01A Never Used Stage IB -24952 49 0 469 NO Scheduled Follow-up Submission 2011-12-8 FEMALE 170 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 450 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-BG-A0RY.170B34D7-94B3-4129-9B4D-E36AF7A09897.pdf A0RY 96 negative TUMOR FREE 0 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO NO YES BG 0 0 0 9 Endometrial A LIVING 118 2010 TCGA-BG-A0RY-01 TCGA-BG-A0RY-01 TCGA-BG-A0RY-01A-21-A163-20 C6B6D0CE-40DE-4854-9839-31E44642187F TCGA-BG-A0RY-01 TCGA-BG-A0RY-01A-11D-A10B-09 TCGA-BG-A0RY-01A-11D-A10B-09 TCGA-BG-A0RY-01A-11D-A10B-09 514a9fc3-0b51-41f3-8c94-f6c8d8c0911e TCGA-BG-A0RY-01A-11D-A102-01 TCGA-BG-A0RY-01A-11D-A102-01 TCGA-BG-A0RY-01 TCGA-BG-A0RY-01A-11D-A10Q-05 514a9fc3-0b51-41f3-8c94-f6c8d8c0911e TCGA-BG-A0VT-01 MSS TCGA-BG-A0VT-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation c1uster 9 TCGA-BG-A0VT TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 0 TCGA-BG-A0VT-F71773 TCGA-BG-A0VT TCGA-BG-A0VT-01A Stage IIIA -20602 87 0 1568 2015-3-30 FEMALE 170 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 70 NO NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G2 NO true No TCGA-BG-A0VT.0BC38740-A7B9-4086-9F03-A139287B33CC.pdf A0VT 20 TUMOR FREE 0 YES Complete Remission/Response NO R0 Primary Tumor 01 Minimally Invasive 2009 NO YES BG 3 3 Endometrial A LIVING 144 2010 TCGA-BG-A0VT-01 TCGA-BG-A0VT-01 TCGA-BG-A0VT-01A-31-A163-20 EA1D2D67-9237-433D-A6B5-D3918D8BF59A TCGA-BG-A0VT-01 TCGA-BG-A0VT-01A-11D-A10M-09 TCGA-BG-A0VT-01A-11D-A10M-09 TCGA-BG-A0VT-01A-11D-A10M-09 666ecfed-75d2-412a-bd7f-24b9775db969 TCGA-BG-A0VT-01A-11D-A10L-01 TCGA-BG-A0VT-01A-11D-A10L-01 TCGA-BG-A0VT-01 TCGA-BG-A0VT-01A-11D-A10N-05 666ecfed-75d2-412a-bd7f-24b9775db969 TCGA-BG-A0VV-01 MSS TCGA-BG-A0VV-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-BG-A0VV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 0 TCGA-BG-A0VV-F71775 TCGA-BG-A0VV TCGA-BG-A0VV-01A Stage IA -19581 217 0 1553 2015-3-30 FEMALE 162 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 130 NO NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G1 NO true No TCGA-BG-A0VV.42E7D5FF-18CD-4DEA-9518-9B9732BCA635.pdf A0VV 50 negative TUMOR FREE 0 NO Complete Remission/Response NO R0 Primary Tumor 01 open 2009 NO YES BG 2 6 Endometrial A LIVING 147 2010 TCGA-BG-A0VV-01 TCGA-BG-A0VV-01A-11-A163-20 B296BC3F-3E22-46FD-AD09-8C08D18CC239 TCGA-BG-A0VV-01A-21D-A122-09 TCGA-BG-A0VV-01A-21D-A122-09 TCGA-BG-A0VV-01 34a66e0d-169f-4e39-89a2-78376bf741ae TCGA-BG-A0VV-01A-21D-A120-01 TCGA-BG-A0VV-01A-21D-A120-01 TCGA-BG-A0VV-01 TCGA-BG-A0VV-01 TCGA-BG-A0VV-01A-21D-A123-05 34a66e0d-169f-4e39-89a2-78376bf741ae TCGA-BG-A0VW-01 MSI-H TCGA-BG-A0VW-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 12 TCGA-BG-A0VW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 77 0 TCGA-BG-A0VW-F71776 TCGA-BG-A0VW TCGA-BG-A0VW-01A Stage IA -28383 246 0 1582 2015-3-30 FEMALE 157 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 90 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-BG-A0VW.7663D410-13EC-4A5B-B655-F7DCCC9C8E8D.pdf A0VW 50 negative TUMOR FREE 0 NO Complete Remission/Response NO R0 Primary Tumor 01 open 2009 NO YES BG 2 10 Endometrial A LIVING 93 2010 TCGA-BG-A0VW-01 TCGA-BG-A0VW-01A-11D-A122-09 TCGA-BG-A0VW-01A-11D-A122-09 TCGA-BG-A0VW-01 818368c5-a7b6-40d2-a24f-39604ea80303 TCGA-BG-A0VW-01A-11D-A120-01 TCGA-BG-A0VW-01A-11D-A120-01 TCGA-BG-A0VW-01 TCGA-BG-A0VW-01 TCGA-BG-A0VW-01A-11D-A123-05 818368c5-a7b6-40d2-a24f-39604ea80303 TCGA-BG-A0VX-01 MSS TCGA-BG-A0VX-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c11 miRNA cluster 13 cluster 2 mutation cluster 4 TCGA-BG-A0VX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 TCGA-BG-A0VX-F34087 TCGA-BG-A0VX Stage IB NO -21425 0 1043 NO 2012-7-30 FEMALE 152 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Excisional Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO No A0VX 15 TUMOR FREE NO Complete Remission/Response YES RX Primary Tumor 01 open 1988 NO YES BG Endometrial LIVING 157 2008 TCGA-BG-A0VX-01 TCGA-BG-A0VX-01A-11D-A122-09 TCGA-BG-A0VX-01A-11D-A122-09 TCGA-BG-A0VX-01A-11D-A122-09 TCGA-BG-A0VX-01 e6322f79-edd2-48f2-9712-82f7153b6e1e TCGA-BG-A0VX-01A-11D-A120-01 TCGA-BG-A0VX-01A-11D-A120-01 TCGA-BG-A0VX-01 TCGA-BG-A0VX-01 TCGA-BG-A0VX-01A-11D-A123-05 e6322f79-edd2-48f2-9712-82f7153b6e1e TCGA-BG-A0VZ-01 MSI-H TCGA-BG-A0VZ-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 1 TCGA-BG-A0VZ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 TCGA-BG-A0VZ-F34091 TCGA-BG-A0VZ TCGA-BG-A0VZ-01A Stage IIIA NO -21414 876 0 1601 NO 2012-7-30 FEMALE 165 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 70 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-BG-A0VZ.6CCCA758-AB3D-4260-BD25-16716E34B3BB.pdf A0VZ 52 negative TUMOR FREE YES 1 Complete Remission/Response NO R0 Primary Tumor 01 open 1988 NO YES BG Endometrial A LIVING 109 2008 TCGA-BG-A0VZ-01 TCGA-BG-A0VZ-01 TCGA-BG-A0VZ-01 TCGA-BG-A0VZ-01A-11D-A10G-09 TCGA-BG-A0VZ-01A-11D-A10G-09 TCGA-BG-A0VZ-01A-11D-A10G-09 740f4c64-0bc1-4691-8b37-7830ae67a080 TCGA-BG-A0VZ-01A-11D-A107-01 TCGA-BG-A0VZ-01A-11D-A107-01 TCGA-BG-A0VZ-01 TCGA-BG-A0VZ-01A-11D-A10A-05 740f4c64-0bc1-4691-8b37-7830ae67a080 TCGA-BG-A0W1-01 MSS TCGA-BG-A0W1-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-BG-A0W1 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 89 TCGA-BG-A0W1-F34127 TCGA-BG-A0W1 TCGA-BG-A0W1-01A Stage II NO -32750 1014 0 1607 NO 2012-7-30 FEMALE 130 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 100 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-BG-A0W1.BE7CC54D-8220-4AC6-9F8D-016DE4167B35.pdf A0W1 45 TUMOR FREE 0 NO Complete Remission/Response NO R0 Primary Tumor 01 open 1988 NO YES BG 11 Endometrial A LIVING 56 2007 TCGA-BG-A0W1-01 TCGA-BG-A0W1-01 TCGA-BG-A0W1-01A-21-A163-20 882F0777-CF03-43CE-ACAD-42A6E98D7D64 TCGA-BG-A0W1-01 TCGA-BG-A0W1-01A-12D-A10G-09 TCGA-BG-A0W1-01A-12D-A10G-09 TCGA-BG-A0W1-01A-12D-A10G-09 85dd6956-38ee-4f12-9210-ffe2a8964aef TCGA-BG-A0W1-01A-12D-A107-01 TCGA-BG-A0W1-01A-12D-A107-01 TCGA-BG-A0W1-01 TCGA-BG-A0W1-01A-12D-A10A-05 85dd6956-38ee-4f12-9210-ffe2a8964aef TCGA-BG-A0W2-01 MSS TCGA-BG-A0W2-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-BG-A0W2 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 TCGA-BG-A0W2-F49543 TCGA-BG-A0W2 TCGA-BG-A0W2-01A Stage IA -20998 1073 0 1721 2013-10-3 FEMALE 165 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 80 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-BG-A0W2.D9BDB0FB-9205-4E41-9D7D-B12C206A608E.pdf A0W2 0 TUMOR FREE NO Complete Remission/Response NO RX Primary Tumor 01 open 1988 NO YES BG 0 0 Endometrial A LIVING 121 2007 TCGA-BG-A0W2-01 TCGA-BG-A0W2-01 TCGA-BG-A0W2-01 TCGA-BG-A0W2-01A-11D-A117-09 TCGA-BG-A0W2-01A-11D-A117-09 TCGA-BG-A0W2-01A-11D-A117-09 8f9d6b78-c294-4f11-99ea-dc834a7f1741 TCGA-BG-A0W2-01A-11D-A107-01 TCGA-BG-A0W2-01A-11D-A107-01 TCGA-BG-A0W2-01 TCGA-BG-A0W2-01A-11D-A10A-05 8f9d6b78-c294-4f11-99ea-dc834a7f1741 TCGA-BG-A0YU-01 MSS TCGA-BG-A0YU-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 4 TCGA-BG-A0YU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 37 TCGA-BG-A0YU-F19334 TCGA-BG-A0YU TCGA-BG-A0YU-01A Stage IA -13644 166 0 451 NO Scheduled Follow-up Submission 2011-12-8 FEMALE 157 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES pelvic wash specimen from PAP Other method, specify: 310 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G1 NO true No TCGA-BG-A0YU.5E3AA4BA-20F6-4241-AD70-8E5DEDA9D129.pdf A0YU 50 TUMOR FREE Complete Remission/Response Never Used NO RX Primary Tumor 01 open 2009 NO NO YES BG Endometrial A LIVING 107 2010 TCGA-BG-A0YU-01 TCGA-BG-A0YU-01 TCGA-BG-A0YU-01A-11-A163-20 3F6A7393-8558-4803-BC69-541FBB713CF3 TCGA-BG-A0YU-01 TCGA-BG-A0YU-01A-21D-A10M-09 TCGA-BG-A0YU-01A-21D-A10M-09 TCGA-BG-A0YU-01A-21D-A10M-09 6e00c57a-69e5-4b00-9e5e-97aa1d4933c7 TCGA-BG-A0YU-01A-21D-A10L-01 TCGA-BG-A0YU-01A-21D-A10L-01 TCGA-BG-A0YU-01 TCGA-BG-A0YU-01A-21D-A10N-05 6e00c57a-69e5-4b00-9e5e-97aa1d4933c7 TCGA-BG-A0YV-01 MSS TCGA-BG-A0YV-01 Squamous C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 13 TCGA-BG-A0YV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 TCGA-BG-A0YV-F19335 TCGA-BG-A0YV TCGA-BG-A0YV-01A Never Used Stage IIIA -24567 62 0 382 NO Scheduled Follow-up Submission 2011-12-8 FEMALE 155 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Cytology (e.g. Peritoneal or pleural fluid) 330 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true Yes TCGA-BG-A0YV.D037EFD1-22CB-43FE-BE0A-F2189C5FB202.pdf A0YV TUMOR FREE Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO YES BG Endometrial A LIVING 54 2010 TCGA-BG-A0YV-01 TCGA-BG-A0YV-01A-21-A163-20 5F0A557D-F6A8-4FFA-93C5-0236054DB568 TCGA-BG-A0YV-01A-11D-A10M-09 TCGA-BG-A0YV-01A-11D-A10M-09 TCGA-BG-A0YV-01A-11D-A10M-09 TCGA-BG-A0YV-01 9b120d0b-5e47-4428-8116-557fcb7edf8a TCGA-BG-A0YV-01A-11D-A10L-01 TCGA-BG-A0YV-01A-11D-A10L-01 TCGA-BG-A0YV-01 TCGA-BG-A0YV-01 TCGA-BG-A0YV-01A-11D-A10N-05 9b120d0b-5e47-4428-8116-557fcb7edf8a TCGA-BG-A186-01 MSS TCGA-BG-A186-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 4 TCGA-BG-A186 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 61 0 TCGA-BG-A186-F28644 TCGA-BG-A186 TCGA-BG-A186-01A Stage IIIA NO -22370 104 0 419 NO Scheduled Follow-up Submission 2012-2-22 FEMALE 162 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 100 NO G2 NO true No TCGA-BG-A186.76C588F1-ED43-485D-8FFF-32F4C5D92202.pdf A186 28 positive TUMOR FREE 0 2 Complete Remission/Response Never Used YES RX Primary Tumor 01 open 2009 YES NO YES BG 6 23 Endometrial A LIVING 75 2010 TCGA-BG-A186-01 TCGA-BG-A186-01A-21-A164-20 F987438A-987D-4FB1-87B9-4FAA77E7AA3C TCGA-BG-A186-01A-11D-A12J-09 TCGA-BG-A186-01A-11D-A12J-09 TCGA-BG-A186-01A-11D-A12J-09 TCGA-BG-A186-01 fcf451be-340a-4479-86ed-d6757d680386 TCGA-BG-A186-01A-11D-A12G-01 TCGA-BG-A186-01A-11D-A12G-01 TCGA-BG-A186-01 TCGA-BG-A186-01 TCGA-BG-A186-01A-11D-A12K-05 fcf451be-340a-4479-86ed-d6757d680386 TCGA-BG-A187-01 MSI-L TCGA-BG-A187-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 1 TCGA-BG-A187 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 65 TCGA-BG-A187-F28645 TCGA-BG-A187 TCGA-BG-A187-01A Stage IB NO -24099 97 0 448 NO Scheduled Follow-up Submission 2012-2-22 FEMALE 160 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 360 NO G2 NO true No TCGA-BG-A187.CB8E915A-CE5D-4181-9303-22BD8CBCB80D.pdf A187 80 negative TUMOR FREE 0 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES BG 3 4 Endometrial A LIVING 61 2010 TCGA-BG-A187-01 TCGA-BG-A187-01A-21-A164-20 F00FE736-702F-4CFE-9019-012CFD2D2BA0 TCGA-BG-A187-01A-11D-A12J-09 TCGA-BG-A187-01A-11D-A12J-09 TCGA-BG-A187-01A-11D-A12J-09 TCGA-BG-A187-01 3486bd36-927d-46c7-8efe-5f2d6c80ac5e TCGA-BG-A187-01A-11D-A12G-01 TCGA-BG-A187-01A-11D-A12G-01 TCGA-BG-A187-01 TCGA-BG-A187-01 TCGA-BG-A187-01A-11D-A12K-05 3486bd36-927d-46c7-8efe-5f2d6c80ac5e TCGA-BG-A18A-01 MSS TCGA-BG-A18A-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 4 TCGA-BG-A18A TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 74 0 TCGA-BG-A18A-F28647 TCGA-BG-A18A TCGA-BG-A18A-01A Former User Stage IA NO -27086 146 0 426 NO Scheduled Follow-up Submission 2012-2-22 FEMALE 162 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 130 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO true No TCGA-BG-A18A.099561AC-A5E7-4CA9-8F07-EEA7B3A96EEA.pdf A18A 50 negative TUMOR FREE 0 2 Complete Remission/Response Never Used YES RX Primary Tumor 01 Minimally Invasive 2009 NO NO YES BG 2 11 Endometrial A LIVING 84 2010 TCGA-BG-A18A-01 TCGA-BG-A18A-01A-11-A163-20 A76C4656-73EF-4F33-AF5F-0278428FB79A TCGA-BG-A18A-01A-21D-A12J-09 TCGA-BG-A18A-01A-21D-A12J-09 TCGA-BG-A18A-01A-21D-A12J-09 TCGA-BG-A18A-01 71679725-d65f-47d4-b851-e4467f9d3f62 TCGA-BG-A18A-01A-21D-A12G-01 TCGA-BG-A18A-01A-21D-A12G-01 TCGA-BG-A18A-01 TCGA-BG-A18A-01 TCGA-BG-A18A-01A-21D-A12K-05 71679725-d65f-47d4-b851-e4467f9d3f62 TCGA-BG-A18B-01 MSI-H TCGA-BG-A18B-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 mutation cluster 7 TCGA-BG-A18B TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 TCGA-BG-A18B-F28649 TCGA-BG-A18B TCGA-BG-A18B-01A Former User Stage I NO -19550 56 0 470 NO Scheduled Follow-up Submission 2012-2-22 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 480 NO Peri (6-12 months since last menstrual period) G2 NO true No TCGA-BG-A18B.E7006FF4-33D9-4369-A4E0-42D124EAE1E0.pdf A18B TUMOR FREE 0 1 Complete Remission/Response Never Used NO RX Primary Tumor 01 open 2009 NO NO YES BG 0 5 Endometrial A LIVING 116 2010 TCGA-BG-A18B-01 TCGA-BG-A18B-01A-21-A164-20 8A7E6C09-E5B7-4C2E-B645-C88DB29F8318 TCGA-BG-A18B-01A-11D-A12J-09 TCGA-BG-A18B-01A-11D-A12J-09 TCGA-BG-A18B-01A-11D-A12J-09 TCGA-BG-A18B-01 5e981b2d-fef0-44c2-8228-8f5f7e9e3026 TCGA-BG-A18B-01A-11D-A12G-01 TCGA-BG-A18B-01A-11D-A12G-01 TCGA-BG-A18B-01 TCGA-BG-A18B-01 TCGA-BG-A18B-01A-11D-A12K-05 5e981b2d-fef0-44c2-8228-8f5f7e9e3026 TCGA-BG-A18C-01 MSS TCGA-BG-A18C-01 High C6-UCEC Cluster 5 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 13 TCGA-BG-A18C TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 72 0 TCGA-BG-A18C-F28650 TCGA-BG-A18C TCGA-BG-A18C-01A Never Used Stage IA NO -26602 52 0 470 YES Scheduled Follow-up Submission 2012-2-22 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 340 NO G2 NO true No TCGA-BG-A18C.2A6FB6E4-7FBF-45EA-B9B0-C4EDC78C35E2.pdf A18C 13 TUMOR FREE 0 2 Complete Remission/Response Never Used NO RX Primary Tumor 01 Minimally Invasive 2009 NO NO YES BG 5 25 Endometrial A LIVING 96 2010 TCGA-BG-A18C-01 TCGA-BG-A18C-01A-21-A164-20 42648EF0-3A6A-4CF2-9A7B-E3AA008D4BEE TCGA-BG-A18C-01A-11D-A12J-09 TCGA-BG-A18C-01A-11D-A12J-09 TCGA-BG-A18C-01A-11D-A12J-09 TCGA-BG-A18C-01 484a9564-c6dd-4e54-a319-4d826f308d0c TCGA-BG-A18C-01A-11D-A12G-01 TCGA-BG-A18C-01A-11D-A12G-01 TCGA-BG-A18C-01 TCGA-BG-A18C-01 TCGA-BG-A18C-01A-11D-A12K-05 484a9564-c6dd-4e54-a319-4d826f308d0c TCGA-BG-A220-01 MSI-H TCGA-BG-A220-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 TCGA-BG-A220 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 69 TCGA-BG-A220-F28651 TCGA-BG-A220 TCGA-BG-A220-01A Stage IA NO -25346 110 0 434 YES Scheduled Follow-up Submission 2012-2-22 FEMALE Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 190 NO G3 NO true Yes TCGA-BG-A220.59CD459F-FB2B-4B0E-9E16-3E26BDF252E1.pdf A220 TUMOR FREE 4+ Complete Remission/Response Never Used YES Primary Tumor 01 open 2009 NO NO YES BG 0 0 Endometrial A LIVING 127 2010 TCGA-BG-A220-01 TCGA-BG-A220-01A-21-A18R-20 3F856469-13FA-4F9E-957A-172BCD5064AE f26378d3-9f18-4367-a553-1a6c02e72575 TCGA-BG-A220-01A-11D-A160-01 TCGA-BG-A220-01A-11D-A160-01 TCGA-BG-A220-01 TCGA-BG-A220-01A-11D-A161-05 f26378d3-9f18-4367-a553-1a6c02e72575 TCGA-BG-A221-01 MSI-H TCGA-BG-A221-01 BRCA-LUAD+ C6-UCEC UCEC non-CIMP c3 cluster 4 squamous c3 UCEC-like c11 miRNA cluster 4 cluster 2 TCGA-BG-A221 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 84 0 TCGA-BG-A221-F28653 TCGA-BG-A221 TCGA-BG-A221-01A Stage IB NO -30960 99 0 55 NO Scheduled Follow-up Submission 2012-2-22 FEMALE 157 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 240 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true Yes TCGA-BG-A221.58D68577-9022-4EF3-82E9-6EE159D41947.pdf A221 TUMOR FREE 0 4+ Complete Remission/Response Never Used NO Primary Tumor 01 open 2009 NO NO YES BG 3 15 Endometrial A LIVING 62 2010 TCGA-BG-A221-01 TCGA-BG-A221-01A-11-A18R-20 8E13B416-DB5F-4D41-8126-0E55123579A2 58957940-d71f-4ad5-98a8-c8f2913801c5 TCGA-BG-A221-01A-21D-A160-01 TCGA-BG-A221-01A-21D-A160-01 TCGA-BG-A221-01 TCGA-BG-A221-01A-21D-A161-05 58957940-d71f-4ad5-98a8-c8f2913801c5 TCGA-BG-A222-01 MSI-H TCGA-BG-A222-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 squamous c3 UCEC-like c11 miRNA cluster 7 cluster 1 TCGA-BG-A222 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 49 0 TCGA-BG-A222-F28654 TCGA-BG-A222 TCGA-BG-A222-01A Stage IA NO -18220 50 0 291 NO Scheduled Follow-up Submission 2012-2-22 FEMALE 167 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 630 NO G3 NO true No TCGA-BG-A222.32837D2C-0D2B-4A47-9E42-1A809CB4A25A.pdf A222 negative TUMOR FREE 0 1 Complete Remission/Response Never Used YES Primary Tumor 01 open 2009 YES NO YES BG 7 25 Endometrial A LIVING 132 2011 TCGA-BG-A222-01 TCGA-BG-A222-01A-21-A18R-20 0426C930-B68C-4971-A8C8-8449D94146BC TCGA-BG-A222-01 0e8881cf-4745-4fb5-9842-dface6532da3 TCGA-BG-A222-01A-11D-A160-01 TCGA-BG-A222-01A-11D-A160-01 TCGA-BG-A222-01 TCGA-BG-A222-01 TCGA-BG-A222-01A-11D-A161-05 0e8881cf-4745-4fb5-9842-dface6532da3 TCGA-BG-A2AD-01 MSI-H TCGA-BG-A2AD-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 TCGA-BG-A2AD TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 0 TCGA-BG-A2AD-F49552 TCGA-BG-A2AD TCGA-BG-A2AD-01A Stage IIIB -23064 45 0 609 2013-10-3 FEMALE 160 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 770 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-BG-A2AD.E3FBF856-C09F-4F3A-975E-A1D07286A0EB.pdf A2AD positive TUMOR FREE 0 YES Complete Remission/Response NO Primary Tumor 01 Minimally Invasive 2009 NO YES BG 8 18 Endometrial A LIVING 80 2011 TCGA-BG-A2AD-01 TCGA-BG-A2AD-01A-11-A18R-20 90232DA4-577D-4CA4-9091-7C7BC7B16A08 TCGA-BG-A2AD-01 a6ed9981-f7df-4f36-be2e-da4c96722680 TCGA-BG-A2AD-01A-21D-A16C-01 TCGA-BG-A2AD-01A-21D-A16C-01 TCGA-BG-A2AD-01 TCGA-BG-A2AD-01 TCGA-BG-A2AD-01A-21D-A16G-05 a6ed9981-f7df-4f36-be2e-da4c96722680 TCGA-BG-A2AD-11 MSI-H TCGA-BG-A2AD-11 C6-UCEC TCGA-BG-A2AD TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 0 TCGA-BG-A2AD-F49552 TCGA-BG-A2AD Stage IIIB -23064 0 609 2013-10-3 FEMALE 160 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO No A2AD positive TUMOR FREE 0 YES Complete Remission/Response NO Solid Tissue Normal 11 Minimally Invasive 2009 NO YES BG 8 18 Endometrial LIVING 80 2011 be03335f-81c9-4cdc-8805-c47c3e7756a1 be03335f-81c9-4cdc-8805-c47c3e7756a1 be03335f-81c9-4cdc-8805-c47c3e7756a1 be03335f-81c9-4cdc-8805-c47c3e7756a1 TCGA-BG-A2AD-11 TCGA-BG-A2AD-11 TCGA-BG-A2AD-11A-11D-A16G-05 TCGA-BG-A2AE-01 MSS TCGA-BG-A2AE-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 1 TCGA-BG-A2AE TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 TCGA-BG-A2AE-F49553 TCGA-BG-A2AE TCGA-BG-A2AE-01A Stage IB -21069 50 0 721 2013-10-3 FEMALE 179 Endometrioid endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 460 NO NO Peri (6-12 months since last menstrual period) G3 NO true No TCGA-BG-A2AE.BA5BC88E-6A6C-425E-84B4-EC33DB9AC146.pdf A2AE TUMOR FREE 1 YES Complete Remission/Response YES Primary Tumor 01 open 2009 NO YES BG 8 Endometrial A LIVING 135 2011 TCGA-BG-A2AE-01 TCGA-BG-A2AE-01A-21-A18R-20 F0576BE1-156D-4AB2-B139-A4AD29B28209 TCGA-BG-A2AE-01A-11D-A16D-09 TCGA-BG-A2AE-01A-11D-A16D-09 TCGA-BG-A2AE-01A-11D-A16D-09 TCGA-BG-A2AE-01 7a5dd0ca-549d-452a-beb8-ea8a3f5528ec TCGA-BG-A2AE-01A-11D-A16C-01 TCGA-BG-A2AE-01A-11D-A16C-01 TCGA-BG-A2AE-01 TCGA-BG-A2AE-01 TCGA-BG-A2AE-01A-11D-A16G-05 7a5dd0ca-549d-452a-beb8-ea8a3f5528ec TCGA-BG-A2AE-11 MSS TCGA-BG-A2AE-11 C6-UCEC mutation cluster 1 TCGA-BG-A2AE TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 TCGA-BG-A2AE-F49553 TCGA-BG-A2AE TCGA-BG-A2AE-11A Stage IB -21069 50 0 721 2013-10-3 FEMALE 179 Endometrioid endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 40 NO NO Peri (6-12 months since last menstrual period) G3 NO true No A2AE TUMOR FREE 1 YES Complete Remission/Response YES Solid Tissue Normal 11 open 2009 NO YES BG 8 Endometrial A LIVING 135 2011 TCGA-BG-A2AE-11A-11D-A16G-05 TCGA-BG-A2L7-01 MSI-H TCGA-BG-A2L7-01 Quiet C6-UCEC UCEC CIMP c18 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 TCGA-BG-A2L7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 0 TCGA-BG-A2L7-F49554 TCGA-BG-A2L7 TCGA-BG-A2L7-01A Stage IA -25091 141 0 612 2013-10-3 FEMALE Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 110 NO NO G3 NO true No TCGA-BG-A2L7.6A14E5E4-ED0F-415A-B54B-DE16D7DC6E78.pdf A2L7 TUMOR FREE 0 YES Complete Remission/Response YES RX Primary Tumor 01 open 2009 NO YES BG 1 15 Endometrial A LIVING 2011 TCGA-BG-A2L7-01 TCGA-BG-A2L7-01A-21-A23Z-20 9C365A47-24D5-4301-B47E-FD745ABBE8E7 TCGA-BG-A2L7-01 16ce8070-8c04-4cc7-b00a-c094a524b133 TCGA-BG-A2L7-01A-11D-A18N-01 TCGA-BG-A2L7-01A-11D-A18N-01 TCGA-BG-A2L7-01 TCGA-BG-A2L7-01 TCGA-BG-A2L7-01A-11D-A18O-05 16ce8070-8c04-4cc7-b00a-c094a524b133 TCGA-BG-A2L7-11 MSI-H TCGA-BG-A2L7-11 C6-UCEC TCGA-BG-A2L7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 0 TCGA-BG-A2L7-F49554 TCGA-BG-A2L7 TCGA-BG-A2L7-11A Stage IA -25091 141 0 612 2013-10-3 FEMALE Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 320 NO NO G3 NO true No A2L7 TUMOR FREE 0 YES Complete Remission/Response YES RX Solid Tissue Normal 11 open 2009 NO YES BG 1 15 Endometrial A LIVING 2011 TCGA-BG-A2L7-11A-11D-A18O-05 TCGA-BG-A3EW-01 MSI-H TCGA-BG-A3EW-01 Iq UCEC CIMP c18 UCEC-like c5 miRNA c1uster 10 TCGA-BG-A3EW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 62 0 TCGA-BG-A3EW-F39618 TCGA-BG-A3EW TCGA-BG-A3EW-01A Stage III -22705 24 0 344 2013-1-28 FEMALE 166 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure 130 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-BG-A3EW.0463CA05-339C-4AB9-A236-CEAE733AD5F6.pdf A3EW 12 TUMOR FREE 0 NO Complete Remission/Response YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO BG 2 9 Endometrial A LIVING 126 2011 8b8048b4-fe60-45f4-97c5-662c45169334 TCGA-BG-A3EW-01 8b8048b4-fe60-45f4-97c5-662c45169334 TCGA-BG-A3EW-01A-21-A23Z-20 918C09B1-BCFE-4194-A61C-90B4A30DB902 8b8048b4-fe60-45f4-97c5-662c45169334 8b8048b4-fe60-45f4-97c5-662c45169334 TCGA-BG-A3EW-01 TCGA-BG-A3EW-01A-11D-A227-01 TCGA-BG-A3EW-01A-11D-A227-01 TCGA-BG-A3EW-01 TCGA-BG-A3EW-01 TCGA-BG-A3EW-01A-11D-A22B-05 TCGA-BG-A3EW-11 MSI-H TCGA-BG-A3EW-11 TCGA-BG-A3EW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 62 0 TCGA-BG-A3EW-F39618 TCGA-BG-A3EW Stage III -22705 0 344 2013-1-28 FEMALE 166 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Dilation and curettage procedure NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO No A3EW 12 TUMOR FREE 0 NO Complete Remission/Response YES R0 Solid Tissue Normal 11 Minimally Invasive 2009 YES NO BG 2 9 Endometrial LIVING 126 2011 a75c4597-041a-44ad-88e1-0466278f621c a75c4597-041a-44ad-88e1-0466278f621c a75c4597-041a-44ad-88e1-0466278f621c a75c4597-041a-44ad-88e1-0466278f621c TCGA-BG-A3EW-11 TCGA-BG-A3EW-11 TCGA-BG-A3EW-11A-22D-A22B-05 TCGA-BG-A3PP-01 MSS TCGA-BG-A3PP-01 Squamous UCEC Serous c4 UCEC-like c5 miRNA cluster 5 TCGA-BG-A3PP TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 82 TCGA-BG-A3PP-F57825 TCGA-BG-A3PP TCGA-BG-A3PP-01A Stage II -30227 143 0 681 665 2014-3-27 FEMALE Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 320 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Vagina apex YES true No TCGA-BG-A3PP.728D12CF-B846-49B7-8B16-463460CAD5C0.pdf A3PP positive WITH TUMOR 0 YES Progressive Disease YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO BG 3 Endometrial A LIVING 2011 5ece050b-b22d-44b9-b920-257a351b5602 TCGA-BG-A3PP-01 5ece050b-b22d-44b9-b920-257a351b5602 TCGA-BG-A3PP-01A-21-A23Z-20 1EFCFA38-5D77-420A-A635-9657E138099C 5ece050b-b22d-44b9-b920-257a351b5602 5ece050b-b22d-44b9-b920-257a351b5602 TCGA-BG-A3PP-01 TCGA-BG-A3PP-01A-11D-A227-01 TCGA-BG-A3PP-01A-11D-A227-01 TCGA-BG-A3PP-01 TCGA-BG-A3PP-01 TCGA-BG-A3PP-01A-11D-A22B-05 TCGA-BG-A3PP-11 MSS TCGA-BG-A3PP-11 TCGA-BG-A3PP TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 82 TCGA-BG-A3PP-F57825 TCGA-BG-A3PP TCGA-BG-A3PP-11A Stage II -30227 143 0 681 665 2014-3-27 FEMALE Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 190 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Vagina apex YES true No A3PP positive WITH TUMOR 0 YES Progressive Disease YES R0 Solid Tissue Normal 11 Minimally Invasive 2009 YES NO BG 3 Endometrial A LIVING 2011 02446b95-1e3f-474b-8123-f49117f58893 02446b95-1e3f-474b-8123-f49117f58893 02446b95-1e3f-474b-8123-f49117f58893 02446b95-1e3f-474b-8123-f49117f58893 TCGA-BG-A3PP-11 TCGA-BG-A3PP-11 TCGA-BG-A3PP-11A-11D-A22B-05 TCGA-BK-A0C9-01 MSI-H TCGA-BK-A0C9-01 BRCA-LUAD+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 7 TCGA-BK-A0C9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 0 0 TCGA-BK-A0C9-F41805 TCGA-BK-A0C9 TCGA-BK-A0C9-01A Never Used Stage IB NO -20876 192 0 1092 NO 2013-3-28 FEMALE 168 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 490 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-BK-A0C9.3E14F5F3-2C40-403F-A499-BE64857E8559.pdf A0C9 40 negative TUMOR FREE 0 0 NO 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO YES NO BK 0 4 0 18 Endometrial A LIVING 127 2009 TCGA-BK-A0C9-01 TCGA-BK-A0C9-01 TCGA-BK-A0C9-01A-21-A162-20 FC84BD3F-BCE6-41AF-98D4-A4586B56F810 TCGA-BK-A0C9-01 TCGA-BK-A0C9-01 TCGA-BK-A0C9-01A-11W-A027-09 TCGA-BK-A0C9-01A-11W-A027-09 TCGA-BK-A0C9-01A-11W-A027-09 TCGA-BK-A0C9-01 71ef8bce-4b04-4fba-9ae6-8c8f2b18b2c7 TCGA-BK-A0C9-01A-11D-A00X-01 TCGA-BK-A0C9-01A-11R-A00V-07 TCGA-BK-A0C9-01A-11D-A00X-01 TCGA-BK-A0C9-01 TCGA-BK-A0C9-01A-11D-A00U-05 71ef8bce-4b04-4fba-9ae6-8c8f2b18b2c7 TCGA-BK-A0CA-01 TCGA-BK-A0CA-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 4 TCGA-BK-A0CA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 61 29 TCGA-BK-A0CA-F40261 TCGA-BK-A0CA TCGA-BK-A0CA-01A Stage IIIC NO -22378 86 0 1064 NO FPPP 2013-2-14 FEMALE 163 Mixed serous and endometrioid No YES C54.1 8441/3 C54.1 YES Cytology (e.g. Peritoneal or pleural fluid) 300 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-BK-A0CA.883D4832-75FB-495C-B93F-904FCA1AB18C.pdf A0CA negative TUMOR FREE 9 YES 1 Complete Remission/Response Never Used TCGA NO RX Primary Tumor 01 Minimally Invasive YES YES NO BK 29 32 9 14 Endometrial A LIVING 2010 TCGA-BK-A0CA-01 TCGA-BK-A0CA-01A-11-A162-20 30A62556-2260-4232-BA09-E3EFCA44EF7E TCGA-BK-A0CA-01A-21D-A122-09 TCGA-BK-A0CA-01A-21D-A122-09 TCGA-BK-A0CA-01A-21D-A122-09 TCGA-BK-A0CA-01 20f433c2-0909-4b42-9429-215774b19604 TCGA-BK-A0CA-01A-21D-A275-01 TCGA-BK-A0CA-01A-21D-A275-01 TCGA-BK-A0CA-01 TCGA-BK-A0CA-01 TCGA-BK-A0CA-01A-21D-A27B-05,TCGA-BK-A0CA-01B-02D-A27B-05,TCGA-BK-A0CA-01A-21D-A123-05 20f433c2-0909-4b42-9429-215774b19604 TCGA-BK-A0CB-01 MSS TCGA-BK-A0CB-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 mutation cluster 4 TCGA-BK-A0CB TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 0 2 TCGA-BK-A0CB-F39909 TCGA-BK-A0CB TCGA-BK-A0CB-01A Stage IIIC NO -21930 64 0 1092 YES 2013-2-13 FEMALE 154 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Incisional Biopsy 450 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-BK-A0CB.37923E3D-3CCB-41DB-8F30-C19FDE7407CB.pdf A0CB 76 negative TUMOR FREE 0 0 YES 0 Complete Remission/Response NO R0 Primary Tumor 01 open YES YES NO BK 2 8 0 13 Endometrial A LIVING 111 2010 TCGA-BK-A0CB-01 TCGA-BK-A0CB-01A-21-A162-20 248C77AA-3235-42DD-AE94-A1415F70AB72 TCGA-BK-A0CB-01A-32D-A10B-09 TCGA-BK-A0CB-01A-32D-A10B-09 TCGA-BK-A0CB-01A-32D-A10B-09 6b8a0d03-6a82-49ed-b3ee-66937dc06201 TCGA-BK-A0CB-01A-32D-A102-01 TCGA-BK-A0CB-01A-32D-A102-01 TCGA-BK-A0CB-01 TCGA-BK-A0CB-01A-32D-A10Q-05 6b8a0d03-6a82-49ed-b3ee-66937dc06201 TCGA-BK-A0CB-11 MSS TCGA-BK-A0CB-11 C6-UCEC mutation cluster 4 TCGA-BK-A0CB TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 0 2 TCGA-BK-A0CB-F39909 TCGA-BK-A0CB TCGA-BK-A0CB-11A Stage IIIC NO -21930 64 0 1092 YES 2013-2-13 FEMALE 154 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Incisional Biopsy 420 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No A0CB 76 negative TUMOR FREE 0 0 YES 0 Complete Remission/Response NO R0 Solid Tissue Normal 11 open YES YES NO BK 2 8 0 13 Endometrial A LIVING 111 2010 TCGA-BK-A0CB-11 TCGA-BK-A0CB-11 7865a23a-f7a6-43b0-b395-16c8306cea2f TCGA-BK-A0CB-11A-33D-A10Q-05 7865a23a-f7a6-43b0-b395-16c8306cea2f TCGA-BK-A0CC-01 TCGA-BK-A0CC-01 High C6-UCEC UCEC Serous c4 cluster 3 OV-like c4 UCEC-like c11 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-BK-A0CC TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Progressive Disease 69 0 0 TCGA-BK-A0CC-F39535 TCGA-BK-A0CC TCGA-BK-A0CC-01A Stage IIIC NO -25479 52 0 1067 1010 YES FPPP 2013-1-24 FEMALE 152 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES Incisional Biopsy 310 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Right Pelvic Mass NO YES false No TCGA-BK-A0CC.6A2AAC78-98B9-44D4-AF8D-9A132579CC2D.pdf A0CC 54 negative WITH TUMOR 0 2 YES 3 Complete Remission/Response Never Used TCGA YES Other Method, Specify Below CT guided Fine Needle Aspiration RX Primary Tumor 01 open YES YES NO BK 0 5 2 12 Endometrial A LIVING 72 2010 TCGA-BK-A0CC-01 TCGA-BK-A0CC-01 TCGA-BK-A0CC-01A-11-A162-20 D106BF3B-A21D-465D-873E-DD7478086913 TCGA-BK-A0CC-01 TCGA-BK-A0CC-01 TCGA-BK-A0CC-01A-21W-A027-09 TCGA-BK-A0CC-01A-21W-A027-09 TCGA-BK-A0CC-01A-21W-A027-09 TCGA-BK-A0CC-01 ac44efb2-7079-49a7-8bc6-285ae009ad89 TCGA-BK-A0CC-01A-21D-A275-01 TCGA-BK-A0CC-01A-21R-A00V-07 TCGA-BK-A0CC-01A-21D-A275-01 TCGA-BK-A0CC-01 TCGA-BK-A0CC-01A-21D-A27B-05,TCGA-BK-A0CC-01B-04D-A27B-05 TCGA-BK-A0CC-01A-21D-A00U-05 ac44efb2-7079-49a7-8bc6-285ae009ad89 TCGA-BK-A139-01 TCGA-BK-A139-01 Squamous C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 3 TCGA-BK-A139 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO Progressive Disease 74 0 0 TCGA-BK-A139-F39375 TCGA-BK-A139 TCGA-BK-A139-01A Stage IB NO -27077 175 943 0 309 810 684 NO FPPP Scheduled Follow-up Submission 2013-1-21 FEMALE 154 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 770 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Paravaginal mass involving the bladder and rectal walls YES YES false No TCGA-BK-A139.5F8C376B-31F8-4566-8EBF-21E7F4E6499D.pdf A139 WITH TUMOR 0 0 NO 2 Complete Remission/Response Never Used TCGA NO Other Method, Specify Below Total Pelvis Exenteration, mobilation of the splenic fexure, and sigmoid colostomy, ileal conduit diversion. R0 Primary Tumor 01 Minimally Invasive NO YES NO BK 0 9 0 24 Endometrial A DECEASED 59 2010 TCGA-BK-A139-01 TCGA-BK-A139-01A-21-A163-20 1260487B-9CF7-43E6-8B3A-AD1B7CC40DEC TCGA-BK-A139-01A-11D-A122-09 TCGA-BK-A139-01A-11D-A122-09 TCGA-BK-A139-01 4b398b99-8916-440b-9ed5-9ed67db19b9b TCGA-BK-A139-01A-11D-A275-01 TCGA-BK-A139-01A-11D-A275-01 TCGA-BK-A139-01 TCGA-BK-A139-01 TCGA-BK-A139-01C-08D-A27B-05,TCGA-BK-A139-01A-11D-A123-05,TCGA-BK-A139-01A-11D-A27B-05 4b398b99-8916-440b-9ed5-9ed67db19b9b TCGA-BK-A139-02 TCGA-BK-A139-02 C6-UCEC mutation cluster 3 TCGA-BK-A139 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO Progressive Disease 74 0 0 TCGA-BK-A139-F39375 TCGA-BK-A139 TCGA-BK-A139-02A Stage IB NO -27077 874 943 0 309 810 684 NO FPPP Scheduled Follow-up Submission 2013-1-21 FEMALE 154 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 430 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Paravaginal mass involving the bladder and rectal walls YES YES false No TCGA-BK-A139.FE6C557C-6F28-4F5C-B48C-E2A3BB7EF14F.pdf A139 WITH TUMOR 0 0 NO 2 Complete Remission/Response Never Used TCGA NO Other Method, Specify Below Total Pelvis Exenteration, mobilation of the splenic fexure, and sigmoid colostomy, ileal conduit diversion. R0 Recurrent Tumor 02 Minimally Invasive NO YES NO BK 0 9 0 24 Endometrial A DECEASED 59 2010 923217e0-602c-4cf7-b17a-37269d9371c4 923217e0-602c-4cf7-b17a-37269d9371c4 923217e0-602c-4cf7-b17a-37269d9371c4 923217e0-602c-4cf7-b17a-37269d9371c4 TCGA-BK-A139-02 TCGA-BK-A139-02 TCGA-BK-A139-02A-11D-A27Y-05 TCGA-BK-A13B-01 MSI-H TCGA-BK-A13B-01 Iq UCEC CIMP c18 UCEC-like c5 miRNA cluster 7 TCGA-BK-A13B TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Progressive Disease 58 TCGA-BK-A13B-F40746 TCGA-BK-A13B TCGA-BK-A13B-01A Stage IB NO -21493 140 0 966 760 YES Scheduled Follow-up Submission 2013-3-14 FEMALE 170 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 830 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Vaginal NO YES false No TCGA-BK-A13B.F8B15B22-27A6-4D7A-BCDC-B46EBCA5888E.pdf A13B negative WITH TUMOR NO 1 Complete Remission/Response Never Used YES Other Method, Specify Below Vaginal Biopsy Primary Tumor 01 2009 NO YES NO BK 0 10 0 15 Endometrial A LIVING 131 2010 ed2e8014-4042-45fe-ae9d-78606344955b TCGA-BK-A13B-01 ed2e8014-4042-45fe-ae9d-78606344955b TCGA-BK-A13B-01A-41-A23Z-20 B28F46F3-27E5-4A3D-9757-DB40F7859E76 ed2e8014-4042-45fe-ae9d-78606344955b ed2e8014-4042-45fe-ae9d-78606344955b TCGA-BK-A13B-01 TCGA-BK-A13B-01A-51D-A227-01 TCGA-BK-A13B-01A-51D-A227-01 TCGA-BK-A13B-01 TCGA-BK-A13B-01 TCGA-BK-A13B-01A-51D-A22B-05 TCGA-BK-A13C-01 MSS TCGA-BK-A13C-01 Iq C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation c1uster 10 TCGA-BK-A13C TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 47 0 0 TCGA-BK-A13C-F40813 TCGA-BK-A13C TCGA-BK-A13C-01A Stage IB NO -17317 146 0 760 NO Scheduled Follow-up Submission 2013-3-1 FEMALE 166 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 310 NO NO Peri (6-12 months since last menstrual period) G2 NO false No TCGA-BK-A13C.2043D579-6785-4775-8A28-CDE3F1400BA2.pdf A13C 17 negative TUMOR FREE 0 0 NO 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive NO YES NO BK 0 5 0 25 Endometrial A LIVING 93 2010 TCGA-BK-A13C-01 TCGA-BK-A13C-01A-21-A163-20 C833D378-9B97-4808-806E-A9DEE1298AE3 TCGA-BK-A13C-01A-11D-A122-09 TCGA-BK-A13C-01A-11D-A122-09 TCGA-BK-A13C-01 a7dc4fdb-a62d-4d84-b351-16d84ab202e3 TCGA-BK-A13C-01A-11D-A120-01 TCGA-BK-A13C-01A-11D-A120-01 TCGA-BK-A13C-01 TCGA-BK-A13C-01 TCGA-BK-A13C-01A-11D-A123-05 a7dc4fdb-a62d-4d84-b351-16d84ab202e3 TCGA-BK-A13C-11 MSS TCGA-BK-A13C-11 C6-UCEC mutation c1uster 10 TCGA-BK-A13C TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 47 0 0 TCGA-BK-A13C-F40813 TCGA-BK-A13C TCGA-BK-A13C-11A Stage IB NO -17317 146 0 760 NO Scheduled Follow-up Submission 2013-3-1 FEMALE 166 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 270 NO NO Peri (6-12 months since last menstrual period) G2 NO false No A13C 17 negative TUMOR FREE 0 0 NO 0 Complete Remission/Response Never Used NO R0 Solid Tissue Normal 11 Minimally Invasive NO YES NO BK 0 5 0 25 Endometrial A LIVING 93 2010 a6ba27cf-7e06-4a44-a948-8575593272cb TCGA-BK-A13C-11A-11D-A123-05 a6ba27cf-7e06-4a44-a948-8575593272cb TCGA-BK-A26L-01 TCGA-BK-A26L-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 2 TCGA-BK-A26L TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 71 0 0 TCGA-BK-A26L-F40279 TCGA-BK-A26L TCGA-BK-A26L-01A Former User Stage IIIC1 NO -26002 131 0 734 NO FPPP Scheduled Follow-up Submission 2013-2-15 FEMALE 152 Serous endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 320 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-BK-A26L.979388A8-CC61-4C03-BADC-BEF9EC50C40A.pdf A26L 80 negative TUMOR FREE 0 0 YES 3 Complete Remission/Response Never Used TCGA YES RX Primary Tumor 01 Minimally Invasive 2009 YES YES NO BK 0 3 1 10 Endometrial A LIVING 75 2010 TCGA-BK-A26L-01 TCGA-BK-A26L-01A-21-A18R-20 E78FD774-2F02-41DA-BE47-D049CACC8560 TCGA-BK-A26L-01 80b16496-74bd-4fe7-967c-31058b2c022b TCGA-BK-A26L-01A-11D-A275-01 TCGA-BK-A26L-01A-11D-A275-01 TCGA-BK-A26L-01 TCGA-BK-A26L-01 TCGA-BK-A26L-01A-11D-A16G-05,TCGA-BK-A26L-01C-04D-A27B-05,TCGA-BK-A26L-01A-11D-A27B-05 80b16496-74bd-4fe7-967c-31058b2c022b TCGA-BK-A4ZD-01 MSS TCGA-BK-A4ZD-01 TCGA-BK-A4ZD TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 42 0 TCGA-BK-A4ZD-F52698 TCGA-BK-A4ZD TCGA-BK-A4ZD-01A Stage IA NO -15536 92 0 506 YES 2013-12-5 FEMALE 163 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 300 NO NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 NO false No TCGA-BK-A4ZD.388C7674-9CA2-446C-A67D-9639A28ADEB4.pdf A4ZD 25 negative TUMOR FREE 0 NO 3 Complete Remission/Response NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO BK 0 2 0 14 Endometrial A LIVING 142 2012 31bd06c7-98c1-4d2e-81ff-4e210e7bba75 TCGA-BK-A4ZD-01 31bd06c7-98c1-4d2e-81ff-4e210e7bba75 BD615DAC-024C-47F4-A6AE-99344CA93774 31bd06c7-98c1-4d2e-81ff-4e210e7bba75 31bd06c7-98c1-4d2e-81ff-4e210e7bba75 TCGA-BK-A4ZD-01 TCGA-BK-A4ZD-01A-11D-A27O-01 TCGA-BK-A4ZD-01A-11D-A27O-01 TCGA-BK-A4ZD-01 TCGA-BK-A4ZD-01 TCGA-BK-A4ZD-01A-11D-A27Y-05 TCGA-BK-A4ZD-11 MSS TCGA-BK-A4ZD-11 TCGA-BK-A4ZD TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 42 0 TCGA-BK-A4ZD-F52698 TCGA-BK-A4ZD Stage IA NO -15536 0 506 YES 2013-12-5 FEMALE 163 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 NO No A4ZD 25 negative TUMOR FREE 0 NO 3 Complete Remission/Response NO R0 Solid Tissue Normal 11 Minimally Invasive 2009 YES NO BK 0 2 0 14 Endometrial LIVING 142 2012 babe74ee-b0dc-41c3-9968-2faac94addf2 babe74ee-b0dc-41c3-9968-2faac94addf2 babe74ee-b0dc-41c3-9968-2faac94addf2 babe74ee-b0dc-41c3-9968-2faac94addf2 TCGA-BK-A4ZD-11 TCGA-BK-A4ZD-11 TCGA-BK-A4ZD-11A-12D-A27Y-05 TCGA-BK-A56F-01 MSS TCGA-BK-A56F-01 TCGA-BK-A56F TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 75 TCGA-BK-A56F-F49745 TCGA-BK-A56F TCGA-BK-A56F-01A Stage IB NO -27523 93 0 401 YES 2013-10-10 FEMALE 163 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 360 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-BK-A56F.2778F3EE-0211-4B51-8FBE-050FC7A4D0FF.pdf A56F 60 negative TUMOR FREE NO 4+ Complete Remission/Response YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO BK 0 3 0 10 Endometrial A LIVING 84 2012 5d83ceb3-a3f0-419e-945a-a5cf49d439e9 TCGA-BK-A56F-01 5d83ceb3-a3f0-419e-945a-a5cf49d439e9 5d83ceb3-a3f0-419e-945a-a5cf49d439e9 5d83ceb3-a3f0-419e-945a-a5cf49d439e9 TCGA-BK-A56F-01 TCGA-BK-A56F-01A-32D-A27O-01 TCGA-BK-A56F-01A-32D-A27O-01 TCGA-BK-A56F-01 TCGA-BK-A56F-01 TCGA-BK-A56F-01A-32D-A27Y-05 TCGA-BK-A6W3-01 MSS TCGA-BK-A6W3-01 TCGA-BK-A6W3 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 34 TCGA-BK-A6W3-F57503 TCGA-BK-A6W3 TCGA-BK-A6W3-01A Stage II NO -12590 94 0 305 NO 2014-3-12 FEMALE 167 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 150 NO NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G2 NO false No TCGA-BK-A6W3.15A94B35-48FD-4F94-94E4-25F8084F8B91.pdf A6W3 negative TUMOR FREE NO 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 2009 YES NO BK 0 0 Endometrial A LIVING 89 2013 abec519f-1747-400d-944d-7e53d12d6dea TCGA-BK-A6W3-01 abec519f-1747-400d-944d-7e53d12d6dea 42DDB0FE-9C22-4E46-AF94-D56C01B6C949 abec519f-1747-400d-944d-7e53d12d6dea abec519f-1747-400d-944d-7e53d12d6dea TCGA-BK-A6W3-01 TCGA-BK-A6W3-01A-12D-A34P-01 TCGA-BK-A6W3-01A-12D-A34P-01 TCGA-BK-A6W3-01 TCGA-BK-A6W3-01 TCGA-BK-A6W3-01A-12D-A34S-05 TCGA-BK-A6W4-01 MSS TCGA-BK-A6W4-01 TCGA-BK-A6W4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 62 TCGA-BK-A6W4-F57489 TCGA-BK-A6W4 TCGA-BK-A6W4-01A Stage IA NO -22766 118 0 300 YES 2014-3-12 FEMALE 157 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 180 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-BK-A6W4.5F25185F-4F80-4137-A07C-230FB3ACE3AE.pdf A6W4 32 TUMOR FREE NO 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 2009 YES NO BK 0 0 Endometrial A LIVING 107 2013 1073a603-5546-48b8-b6aa-9a16f909547b TCGA-BK-A6W4-01 1073a603-5546-48b8-b6aa-9a16f909547b 1073a603-5546-48b8-b6aa-9a16f909547b 1073a603-5546-48b8-b6aa-9a16f909547b TCGA-BK-A6W4-01 TCGA-BK-A6W4-01A-12D-A34P-01 TCGA-BK-A6W4-01A-12D-A34P-01 TCGA-BK-A6W4-01 TCGA-BK-A6W4-01 TCGA-BK-A6W4-01A-12D-A34S-05 TCGA-BS-A0T9-01 MSS TCGA-BS-A0T9-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 4 TCGA-BS-A0T9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES YES Progressive Disease 39 0 0 TCGA-BS-A0T9-F9188 TCGA-BS-A0T9 TCGA-BS-A0T9-01A Never Used Stage IVB NO 922 -14253 2009 1428 0 634 NO 2010-11-19 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Tumor resection 600 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 false No TCGA-BS-A0T9.C9151621-D012-48F9-B7E1-F540567E791C.pdf A0T9 67 positive WITH TUMOR 0 0 0 Complete Remission/Response Never Used NO Surgical Resection R2 R2 Primary Tumor 01 open 1988 YES NO YES BS 1 2 2 2 Endometrial A DECEASED 109 2005 TCGA-BS-A0T9-01 TCGA-BS-A0T9-01A-21-A163-20 BA865E56-EF20-4543-AE3B-465967C47508 TCGA-BS-A0T9-01A-11D-A12J-09 TCGA-BS-A0T9-01A-11D-A12J-09 TCGA-BS-A0T9-01A-11D-A12J-09 TCGA-BS-A0T9-01 8947d611-8c3f-4096-9479-063660ee8607 TCGA-BS-A0T9-01A-11D-A12G-01 TCGA-BS-A0T9-01A-11D-A12G-01 TCGA-BS-A0T9-01 TCGA-BS-A0T9-01 TCGA-BS-A0T9-01A-11D-A12K-05 8947d611-8c3f-4096-9479-063660ee8607 TCGA-BS-A0TA-01 MSI-H TCGA-BS-A0TA-01 Quiet C6-UCEC UCEC CIMP c18 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 4 cluster 2 mutation c1uster 10 TCGA-BS-A0TA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO NO Progressive Disease 58 0 0 TCGA-BS-A0TA-F68985 TCGA-BS-A0TA TCGA-BS-A0TA-01A Never Used Stage IVB NO -21505 1788 740 0 714 581 YES 2014-12-24 FEMALE 152 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Fine needle aspiration biopsy 300 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Distant Metastasis Right Adrenal Gland NO YES false No TCGA-BS-A0TA.5F009A9A-549F-4EEB-BB6D-C67353C7A292.pdf A0TA 88 negative WITH TUMOR 0 0 YES 0 Stable Disease Never Used YES RX Primary Tumor 01 open 1988 YES NO YES BS 1 1 2 14 Endometrial A DECEASED 90 2005 TCGA-BS-A0TA-01 TCGA-BS-A0TA-01 TCGA-BS-A0TA-01A-21-A163-20 9553C69B-1FB7-4D93-9B62-19E9A7AE9C62 TCGA-BS-A0TA-01 TCGA-BS-A0TA-01A-11D-A10B-09 TCGA-BS-A0TA-01A-11D-A10B-09 TCGA-BS-A0TA-01A-11D-A10B-09 c1621135-fa9b-4043-8168-356402d45f01 TCGA-BS-A0TA-01A-11D-A102-01 TCGA-BS-A0TA-01A-11D-A102-01 TCGA-BS-A0TA-01 TCGA-BS-A0TA-01A-11D-A10Q-05 c1621135-fa9b-4043-8168-356402d45f01 TCGA-BS-A0TC-01 MSS TCGA-BS-A0TC-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 11 TCGA-BS-A0TC TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 69 0 0 TCGA-BS-A0TC-F4391 TCGA-BS-A0TC TCGA-BS-A0TC-01A Never Used Stage IB NO -25560 2227 0 2602 YES 2010-11-19 FEMALE 147 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.3 8380/3 C54.3 YES Office Endometrial Biopsy 120 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 false No TCGA-BS-A0TC.8AA64402-A062-410D-85B8-24DAD320916D.pdf A0TC 9 negative TUMOR FREE 0 0 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 03 0 20 Endometrial A LIVING 68 2004 TCGA-BS-A0TC-01 TCGA-BS-A0TC-01 TCGA-BS-A0TC-01A-21-A163-20 5F9C0254-8925-4A04-A019-C001594FF615 TCGA-BS-A0TC-01 TCGA-BS-A0TC-01A-11D-A10B-09 TCGA-BS-A0TC-01A-11D-A10B-09 0b2aa3d5-f8cd-4047-91cf-295e6b4c8891 TCGA-BS-A0TC-01A-11D-A102-01 TCGA-BS-A0TC-01A-11D-A102-01 TCGA-BS-A0TC-01 TCGA-BS-A0TC-01A-11D-A10Q-05 0b2aa3d5-f8cd-4047-91cf-295e6b4c8891 TCGA-BS-A0TD-01 MSS TCGA-BS-A0TD-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 mutation cluster 4 TCGA-BS-A0TD TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 65 TCGA-BS-A0TD-F4393 TCGA-BS-A0TD TCGA-BS-A0TD-01A Former User Stage IB NO -23950 2004 0 2379 YES 2010-11-19 FEMALE 155 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.9 8380/3 C54.9 YES Tumor resection 150 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 false No TCGA-BS-A0TD.51ABEFF0-EEA1-48CA-9E00-CC57D1A2DEB0.pdf A0TD 3 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 0 13 Endometrial A LIVING 85 2005 TCGA-BS-A0TD-01 TCGA-BS-A0TD-01 TCGA-BS-A0TD-01A-21-A163-20 930AAB77-0151-4616-8E43-674B780895E3 TCGA-BS-A0TD-01 TCGA-BS-A0TD-01A-11D-A10B-09 TCGA-BS-A0TD-01A-11D-A10B-09 TCGA-BS-A0TD-01A-11D-A10B-09 ca81a393-ec7d-4538-a64a-417ed188a320 TCGA-BS-A0TD-01A-11D-A102-01 TCGA-BS-A0TD-01A-11D-A102-01 TCGA-BS-A0TD-01 TCGA-BS-A0TD-01A-11D-A10Q-05 ca81a393-ec7d-4538-a64a-417ed188a320 TCGA-BS-A0TE-01 MSI-H TCGA-BS-A0TE-01 High C1-LUAD-enriched Cluster 5 cluster 3 COADREAD-like c15 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-BS-A0TE TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES NO Progressive Disease 35 TCGA-BS-A0TE-F4407 TCGA-BS-A0TE TCGA-BS-A0TE-01A Former User Stage IVB NO -12983 1835 146 0 58 NO 2010-11-19 FEMALE 168 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.9 8380/3 C54.9 YES biopsy of cervical tissue Other method, specify: 50 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 false No TCGA-BS-A0TE.8FD57BC9-19A1-4427-B68F-3E58639FEA40.pdf A0TE 100 positive WITH TUMOR 4 0 1 Progressive Disease Never Used NO R2 Primary Tumor 01 open 1988 YES NO YES BS 0 0 6 Endometrial A DECEASED 91 2005 TCGA-BS-A0TE-01 TCGA-BS-A0TE-01 TCGA-BS-A0TE-01 TCGA-BS-A0TE-01A-11D-A10B-09 TCGA-BS-A0TE-01A-11D-A10B-09 TCGA-BS-A0TE-01A-11D-A10B-09 8edc23c4-43f8-4dd3-8c40-257297393492 TCGA-BS-A0TE-01A-11D-A102-01 TCGA-BS-A0TE-01A-11D-A102-01 TCGA-BS-A0TE-01 TCGA-BS-A0TE-01A-11D-A10Q-05 8edc23c4-43f8-4dd3-8c40-257297393492 TCGA-BS-A0TG-01 MSS TCGA-BS-A0TG-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 squamous c3 UCEC-like c11 miRNA cluster 13 cluster 2 mutation cluster 1 TCGA-BS-A0TG TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 60 0 0 TCGA-BS-A0TG-F4395 TCGA-BS-A0TG TCGA-BS-A0TG-01A Former User Stage IIIA NO -22043 1996 0 2371 NO 2010-11-19 FEMALE 163 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 270 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 false No TCGA-BS-A0TG.7A7B4B4B-5EE2-4D8D-A90A-DDFB96AE49A8.pdf A0TG 40 positive WITH TUMOR 0 0 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1988 NO NO YES BS 0 1 0 07 Endometrial A LIVING 64 2005 TCGA-BS-A0TG-01 TCGA-BS-A0TG-01 TCGA-BS-A0TG-01A-21-A163-20 70DE1BC1-F8A6-49A4-B2B2-22905D8C2A48 TCGA-BS-A0TG-01 TCGA-BS-A0TG-01A-32D-A10B-09 TCGA-BS-A0TG-01A-32D-A10B-09 TCGA-BS-A0TG-01A-32D-A10B-09 5fcefe73-6ed0-42f2-beda-3afc67aba867 TCGA-BS-A0TG-01A-32D-A102-01 TCGA-BS-A0TG-01A-32D-A102-01 TCGA-BS-A0TG-01 TCGA-BS-A0TG-01A-32D-A10Q-05 5fcefe73-6ed0-42f2-beda-3afc67aba867 TCGA-BS-A0TI-01 MSS TCGA-BS-A0TI-01 High C6-UCEC UCEC Serous c4 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 1 mutation cluster 5 TCGA-BS-A0TI TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 64 0 0 TCGA-BS-A0TI-F4406 TCGA-BS-A0TI TCGA-BS-A0TI-01A Former User Stage IC NO -23705 1507 0 1882 NO 2010-11-19 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 250 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-BS-A0TI.60212550-2757-4AB0-B778-723AE046F6BE.pdf A0TI 92 negative TUMOR FREE 0 0 0 Complete Remission/Response NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 4 0 14 Endometrial A LIVING 59 2006 TCGA-BS-A0TI-01 TCGA-BS-A0TI-01 TCGA-BS-A0TI-01A-21-A163-20 03D002A0-05DE-4B9B-99B9-0DD455E3BAD7 TCGA-BS-A0TI-01 TCGA-BS-A0TI-01A-11D-A10B-09 TCGA-BS-A0TI-01A-11D-A10B-09 TCGA-BS-A0TI-01A-11D-A10B-09 4fefb750-f793-4c1f-92cc-bd8fd9998cc6 TCGA-BS-A0TI-01A-11D-A102-01 TCGA-BS-A0TI-01A-11D-A102-01 TCGA-BS-A0TI-01 TCGA-BS-A0TI-01A-11D-A10Q-05 4fefb750-f793-4c1f-92cc-bd8fd9998cc6 TCGA-BS-A0TJ-01 MSI-H TCGA-BS-A0TJ-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 1 TCGA-BS-A0TJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 59 0 0 TCGA-BS-A0TJ-F4441 TCGA-BS-A0TJ TCGA-BS-A0TJ-01A Former User Stage IC NO -21663 1431 0 2068 NO 2010-11-19 FEMALE 152 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 270 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-BS-A0TJ.17D921D9-F2ED-4F8E-8C6F-729C9A0FE5B0.pdf A0TJ 58 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1988 NO NO YES BS 0 9 0 34 Endometrial A LIVING 88 2006 TCGA-BS-A0TJ-01 TCGA-BS-A0TJ-01 TCGA-BS-A0TJ-01A-21-A163-20 6DA84EAF-5E8E-48C1-B7D2-BC98EB76E31A TCGA-BS-A0TJ-01 TCGA-BS-A0TJ-01A-11D-A10B-09 TCGA-BS-A0TJ-01A-11D-A10B-09 TCGA-BS-A0TJ-01A-11D-A10B-09 3ecbfdb2-c75a-47ce-9db6-ae7d36eab559 TCGA-BS-A0TJ-01A-11D-A102-01 TCGA-BS-A0TJ-01A-11D-A102-01 TCGA-BS-A0TJ-01 TCGA-BS-A0TJ-01A-11D-A10Q-05 3ecbfdb2-c75a-47ce-9db6-ae7d36eab559 TCGA-BS-A0U5-01 MSS TCGA-BS-A0U5-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 4 TCGA-BS-A0U5 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 76 0 0 TCGA-BS-A0U5-F16697 TCGA-BS-A0U5 TCGA-BS-A0U5-01A Stage IA NO -27945 2525 0 2935 NO Scheduled Follow-up Submission 2011-3-25 FEMALE 165 Endometrioid endometrial adenocarcinoma No Yes, I am currently taking menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 110 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-BS-A0U5.8024498D-449C-45C6-B57D-846DDBA3FF30.pdf A0U5 0 TUMOR FREE 0 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 1 0 10 Endometrial A LIVING 59 2003 TCGA-BS-A0U5-01 TCGA-BS-A0U5-01 TCGA-BS-A0U5-01 TCGA-BS-A0U5-01A-11D-A10G-09 TCGA-BS-A0U5-01A-11D-A10G-09 TCGA-BS-A0U5-01A-11D-A10G-09 2bb7d230-0982-4ce5-908a-a04064cb7665 TCGA-BS-A0U5-01A-11D-A107-01 TCGA-BS-A0U5-01A-11D-A107-01 TCGA-BS-A0U5-01 TCGA-BS-A0U5-01A-11D-A10A-05 2bb7d230-0982-4ce5-908a-a04064cb7665 TCGA-BS-A0U7-01 MSI-L TCGA-BS-A0U7-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 2 mutation cluster 14 TCGA-BS-A0U7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 63 0 0 TCGA-BS-A0U7-F16698 TCGA-BS-A0U7 TCGA-BS-A0U7-01A Stage IC NO -23166 2466 935 0 NO Scheduled Follow-up Submission 2011-3-25 FEMALE 165 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 190 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-BS-A0U7.BE83021F-D4D5-4ECA-8484-8A37B2FE67C0.pdf A0U7 51 TUMOR FREE 0 0 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 14 0 13 Endometrial A DECEASED 66 2003 TCGA-BS-A0U7-01 TCGA-BS-A0U7-01 TCGA-BS-A0U7-01A-11-A163-20 D35AAF56-A418-4154-BF07-5E0F655276D1 TCGA-BS-A0U7-01 TCGA-BS-A0U7-01A-21D-A10B-09 TCGA-BS-A0U7-01A-21D-A10B-09 TCGA-BS-A0U7-01A-21D-A10B-09 cf1bf8d7-3971-4919-93ef-2ef85b3dc61d TCGA-BS-A0U7-01A-21D-A102-01 TCGA-BS-A0U7-01A-21D-A102-01 TCGA-BS-A0U7-01 TCGA-BS-A0U7-01A-21D-A10Q-05 cf1bf8d7-3971-4919-93ef-2ef85b3dc61d TCGA-BS-A0U8-01 MSI-H TCGA-BS-A0U8-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 12 TCGA-BS-A0U8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 55 0 0 TCGA-BS-A0U8-F16703 TCGA-BS-A0U8 TCGA-BS-A0U8-01A Stage IIIC NO -20402 2432 0 2963 NO Scheduled Follow-up Submission 2011-3-25 FEMALE 170 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 190 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-BS-A0U8.EAE30BBB-B895-42B9-8AAB-937278A3EBB0.pdf A0U8 100 negative TUMOR FREE 0 0 0 Complete Remission/Response Never Used YES Primary Tumor 01 open 1988 YES NO YES BS 0 1 3 4 Endometrial A LIVING 82 2004 TCGA-BS-A0U8-01 TCGA-BS-A0U8-01 TCGA-BS-A0U8-01A-21-A163-20 0A9A4E64-690F-4D6D-AA72-633B924E0ADF TCGA-BS-A0U8-01 TCGA-BS-A0U8-01A-11D-A10B-09 TCGA-BS-A0U8-01A-11D-A10B-09 TCGA-BS-A0U8-01A-11D-A10B-09 6fc8c938-15ec-452d-9cf7-16b97e0a2c8f TCGA-BS-A0U8-01A-11D-A102-01 TCGA-BS-A0U8-01A-11D-A102-01 TCGA-BS-A0U8-01 TCGA-BS-A0U8-01A-11D-A10Q-05 6fc8c938-15ec-452d-9cf7-16b97e0a2c8f TCGA-BS-A0U9-01 MSS TCGA-BS-A0U9-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 3 TCGA-BS-A0U9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 59 0 0 TCGA-BS-A0U9-F68986 TCGA-BS-A0U9 TCGA-BS-A0U9-01B Never Used Stage IIA NO -21580 1637 0 2825 YES Scheduled Follow-up Submission 2014-12-24 FEMALE 170 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Cytology (e.g. Peritoneal or pleural fluid) 430 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-BS-A0U9.029B0BBB-D88D-4492-AC9A-9094E0DD101C.pdf A0U9 5 negative TUMOR FREE 0 0 NO 4+ Complete Remission/Response Never Used NO RX Primary Tumor 01 open 1988 NO NO YES BS 0 3 0 34 Endometrial B LIVING 99 2006 TCGA-BS-A0U9-01 TCGA-BS-A0U9-01 TCGA-BS-A0U9-01B-11-A163-20 F2D7C005-5AB3-44EC-954F-D0CDFB98C51F TCGA-BS-A0U9-01 TCGA-BS-A0U9-01B-21D-A10M-09 TCGA-BS-A0U9-01B-21D-A10M-09 TCGA-BS-A0U9-01B-21D-A10M-09 b280c179-336d-4638-9309-0f51426f8054 TCGA-BS-A0U9-01B-21D-A10L-01 TCGA-BS-A0U9-01B-21D-A10L-01 TCGA-BS-A0U9-01 TCGA-BS-A0U9-01B-21D-A10N-05 b280c179-336d-4638-9309-0f51426f8054 TCGA-BS-A0UA-01 MSI-H TCGA-BS-A0UA-01 Quiet C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c11 miRNA cluster 13 cluster 1 mutation cluster 4 TCGA-BS-A0UA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES NO Complete Response 68 TCGA-BS-A0UA-F68987 TCGA-BS-A0UA TCGA-BS-A0UA-01A Stage IB NO -24872 2361 0 3495 520 NO Scheduled Follow-up Submission 2014-12-24 FEMALE 152 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 50 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 Other, specify Locoregional Disease endometrium NO false No TCGA-BS-A0UA.58DC7332-5100-408B-9A1E-F0282B013648.pdf A0UA 26 negative TUMOR FREE NO 1 Complete Remission/Response Never Used NO Other Method, Specify Below right vaginal cuff biopsy R0 Primary Tumor 01 open 1988 NO NO YES BS 0 0 Endometrial A LIVING 64 2004 TCGA-BS-A0UA-01 TCGA-BS-A0UA-01A-11D-A122-09 TCGA-BS-A0UA-01A-11D-A122-09 TCGA-BS-A0UA-01 97ffaeb2-3ff9-41ff-9552-27f622469460 TCGA-BS-A0UA-01A-11D-A120-01 TCGA-BS-A0UA-01A-11D-A120-01 TCGA-BS-A0UA-01 TCGA-BS-A0UA-01 TCGA-BS-A0UA-01A-11D-A123-05 97ffaeb2-3ff9-41ff-9552-27f622469460 TCGA-BS-A0UF-01 MSS TCGA-BS-A0UF-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 1 mutation cluster 11 TCGA-BS-A0UF TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 65 0 0 TCGA-BS-A0UF-F16712 TCGA-BS-A0UF TCGA-BS-A0UF-01A Never Used Stage IB NO -23771 2285 0 2611 NO Scheduled Follow-up Submission 2011-3-28 FEMALE 147 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 270 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-BS-A0UF.719E2A48-0E04-4EAD-A5CC-6416450FC68F.pdf A0UF 30 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 4 0 9 Endometrial A LIVING 57 2004 TCGA-BS-A0UF-01 TCGA-BS-A0UF-01 TCGA-BS-A0UF-01A-21-A163-20 27E906A3-706B-43A0-B6B4-46A029C7AB11 TCGA-BS-A0UF-01 TCGA-BS-A0UF-01A-11D-A10B-09 TCGA-BS-A0UF-01A-11D-A10B-09 2ae9f382-fd01-4707-8dae-3ec3c527a226 TCGA-BS-A0UF-01A-11D-A102-01 TCGA-BS-A0UF-01A-11D-A102-01 TCGA-BS-A0UF-01 TCGA-BS-A0UF-01A-11D-A10Q-05 2ae9f382-fd01-4707-8dae-3ec3c527a226 TCGA-BS-A0UJ-01 MSI-H TCGA-BS-A0UJ-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 11 TCGA-BS-A0UJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 68 TCGA-BS-A0UJ-F16700 TCGA-BS-A0UJ TCGA-BS-A0UJ-01A Stage IA NO -25149 2180 0 2506 YES Scheduled Follow-up Submission 2011-3-25 FEMALE 155 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 160 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-BS-A0UJ.DEE9AA2E-DA73-4074-9588-C75DDEC4D29B.pdf A0UJ 0 negative TUMOR FREE 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 0 Endometrial A LIVING 52 2004 TCGA-BS-A0UJ-01 TCGA-BS-A0UJ-01 TCGA-BS-A0UJ-01A-21-A163-20 8B861700-DD5C-42DE-AD5C-357CE568B427 TCGA-BS-A0UJ-01 TCGA-BS-A0UJ-01A-12D-A10B-09 TCGA-BS-A0UJ-01A-12D-A10B-09 835f4f9a-3c90-45d5-809c-6b4316a972b9 TCGA-BS-A0UJ-01A-12D-A102-01 TCGA-BS-A0UJ-01A-12D-A102-01 TCGA-BS-A0UJ-01 TCGA-BS-A0UJ-01A-12D-A10Q-05 835f4f9a-3c90-45d5-809c-6b4316a972b9 TCGA-BS-A0UL-01 MSI-H TCGA-BS-A0UL-01 Quiet C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 1 TCGA-BS-A0UL TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 54 TCGA-BS-A0UL-F16702 TCGA-BS-A0UL TCGA-BS-A0UL-01A Stage IA NO -19982 2155 0 2481 YES Scheduled Follow-up Submission 2011-3-25 FEMALE 170 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 70 NO Peri (6-12 months since last menstrual period) G1 NO false No TCGA-BS-A0UL.323FC36E-D8E3-4F6B-A8FE-2040F3E44BB9.pdf A0UL 0 negative TUMOR FREE 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 0 Endometrial A LIVING 114 2004 TCGA-BS-A0UL-01 TCGA-BS-A0UL-01 TCGA-BS-A0UL-01 TCGA-BS-A0UL-01A-11D-A10G-09 TCGA-BS-A0UL-01A-11D-A10G-09 TCGA-BS-A0UL-01A-11D-A10G-09 954c9805-885f-481a-9dac-024d4481256b TCGA-BS-A0UL-01A-11D-A107-01 TCGA-BS-A0UL-01A-11D-A107-01 TCGA-BS-A0UL-01 TCGA-BS-A0UL-01A-11D-A10A-05 954c9805-885f-481a-9dac-024d4481256b TCGA-BS-A0UM-01 MSI-H TCGA-BS-A0UM-01 UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 1 TCGA-BS-A0UM TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES NO 64 0 0 TCGA-BS-A0UM-F17016 TCGA-BS-A0UM TCGA-BS-A0UM-01A Stage IB NO -23400 2072 0 2644 1454 NO Scheduled Follow-up Submission 2011-3-25 FEMALE 160 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 90 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 Brain Metastatic YES false No TCGA-BS-A0UM.97354B28-9E9A-4DBD-B0C7-79C1165AD1CA.pdf A0UM 22 negative WITH TUMOR 0 0 2 Complete Remission/Response Never Used NO Other Method, Specify Below lef lung biopsy R0 Primary Tumor 01 open 1988 NO NO YES BS 0 4 0 5 Endometrial A LIVING 90 2005 TCGA-BS-A0UM-01 TCGA-BS-A0UM-01 TCGA-BS-A0UM-01 TCGA-BS-A0UM-01A-11W-A10C-09 TCGA-BS-A0UM-01A-11W-A10C-09 TCGA-BS-A0UM-01A-11W-A10C-09 40c2c93a-81a9-4baa-91b3-3c950042475a TCGA-BS-A0UM-01A-11D-A10Q-05 40c2c93a-81a9-4baa-91b3-3c950042475a TCGA-BS-A0UT-01 MSS TCGA-BS-A0UT-01 High C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 4 TCGA-BS-A0UT TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 62 0 0 TCGA-BS-A0UT-F16711 TCGA-BS-A0UT Never Used Stage IIB NO -22775 0 2212 NO Scheduled Follow-up Submission 2011-3-25 FEMALE 152 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO No A0UT 33 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 5 0 22 Endometrial LIVING 65 2005 TCGA-BS-A0UT-01 TCGA-BS-A0UT-01 TCGA-BS-A0UT-01 TCGA-BS-A0UT-01A-11D-A10B-09 TCGA-BS-A0UT-01A-11D-A10B-09 TCGA-BS-A0UT-01A-11D-A10B-09 ece7dac4-4f09-45c9-8a63-e4375ebf4c88 TCGA-BS-A0UT-01A-11D-A102-01 TCGA-BS-A0UT-01A-11D-A102-01 TCGA-BS-A0UT-01 TCGA-BS-A0UT-01A-11D-A10Q-05 ece7dac4-4f09-45c9-8a63-e4375ebf4c88 TCGA-BS-A0UV-01 MSI-L TCGA-BS-A0UV-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 11 TCGA-BS-A0UV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 55 0 0 TCGA-BS-A0UV-F16696 TCGA-BS-A0UV TCGA-BS-A0UV-01A Former User Stage IIIC NO -20266 1902 0 2228 YES Scheduled Follow-up Submission 2011-3-28 FEMALE 168 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 80 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-BS-A0UV.9414D0B9-3126-42E9-8189-7C1EC38B2AAB.pdf A0UV 65 negative TUMOR FREE 0 0 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 8 1 8 Endometrial A LIVING 112 2005 TCGA-BS-A0UV-01 TCGA-BS-A0UV-01 TCGA-BS-A0UV-01 TCGA-BS-A0UV-01A-11D-A10B-09 TCGA-BS-A0UV-01A-11D-A10B-09 08890bb3-7ad1-41c2-8774-b10bf86ee047 TCGA-BS-A0UV-01A-11D-A102-01 TCGA-BS-A0UV-01A-11D-A102-01 TCGA-BS-A0UV-01 TCGA-BS-A0UV-01A-11D-A10Q-05 08890bb3-7ad1-41c2-8774-b10bf86ee047 TCGA-BS-A0V4-01 MSI-H TCGA-BS-A0V4-01 Iq UCEC CIMP c18 cluster 1 UCEC-like c5 miRNA cluster 7 cluster 1 TCGA-BS-A0V4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 56 0 0 TCGA-BS-A0V4-F16710 TCGA-BS-A0V4 TCGA-BS-A0V4-01A Never Used Stage IB NO -20777 1576 0 1810 NO Scheduled Follow-up Submission 2011-3-25 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 310 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-BS-A0V4.AA0FFBF8-693C-484E-A29D-02F859E1E4C5.pdf A0V4 4 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO Primary Tumor 01 open 1988 NO NO YES BS 0 2 0 33 Endometrial A LIVING 96 2006 5deaf911-f777-4c38-95bf-19af647e7806 TCGA-BS-A0V4-01 5deaf911-f777-4c38-95bf-19af647e7806 TCGA-BS-A0V4-01A-21-A18Q-20 3B2AACBD-F667-4B5E-A678-B3E0A5542839 5deaf911-f777-4c38-95bf-19af647e7806 5deaf911-f777-4c38-95bf-19af647e7806 TCGA-BS-A0V4-01 TCGA-BS-A0V4-01A-11D-A14F-01 TCGA-BS-A0V4-01A-11D-A14F-01 TCGA-BS-A0V4-01 TCGA-BS-A0V4-01 TCGA-BS-A0V4-01A-11D-A14H-05 TCGA-BS-A0V6-01 MSS TCGA-BS-A0V6-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c11 miRNA c1uster 10 cluster 4 mutation cluster 4 TCGA-BS-A0V6 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 55 0 0 TCGA-BS-A0V6-F68988 TCGA-BS-A0V6 Never Used Stage IB NO -20369 0 2725 NO Scheduled Follow-up Submission 2014-12-24 FEMALE 157 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO No A0V6 5.6 negative TUMOR FREE 0 0 NO 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 8 0 22 Endometrial LIVING 83 2006 TCGA-BS-A0V6-01 TCGA-BS-A0V6-01A-11D-A122-09 TCGA-BS-A0V6-01A-11D-A122-09 TCGA-BS-A0V6-01A-11D-A122-09 TCGA-BS-A0V6-01 a7efbfc2-48f4-44ec-a8a6-7e565cfe2b6a TCGA-BS-A0V6-01A-11D-A120-01 TCGA-BS-A0V6-01A-11D-A120-01 TCGA-BS-A0V6-01 TCGA-BS-A0V6-01 TCGA-BS-A0V6-01A-11D-A123-05 a7efbfc2-48f4-44ec-a8a6-7e565cfe2b6a TCGA-BS-A0V7-01 MSS TCGA-BS-A0V7-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 miRNA cluster 5 cluster 4 mutation cluster 1 TCGA-BS-A0V7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 48 0 0 TCGA-BS-A0V7-F17014 TCGA-BS-A0V7 TCGA-BS-A0V7-01A Never Used Stage IB NO -17810 1455 0 1934 YES Scheduled Follow-up Submission 2011-3-28 FEMALE 170 Endometrioid endometrial adenocarcinoma No Yes, I am currently taking menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES suction using pipelle Other method, specify: 130 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G1 NO false No TCGA-BS-A0V7.A4515806-9888-48E8-8F9E-491527FFC29C.pdf A0V7 36.7 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 1 0 26 Endometrial A LIVING 102 2006 0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c TCGA-BS-A0V7-01 0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c TCGA-BS-A0V7-01A-11-A163-20 E32601C9-C3CF-4923-93AA-40DDFA630978 0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c TCGA-BS-A0V7-01A-21D-A122-09 TCGA-BS-A0V7-01A-21D-A122-09 0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c TCGA-BS-A0V7-01 TCGA-BS-A0V7-01A-21D-A120-01 TCGA-BS-A0V7-01A-21D-A120-01 TCGA-BS-A0V7-01 TCGA-BS-A0V7-01 TCGA-BS-A0V7-01A-21D-A123-05 TCGA-BS-A0V8-01 MSS TCGA-BS-A0V8-01 Squamous C6-UCEC UCEC non-CIMP c3 cluster 3 UCEC-like c11 miRNA cluster 5 cluster 4 mutation cluster 5 TCGA-BS-A0V8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 0 0 TCGA-BS-A0V8-F68989 TCGA-BS-A0V8 TCGA-BS-A0V8-01A Never Used Stage IIB NO -24981 1410 0 2544 YES Scheduled Follow-up Submission 2014-12-24 FEMALE 157 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 120 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-BS-A0V8.A024F121-F6C9-4CDF-B0ED-B58708DB6DFE.pdf A0V8 75 negative TUMOR FREE 0 0 NO 4+ Complete Remission/Response Never Used YES R1 Primary Tumor 01 open 1988 NO NO YES BS 0 5 0 13 Endometrial A LIVING 85 2006 TCGA-BS-A0V8-01 TCGA-BS-A0V8-01A-11D-A122-09 TCGA-BS-A0V8-01A-11D-A122-09 TCGA-BS-A0V8-01 1c908135-7fdf-4257-8b9e-92e6aa0850a6 TCGA-BS-A0V8-01A-11D-A120-01 TCGA-BS-A0V8-01A-11D-A120-01 TCGA-BS-A0V8-01 TCGA-BS-A0V8-01 TCGA-BS-A0V8-01A-11D-A123-05 1c908135-7fdf-4257-8b9e-92e6aa0850a6 TCGA-BS-A0VI-01 MSI-H TCGA-BS-A0VI-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 squamous c3 UCEC-like c11 miRNA cluster 7 cluster 1 TCGA-BS-A0VI TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 0 0 TCGA-BS-A0VI-F68993 TCGA-BS-A0VI TCGA-BS-A0VI-01A Never Used Stage IIB NO -21198 1514 0 2646 NO Scheduled Follow-up Submission 2014-12-24 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 340 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-BS-A0VI.EC10AA0B-A597-4224-8807-52F7228C6D07.pdf A0VI 93 TUMOR FREE 0 0 NO 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 1 0 23 Endometrial A LIVING 91 2006 TCGA-BS-A0VI-01 TCGA-BS-A0VI-01A-21-A18Q-20 98BED513-3C0E-4D93-95BC-5F6736F69ADC TCGA-BS-A0VI-01 eb32a70b-8e73-4c44-8a44-c623158e87b1 TCGA-BS-A0VI-01A-11D-A14F-01 TCGA-BS-A0VI-01A-11D-A14F-01 TCGA-BS-A0VI-01 TCGA-BS-A0VI-01 TCGA-BS-A0VI-01A-11D-A14H-05 eb32a70b-8e73-4c44-8a44-c623158e87b1 TCGA-BS-A0WQ-01 MSS TCGA-BS-A0WQ-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-BS-A0WQ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 55 0 0 TCGA-BS-A0WQ-F16701 TCGA-BS-A0WQ TCGA-BS-A0WQ-01A Stage IA NO -20131 1696 0 2022 YES Scheduled Follow-up Submission 2011-3-25 FEMALE 160 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 140 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-BS-A0WQ.207B2565-ABB2-4F05-8B54-2280DAC57AD3.pdf A0WQ 0 negative TUMOR FREE 0 0 0 Complete Remission/Response Former User NO R0 Primary Tumor 01 open 1988 NO NO YES BS 0 11 0 14 Endometrial A LIVING 93 2006 TCGA-BS-A0WQ-01 TCGA-BS-A0WQ-01 TCGA-BS-A0WQ-01 TCGA-BS-A0WQ-01A-21D-A10G-09 TCGA-BS-A0WQ-01A-21D-A10G-09 TCGA-BS-A0WQ-01A-21D-A10G-09 432f025e-4ece-432e-b573-01a8e6f9a1e5 TCGA-BS-A0WQ-01A-21D-A107-01 TCGA-BS-A0WQ-01A-21D-A107-01 TCGA-BS-A0WQ-01 TCGA-BS-A0WQ-01A-21D-A10A-05 432f025e-4ece-432e-b573-01a8e6f9a1e5 TCGA-D1-A0ZN-01 MSS TCGA-D1-A0ZN-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA cluster 13 cluster 1 mutation cluster 4 TCGA-D1-A0ZN TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES NO Complete Response 60 0 0 TCGA-D1-A0ZN-F17736 TCGA-D1-A0ZN TCGA-D1-A0ZN-01A Stage IA NO -22026 567 0 512 448 NO Scheduled Follow-up Submission 2011-10-24 FEMALE 168 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8380/3 C54.1 YES Tumor resection 120 NO Peri (6-12 months since last menstrual period) G1 Other, specify New Primary Tumor Breast left YES false No TCGA-D1-A0ZN.53DB2270-9308-47F5-BD1F-4D4C737F98AC.pdf A0ZN 0 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open NO NO YES D1 0 0 0 0 Endometrial A LIVING 82 2009 TCGA-D1-A0ZN-01 TCGA-D1-A0ZN-01A-11D-A122-09 TCGA-D1-A0ZN-01A-11D-A122-09 TCGA-D1-A0ZN-01 2d12622b-f828-43b0-a63f-fc542af894db TCGA-D1-A0ZN-01A-11D-A120-01 TCGA-D1-A0ZN-01A-11D-A120-01 TCGA-D1-A0ZN-01 TCGA-D1-A0ZN-01 TCGA-D1-A0ZN-01A-11D-A123-05 2d12622b-f828-43b0-a63f-fc542af894db TCGA-D1-A0ZO-01 MSI-H TCGA-D1-A0ZO-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 1 TCGA-D1-A0ZO TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 75 0 0 TCGA-D1-A0ZO-F17744 TCGA-D1-A0ZO TCGA-D1-A0ZO-01A Stage IB NO -27482 586 0 602 NO Scheduled Follow-up Submission 2011-10-24 FEMALE 165 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 50 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false Yes TCGA-D1-A0ZO.13826E23-2184-4D03-B67C-B312BF4FA87E.pdf A0ZO 30 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive NO NO YES D1 0 0 0 18 Endometrial A LIVING 110 2009 TCGA-D1-A0ZO-01 TCGA-D1-A0ZO-01A-11D-A122-09 TCGA-D1-A0ZO-01A-11D-A122-09 TCGA-D1-A0ZO-01A-11D-A122-09 TCGA-D1-A0ZO-01 0e70ff34-799d-4e88-9911-85357f2bb0a2 TCGA-D1-A0ZO-01A-11D-A120-01 TCGA-D1-A0ZO-01A-11D-A120-01 TCGA-D1-A0ZO-01 TCGA-D1-A0ZO-01 TCGA-D1-A0ZO-01A-11D-A123-05 0e70ff34-799d-4e88-9911-85357f2bb0a2 TCGA-D1-A0ZP-01 MSI-L TCGA-D1-A0ZP-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 4 cluster 2 mutation cluster 4 TCGA-D1-A0ZP TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO YES Complete Response 59 0 0 TCGA-D1-A0ZP-F17745 TCGA-D1-A0ZP TCGA-D1-A0ZP-01A Stage IVA NO 783 -21581 552 0 911 629 NO Scheduled Follow-up Submission 2011-10-24 FEMALE 161 Serous endometrial adenocarcinoma No NO C54.1 8441/3 C54.1 YES Tumor resection 180 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Disease Recurrent endometrial carcinoma in retriponeal lymphnodes YES false No TCGA-D1-A0ZP.FD46BB74-914F-4B4E-819A-5AD5F4548672.pdf A0ZP 30 positive TUMOR FREE 0 0 1 Complete Remission/Response Never Used YES Excisional Biopsy R0 RX Primary Tumor 01 open YES NO YES D1 0 19 0 51 Endometrial A LIVING 58 2009 TCGA-D1-A0ZP-01 TCGA-D1-A0ZP-01 TCGA-D1-A0ZP-01A-11-A163-20 A0FF554C-EDC0-4E64-B073-E447DB25593B TCGA-D1-A0ZP-01 TCGA-D1-A0ZP-01A-21D-A10M-09 TCGA-D1-A0ZP-01A-21D-A10M-09 TCGA-D1-A0ZP-01A-21D-A10M-09 2188d23d-209d-4d3c-b737-f48892e08d31 TCGA-D1-A0ZP-01A-21D-A10L-01 TCGA-D1-A0ZP-01A-21D-A10L-01 TCGA-D1-A0ZP-01 TCGA-D1-A0ZP-01A-21D-A10N-05 2188d23d-209d-4d3c-b737-f48892e08d31 TCGA-D1-A0ZQ-01 MSS TCGA-D1-A0ZQ-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c11 miRNA cluster 5 cluster 4 mutation cluster 4 TCGA-D1-A0ZQ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 90 0 0 TCGA-D1-A0ZQ-F17747 TCGA-D1-A0ZQ TCGA-D1-A0ZQ-01A Never Used Stage IB NO -32873 540 0 260 NO Scheduled Follow-up Submission 2011-10-24 FEMALE 155 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 120 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A0ZQ.BAC6E925-0499-41AD-9F58-2CB8E3EE058E.pdf A0ZQ 60 TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive NO NO YES D1 0 0 0 0 Endometrial A LIVING 69 2009 TCGA-D1-A0ZQ-01 TCGA-D1-A0ZQ-01A-11D-A122-09 TCGA-D1-A0ZQ-01A-11D-A122-09 TCGA-D1-A0ZQ-01A-11D-A122-09 TCGA-D1-A0ZQ-01 650687c0-616b-41a5-ae29-322ba9cfc462 TCGA-D1-A0ZQ-01A-11D-A120-01 TCGA-D1-A0ZQ-01A-11D-A120-01 TCGA-D1-A0ZQ-01 TCGA-D1-A0ZQ-01 TCGA-D1-A0ZQ-01A-11D-A123-05 650687c0-616b-41a5-ae29-322ba9cfc462 TCGA-D1-A0ZR-01 MSS TCGA-D1-A0ZR-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 3 mutation c1uster 10 TCGA-D1-A0ZR TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 0 0 TCGA-D1-A0ZR-F17748 TCGA-D1-A0ZR TCGA-D1-A0ZR-01A Stage IB NO -21157 537 0 17 YES Scheduled Follow-up Submission 2011-10-24 FEMALE 165 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 240 NO Indeterminate (neither Pre or Postmenopausal) G2 NO false No TCGA-D1-A0ZR.ECC5B77F-7B6C-4C4A-A32C-1346DC3AF24D.pdf A0ZR 12 negative TUMOR FREE 0 0 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES D1 0 10 0 48 Endometrial A LIVING 117 2009 TCGA-D1-A0ZR-01 TCGA-D1-A0ZR-01 TCGA-D1-A0ZR-01A-11-A163-20 B7CAE504-6F63-49DF-8575-2409EEAD4418 TCGA-D1-A0ZR-01 TCGA-D1-A0ZR-01A-21D-A10M-09 TCGA-D1-A0ZR-01A-21D-A10M-09 TCGA-D1-A0ZR-01A-21D-A10M-09 41f4268d-a222-4d6b-b4aa-515bb8765c6c TCGA-D1-A0ZR-01A-21D-A10L-01 TCGA-D1-A0ZR-01A-21D-A10L-01 TCGA-D1-A0ZR-01 TCGA-D1-A0ZR-01A-21D-A10N-05 41f4268d-a222-4d6b-b4aa-515bb8765c6c TCGA-D1-A0ZS-01 MSI-H TCGA-D1-A0ZS-01 Quiet C11-small-various UCEC CIMP c18 cluster 2 GBM-like c6 miRNA cluster 5 cluster 4 mutation cluster 1 TCGA-D1-A0ZS TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 54 0 0 TCGA-D1-A0ZS-F17755 TCGA-D1-A0ZS Stage IB NO -19821 0 148 NO Scheduled Follow-up Submission 2011-10-24 FEMALE 164 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO No A0ZS 40 TUMOR FREE 0 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive NO NO YES D1 0 19 0 27 Endometrial LIVING 62 2009 TCGA-D1-A0ZS-01 TCGA-D1-A0ZS-01A-11D-A122-09 TCGA-D1-A0ZS-01A-11D-A122-09 TCGA-D1-A0ZS-01A-11D-A122-09 TCGA-D1-A0ZS-01 f35db751-0250-4045-9faf-2c0f1158b354 TCGA-D1-A0ZS-01A-11D-A120-01 TCGA-D1-A0ZS-01A-11D-A120-01 TCGA-D1-A0ZS-01 TCGA-D1-A0ZS-01 TCGA-D1-A0ZS-01A-11D-A123-05 f35db751-0250-4045-9faf-2c0f1158b354 TCGA-D1-A0ZU-01 MSS TCGA-D1-A0ZU-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 4 TCGA-D1-A0ZU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 34 0 0 TCGA-D1-A0ZU-F17749 TCGA-D1-A0ZU TCGA-D1-A0ZU-01A Stage IB NO -12458 508 0 872 NO Scheduled Follow-up Submission 2011-10-24 FEMALE 170 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8382/3 C54.1 YES Office Endometrial Biopsy 180 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G2 NO false No TCGA-D1-A0ZU.D0BC0903-390B-4344-A613-48ABF71CF08D.pdf A0ZU 5 negative TUMOR FREE 0 0 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive YES NO YES D1 0 0 0 0 Endometrial A LIVING 94 2009 TCGA-D1-A0ZU-01 TCGA-D1-A0ZU-01 TCGA-D1-A0ZU-01A-21-A163-20 8C9B9C6B-D8EB-4609-AAF6-8C92BA431FEF TCGA-D1-A0ZU-01 TCGA-D1-A0ZU-01A-11D-A10M-09 TCGA-D1-A0ZU-01A-11D-A10M-09 TCGA-D1-A0ZU-01A-11D-A10M-09 8708462d-d090-4fa2-95a6-f6021ce0489b TCGA-D1-A0ZU-01A-11D-A10L-01 TCGA-D1-A0ZU-01A-11D-A10L-01 TCGA-D1-A0ZU-01 TCGA-D1-A0ZU-01A-11D-A10N-05 8708462d-d090-4fa2-95a6-f6021ce0489b TCGA-D1-A0ZV-01 MSS TCGA-D1-A0ZV-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 4 TCGA-D1-A0ZV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 0 0 TCGA-D1-A0ZV-F19531 TCGA-D1-A0ZV TCGA-D1-A0ZV-01A Stage IB NO -21374 324 0 728 NO Scheduled Follow-up Submission 2011-12-13 FEMALE 170 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 110 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A0ZV.C9AE2762-705F-4061-B3B6-325426D0C0C8.pdf A0ZV 30 TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES D1 0 0 0 23 Endometrial A LIVING 77 2009 TCGA-D1-A0ZV-01 TCGA-D1-A0ZV-01 TCGA-D1-A0ZV-01 TCGA-D1-A0ZV-01A-11D-A10M-09 TCGA-D1-A0ZV-01A-11D-A10M-09 TCGA-D1-A0ZV-01A-11D-A10M-09 45676252-677e-45f6-a1e3-3052d3615472 TCGA-D1-A0ZV-01A-11D-A10L-01 TCGA-D1-A0ZV-01A-11D-A10L-01 TCGA-D1-A0ZV-01 TCGA-D1-A0ZV-01A-11D-A10N-05 45676252-677e-45f6-a1e3-3052d3615472 TCGA-D1-A0ZZ-01 MSS TCGA-D1-A0ZZ-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 2 cluster 2 mutation cluster 13 TCGA-D1-A0ZZ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 80 0 0 TCGA-D1-A0ZZ-F17753 TCGA-D1-A0ZZ TCGA-D1-A0ZZ-01A Stage IB NO -29420 349 0 686 NO Scheduled Follow-up Submission 2011-10-24 FEMALE 154 Mixed serous and endometrioid No NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 220 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-D1-A0ZZ.4339EAC6-F56E-49E6-8EF9-2256165CADB5.pdf A0ZZ 11 negative TUMOR FREE 0 0 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open YES NO YES D1 0 12 0 26 Endometrial A LIVING 51 2009 TCGA-D1-A0ZZ-01 TCGA-D1-A0ZZ-01 TCGA-D1-A0ZZ-01A-21-A163-20 9AD5DB69-7DCA-4BE6-BA19-74509C89A963 TCGA-D1-A0ZZ-01 TCGA-D1-A0ZZ-01A-11D-A10M-09 TCGA-D1-A0ZZ-01A-11D-A10M-09 TCGA-D1-A0ZZ-01A-11D-A10M-09 b50b6ebf-8b11-47db-803b-e2739e7dd005 TCGA-D1-A0ZZ-01A-11D-A10L-01 TCGA-D1-A0ZZ-01A-11D-A10L-01 TCGA-D1-A0ZZ-01 TCGA-D1-A0ZZ-01A-11D-A10N-05 b50b6ebf-8b11-47db-803b-e2739e7dd005 TCGA-D1-A101-01 MSI-H TCGA-D1-A101-01 Quiet C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 1 TCGA-D1-A101 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 0 0 TCGA-D1-A101-F17752 TCGA-D1-A101 TCGA-D1-A101-01A Stage IB NO -22078 349 0 53 YES Scheduled Follow-up Submission 2011-10-24 FEMALE 150 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 150 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A101.2D6287C8-9C22-4046-8F14-3886DDE62695.pdf A101 10 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO RX Primary Tumor 01 Minimally Invasive NO NO YES D1 0 0 0 0 Endometrial A LIVING 82 2009 TCGA-D1-A101-01 TCGA-D1-A101-01 TCGA-D1-A101-01A-21-A163-20 AF6EEC20-46D9-4B44-989E-B36509847182 TCGA-D1-A101-01 TCGA-D1-A101-01A-12D-A10M-09 TCGA-D1-A101-01A-12D-A10M-09 TCGA-D1-A101-01A-12D-A10M-09 df97f5e0-e49a-4f34-911c-92502e7df570 TCGA-D1-A101-01A-12D-A10L-01 TCGA-D1-A101-01A-12D-A10L-01 TCGA-D1-A101-01 TCGA-D1-A101-01A-12D-A10N-05 df97f5e0-e49a-4f34-911c-92502e7df570 TCGA-D1-A102-01 MSS TCGA-D1-A102-01 BRCA-LUAD+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 1 mutation cluster 4 TCGA-D1-A102 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 49 0 0 TCGA-D1-A102-F17750 TCGA-D1-A102 TCGA-D1-A102-01A Stage IB NO -17991 380 0 135 YES Scheduled Follow-up Submission 2011-10-24 FEMALE 178 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 200 NO Peri (6-12 months since last menstrual period) G2 NO false Yes TCGA-D1-A102.9983D576-706A-48D2-93EE-70EABB3BD77C.pdf A102 13 negative TUMOR FREE 0 0 0 Complete Remission/Response Never Used NO RX Primary Tumor 01 open NO NO YES D1 0 0 0 45 Endometrial A LIVING 122 2009 TCGA-D1-A102-01 TCGA-D1-A102-01A-21-A163-20 E113E37B-D85D-48E7-9AE4-DD3FDF12155C TCGA-D1-A102-01A-11D-A10M-09 TCGA-D1-A102-01A-11D-A10M-09 TCGA-D1-A102-01A-11D-A10M-09 TCGA-D1-A102-01 120e984a-ef3b-4240-8990-20aeadce8226 TCGA-D1-A102-01A-11D-A10L-01 TCGA-D1-A102-01A-11D-A10L-01 TCGA-D1-A102-01 TCGA-D1-A102-01 TCGA-D1-A102-01A-11D-A10N-05 120e984a-ef3b-4240-8990-20aeadce8226 TCGA-D1-A103-01 MSI-L TCGA-D1-A103-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 3 mutation cluster 11 TCGA-D1-A103 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 87 0 0 TCGA-D1-A103-F17751 TCGA-D1-A103 TCGA-D1-A103-01A Stage IB NO -31841 376 0 669 NO Scheduled Follow-up Submission 2011-10-24 FEMALE 150 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 170 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A103.AE2FAD3D-FA6A-4648-90A5-2D2C442796AF.pdf A103 0 TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open NO NO YES D1 0 0 0 0 Endometrial A LIVING 60 2009 TCGA-D1-A103-01 TCGA-D1-A103-01A-21-A163-20 93FD8223-7024-4A46-88F8-922B00C25EFA TCGA-D1-A103-01A-11D-A10M-09 TCGA-D1-A103-01A-11D-A10M-09 TCGA-D1-A103-01 ba50902a-fcf9-4023-bdbc-3e7d61c7011b TCGA-D1-A103-01A-11D-A10L-01 TCGA-D1-A103-01A-11D-A10L-01 TCGA-D1-A103-01 TCGA-D1-A103-01 TCGA-D1-A103-01A-11D-A10N-05 ba50902a-fcf9-4023-bdbc-3e7d61c7011b TCGA-D1-A15V-01 MSS TCGA-D1-A15V-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 mutation cluster 3 TCGA-D1-A15V TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 0 0 TCGA-D1-A15V-F18453 TCGA-D1-A15V TCGA-D1-A15V-01A Stage IB NO -24886 895 0 1201 NO Scheduled Follow-up Submission 2011-11-17 FEMALE 160 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Dilation and curettage procedure 250 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-D1-A15V.597F20F2-AE36-4A9F-A7AF-1647CB56B453.pdf A15V 20 negative TUMOR FREE 0 0 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 1995 YES NO YES D1 0 16 0 38 Endometrial A LIVING 69 2008 TCGA-D1-A15V-01 TCGA-D1-A15V-01A-21-A163-20 034BEF37-E51A-43DC-8C33-A8D8423EBE75 TCGA-D1-A15V-01A-11D-A122-09 TCGA-D1-A15V-01A-11D-A122-09 TCGA-D1-A15V-01 30f27799-c311-47c4-ad9e-6c80863a3cd2 TCGA-D1-A15V-01A-11D-A120-01 TCGA-D1-A15V-01A-11D-A120-01 TCGA-D1-A15V-01 TCGA-D1-A15V-01 TCGA-D1-A15V-01A-11D-A123-05 30f27799-c311-47c4-ad9e-6c80863a3cd2 TCGA-D1-A15W-01 MSS TCGA-D1-A15W-01 Quiet C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 5 cluster 4 mutation cluster 7 TCGA-D1-A15W TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 0 0 TCGA-D1-A15W-F18462 TCGA-D1-A15W TCGA-D1-A15W-01A Stage IIIC NO -21545 906 0 915 YES Scheduled Follow-up Submission 2011-11-17 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 190 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A15W.1C938760-9492-4F4E-87CE-85CE3C15BBCA.pdf A15W 38 negative TUMOR FREE 0 1 0 Complete Remission/Response Never Used YES RX Primary Tumor 01 open 1995 YES NO YES D1 0 8 1 34 Endometrial A LIVING 126 2008 TCGA-D1-A15W-01 TCGA-D1-A15W-01A-21-A164-20 CAFD3FC6-B826-40D0-BDA1-E66AB5BFA073 TCGA-D1-A15W-01A-11D-A122-09 TCGA-D1-A15W-01A-11D-A122-09 TCGA-D1-A15W-01A-11D-A122-09 TCGA-D1-A15W-01 9def1496-a891-431c-b5c2-75d258e7ec29 TCGA-D1-A15W-01A-11D-A120-01 TCGA-D1-A15W-01A-11D-A120-01 TCGA-D1-A15W-01 TCGA-D1-A15W-01 TCGA-D1-A15W-01A-11D-A123-05 9def1496-a891-431c-b5c2-75d258e7ec29 TCGA-D1-A15X-01 MSI-L TCGA-D1-A15X-01 Quiet C6-UCEC UCEC CIMP c18 cluster 2 squamous c3 UCEC-like c11 miRNA cluster 14 cluster 2 mutation cluster 11 TCGA-D1-A15X TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 45 0 0 TCGA-D1-A15X-F18473 TCGA-D1-A15X TCGA-D1-A15X-01A Current User Stage IA NO -16532 897 0 909 NO Scheduled Follow-up Submission 2011-11-17 FEMALE 169 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 130 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) High Grade NO false No TCGA-D1-A15X.F32EB1C9-4802-4873-8F0E-E10724DA9C15.pdf A15X 0 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1995 NO NO YES D1 0 16 0 29 Endometrial A LIVING 72 2008 TCGA-D1-A15X-01 TCGA-D1-A15X-01A-21-A164-20 D5DF60B0-AEC5-44E0-BB4C-99DF11B9AE51 TCGA-D1-A15X-01A-11D-A122-09 TCGA-D1-A15X-01A-11D-A122-09 TCGA-D1-A15X-01 51f60923-90f4-4bf7-9cc4-0bcdd9ed50e1 TCGA-D1-A15X-01A-11D-A120-01 TCGA-D1-A15X-01A-11D-A120-01 TCGA-D1-A15X-01 TCGA-D1-A15X-01 TCGA-D1-A15X-01A-11D-A123-05 51f60923-90f4-4bf7-9cc4-0bcdd9ed50e1 TCGA-D1-A15Z-01 MSI-L TCGA-D1-A15Z-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation c1uster 9 TCGA-D1-A15Z TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 72 0 0 TCGA-D1-A15Z-F18475 TCGA-D1-A15Z TCGA-D1-A15Z-01A Stage IB NO -26638 884 58 0 YES Scheduled Follow-up Submission 2011-11-17 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 160 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A15Z.280F86BF-4834-4FA9-B153-DE7BE312E619.pdf A15Z 30 TUMOR FREE 0 0 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1995 NO NO YES D1 0 5 0 28 Endometrial A DECEASED 125 2008 TCGA-D1-A15Z-01 TCGA-D1-A15Z-01A-21-A163-20 9589DF72-D456-456F-8B39-94E788ADCC03 TCGA-D1-A15Z-01A-11D-A122-09 TCGA-D1-A15Z-01A-11D-A122-09 TCGA-D1-A15Z-01A-11D-A122-09 TCGA-D1-A15Z-01 0ca45a1d-6cdc-48f5-8bde-633cfd15d687 TCGA-D1-A15Z-01A-11D-A120-01 TCGA-D1-A15Z-01A-11D-A120-01 TCGA-D1-A15Z-01 TCGA-D1-A15Z-01 TCGA-D1-A15Z-01A-11D-A123-05 0ca45a1d-6cdc-48f5-8bde-633cfd15d687 TCGA-D1-A160-01 MSI-H TCGA-D1-A160-01 Iq C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 1 TCGA-D1-A160 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 70 0 0 TCGA-D1-A160-F18477 TCGA-D1-A160 TCGA-D1-A160-01A Stage IB NO -25673 895 0 112 YES Scheduled Follow-up Submission 2011-11-17 FEMALE 172 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 100 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A160.F349C87E-F324-4A8E-81E1-153C99173E21.pdf A160 20 negative TUMOR FREE 0 0 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1995 NO NO YES D1 0 13 0 29 Endometrial A LIVING 122 2008 TCGA-D1-A160-01 TCGA-D1-A160-01A-21-A163-20 A35BF473-635A-43CF-8507-E4328B2155FC TCGA-D1-A160-01A-11D-A122-09 TCGA-D1-A160-01A-11D-A122-09 TCGA-D1-A160-01 ac9c8753-ae35-4367-9aef-d42522bc8db7 TCGA-D1-A160-01A-11D-A120-01 TCGA-D1-A160-01A-11D-A120-01 TCGA-D1-A160-01 TCGA-D1-A160-01 TCGA-D1-A160-01A-11D-A123-05 ac9c8753-ae35-4367-9aef-d42522bc8db7 TCGA-D1-A161-01 MSS TCGA-D1-A161-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 4 TCGA-D1-A161 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 78 0 0 TCGA-D1-A161-F18478 TCGA-D1-A161 TCGA-D1-A161-01A Stage IC NO -28695 864 0 892 NO Scheduled Follow-up Submission 2011-11-17 FEMALE 159 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 170 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A161.E68A0ED2-CBE3-40A9-8DBF-A3BBC49204DD.pdf A161 70 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 1995 NO NO YES D1 0 9 0 21 Endometrial A LIVING 71 2008 TCGA-D1-A161-01 TCGA-D1-A161-01A-21-A163-20 E9312DE7-7981-4E1C-864B-5C4273A4C04B TCGA-D1-A161-01A-11D-A122-09 TCGA-D1-A161-01A-11D-A122-09 TCGA-D1-A161-01 9336e8ea-7afe-45b3-b9e7-add7141ecca0 TCGA-D1-A161-01A-11D-A120-01 TCGA-D1-A161-01A-11D-A120-01 TCGA-D1-A161-01 TCGA-D1-A161-01 TCGA-D1-A161-01A-11D-A123-05 9336e8ea-7afe-45b3-b9e7-add7141ecca0 TCGA-D1-A162-01 MSS TCGA-D1-A162-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-D1-A162 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 69 0 0 TCGA-D1-A162-F18479 TCGA-D1-A162 TCGA-D1-A162-01A Stage IB NO -25543 874 0 1145 NO Scheduled Follow-up Submission 2011-11-17 FEMALE 170 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 180 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A162.CB5E7FA1-33EE-492F-B2B0-F4C9332640A9.pdf A162 50 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1995 NO NO YES D1 0 16 0 45 Endometrial A LIVING 100 2008 TCGA-D1-A162-01 TCGA-D1-A162-01A-21-A163-20 192B1720-C24A-43FE-9F8B-D9164E4C37C0 TCGA-D1-A162-01 4f440484-1605-442b-b1e5-b3534277b9c2 TCGA-D1-A162-01 TCGA-D1-A162-01A-11D-A123-05 4f440484-1605-442b-b1e5-b3534277b9c2 TCGA-D1-A163-01 MSI-H TCGA-D1-A163-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 1 TCGA-D1-A163 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO YES Complete Response 50 0 0 TCGA-D1-A163-F18485 TCGA-D1-A163 TCGA-D1-A163-01A Stage IIIC NO 327 -18604 854 0 991 223 NO Scheduled Follow-up Submission 2011-11-17 FEMALE 169 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 170 NO Peri (6-12 months since last menstrual period) G2 Other, specify Metastatic Paraaortic retroperitoneal lymphnode YES false No TCGA-D1-A163.993B9CE9-7D25-4B2B-B246-F642550C70CD.pdf A163 12 negative TUMOR FREE 0 2 1 Complete Remission/Response Never Used YES Surgical Resection R0 R0 Primary Tumor 01 open 1995 NO NO YES D1 0 38 2 53 Endometrial A LIVING 109 2008 TCGA-D1-A163-01 TCGA-D1-A163-01A-21-A163-20 78CB9680-D489-4ED4-BFDF-56CF4E9B2C9C TCGA-D1-A163-01A-11D-A12J-09 TCGA-D1-A163-01A-11D-A12J-09 TCGA-D1-A163-01A-11D-A12J-09 TCGA-D1-A163-01 b9d45e58-d758-4aa0-a282-1366dc00f833 TCGA-D1-A163-01A-11D-A12G-01 TCGA-D1-A163-01A-11D-A12G-01 TCGA-D1-A163-01 TCGA-D1-A163-01 TCGA-D1-A163-01A-11D-A12K-05 b9d45e58-d758-4aa0-a282-1366dc00f833 TCGA-D1-A165-01 MSS TCGA-D1-A165-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 4 TCGA-D1-A165 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 0 TCGA-D1-A165-F18493 TCGA-D1-A165 TCGA-D1-A165-01A Stage IIIA NO -23526 848 0 20 NO Scheduled Follow-up Submission 2011-11-17 FEMALE 181 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 90 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A165.476F8219-DAAE-4DB3-BA31-C64AC24ACF65.pdf A165 25 positive TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 1995 NO NO YES D1 0 13 0 30 Endometrial A LIVING 87 2008 TCGA-D1-A165-01 TCGA-D1-A165-01A-21-A163-20 2DC14A00-8265-4379-A0FD-EB8E9E199B59 TCGA-D1-A165-01A-11D-A12J-09 TCGA-D1-A165-01A-11D-A12J-09 TCGA-D1-A165-01A-11D-A12J-09 TCGA-D1-A165-01 6d1d9284-004e-4ed7-91dd-71f4fa919632 TCGA-D1-A165-01A-11D-A12G-01 TCGA-D1-A165-01A-11D-A12G-01 TCGA-D1-A165-01 TCGA-D1-A165-01 TCGA-D1-A165-01A-11D-A12K-05 6d1d9284-004e-4ed7-91dd-71f4fa919632 TCGA-D1-A167-01 MSI-H TCGA-D1-A167-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 11 TCGA-D1-A167 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 70 0 0 TCGA-D1-A167-F18494 TCGA-D1-A167 TCGA-D1-A167-01A Stage IC NO -25575 841 0 478 NO Scheduled Follow-up Submission 2011-11-17 FEMALE 152 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 140 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A167.4E67EAA4-3069-4B62-A403-9300A9FA494C.pdf A167 60 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1995 NO NO YES D1 0 20 0 52 Endometrial A LIVING 72 2008 TCGA-D1-A167-01 TCGA-D1-A167-01A-21-A163-20 8ABC7390-66A1-4E32-B8B5-747673551370 TCGA-D1-A167-01A-11D-A12J-09 TCGA-D1-A167-01A-11D-A12J-09 TCGA-D1-A167-01 09807f16-30aa-47b0-ace0-0dfb6a5342c2 TCGA-D1-A167-01A-11D-A12G-01 TCGA-D1-A167-01A-11D-A12G-01 TCGA-D1-A167-01 TCGA-D1-A167-01 TCGA-D1-A167-01A-11D-A12K-05 09807f16-30aa-47b0-ace0-0dfb6a5342c2 TCGA-D1-A168-01 MSS TCGA-D1-A168-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 BLCA nonsquamous-like c1 miRNA cluster 12 cluster 4 mutation cluster 1 TCGA-D1-A168 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 0 0 TCGA-D1-A168-F18501 TCGA-D1-A168 TCGA-D1-A168-01A Stage IB NO -24586 821 0 1098 NO Scheduled Follow-up Submission 2011-11-18 FEMALE 162 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 120 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-D1-A168.B9D9D808-17B1-415F-9E58-4FDBC1BF30C0.pdf A168 35 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1995 NO NO YES D1 0 19 0 49 Endometrial A LIVING 76 2008 TCGA-D1-A168-01 TCGA-D1-A168-01A-21-A163-20 770C564F-5591-4122-9855-BA6C3CE96517 TCGA-D1-A168-01A-31D-A12J-09 TCGA-D1-A168-01A-31D-A12J-09 TCGA-D1-A168-01A-31D-A12J-09 TCGA-D1-A168-01 9ca7ed26-2a2c-47cd-8423-f9b100beccc3 TCGA-D1-A168-01A-31D-A12G-01 TCGA-D1-A168-01A-31D-A12G-01 TCGA-D1-A168-01 TCGA-D1-A168-01 TCGA-D1-A168-01A-31D-A12K-05 9ca7ed26-2a2c-47cd-8423-f9b100beccc3 TCGA-D1-A169-01 MSS TCGA-D1-A169-01 Squamous C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 1 mutation cluster 3 TCGA-D1-A169 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO YES Stable Disease 63 0 0 TCGA-D1-A169-F18503 TCGA-D1-A169 TCGA-D1-A169-01A Stage IV NO 519 -23238 800 0 1135 519 NO Scheduled Follow-up Submission 2011-11-18 FEMALE 170 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 180 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 Other, specify Metastatic Bladder nodule YES false No TCGA-D1-A169.F7B4C0DC-2259-4A0A-81D3-E145EFA91279.pdf A169 45 positive WITH TUMOR 0 0 0 Complete Remission/Response Never Used NO Excisional Biopsy R2 R0 Primary Tumor 01 Minimally Invasive 1995 YES NO YES D1 0 23 0 29 Endometrial A LIVING 102 2008 TCGA-D1-A169-01 TCGA-D1-A169-01A-21-A163-20 EED70D33-031C-4464-A665-1E4B090ECAE8 TCGA-D1-A169-01A-11D-A12J-09 TCGA-D1-A169-01A-11D-A12J-09 TCGA-D1-A169-01A-11D-A12J-09 TCGA-D1-A169-01 7a487d4e-9e11-4adc-86a1-cf6a7bde4f67 TCGA-D1-A169-01A-11D-A12G-01 TCGA-D1-A169-01A-11D-A12G-01 TCGA-D1-A169-01 TCGA-D1-A169-01 TCGA-D1-A169-01A-11D-A12K-05 7a487d4e-9e11-4adc-86a1-cf6a7bde4f67 TCGA-D1-A16B-01 MSS TCGA-D1-A16B-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 mutation cluster 4 TCGA-D1-A16B TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 0 TCGA-D1-A16B-F18508 TCGA-D1-A16B TCGA-D1-A16B-01A Stage IC NO -23450 793 0 1106 NO Scheduled Follow-up Submission 2011-11-18 FEMALE 159 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 150 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A16B.1B9ED459-4046-4DD9-ABA5-E815A90601A3.pdf A16B 56 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 1995 NO NO YES D1 0 12 0 18 Endometrial A LIVING 86 2008 TCGA-D1-A16B-01 TCGA-D1-A16B-01A-21-A163-20 FAAC5466-A988-4DF3-8098-C4208C4D0453 TCGA-D1-A16B-01A-11D-A12J-09 TCGA-D1-A16B-01A-11D-A12J-09 TCGA-D1-A16B-01A-11D-A12J-09 TCGA-D1-A16B-01 90250b43-5a36-42c0-886f-32a0ed39bea6 TCGA-D1-A16B-01A-11D-A12G-01 TCGA-D1-A16B-01A-11D-A12G-01 TCGA-D1-A16B-01 TCGA-D1-A16B-01 TCGA-D1-A16B-01A-11D-A12K-05 90250b43-5a36-42c0-886f-32a0ed39bea6 TCGA-D1-A16D-01 MSS TCGA-D1-A16D-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 mutation cluster 1 TCGA-D1-A16D TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 49 0 0 TCGA-D1-A16D-F18509 TCGA-D1-A16D TCGA-D1-A16D-01A Stage IC NO -17933 799 0 1141 YES Scheduled Follow-up Submission 2011-11-18 FEMALE 164 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 130 NO Peri (6-12 months since last menstrual period) G2 NO false No TCGA-D1-A16D.795A5264-493A-498D-A731-87ECB0A7F612.pdf A16D 86 negative TUMOR FREE 0 0 0 Complete Remission/Response Never Used YES RX Primary Tumor 01 open 1995 YES NO YES D1 0 0 0 34 Endometrial A LIVING 151 2008 TCGA-D1-A16D-01 TCGA-D1-A16D-01A-21-A164-20 5F2C5422-2513-4C05-9668-74E46BCA6563 TCGA-D1-A16D-01A-11D-A12J-09 TCGA-D1-A16D-01A-11D-A12J-09 TCGA-D1-A16D-01A-11D-A12J-09 TCGA-D1-A16D-01 619e7a96-8900-484b-b1e2-54ef91b9109d TCGA-D1-A16D-01A-11D-A12G-01 TCGA-D1-A16D-01A-11D-A12G-01 TCGA-D1-A16D-01 TCGA-D1-A16D-01 TCGA-D1-A16D-01A-11D-A12K-05 619e7a96-8900-484b-b1e2-54ef91b9109d TCGA-D1-A16E-01 MSS TCGA-D1-A16E-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 squamous c3 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 4 TCGA-D1-A16E TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 73 0 0 TCGA-D1-A16E-F18558 TCGA-D1-A16E TCGA-D1-A16E-01A Stage IB NO -26859 790 0 1119 NO Scheduled Follow-up Submission 2011-11-21 FEMALE 154 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 170 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A16E.DF926973-D344-48AE-A6F6-5901A4A8C846.pdf A16E 25 TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1995 NO NO YES D1 0 0 0 0 Endometrial A LIVING 60 2008 TCGA-D1-A16E-01 TCGA-D1-A16E-01A-11-A164-20 564E1D1E-8143-473D-B49A-A701458F6516 TCGA-D1-A16E-01A-22D-A12J-09 TCGA-D1-A16E-01A-22D-A12J-09 TCGA-D1-A16E-01A-22D-A12J-09 TCGA-D1-A16E-01 abe099ed-caea-4903-aa4a-2729d2b28da2 TCGA-D1-A16E-01A-22D-A12G-01 TCGA-D1-A16E-01A-22D-A12G-01 TCGA-D1-A16E-01 TCGA-D1-A16E-01 TCGA-D1-A16E-01A-22D-A12K-05 abe099ed-caea-4903-aa4a-2729d2b28da2 TCGA-D1-A16F-01 MSI-H TCGA-D1-A16F-01 C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 mutation cluster 7 TCGA-D1-A16F TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 0 0 TCGA-D1-A16F-F18559 TCGA-D1-A16F TCGA-D1-A16F-01A Stage IB NO -22242 783 0 80 YES Scheduled Follow-up Submission 2011-11-21 FEMALE 157 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 280 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A16F.E89C4CBF-45D5-405D-A673-F67186C206B3.pdf A16F 25 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1995 NO NO YES D1 0 6 0 15 Endometrial A LIVING 90 2008 TCGA-D1-A16F-01 TCGA-D1-A16F-01A-21-A164-20 2D4EB2C7-4E8D-4D10-B6D7-C6EE8965053E TCGA-D1-A16F-01A-11D-A12J-09 TCGA-D1-A16F-01A-11D-A12J-09 TCGA-D1-A16F-01 7eab3a7a-c66e-4289-8fb4-ae751b2103e6 TCGA-D1-A16F-01 TCGA-D1-A16F-01A-11D-A12K-05 7eab3a7a-c66e-4289-8fb4-ae751b2103e6 TCGA-D1-A16G-01 MSS TCGA-D1-A16G-01 Squamous C7-COAD/READ UCEC non-CIMP c3 cluster 4 squamous c3 COADREAD-like c15 miRNA cluster 8 cluster 2 mutation cluster 3 TCGA-D1-A16G TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO NO Progressive Disease 74 0 0 TCGA-D1-A16G-F18560 TCGA-D1-A16G TCGA-D1-A16G-01A Stage IV NO -27065 769 834 0 642 NO Scheduled Follow-up Submission 2011-11-21 FEMALE 173 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 250 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) High Grade Other, specify Locoregional Disease Lymph nodes YES false No TCGA-D1-A16G.778F9F58-841E-48F3-B6EA-7CF58463808B.pdf A16G 100 positive WITH TUMOR 0 0 3 Complete Remission/Response Never Used YES RX Primary Tumor 01 open 1995 YES NO YES D1 0 15 0 30 Endometrial A DECEASED 75 2008 TCGA-D1-A16G-01 TCGA-D1-A16G-01A-21-A164-20 D63DB6BF-75DA-431D-947C-1609C481A48A TCGA-D1-A16G-01A-31D-A12J-09 TCGA-D1-A16G-01A-31D-A12J-09 TCGA-D1-A16G-01A-31D-A12J-09 TCGA-D1-A16G-01 deeb2238-8ed6-4651-8b63-428c76914c94 TCGA-D1-A16G-01A-31D-A12G-01 TCGA-D1-A16G-01A-31D-A12G-01 TCGA-D1-A16G-01 TCGA-D1-A16G-01 TCGA-D1-A16G-01A-31D-A12K-05 deeb2238-8ed6-4651-8b63-428c76914c94 TCGA-D1-A16I-01 MSS TCGA-D1-A16I-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 5 TCGA-D1-A16I TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 62 0 0 TCGA-D1-A16I-F18573 TCGA-D1-A16I TCGA-D1-A16I-01A Stage IC NO -22836 763 350 0 NO Scheduled Follow-up Submission 2011-11-21 FEMALE 163 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 190 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) High Grade NO false No TCGA-D1-A16I.3D30B053-444A-4F4D-B451-EB8746A157A2.pdf A16I 66 TUMOR FREE 0 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 1995 YES NO YES D1 0 22 0 29 Endometrial A DECEASED 84 2008 TCGA-D1-A16I-01 TCGA-D1-A16I-01A-21-A164-20 86D661F5-6386-4735-B9F1-04B2B4B96418 TCGA-D1-A16I-01A-11D-A12J-09 TCGA-D1-A16I-01A-11D-A12J-09 TCGA-D1-A16I-01A-11D-A12J-09 TCGA-D1-A16I-01 21e840d7-f768-45b3-8a3a-bf228f7227e7 TCGA-D1-A16I-01A-11D-A12G-01 TCGA-D1-A16I-01A-11D-A12G-01 TCGA-D1-A16I-01 TCGA-D1-A16I-01 TCGA-D1-A16I-01A-11D-A12K-05 21e840d7-f768-45b3-8a3a-bf228f7227e7 TCGA-D1-A16J-01 MSS TCGA-D1-A16J-01 COAD-READ C1-LUAD-enriched Cluster 6 cluster 1 squamous c3 UCEC-like c11 miRNA cluster 7 cluster 2 mutation cluster 1 TCGA-D1-A16J TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 61 0 0 TCGA-D1-A16J-F18579 TCGA-D1-A16J TCGA-D1-A16J-01A Stage IIB NO -22319 735 0 910 NO Scheduled Follow-up Submission 2011-11-21 FEMALE 174 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 150 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A16J.7A1F7567-5D17-4074-B099-1E60C8069FA1.pdf A16J 100 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1995 YES NO YES D1 0 13 0 50 Endometrial A LIVING 130 2008 TCGA-D1-A16J-01 TCGA-D1-A16J-01A-21-A164-20 6C745697-65BC-44B8-8F15-B8482F902E85 TCGA-D1-A16J-01A-11D-A12J-09 TCGA-D1-A16J-01A-11D-A12J-09 TCGA-D1-A16J-01A-11D-A12J-09 TCGA-D1-A16J-01 43ae3721-059e-467e-a8a3-7875e738ccef TCGA-D1-A16J-01A-11D-A12G-01 TCGA-D1-A16J-01A-11D-A12G-01 TCGA-D1-A16J-01 TCGA-D1-A16J-01 TCGA-D1-A16J-01A-11D-A12K-05 43ae3721-059e-467e-a8a3-7875e738ccef TCGA-D1-A16N-01 MSI-H TCGA-D1-A16N-01 Squamous C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 3 mutation cluster 3 TCGA-D1-A16N TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 51 0 0 TCGA-D1-A16N-F18584 TCGA-D1-A16N TCGA-D1-A16N-01A Stage IIIA NO -18787 629 0 945 YES Scheduled Follow-up Submission 2011-11-21 FEMALE 155 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 240 NO Peri (6-12 months since last menstrual period) G3 NO false No TCGA-D1-A16N.81CFA07C-5FCE-41F3-88D1-FFD17840B293.pdf A16N 42 positive TUMOR FREE 0 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1995 YES NO YES D1 0 10 0 49 Endometrial A LIVING 89 2009 TCGA-D1-A16N-01 TCGA-D1-A16N-01A-21-A164-20 4C1FD9BC-7AE2-4325-B08F-56075E677662 TCGA-D1-A16N-01A-11D-A12J-09 TCGA-D1-A16N-01A-11D-A12J-09 TCGA-D1-A16N-01A-11D-A12J-09 TCGA-D1-A16N-01 55b006ca-aacf-4ed5-a0bc-7238eacfb23e TCGA-D1-A16N-01A-11D-A12G-01 TCGA-D1-A16N-01A-11D-A12G-01 TCGA-D1-A16N-01 TCGA-D1-A16N-01 TCGA-D1-A16N-01A-11D-A12K-05 55b006ca-aacf-4ed5-a0bc-7238eacfb23e TCGA-D1-A16O-01 MSS TCGA-D1-A16O-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 1 mutation cluster 1 TCGA-D1-A16O TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 44 0 0 TCGA-D1-A16O-F18652 TCGA-D1-A16O TCGA-D1-A16O-01A Stage IB NO -16114 756 0 1023 NO Scheduled Follow-up Submission 2011-11-21 FEMALE 169 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 120 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A16O.B4EFFDB8-CB4C-46D7-96AD-9D33DF7163C0.pdf A16O 12 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 0 0 0 Endometrial A LIVING 102 2008 TCGA-D1-A16O-01 TCGA-D1-A16O-01A-21-A164-20 641D2D76-4BC1-4A7F-8F59-87BF90319D4F TCGA-D1-A16O-01A-11D-A12J-09 TCGA-D1-A16O-01A-11D-A12J-09 TCGA-D1-A16O-01A-11D-A12J-09 TCGA-D1-A16O-01 3581b34d-0e76-4feb-a872-b510effff12a TCGA-D1-A16O-01A-11D-A12G-01 TCGA-D1-A16O-01A-11D-A12G-01 TCGA-D1-A16O-01 TCGA-D1-A16O-01 TCGA-D1-A16O-01A-11D-A12K-05 3581b34d-0e76-4feb-a872-b510effff12a TCGA-D1-A16Q-01 MSS TCGA-D1-A16Q-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-D1-A16Q TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 54 0 0 TCGA-D1-A16Q-F18653 TCGA-D1-A16Q TCGA-D1-A16Q-01A Stage II NO -19873 136 0 324 YES Scheduled Follow-up Submission 2011-11-21 FEMALE 172 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 240 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A16Q.60635568-D27E-4C72-BFF2-238CF2992925.pdf A16Q 77 negative TUMOR FREE 0 0 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO YES D1 0 19 0 74 Endometrial A LIVING 117 2010 TCGA-D1-A16Q-01 TCGA-D1-A16Q-01A-21-A164-20 088C67D6-5A80-407A-BA4A-2F02C25C7A65 TCGA-D1-A16Q-01A-12D-A12J-09 TCGA-D1-A16Q-01A-12D-A12J-09 TCGA-D1-A16Q-01A-12D-A12J-09 TCGA-D1-A16Q-01 6f456a65-f075-469d-a0f9-365cae129564 TCGA-D1-A16Q-01A-12D-A12G-01 TCGA-D1-A16Q-01A-12D-A12G-01 TCGA-D1-A16Q-01 TCGA-D1-A16Q-01 TCGA-D1-A16Q-01A-12D-A12K-05 6f456a65-f075-469d-a0f9-365cae129564 TCGA-D1-A16R-01 MSS TCGA-D1-A16R-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 4 TCGA-D1-A16R TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 39 0 0 TCGA-D1-A16R-F20316 TCGA-D1-A16R TCGA-D1-A16R-01A Stage IA NO -14465 161 0 21 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 159 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 290 NO Indeterminate (neither Pre or Postmenopausal) G1 NO false No TCGA-D1-A16R.D9641375-D204-4469-989A-ED08DDE66408.pdf A16R 19 negative TUMOR FREE 0 0 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 0 0 49 Endometrial A LIVING 105 2010 TCGA-D1-A16R-01 TCGA-D1-A16R-01A-21-A164-20 B11290FB-906E-40FD-BB7C-B6F5660388EB TCGA-D1-A16R-01A-11D-A12J-09 TCGA-D1-A16R-01A-11D-A12J-09 TCGA-D1-A16R-01A-11D-A12J-09 TCGA-D1-A16R-01 16c07e59-0ad4-4a8d-82a0-a77c78119175 TCGA-D1-A16R-01A-11D-A12G-01 TCGA-D1-A16R-01A-11D-A12G-01 TCGA-D1-A16R-01 TCGA-D1-A16R-01 TCGA-D1-A16R-01A-11D-A12K-05 16c07e59-0ad4-4a8d-82a0-a77c78119175 TCGA-D1-A16S-01 MSS TCGA-D1-A16S-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 2 mutation cluster 3 TCGA-D1-A16S TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 70 0 0 TCGA-D1-A16S-F20314 TCGA-D1-A16S TCGA-D1-A16S-01A Stage IIIC NO -25690 177 0 568 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 162 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 290 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) High Grade NO false No TCGA-D1-A16S.D69D2E09-B195-4F3F-B5A1-821A87852266.pdf A16S 100 negative TUMOR FREE 0 1 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 20 1 35 Endometrial A LIVING 59 2010 TCGA-D1-A16S-01 TCGA-D1-A16S-01A-21-A164-20 70A0402E-460F-443A-8851-58C7A2D0BD97 TCGA-D1-A16S-01A-11D-A12J-09 TCGA-D1-A16S-01A-11D-A12J-09 TCGA-D1-A16S-01A-11D-A12J-09 TCGA-D1-A16S-01 7c0fca0e-60ff-4c7e-a337-fb7489f69151 TCGA-D1-A16S-01A-11D-A12G-01 TCGA-D1-A16S-01A-11D-A12G-01 TCGA-D1-A16S-01 TCGA-D1-A16S-01 TCGA-D1-A16S-01A-11D-A12K-05 7c0fca0e-60ff-4c7e-a337-fb7489f69151 TCGA-D1-A16V-01 MSS TCGA-D1-A16V-01 Squamous C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 3 TCGA-D1-A16V TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Stable Disease 78 0 7 TCGA-D1-A16V-F20230 TCGA-D1-A16V TCGA-D1-A16V-01A Stage IIIC NO -28635 609 120 0 43 YES Scheduled Follow-up Submission 2012-1-8 FEMALE 173 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Tumor resection 410 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-D1-A16V.92EA83B6-8041-4449-BAE6-5060C32966D0.pdf A16V 73 TUMOR FREE 0 15 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 7 30 15 35 Endometrial A DECEASED 105 2009 TCGA-D1-A16V-01 TCGA-D1-A16V-01A-21-A164-20 C3D27B98-8016-4388-9F04-B07D6389F0EF TCGA-D1-A16V-01 860613bc-72b2-47bb-90ac-2b272e549860 TCGA-D1-A16V-01A-11D-A12G-01 TCGA-D1-A16V-01A-11D-A12G-01 TCGA-D1-A16V-01 TCGA-D1-A16V-01 TCGA-D1-A16V-01A-11D-A12K-05 860613bc-72b2-47bb-90ac-2b272e549860 TCGA-D1-A16X-01 MSS TCGA-D1-A16X-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 11 TCGA-D1-A16X TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 54 0 0 TCGA-D1-A16X-F20231 TCGA-D1-A16X TCGA-D1-A16X-01A Stage IB NO -19799 618 0 111 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 230 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A16X.0C395D2C-1864-448E-8FB7-09BFE5FF4C50.pdf A16X 18 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 26 0 46 Endometrial A LIVING 101 2009 TCGA-D1-A16X-01 TCGA-D1-A16X-01A-21-A164-20 3845198C-CE52-4BAC-936E-CB1FC79D2176 TCGA-D1-A16X-01A-11D-A12J-09 TCGA-D1-A16X-01A-11D-A12J-09 TCGA-D1-A16X-01 4468bb31-bb94-4353-9d13-556d4b8a892a TCGA-D1-A16X-01A-11D-A12G-01 TCGA-D1-A16X-01A-11D-A12G-01 TCGA-D1-A16X-01 TCGA-D1-A16X-01 TCGA-D1-A16X-01A-11D-A12K-05 4468bb31-bb94-4353-9d13-556d4b8a892a TCGA-D1-A16Y-01 MSI-L TCGA-D1-A16Y-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 mutation cluster 2 TCGA-D1-A16Y TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 0 0 TCGA-D1-A16Y-F20232 TCGA-D1-A16Y TCGA-D1-A16Y-01A Stage IB NO -20455 610 0 532 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 156 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 220 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A16Y.0A0451C4-2A58-4404-934E-3517443E4CEE.pdf A16Y 8 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO RX Primary Tumor 01 open 2009 NO NO YES D1 0 6 0 20 Endometrial A LIVING 87 2009 TCGA-D1-A16Y-01 TCGA-D1-A16Y-01A-21-A164-20 B3D6CAEC-CBFC-4417-8810-8CB3BF4AE37B TCGA-D1-A16Y-01A-31D-A12J-09 TCGA-D1-A16Y-01A-31D-A12J-09 TCGA-D1-A16Y-01 486755e1-9b18-4310-a1bb-ddd325f212b0 TCGA-D1-A16Y-01A-31D-A12G-01 TCGA-D1-A16Y-01A-31D-A12G-01 TCGA-D1-A16Y-01 TCGA-D1-A16Y-01 TCGA-D1-A16Y-01A-31D-A12K-05 486755e1-9b18-4310-a1bb-ddd325f212b0 TCGA-D1-A174-01 MSI-H TCGA-D1-A174-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA cluster 6 cluster 1 mutation cluster 11 TCGA-D1-A174 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 51 0 0 TCGA-D1-A174-F20312 TCGA-D1-A174 TCGA-D1-A174-01A Stage IA NO -18702 219 0 594 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 157 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 80 NO Indeterminate (neither Pre or Postmenopausal) G3 NO false No TCGA-D1-A174.E45B2436-C0B2-44C3-B400-49C668114B01.pdf A174 8 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES D1 0 9 0 19 Endometrial A LIVING 65 2010 TCGA-D1-A174-01 TCGA-D1-A174-01A-11D-A12J-09 TCGA-D1-A174-01A-11D-A12J-09 TCGA-D1-A174-01A-11D-A12J-09 TCGA-D1-A174-01 67f6f0d9-6581-4946-a9c7-a6629da86888 TCGA-D1-A174-01A-11D-A12G-01 TCGA-D1-A174-01A-11D-A12G-01 TCGA-D1-A174-01 TCGA-D1-A174-01 TCGA-D1-A174-01A-11D-A12K-05 67f6f0d9-6581-4946-a9c7-a6629da86888 TCGA-D1-A175-01 MSI-H TCGA-D1-A175-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 TCGA-D1-A175 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 48 0 0 TCGA-D1-A175-F20245 TCGA-D1-A175 TCGA-D1-A175-01A Stage IC NO -17802 566 0 202 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 161 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 200 NO Indeterminate (neither Pre or Postmenopausal) G3 NO false No TCGA-D1-A175.4A0D74F3-74A0-4CAE-960B-71D37DF4F4DE.pdf A175 90 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO YES D1 0 17 0 23 Endometrial A LIVING 64 2009 TCGA-D1-A175-01 TCGA-D1-A175-01A-21-A164-20 E0B67C97-4029-436E-9E17-2A5595C3CF03 TCGA-D1-A175-01 5ff09a0f-1deb-41fe-9cad-4ed6556f2bf8 TCGA-D1-A175-01A-11D-A12G-01 TCGA-D1-A175-01A-11D-A12G-01 TCGA-D1-A175-01 TCGA-D1-A175-01 TCGA-D1-A175-01A-11D-A12K-05 5ff09a0f-1deb-41fe-9cad-4ed6556f2bf8 TCGA-D1-A176-01 MSI-H TCGA-D1-A176-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 1 mutation cluster 4 TCGA-D1-A176 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 0 TCGA-D1-A176-F20248 TCGA-D1-A176 TCGA-D1-A176-01A Stage IB NO -24521 555 0 917 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 167 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 100 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A176.6F361A45-F13E-44F7-8F3C-00C8B30ACB7A.pdf A176 13 negative TUMOR FREE 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 33 0 57 Endometrial A LIVING 94 2009 TCGA-D1-A176-01 TCGA-D1-A176-01A-21-A164-20 CF18931D-E2F9-4E89-A78D-93E5DE195854 TCGA-D1-A176-01A-11D-A12J-09 TCGA-D1-A176-01A-11D-A12J-09 TCGA-D1-A176-01A-11D-A12J-09 TCGA-D1-A176-01 8e075c0e-43b4-48b0-9bdc-b27b6d6568b3 TCGA-D1-A176-01A-11D-A12G-01 TCGA-D1-A176-01A-11D-A12G-01 TCGA-D1-A176-01 TCGA-D1-A176-01 TCGA-D1-A176-01A-11D-A12K-05 8e075c0e-43b4-48b0-9bdc-b27b6d6568b3 TCGA-D1-A177-01 MSI-H TCGA-D1-A177-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 12 TCGA-D1-A177 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES YES Complete Response 70 0 TCGA-D1-A177-F20307 TCGA-D1-A177 TCGA-D1-A177-01A Stage IB NO 347 -25602 227 0 548 347 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 152 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 190 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 Other, specify Locoregional Disease paraaortic lymph nodes YES false No TCGA-D1-A177.28FF1BEE-6F93-4BCA-A6DC-56A1EA8EA337.pdf A177 93 negative TUMOR FREE 0 2 Complete Remission/Response Never Used YES Surgical Resection RX R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES D1 0 15 0 45 Endometrial A LIVING 53 2010 TCGA-D1-A177-01 TCGA-D1-A177-01A-11-A164-20 10E516C6-19DC-483A-ABA2-471E8FB9CB7E TCGA-D1-A177-01A-21D-A12J-09 TCGA-D1-A177-01A-21D-A12J-09 TCGA-D1-A177-01A-21D-A12J-09 TCGA-D1-A177-01 75b0fdbd-9670-468e-b426-410c95d84426 TCGA-D1-A177-01A-21D-A12G-01 TCGA-D1-A177-01A-21D-A12G-01 TCGA-D1-A177-01 TCGA-D1-A177-01 TCGA-D1-A177-01A-21D-A12K-05 75b0fdbd-9670-468e-b426-410c95d84426 TCGA-D1-A179-01 MSS TCGA-D1-A179-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 OV-like c4 UCEC-like c11 miRNA cluster 13 cluster 6 TCGA-D1-A179 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO Progressive Disease 76 6 TCGA-D1-A179-F20304 TCGA-D1-A179 TCGA-D1-A179-01A Stage IIIC NO -28037 230 448 0 206 427 YES Scheduled Follow-up Submission 2012-1-9 FEMALE 162 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 250 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) High Grade Lung Metastatic YES false No TCGA-D1-A179.F8F4C024-B723-424C-B98D-AA885C38CDFB.pdf A179 25 negative WITH TUMOR 2 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO YES D1 6 9 2 21 Endometrial A DECEASED 95 2010 TCGA-D1-A179-01 TCGA-D1-A179-01A-21-A164-20 1DBC4EDF-4733-486E-9F7E-FE0BFF8A4428 TCGA-D1-A179-01 c64d52eb-c0aa-4ebe-a21d-0e7f11be7d09 TCGA-D1-A179-01A-11D-A12G-01 TCGA-D1-A179-01A-11D-A12G-01 TCGA-D1-A179-01 TCGA-D1-A179-01 TCGA-D1-A179-01A-11D-A12K-05 c64d52eb-c0aa-4ebe-a21d-0e7f11be7d09 TCGA-D1-A17A-01 MSI-H TCGA-D1-A17A-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA cluster 13 cluster 6 mutation cluster 1 TCGA-D1-A17A TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 59 0 TCGA-D1-A17A-F20250 TCGA-D1-A17A TCGA-D1-A17A-01A Stage IIA NO -21560 553 0 48 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 176 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 60 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-D1-A17A.9E0E5CDA-AE46-4ABC-8AF7-C89FE86B7472.pdf A17A 41 negative TUMOR FREE 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 23 0 40 Endometrial A LIVING 102 2009 TCGA-D1-A17A-01 TCGA-D1-A17A-01A-11D-A12J-09 TCGA-D1-A17A-01A-11D-A12J-09 TCGA-D1-A17A-01A-11D-A12J-09 TCGA-D1-A17A-01 88aec124-1462-4fd5-b209-b0dadf1138bc TCGA-D1-A17A-01A-11D-A12G-01 TCGA-D1-A17A-01A-11D-A12G-01 TCGA-D1-A17A-01 TCGA-D1-A17A-01 TCGA-D1-A17A-01A-11D-A12K-05 88aec124-1462-4fd5-b209-b0dadf1138bc TCGA-D1-A17B-01 MSI-H TCGA-D1-A17B-01 Iq C6-UCEC UCEC CIMP c18 cluster 2 squamous c3 UCEC-like c11 miRNA cluster 12 cluster 2 mutation cluster 4 TCGA-D1-A17B TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 69 TCGA-D1-A17B-F20251 TCGA-D1-A17B TCGA-D1-A17B-01A Stage IB NO -25504 685 0 213 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 162 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 140 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A17B.FBE330EA-52BC-4B16-A046-3858318348F5.pdf A17B 8 negative TUMOR FREE 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES D1 0 42 Endometrial A LIVING 110 2009 TCGA-D1-A17B-01 TCGA-D1-A17B-01A-31-A164-20 B0A6109A-AA31-450B-AD32-4B07EB833EC4 TCGA-D1-A17B-01A-22D-A12J-09 TCGA-D1-A17B-01A-22D-A12J-09 TCGA-D1-A17B-01A-22D-A12J-09 TCGA-D1-A17B-01 7dc8574f-d39c-4a7d-be83-e326a577b5bb TCGA-D1-A17B-01A-22D-A12G-01 TCGA-D1-A17B-01A-22D-A12G-01 TCGA-D1-A17B-01 TCGA-D1-A17B-01 TCGA-D1-A17B-01A-22D-A12K-05 7dc8574f-d39c-4a7d-be83-e326a577b5bb TCGA-D1-A17C-01 MSS TCGA-D1-A17C-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 4 TCGA-D1-A17C TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 78 TCGA-D1-A17C-F20302 TCGA-D1-A17C TCGA-D1-A17C-01A Stage IA NO -28571 249 0 30 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 161 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 130 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A17C.213A073E-C5E1-4BA8-B4D5-23C92E539FA5.pdf A17C 14 negative TUMOR FREE 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES D1 0 0 Endometrial A LIVING 81 2010 TCGA-D1-A17C-01 TCGA-D1-A17C-01A-21-A164-20 1EA520E6-0092-4DEB-992A-8CA0BB2B9B6C TCGA-D1-A17C-01A-11D-A12J-09 TCGA-D1-A17C-01A-11D-A12J-09 TCGA-D1-A17C-01A-11D-A12J-09 TCGA-D1-A17C-01 1f3910ae-d1c0-4815-836b-25f2926f9258 TCGA-D1-A17C-01A-11D-A12G-01 TCGA-D1-A17C-01A-11D-A12G-01 TCGA-D1-A17C-01 TCGA-D1-A17C-01 TCGA-D1-A17C-01A-11D-A12K-05 1f3910ae-d1c0-4815-836b-25f2926f9258 TCGA-D1-A17D-01 MSI-H TCGA-D1-A17D-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 6 TCGA-D1-A17D TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 0 TCGA-D1-A17D-F20254 TCGA-D1-A17D TCGA-D1-A17D-01A Stage IB NO -21441 541 0 926 YES Scheduled Follow-up Submission 2012-1-9 FEMALE 155 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 160 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-D1-A17D.1042404C-E963-4620-BC02-E33751FDB96C.pdf A17D 67 negative TUMOR FREE 0 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO YES D1 0 36 0 23 Endometrial A LIVING 68 2009 TCGA-D1-A17D-01 TCGA-D1-A17D-01A-21-A164-20 AD75151C-839F-4245-9F2C-94BF67FC993D TCGA-D1-A17D-01A-12D-A12J-09 TCGA-D1-A17D-01A-12D-A12J-09 TCGA-D1-A17D-01A-12D-A12J-09 TCGA-D1-A17D-01 ceaaf6e4-8f99-4fe0-8d2e-8d5aee22ebb9 TCGA-D1-A17D-01A-12D-A12G-01 TCGA-D1-A17D-01A-12D-A12G-01 TCGA-D1-A17D-01 TCGA-D1-A17D-01 TCGA-D1-A17D-01A-12D-A12K-05 ceaaf6e4-8f99-4fe0-8d2e-8d5aee22ebb9 TCGA-D1-A17F-01 MSI-H TCGA-D1-A17F-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-D1-A17F TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 TCGA-D1-A17F-F20300 TCGA-D1-A17F TCGA-D1-A17F-01A Stage IA NO -25116 269 0 39 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 158 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 200 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A17F.62F464EA-9410-4511-8DE8-F0E62AB1E482.pdf A17F 21 negative TUMOR FREE 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES D1 0 0 42 Endometrial A LIVING 79 2010 TCGA-D1-A17F-01 TCGA-D1-A17F-01A-21-A164-20 4F996645-41F2-42CA-9D4E-F34184B6F95F TCGA-D1-A17F-01A-11D-A12J-09 TCGA-D1-A17F-01A-11D-A12J-09 TCGA-D1-A17F-01A-11D-A12J-09 TCGA-D1-A17F-01 67a8a629-6001-48cb-99b1-588a69f49ecc TCGA-D1-A17F-01A-11D-A12G-01 TCGA-D1-A17F-01A-11D-A12G-01 TCGA-D1-A17F-01 TCGA-D1-A17F-01 TCGA-D1-A17F-01A-11D-A12K-05 67a8a629-6001-48cb-99b1-588a69f49ecc TCGA-D1-A17H-01 MSI-H TCGA-D1-A17H-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 7 TCGA-D1-A17H TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 61 TCGA-D1-A17H-F20263 TCGA-D1-A17H TCGA-D1-A17H-01A Never Used Stage IB NO -22389 531 0 852 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 167 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 230 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A17H.E2EBC803-BE77-4936-9B6A-9E6E7E6B8FA4.pdf A17H 57 negative TUMOR FREE 0 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 0 28 Endometrial A LIVING 96 2009 TCGA-D1-A17H-01 TCGA-D1-A17H-01A-21-A164-20 E8A0F2A3-5323-48FE-BE8B-D1782EC2CB1E TCGA-D1-A17H-01A-11D-A12J-09 TCGA-D1-A17H-01A-11D-A12J-09 TCGA-D1-A17H-01A-11D-A12J-09 TCGA-D1-A17H-01 e9e9ace8-7686-48a6-9e1b-91899268bd11 TCGA-D1-A17H-01A-11D-A12G-01 TCGA-D1-A17H-01A-11D-A12G-01 TCGA-D1-A17H-01 TCGA-D1-A17H-01 TCGA-D1-A17H-01A-11D-A12K-05 e9e9ace8-7686-48a6-9e1b-91899268bd11 TCGA-D1-A17K-01 MSS TCGA-D1-A17K-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 3 TCGA-D1-A17K TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO YES Progressive Disease 74 TCGA-D1-A17K-F20268 TCGA-D1-A17K TCGA-D1-A17K-01A Stage IA NO 832 -27283 513 0 854 815 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 161 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 140 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 Other, specify Locoregional Disease Vagina, apex YES false No TCGA-D1-A17K.C9E1B85A-8637-4421-A8CD-2E4BB28B3A73.pdf A17K 0 TUMOR FREE 2 Complete Remission/Response Never Used NO Surgical Resection R2 R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES D1 0 0 Endometrial A LIVING 97 2009 TCGA-D1-A17K-01 TCGA-D1-A17K-01A-21-A164-20 0C2F85CC-EEFA-46BA-ADF8-A437B7CFDC8E TCGA-D1-A17K-01A-11D-A12J-09 TCGA-D1-A17K-01A-11D-A12J-09 TCGA-D1-A17K-01A-11D-A12J-09 TCGA-D1-A17K-01 de485b7d-cd88-4889-aff4-e290027f26bb TCGA-D1-A17K-01A-11D-A12G-01 TCGA-D1-A17K-01A-11D-A12G-01 TCGA-D1-A17K-01 TCGA-D1-A17K-01 TCGA-D1-A17K-01A-11D-A12K-05 de485b7d-cd88-4889-aff4-e290027f26bb TCGA-D1-A17L-01 MSS TCGA-D1-A17L-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 1 TCGA-D1-A17L TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 81 TCGA-D1-A17L-F20271 TCGA-D1-A17L TCGA-D1-A17L-01A Stage IA NO -29899 493 0 802 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 172 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 210 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A17L.BCF17C02-8F6E-419F-AEDF-3AC03AA883E7.pdf A17L 22 negative TUMOR FREE 0 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 0 34 Endometrial A LIVING 123 2009 TCGA-D1-A17L-01 TCGA-D1-A17L-01A-21-A164-20 3D47AB97-2F85-4789-82B6-82268ABB08AC TCGA-D1-A17L-01A-11D-A12J-09 TCGA-D1-A17L-01A-11D-A12J-09 TCGA-D1-A17L-01A-11D-A12J-09 TCGA-D1-A17L-01 1622de43-ddd8-4a57-a89c-70c427d0a9f6 TCGA-D1-A17L-01A-11D-A12G-01 TCGA-D1-A17L-01A-11D-A12G-01 TCGA-D1-A17L-01 TCGA-D1-A17L-01 TCGA-D1-A17L-01A-11D-A12K-05 1622de43-ddd8-4a57-a89c-70c427d0a9f6 TCGA-D1-A17M-01 MSI-H TCGA-D1-A17M-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 4 TCGA-D1-A17M TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 TCGA-D1-A17M-F20272 TCGA-D1-A17M TCGA-D1-A17M-01A Stage II NO -20685 454 0 311 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 140 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A17M.E69EF984-AF58-4EB0-93D2-CADE53DF0A6D.pdf A17M 24 negative TUMOR FREE 0 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES D1 0 0 14 Endometrial A LIVING 142 2009 TCGA-D1-A17M-01 TCGA-D1-A17M-01A-11-A164-20 C86897DA-DA1F-47F9-9C4C-3922E75EBE55 TCGA-D1-A17M-01A-21D-A12J-09 TCGA-D1-A17M-01A-21D-A12J-09 TCGA-D1-A17M-01A-21D-A12J-09 TCGA-D1-A17M-01 7e8a4ecc-07b0-4765-a8da-5868523736f5 TCGA-D1-A17M-01A-21D-A12G-01 TCGA-D1-A17M-01A-21D-A12G-01 TCGA-D1-A17M-01 TCGA-D1-A17M-01 TCGA-D1-A17M-01A-21D-A12K-05 7e8a4ecc-07b0-4765-a8da-5868523736f5 TCGA-D1-A17N-01 MSS TCGA-D1-A17N-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 squamous c3 UCEC-like c11 miRNA cluster 13 cluster 4 mutation c1uster 9 TCGA-D1-A17N TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 46 TCGA-D1-A17N-F20274 TCGA-D1-A17N TCGA-D1-A17N-01A Stage IA NO -17045 451 0 46 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 166 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 110 NO Peri (6-12 months since last menstrual period) G2 NO false No TCGA-D1-A17N.AD892375-1A50-4D9E-8235-A9A495C35B97.pdf A17N 0 negative TUMOR FREE 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 0 Endometrial A LIVING 134 2009 TCGA-D1-A17N-01 TCGA-D1-A17N-01A-21-A164-20 2CC2A0B7-B673-4572-94CA-C7FEDD1DB0AC TCGA-D1-A17N-01A-11D-A12J-09 TCGA-D1-A17N-01A-11D-A12J-09 TCGA-D1-A17N-01A-11D-A12J-09 TCGA-D1-A17N-01 ab241aac-4962-4ccd-919c-140031a13dba TCGA-D1-A17N-01A-11D-A12G-01 TCGA-D1-A17N-01A-11D-A12G-01 TCGA-D1-A17N-01 TCGA-D1-A17N-01 TCGA-D1-A17N-01A-11D-A12K-05 ab241aac-4962-4ccd-919c-140031a13dba TCGA-D1-A17Q-01 MSI-L TCGA-D1-A17Q-01 Quiet C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 mutation cluster 11 TCGA-D1-A17Q TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 54 TCGA-D1-A17Q-F20277 TCGA-D1-A17Q TCGA-D1-A17Q-01A Stage IA NO -20015 434 0 54 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 169 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 130 NO Peri (6-12 months since last menstrual period) G2 NO false No TCGA-D1-A17Q.698079B6-EB07-4491-9672-4BDE4E5DAC49.pdf A17Q 12 negative TUMOR FREE 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES D1 0 0 29 Endometrial A LIVING 68 2009 TCGA-D1-A17Q-01 TCGA-D1-A17Q-01A-21-A164-20 5518E1C8-0CB5-4944-B0CD-C80DE1E1B87F TCGA-D1-A17Q-01A-11D-A12J-09 TCGA-D1-A17Q-01A-11D-A12J-09 TCGA-D1-A17Q-01 85b22bad-9b11-474f-9c87-5ddb98c76ccb TCGA-D1-A17Q-01A-11D-A12G-01 TCGA-D1-A17Q-01A-11D-A12G-01 TCGA-D1-A17Q-01 TCGA-D1-A17Q-01 TCGA-D1-A17Q-01A-11D-A12K-05 85b22bad-9b11-474f-9c87-5ddb98c76ccb TCGA-D1-A17R-01 MSI-H TCGA-D1-A17R-01 BRCA-LUAD+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 4 TCGA-D1-A17R TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 TCGA-D1-A17R-F20285 TCGA-D1-A17R TCGA-D1-A17R-01A Stage IA NO -21382 443 339 0 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 150 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G2 NO false No TCGA-D1-A17R.51598364-A609-4EBC-8500-53042C9E79E9.pdf A17R 5 negative TUMOR FREE 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES D1 0 0 11 Endometrial A DECEASED 126 2009 TCGA-D1-A17R-01 TCGA-D1-A17R-01A-21-A164-20 B75B6784-2F5F-4900-8541-D7AD05DA5233 TCGA-D1-A17R-01A-11D-A12J-09 TCGA-D1-A17R-01A-11D-A12J-09 TCGA-D1-A17R-01A-11D-A12J-09 TCGA-D1-A17R-01 e500f620-089f-4e15-ba8c-25c91e88e7e2 TCGA-D1-A17R-01A-11D-A12G-01 TCGA-D1-A17R-01A-11D-A12G-01 TCGA-D1-A17R-01 TCGA-D1-A17R-01 TCGA-D1-A17R-01A-11D-A12K-05 e500f620-089f-4e15-ba8c-25c91e88e7e2 TCGA-D1-A17S-01 MSS TCGA-D1-A17S-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 4 TCGA-D1-A17S TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 59 TCGA-D1-A17S-F20288 TCGA-D1-A17S TCGA-D1-A17S-01A Stage IA NO -21794 419 0 739 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 280 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A17S.54337BED-9366-4CB6-BA95-BB5999CBF342.pdf A17S 18 negative TUMOR FREE 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 0 52 Endometrial A LIVING 109 2009 TCGA-D1-A17S-01 TCGA-D1-A17S-01A-21-A164-20 3A7C1301-5B80-4043-97F5-99E5B02456A1 TCGA-D1-A17S-01A-11D-A12J-09 TCGA-D1-A17S-01A-11D-A12J-09 TCGA-D1-A17S-01A-11D-A12J-09 TCGA-D1-A17S-01 dcd43fa2-2529-47e6-9d9f-931cbf8d4da5 TCGA-D1-A17S-01A-11D-A12G-01 TCGA-D1-A17S-01A-11D-A12G-01 TCGA-D1-A17S-01 TCGA-D1-A17S-01 TCGA-D1-A17S-01A-11D-A12K-05 dcd43fa2-2529-47e6-9d9f-931cbf8d4da5 TCGA-D1-A17T-01 MSS TCGA-D1-A17T-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 3 mutation cluster 4 TCGA-D1-A17T TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 TCGA-D1-A17T-F20289 TCGA-D1-A17T TCGA-D1-A17T-01A Stage IA NO -24652 318 0 71 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 159 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 130 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A17T.D5927418-5A2B-477D-9917-7CE912628CA4.pdf A17T 25 TUMOR FREE 0 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES D1 0 0 24 Endometrial A LIVING 83 2010 TCGA-D1-A17T-01 TCGA-D1-A17T-01A-21-A164-20 A27DCED7-D683-4251-A4A8-A087059D6F19 TCGA-D1-A17T-01A-11D-A12J-09 TCGA-D1-A17T-01A-11D-A12J-09 TCGA-D1-A17T-01A-11D-A12J-09 TCGA-D1-A17T-01 2ede539e-5856-4781-bb6f-b1c6efbdf23d TCGA-D1-A17T-01A-11D-A12G-01 TCGA-D1-A17T-01A-11D-A12G-01 TCGA-D1-A17T-01 TCGA-D1-A17T-01 TCGA-D1-A17T-01A-11D-A12K-05 2ede539e-5856-4781-bb6f-b1c6efbdf23d TCGA-D1-A17U-01 MSI-H TCGA-D1-A17U-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 mutation cluster 1 TCGA-D1-A17U TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 4 TCGA-D1-A17U-F20293 TCGA-D1-A17U TCGA-D1-A17U-01A Stage IIIC2 NO -19544 314 0 697 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 168 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 210 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-D1-A17U.A0A4164D-FD8D-4472-BAFA-A036469E22CC.pdf A17U 100 negative TUMOR FREE 0 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO YES D1 4 9 0 3 Endometrial A LIVING 87 2010 TCGA-D1-A17U-01 TCGA-D1-A17U-01A-11-A164-20 0D4EB4B1-2250-4BFE-A2B0-CDC6AA7E7247 TCGA-D1-A17U-01A-21D-A12J-09 TCGA-D1-A17U-01A-21D-A12J-09 TCGA-D1-A17U-01A-21D-A12J-09 TCGA-D1-A17U-01 07508c27-8f79-414e-af9d-e78240df5c48 TCGA-D1-A17U-01A-21D-A12G-01 TCGA-D1-A17U-01A-21D-A12G-01 TCGA-D1-A17U-01 TCGA-D1-A17U-01 TCGA-D1-A17U-01A-21D-A12K-05 07508c27-8f79-414e-af9d-e78240df5c48 TCGA-D1-A1NS-01 MSI-H TCGA-D1-A1NS-01 Quiet C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 TCGA-D1-A1NS TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 53 TCGA-D1-A1NS-F21633 TCGA-D1-A1NS TCGA-D1-A1NS-01A Stage IA NO -19638 92 0 43 NO Scheduled Follow-up Submission 2012-2-16 FEMALE 178 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 220 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A1NS.FE397385-B600-4450-AE73-3CB62D5FEA3B.pdf A1NS 17 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 0 41 Endometrial A LIVING 126 2010 TCGA-D1-A1NS-01 TCGA-D1-A1NS-01A-21-A18Q-20 00339539-4450-4AD5-90AC-FDFE11DD167B TCGA-D1-A1NS-01 48ade293-84c9-41cf-97aa-c28bb4ac4ca6 TCGA-D1-A1NS-01A-11D-A14F-01 TCGA-D1-A1NS-01A-11D-A14F-01 TCGA-D1-A1NS-01 TCGA-D1-A1NS-01 TCGA-D1-A1NS-01A-11D-A14H-05 48ade293-84c9-41cf-97aa-c28bb4ac4ca6 TCGA-D1-A1NU-01 MSS TCGA-D1-A1NU-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 3 TCGA-D1-A1NU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 74 0 0 TCGA-D1-A1NU-F21638 TCGA-D1-A1NU TCGA-D1-A1NU-01A Stage IA NO -27272 87 0 402 NO Scheduled Follow-up Submission 2012-2-16 FEMALE 151 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Dilation and curettage procedure 120 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-D1-A1NU.08AE92E6-EDAB-4059-AF51-4A8522EDD463.pdf A1NU 16 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO YES D1 0 8 0 37 Endometrial A LIVING 93 2010 TCGA-D1-A1NU-01 TCGA-D1-A1NU-01A-21-A18Q-20 8E2D8E73-9940-4E05-8463-D5174A602B15 TCGA-D1-A1NU-01A-11D-A14G-09 TCGA-D1-A1NU-01A-11D-A14G-09 TCGA-D1-A1NU-01A-11D-A14G-09 TCGA-D1-A1NU-01 543b9907-bf2a-4f64-b83f-13cc4289310b TCGA-D1-A1NU-01A-11D-A14F-01 TCGA-D1-A1NU-01A-11D-A14F-01 TCGA-D1-A1NU-01 TCGA-D1-A1NU-01 TCGA-D1-A1NU-01A-11D-A14H-05 543b9907-bf2a-4f64-b83f-13cc4289310b TCGA-D1-A1NW-01 MSI-L TCGA-D1-A1NW-01 Squamous UCEC Serous c4 cluster 3 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-D1-A1NW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 72 0 2 TCGA-D1-A1NW-F21642 TCGA-D1-A1NW TCGA-D1-A1NW-01A Stage IVB NO -26556 199 0 22 NO Scheduled Follow-up Submission 2012-2-12 FEMALE 160 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Dilation and curettage procedure 80 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-D1-A1NW.10E1E872-408C-458D-9438-00F5ECA3083A.pdf A1NW 0 positive TUMOR FREE 0 0 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 2 26 0 36 Endometrial A LIVING 98 2010 TCGA-D1-A1NW-01 TCGA-D1-A1NW-01 35759844-0020-4b37-bd5a-ede870b7f0ab TCGA-D1-A1NW-01A-11D-A14J-01 TCGA-D1-A1NW-01A-11D-A14J-01 TCGA-D1-A1NW-01 TCGA-D1-A1NW-01 TCGA-D1-A1NW-01A-11D-A14N-05 35759844-0020-4b37-bd5a-ede870b7f0ab TCGA-D1-A1NX-01 MSS TCGA-D1-A1NX-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 3 TCGA-D1-A1NX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Partial Response 66 0 13 TCGA-D1-A1NX-F21565 TCGA-D1-A1NX Stage IIIC NO -24441 0 555 476 NO Scheduled Follow-up Submission 2012-2-15 FEMALE 159 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Dilation and curettage procedure Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Metastatic Supraclavicular lymphnodes YES No A1NX 95 positive WITH TUMOR 0 8 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO YES D1 13 23 8 39 Endometrial LIVING 87 2010 TCGA-D1-A1NX-01 TCGA-D1-A1NX-01A-11D-A16D-09 TCGA-D1-A1NX-01A-11D-A16D-09 TCGA-D1-A1NX-01 d04855a8-fdd2-464c-967d-1a58e530539f TCGA-D1-A1NX-01A-11D-A16C-01 TCGA-D1-A1NX-01A-11D-A16C-01 TCGA-D1-A1NX-01 TCGA-D1-A1NX-01 TCGA-D1-A1NX-01A-11D-A16G-05 d04855a8-fdd2-464c-967d-1a58e530539f TCGA-D1-A1NY-01 MSI-H TCGA-D1-A1NY-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 TCGA-D1-A1NY TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 0 0 TCGA-D1-A1NY-F21629 TCGA-D1-A1NY TCGA-D1-A1NY-01A Stage IB NO -24683 199 0 513 NO Scheduled Follow-up Submission 2012-2-16 FEMALE 168 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 110 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-D1-A1NY.8F963009-F6C3-4F45-B714-0E96F5D5E526.pdf A1NY 85 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO YES D1 0 10 0 17 Endometrial A LIVING 97 2010 TCGA-D1-A1NY-01 TCGA-D1-A1NY-01A-21-A18Q-20 D5F226EC-8A5F-4393-B698-AF727D23D16C TCGA-D1-A1NY-01 e0397750-69a4-41ef-bcb0-70bc4b2d7c87 TCGA-D1-A1NY-01A-11D-A16C-01 TCGA-D1-A1NY-01A-11D-A16C-01 TCGA-D1-A1NY-01 TCGA-D1-A1NY-01 TCGA-D1-A1NY-01A-11D-A16G-05 e0397750-69a4-41ef-bcb0-70bc4b2d7c87 TCGA-D1-A1NZ-01 MSI-H TCGA-D1-A1NZ-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 squamous c3 UCEC-like c11 miRNA cluster 13 cluster 6 TCGA-D1-A1NZ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 TCGA-D1-A1NZ-F17383 TCGA-D1-A1NZ TCGA-D1-A1NZ-01A Stage IA NO -22027 191 0 548 NO Scheduled Follow-up Submission 2012-2-16 FEMALE 159 Endometrioid endometrial adenocarcinoma No Yes, I am currently taking menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 140 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A1NZ.0AFDCBC0-FA0A-4138-A0BE-E374AEB3CB25.pdf A1NZ 33 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 0 34 Endometrial A LIVING 90 2010 TCGA-D1-A1NZ-01 TCGA-D1-A1NZ-01A-11-A18Q-20 C38FA373-FEA7-4076-BBAA-5E7D6F2443AC TCGA-D1-A1NZ-01 e947ba64-793a-4462-9447-5c02a4a9ff39 TCGA-D1-A1NZ-01A-21D-A14F-01 TCGA-D1-A1NZ-01A-21D-A14F-01 TCGA-D1-A1NZ-01 TCGA-D1-A1NZ-01 TCGA-D1-A1NZ-01A-21D-A14H-05 e947ba64-793a-4462-9447-5c02a4a9ff39 TCGA-D1-A1O0-01 MSS TCGA-D1-A1O0-01 BRCA-LUAD+ UCEC non-CIMP c3 cluster 3 UCEC-like c11 miRNA cluster 12 cluster 5 TCGA-D1-A1O0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 77 0 0 TCGA-D1-A1O0-F21636 TCGA-D1-A1O0 TCGA-D1-A1O0-01A Stage IA NO -28162 195 0 63 YES Scheduled Follow-up Submission 2012-2-16 FEMALE 157 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 50 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-D1-A1O0.2F5CADA5-176C-4B9D-9660-53BE86B1CD39.pdf A1O0 5 negative TUMOR FREE 0 0 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 5 0 38 Endometrial A LIVING 117 2010 TCGA-D1-A1O0-01 TCGA-D1-A1O0-01 6eefe77a-d312-44fc-9b9e-7c3b439a7e23 TCGA-D1-A1O0-01A-11D-A17C-01 TCGA-D1-A1O0-01A-11D-A17C-01 TCGA-D1-A1O0-01 TCGA-D1-A1O0-01 TCGA-D1-A1O0-01A-11D-A17F-05 6eefe77a-d312-44fc-9b9e-7c3b439a7e23 TCGA-D1-A1O5-01 MSS TCGA-D1-A1O5-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 TCGA-D1-A1O5 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 61 TCGA-D1-A1O5-F21574 TCGA-D1-A1O5 TCGA-D1-A1O5-01A Stage IA NO -22580 174 0 458 NO Scheduled Follow-up Submission 2012-2-15 FEMALE 161 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 100 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A1O5.F8BEE46E-D0C9-4977-B1C3-DA87AF089B6D.pdf A1O5 8 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 0 20 Endometrial A LIVING 80 2010 TCGA-D1-A1O5-01 TCGA-D1-A1O5-01A-21-A18Q-20 E9F2117D-AFD1-418A-8580-70586444AB0A TCGA-D1-A1O5-01 7bc83c49-3fd8-4048-adf4-b461fcffcc00 TCGA-D1-A1O5-01A-11D-A14F-01 TCGA-D1-A1O5-01A-11D-A14F-01 TCGA-D1-A1O5-01 TCGA-D1-A1O5-01 TCGA-D1-A1O5-01A-11D-A14H-05 7bc83c49-3fd8-4048-adf4-b461fcffcc00 TCGA-D1-A1O7-01 MSI-H TCGA-D1-A1O7-01 Quiet UCEC CIMP c18 cluster 2 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-D1-A1O7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 TCGA-D1-A1O7-F21637 TCGA-D1-A1O7 TCGA-D1-A1O7-01A Stage IA NO -22037 154 0 32 YES Scheduled Follow-up Submission 2012-2-16 FEMALE 148 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 50 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-D1-A1O7.37C25226-AD56-487E-969B-1538E6E00A5D.pdf A1O7 5 TUMOR FREE 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES D1 0 0 Endometrial A LIVING 96 2010 TCGA-D1-A1O7-01 TCGA-D1-A1O7-01 00ea54c2-1043-4a7f-ae62-e2851eb94ba1 TCGA-D1-A1O7-01A-11D-A14F-01 TCGA-D1-A1O7-01A-11D-A14F-01 TCGA-D1-A1O7-01 TCGA-D1-A1O7-01 TCGA-D1-A1O7-01A-11D-A14H-05 00ea54c2-1043-4a7f-ae62-e2851eb94ba1 TCGA-D1-A1O8-01 MSS TCGA-D1-A1O8-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 RNA cluster 3 miRNA cluster 6 cluster 1 TCGA-D1-A1O8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 70 TCGA-D1-A1O8-F21635 TCGA-D1-A1O8 TCGA-D1-A1O8-01A Stage IIIC NO -25789 147 120 0 NO Scheduled Follow-up Submission 2012-2-16 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 200 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-D1-A1O8.8E7FDFD5-892F-4671-8172-FC2BFB800AE9.pdf A1O8 85 negative TUMOR FREE 0 3 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES D1 0 3 3 Endometrial A DECEASED 85 2010 TCGA-D1-A1O8-01 TCGA-D1-A1O8-01A-21-A18Q-20 B02713DD-EA3F-4965-B8E7-EF2B40F7A599 TCGA-D1-A1O8-01 980faf04-5313-4f74-99b7-ca004f698a93 TCGA-D1-A1O8-01A-11D-A14F-01 TCGA-D1-A1O8-01A-11D-A14F-01 TCGA-D1-A1O8-01 TCGA-D1-A1O8-01 TCGA-D1-A1O8-01A-11D-A14H-05 980faf04-5313-4f74-99b7-ca004f698a93 TCGA-D1-A2G0-01 MSI-H TCGA-D1-A2G0-01 Kirc+ UCEC CIMP c18 cluster 1 UCEC-like c5 miRNA c1uster 10 cluster 3 TCGA-D1-A2G0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 70 0 0 TCGA-D1-A2G0-F41534 TCGA-D1-A2G0 TCGA-D1-A2G0-01A Stage IB NO -25573 1416 0 1484 NO 2015-5-18 FEMALE 171 Mixed serous and endometrioid No NO C54.1 8441/3 C54.1 YES Dilation and curettage procedure 90 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true No TCGA-D1-A2G0.02872006-6F7E-4FB7-B1C2-1C5DD3199FE3.pdf A2G0 17 negative TUMOR FREE 0 0 2 R0 Primary Tumor 01 open 1995 NO YES D1 0 13 0 37 Endometrial A LIVING 73 2007 ca1b7ca7-5c8b-442d-ab3d-29bd16de1229 TCGA-D1-A2G0-01 ca1b7ca7-5c8b-442d-ab3d-29bd16de1229 TCGA-D1-A2G0-01A-21-A18Q-20 AF037631-DDA4-417C-9104-816BFE0B456F ca1b7ca7-5c8b-442d-ab3d-29bd16de1229 ca1b7ca7-5c8b-442d-ab3d-29bd16de1229 TCGA-D1-A2G0-01 TCGA-D1-A2G0-01A-11D-A17C-01 TCGA-D1-A2G0-01A-11D-A17C-01 TCGA-D1-A2G0-01 TCGA-D1-A2G0-01 TCGA-D1-A2G0-01A-11D-A17F-05 TCGA-D1-A2G5-01 MSI-H TCGA-D1-A2G5-01 Iq UCEC CIMP c18 cluster 2 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-D1-A2G5 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES 50 0 0 TCGA-D1-A2G5-F41443 TCGA-D1-A2G5 Stage IB NO -18322 0 1455 1122 1122 NO 2013-3-19 FEMALE 173 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Distant Metastasis omentum YES YES Yes A2G5 20 negative WITH TUMOR 0 1 NO 0 Complete Remission/Response Never Used YES Excisional Biopsy R0 R0 Primary Tumor 01 open 1995 NO YES D1 0 15 1 37 Endometrial LIVING 143 2007 TCGA-D1-A2G5-01 TCGA-D1-A2G5-01 c890843b-4712-4d9f-998d-8ddcb2c39c3c TCGA-D1-A2G5-01A-11D-A17C-01 TCGA-D1-A2G5-01A-11D-A17C-01 TCGA-D1-A2G5-01 TCGA-D1-A2G5-01 TCGA-D1-A2G5-01A-11D-A17F-05 c890843b-4712-4d9f-998d-8ddcb2c39c3c TCGA-D1-A2G6-01 MSI-H TCGA-D1-A2G6-01 BRCA-LUAD+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 4 TCGA-D1-A2G6 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 53 0 0 TCGA-D1-A2G6 TCGA-D1-A2G6-01A Stage IIIC -19547 1350 258 0 2011-6-2 FEMALE 168 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 130 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true No TCGA-D1-A2G6.3375E2AF-173B-4263-84A8-8535DF33BA69.pdf A2G6 94 positive WITH TUMOR 0 2 R0 Primary Tumor 01 open 1995 NO YES D1 0 20 2 30 Endometrial A DECEASED 80 2007 TCGA-D1-A2G6-01 TCGA-D1-A2G6-01A-21-A18Q-20 02777737-0116-4B62-95A0-2A2EBD4426B8 TCGA-D1-A2G6-01 ccc7b7d6-f3a1-48b7-a266-73080858257d TCGA-D1-A2G6-01A-11D-A17C-01 TCGA-D1-A2G6-01A-11D-A17C-01 TCGA-D1-A2G6-01 TCGA-D1-A2G6-01 TCGA-D1-A2G6-01A-11D-A17F-05 ccc7b7d6-f3a1-48b7-a266-73080858257d TCGA-D1-A2G7-01 MSS TCGA-D1-A2G7-01 Squamous C6-UCEC UCEC Serous c4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-D1-A2G7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 65 0 0 TCGA-D1-A2G7-F41607 TCGA-D1-A2G7 TCGA-D1-A2G7-01A Never Used Stage IB -23913 1339 1793 0 1365 YES 2015-5-18 FEMALE 164 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 110 NO NO Peri (6-12 months since last menstrual period) G3 NO true No TCGA-D1-A2G7.5D25FD0B-EEE9-435C-82C7-BC44B0758A14.pdf A2G7 8 negative TUMOR FREE 0 0 NO 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1995 NO YES D1 0 23 0 48 Endometrial A DECEASED 133 2007 TCGA-D1-A2G7-01 TCGA-D1-A2G7-01A-12-A18R-20 4874B9A7-5E58-4F1A-B972-582F6E39C71B TCGA-D1-A2G7-01 bddd28d0-8d22-4949-b890-9cd54a4a0f29 TCGA-D1-A2G7-01A-21D-A17U-01 TCGA-D1-A2G7-01A-21D-A17U-01 TCGA-D1-A2G7-01 TCGA-D1-A2G7-01 TCGA-D1-A2G7-01A-21D-A17Z-05 bddd28d0-8d22-4949-b890-9cd54a4a0f29 TCGA-D1-A3DA-01 MSI-L TCGA-D1-A3DA-01 Iq UCEC non-CIMP c3 UCEC-like c5 miRNA cluster 13 TCGA-D1-A3DA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 77 TCGA-D1-A3DA-F41456 TCGA-D1-A3DA TCGA-D1-A3DA-01A Stage IIIC1 NO -28142 128 0 483 NO 2013-3-27 FEMALE 152 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Excisional Biopsy 110 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-D1-A3DA.8F3D4AFC-2E70-4633-A58F-C98ED00A8964.pdf A3DA 17 positive TUMOR FREE YES 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO YES D1 0 19 1 34 Endometrial A LIVING 57 2011 21fd1035-30e0-4851-88c6-35d2693e6dcd TCGA-D1-A3DA-01 21fd1035-30e0-4851-88c6-35d2693e6dcd TCGA-D1-A3DA-01A-21-A23Z-20 9555CB48-3997-46E2-B1A5-228F8FCFA62E 21fd1035-30e0-4851-88c6-35d2693e6dcd 21fd1035-30e0-4851-88c6-35d2693e6dcd TCGA-D1-A3DA-01 TCGA-D1-A3DA-01A-12D-A20R-01 TCGA-D1-A3DA-01A-12D-A20R-01 TCGA-D1-A3DA-01 TCGA-D1-A3DA-01 TCGA-D1-A3DA-01A-12D-A212-05 TCGA-D1-A3DG-01 MSS TCGA-D1-A3DG-01 Squamous UCEC non-CIMP c3 UCEC-like c5 miRNA c1uster 10 TCGA-D1-A3DG TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 81 TCGA-D1-A3DG-F41478 TCGA-D1-A3DG TCGA-D1-A3DG-01A Stage IVB NO -29771 49 130 0 130 NO 2015-5-18 FEMALE 168 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Excisional Biopsy 140 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-D1-A3DG.97C44FFC-8D88-43DC-BCC9-F634151C7098.pdf A3DG 41 positive TUMOR FREE NO 3 Never Used NO R0 Primary Tumor 01 open 2009 NO YES D1 0 0 Endometrial A DECEASED 86 2011 11a0e295-f45e-4979-8317-10429d515d34 TCGA-D1-A3DG-01 11a0e295-f45e-4979-8317-10429d515d34 TCGA-D1-A3DG-01A-21-A23Z-20 F12A529F-E468-486B-8B4E-A1EBC92C1A73 11a0e295-f45e-4979-8317-10429d515d34 11a0e295-f45e-4979-8317-10429d515d34 TCGA-D1-A3DG-01 TCGA-D1-A3DG-01A-11D-A19X-01 TCGA-D1-A3DG-01A-11D-A19X-01 TCGA-D1-A3DG-01 TCGA-D1-A3DG-01 TCGA-D1-A3DG-01A-11D-A19Z-05 TCGA-D1-A3DH-01 MSS TCGA-D1-A3DH-01 High UCEC Serous c4 UCEC-like c5 miRNA c1uster 9 TCGA-D1-A3DH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 71 TCGA-D1-A3DH-F41531 TCGA-D1-A3DH TCGA-D1-A3DH-01A Stage IA NO -25935 43 0 573 YES 2015-5-18 FEMALE 168 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Excisional Biopsy 150 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-D1-A3DH.C63CF985-CF78-42EE-A7A2-22083FED571D.pdf A3DH 11 negative TUMOR FREE NO 4+ Complete Remission/Response YES R0 Primary Tumor 01 open 2009 NO YES D1 0 14 0 48 Endometrial A LIVING 76 2011 8576f260-e8fb-4fbf-81ad-34fb4af302fd TCGA-D1-A3DH-01 8576f260-e8fb-4fbf-81ad-34fb4af302fd TCGA-D1-A3DH-01A-21-A23Z-20 2EFDF91C-E96E-4A86-BF0C-A275A9FF2BA0 8576f260-e8fb-4fbf-81ad-34fb4af302fd 8576f260-e8fb-4fbf-81ad-34fb4af302fd TCGA-D1-A3DH-01 TCGA-D1-A3DH-01A-11D-A19X-01 TCGA-D1-A3DH-01A-11D-A19X-01 TCGA-D1-A3DH-01 TCGA-D1-A3DH-01 TCGA-D1-A3DH-01A-11D-A19Z-05 TCGA-D1-A3JP-01 MSS TCGA-D1-A3JP-01 Squamous UCEC Serous c4 UCEC-like c5 miRNA cluster 4 TCGA-D1-A3JP TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 61 TCGA-D1-A3JP TCGA-D1-A3JP-01A Stage IA NO -22538 101 0 515 NO 2013-3-20 FEMALE 159 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 170 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true Yes TCGA-D1-A3JP.62290E86-409F-4590-AA2C-D3D2F77148FF.pdf A3JP 0 negative TUMOR FREE NO 2 Partial Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO YES D1 0 18 0 56 Endometrial A LIVING 59 2011 f579f0dc-d6e3-4960-9769-5038e69aa712 TCGA-D1-A3JP-01 f579f0dc-d6e3-4960-9769-5038e69aa712 TCGA-D1-A3JP-01A-21-A240-20 881675F5-0526-4D86-B58F-40868B7B36B1 f579f0dc-d6e3-4960-9769-5038e69aa712 f579f0dc-d6e3-4960-9769-5038e69aa712 TCGA-D1-A3JP-01A-31D-A227-01 TCGA-D1-A3JP-01A-31D-A227-01 TCGA-D1-A3JP-01 TCGA-D1-A3JP-01A-31D-A22B-05 TCGA-D1-A3JQ-01 MSS TCGA-D1-A3JQ-01 Squamous UCEC Serous c4 UCEC-like c5 miRNA cluster 14 TCGA-D1-A3JQ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 61 TCGA-D1-A3JQ-F41416 TCGA-D1-A3JQ TCGA-D1-A3JQ-01A Stage IIIC NO -22297 77 0 526 NO 2013-3-19 FEMALE 161 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 150 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-D1-A3JQ.2001A1EC-1385-4EB3-BC9E-7E48143FD663.pdf A3JQ 32 negative TUMOR FREE YES 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO YES D1 0 20 1 28 Endometrial A LIVING 121 2011 10c76952-15aa-44e9-8197-26529889bb6a TCGA-D1-A3JQ-01 10c76952-15aa-44e9-8197-26529889bb6a TCGA-D1-A3JQ-01A-21-A23Z-20 1EE04796-47C3-4BC2-8316-36ED0C56C6BB 10c76952-15aa-44e9-8197-26529889bb6a 10c76952-15aa-44e9-8197-26529889bb6a TCGA-D1-A3JQ-01 TCGA-D1-A3JQ-01A-11D-A227-01 TCGA-D1-A3JQ-01A-11D-A227-01 TCGA-D1-A3JQ-01 TCGA-D1-A3JQ-01 TCGA-D1-A3JQ-01A-11D-A22B-05 TCGA-DF-A2KN-01 MSI-H TCGA-DF-A2KN-01 Quiet UCEC CIMP c18 UCEC-like c5 miRNA cluster 5 TCGA-DF-A2KN TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response TCGA-DF-A2KN-F51114 TCGA-DF-A2KN TCGA-DF-A2KN-01A Stage IC NO 67 2013-11-7 FEMALE 152 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Tumor resection 200 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-DF-A2KN.A61CE064-B18B-429E-93F1-BA0FC06AB310.pdf A2KN TUMOR FREE NO Complete Remission/Response RX Primary Tumor 01 NO YES DF 0 0 20 Endometrial A LIVING 77 291167cc-8f00-47e1-abe2-72388c98170d TCGA-DF-A2KN-01 291167cc-8f00-47e1-abe2-72388c98170d TCGA-DF-A2KN-01A-21-A18R-20 B215AA1E-6DD0-48DE-BFED-181FC2612DBD 291167cc-8f00-47e1-abe2-72388c98170d 291167cc-8f00-47e1-abe2-72388c98170d TCGA-DF-A2KN-01 TCGA-DF-A2KN-01A-11D-A17U-01 TCGA-DF-A2KN-01A-11D-A17U-01 TCGA-DF-A2KN-01 TCGA-DF-A2KN-01 TCGA-DF-A2KN-01A-11D-A17Z-05 TCGA-DF-A2KR-01 MSS TCGA-DF-A2KR-01 High UCEC non-CIMP c3 miRNA c1uster 10 cluster 2 TCGA-DF-A2KR TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES Complete Response 84 TCGA-DF-A2KR-F49885 TCGA-DF-A2KR Stage IIIC NO -31007 2178 2113 NO 2013-10-14 FEMALE Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES endometrial biopsy, not otherwise specified Other method, specify: NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Lung New Primary Tumor NO YES No A2KR 70 TUMOR FREE 0 1 NO 0 Complete Remission/Response Never Used YES RX Primary Tumor 01 open NO YES DF 1 7 Endometrial LIVING b8e18fd7-ff5d-44b9-b977-945622d2a59e TCGA-DF-A2KR-01 b8e18fd7-ff5d-44b9-b977-945622d2a59e b8e18fd7-ff5d-44b9-b977-945622d2a59e b8e18fd7-ff5d-44b9-b977-945622d2a59e TCGA-DF-A2KR-01 TCGA-DF-A2KR-01A-11D-A17U-01 TCGA-DF-A2KR-01A-11D-A17U-01 TCGA-DF-A2KR-01 TCGA-DF-A2KR-01 TCGA-DF-A2KR-01A-11D-A17Z-05 TCGA-DF-A2KS-01 MSS TCGA-DF-A2KS-01 High C6-UCEC UCEC non-CIMP c3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 TCGA-DF-A2KS TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO Complete Response 69 TCGA-DF-A2KS-F72048 TCGA-DF-A2KS TCGA-DF-A2KS-01A Stage IB NO -25313 3318 2277 YES 2015-4-2 FEMALE Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES endometrial biopsy not otherwise specified Other method, specify: 120 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify New Primary Tumor colorectal YES YES false No TCGA-DF-A2KS.C6638C17-4F05-491F-86ED-6D7DDB1B8FDE.pdf A2KS 31 negative TUMOR FREE 0 0 NO 4+ Complete Remission/Response Never Used YES Surgical Resection RX Primary Tumor 01 Minimally Invasive NO YES DF 0 0 18 Endometrial A LIVING 66 TCGA-DF-A2KS-01 TCGA-DF-A2KS-01A-21-A23Z-20 905BD3B7-05F2-4DE8-B4A2-4D839BC28908 TCGA-DF-A2KS-01 05a3cad5-b1a2-481d-a2b7-f0e80ec78ed2 TCGA-DF-A2KS-01A-11D-A18N-01 TCGA-DF-A2KS-01A-11D-A18N-01 TCGA-DF-A2KS-01 TCGA-DF-A2KS-01 TCGA-DF-A2KS-01A-11D-A18O-05 05a3cad5-b1a2-481d-a2b7-f0e80ec78ed2 TCGA-DF-A2KU-01 MSI-L TCGA-DF-A2KU-01 Kirc+ UCEC CIMP c18 UCEC-like c5 miRNA cluster 13 TCGA-DF-A2KU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response TCGA-DF-A2KU-F72047 TCGA-DF-A2KU TCGA-DF-A2KU-01A Stage IB NO 3067 NO 2015-4-2 FEMALE Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 380 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-DF-A2KU.6F425E9F-E02A-4EFB-A0DE-00BF09D9BB98.pdf A2KU 8 negative TUMOR FREE 0 0 NO 2 Complete Remission/Response Never Used YES RX Primary Tumor 01 open NO YES DF 0 0 9 Endometrial A LIVING ee0873f1-b89d-44ef-9aad-d40c5a8999f1 TCGA-DF-A2KU-01 ee0873f1-b89d-44ef-9aad-d40c5a8999f1 TCGA-DF-A2KU-01A-21-A18R-20 E3626449-4A3F-4515-972E-CBCB111BE320 ee0873f1-b89d-44ef-9aad-d40c5a8999f1 ee0873f1-b89d-44ef-9aad-d40c5a8999f1 TCGA-DF-A2KU-01 TCGA-DF-A2KU-01A-11D-A17U-01 TCGA-DF-A2KU-01A-11D-A17U-01 TCGA-DF-A2KU-01 TCGA-DF-A2KU-01 TCGA-DF-A2KU-01A-11D-A17Z-05 TCGA-DF-A2KV-01 MSS TCGA-DF-A2KV-01 Quiet UCEC non-CIMP c3 UCEC-like c5 miRNA c1uster 10 TCGA-DF-A2KV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 55 TCGA-DF-A2KV-F66260 TCGA-DF-A2KV TCGA-DF-A2KV-01A Stage IB NO -20160 0 2717 NO 2014-10-7 FEMALE Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Cytology (e.g. Peritoneal or pleural fluid) 580 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-DF-A2KV.5717937B-AC81-452E-9B4D-3301FDA7CD0B.pdf A2KV 21 negative TUMOR FREE 0 0 0 RX Primary Tumor 01 open NO YES DF 0 0 21 Endometrial A LIVING 5378bbbf-3ddf-43bf-824d-fcb46028f571 TCGA-DF-A2KV-01 5378bbbf-3ddf-43bf-824d-fcb46028f571 TCGA-DF-A2KV-01A-21-A18R-20 6A4B246D-F732-4F90-8197-0BE951D9C954 5378bbbf-3ddf-43bf-824d-fcb46028f571 5378bbbf-3ddf-43bf-824d-fcb46028f571 TCGA-DF-A2KV-01 TCGA-DF-A2KV-01A-11D-A17U-01 TCGA-DF-A2KV-01A-11D-A17U-01 TCGA-DF-A2KV-01 TCGA-DF-A2KV-01 TCGA-DF-A2KV-01A-11D-A17Z-05 TCGA-DF-A2KY-01 MSI-H TCGA-DF-A2KY-01 Kirc+ BRCA CIMP c7 BRCA basal-like c6 miRNA c1uster 9 TCGA-DF-A2KY TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 49 0 0 TCGA-DF-A2KY TCGA-DF-A2KY-01A Stage IVA -18086 0 332 2014-6-20 FEMALE Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Hysteroscopy and endometrial ablation Other method, specify: 960 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 false No TCGA-DF-A2KY.8A35F74A-AFA4-4B2D-931B-FA2DE895F010.pdf A2KY 73.3 WITH TUMOR 0 1 YES NO R1 Primary Tumor 01 open 2009 NO YES DF 0 0 1 12 Endometrial A LIVING 872ef409-1ec0-4856-859c-37be70ebce35 TCGA-DF-A2KY-01 872ef409-1ec0-4856-859c-37be70ebce35 TCGA-DF-A2KY-01A-41-A23Z-20 2CC0B84B-C141-4904-9895-9906F40CFB08 872ef409-1ec0-4856-859c-37be70ebce35 872ef409-1ec0-4856-859c-37be70ebce35 TCGA-DF-A2KY-01 TCGA-DF-A2KY-01A-21D-A20R-01 TCGA-DF-A2KY-01A-21D-A20R-01 TCGA-DF-A2KY-01 TCGA-DF-A2KY-01 TCGA-DF-A2KY-01A-21D-A212-05 TCGA-DF-A2KZ-01 MSI-H TCGA-DF-A2KZ-01 Iq UCEC CIMP c18 UCEC-like c5 miRNA cluster 13 TCGA-DF-A2KZ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 87 0 0 TCGA-DF-A2KZ TCGA-DF-A2KZ-01A Stage IB -31973 0 826 2014-6-11 FEMALE Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Tumor resection 450 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-DF-A2KZ.D69C73D1-1CEB-4AF5-AAF2-8E707EF4CA38.pdf A2KZ 25 negative TUMOR FREE 0 0 NO YES RX Primary Tumor 01 open 2009 NO YES DF 0 0 0 0 Endometrial A LIVING dff76521-f81c-4de8-9a80-d75d18fe7982 TCGA-DF-A2KZ-01 dff76521-f81c-4de8-9a80-d75d18fe7982 TCGA-DF-A2KZ-01A-21-A23Z-20 16936733-EEF7-44F7-9DC0-C1C8922C8ACA dff76521-f81c-4de8-9a80-d75d18fe7982 dff76521-f81c-4de8-9a80-d75d18fe7982 TCGA-DF-A2KZ-01 TCGA-DF-A2KZ-01A-11D-A20R-01 TCGA-DF-A2KZ-01A-11D-A20R-01 TCGA-DF-A2KZ-01 TCGA-DF-A2KZ-01 TCGA-DF-A2KZ-01A-11D-A212-05 TCGA-DF-A2L0-01 MSS TCGA-DF-A2L0-01 High UCEC non-CIMP c3 UCEC-like c5 miRNA cluster 5 TCGA-DF-A2L0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Progressive Disease 60 TCGA-DF-A2L0-F49841 TCGA-DF-A2L0 TCGA-DF-A2L0-01A Stage IIIC NO -22200 788 523 NO 2013-10-11 FEMALE 168 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES endometrial biopsy not otherwise specified Other method, specify: 520 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Distant Metastasis lymph nodes and retroperitoneal tissue NO YES false No TCGA-DF-A2L0.1679CA2C-86BF-41D1-96E1-62FC89D9AAA7.pdf A2L0 86 WITH TUMOR 0 5 YES 3 Complete Remission/Response Never Used YES RX Primary Tumor 01 open NO YES DF 0 5 17 Endometrial A DECEASED 95 60fc2e50-f36c-4074-879b-b5773d75a466 TCGA-DF-A2L0-01 60fc2e50-f36c-4074-879b-b5773d75a466 TCGA-DF-A2L0-01A-21-A18R-20 D58633C4-B72E-41B7-B8DC-2BBED3A4CD0C 60fc2e50-f36c-4074-879b-b5773d75a466 60fc2e50-f36c-4074-879b-b5773d75a466 TCGA-DF-A2L0-01 TCGA-DF-A2L0-01A-11D-A17U-01 TCGA-DF-A2L0-01A-11D-A17U-01 TCGA-DF-A2L0-01 TCGA-DF-A2L0-01 TCGA-DF-A2L0-01A-11D-A17Z-05 TCGA-DI-A0WH-01 MSI-H TCGA-DI-A0WH-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 mutation cluster 1 TCGA-DI-A0WH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 0 TCGA-DI-A0WH-F16112 TCGA-DI-A0WH TCGA-DI-A0WH-01A Former User Stage IB NO -23692 244 0 496 YES Scheduled Follow-up Submission 2011-9-13 FEMALE 173 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 180 NO G3 NO false No TCGA-DI-A0WH.3D6B2D82-2F6D-40E6-8138-4DBF33DE8BEF.pdf A0WH 15.6 TUMOR FREE 0 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 2009 NO NO YES DI 0 2 0 18 Endometrial A LIVING 107 2010 TCGA-DI-A0WH-01 TCGA-DI-A0WH-01A-21-A163-20 3F62FDDF-883B-41E2-8BA6-226563893CE0 TCGA-DI-A0WH-01A-12D-A12J-09 TCGA-DI-A0WH-01A-12D-A12J-09 TCGA-DI-A0WH-01A-12D-A12J-09 TCGA-DI-A0WH-01 46b06f7a-18ed-42a6-9cb9-75e6dc98b30e TCGA-DI-A0WH-01A-12D-A12G-01 TCGA-DI-A0WH-01A-12D-A12G-01 TCGA-DI-A0WH-01 TCGA-DI-A0WH-01 TCGA-DI-A0WH-01A-12D-A12K-05 46b06f7a-18ed-42a6-9cb9-75e6dc98b30e TCGA-DI-A1BU-01 MSI-H TCGA-DI-A1BU-01 Quiet UCEC non-CIMP c3 cluster 2 UCEC-like c5 miRNA cluster 6 cluster 1 TCGA-DI-A1BU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 55 0 0 TCGA-DI-A1BU-F20903 TCGA-DI-A1BU TCGA-DI-A1BU-01A Former User Stage IIB NO -20114 903 0 1195 NO Scheduled Follow-up Submission 2012-1-24 FEMALE 171 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES endometrial biopsy Other method, specify: 140 NO G3 NO false No TCGA-DI-A1BU.18A286FD-E85B-48FC-B193-456AB10D24B9.pdf A1BU 15.8 TUMOR FREE 0 0 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 2009 YES NO YES DI 0 6 0 25 Endometrial A LIVING 93 2008 60728ff8-1098-4ed9-9cc0-b3d5523736d3 TCGA-DI-A1BU-01 60728ff8-1098-4ed9-9cc0-b3d5523736d3 TCGA-DI-A1BU-01A-21-A18Q-20 11A1BC6D-8970-4733-A5F1-EE1D9E0821C3 60728ff8-1098-4ed9-9cc0-b3d5523736d3 60728ff8-1098-4ed9-9cc0-b3d5523736d3 TCGA-DI-A1BU-01 TCGA-DI-A1BU-01A-11D-A134-01 TCGA-DI-A1BU-01A-11D-A134-01 TCGA-DI-A1BU-01 TCGA-DI-A1BU-01 TCGA-DI-A1BU-01A-11D-A138-05 TCGA-DI-A1BY-01 MSS TCGA-DI-A1BY-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 4 TCGA-DI-A1BY TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 TCGA-DI-A1BY-F20963 TCGA-DI-A1BY TCGA-DI-A1BY-01A Never Used Stage IIB NO -23113 989 0 1114 YES Scheduled Follow-up Submission 2012-1-25 FEMALE 155 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Uterine scrapings Other method, specify: 140 NO G2 NO false No TCGA-DI-A1BY.8B96371D-5E42-461B-B7A2-AB9641D842CD.pdf A1BY 17 negative TUMOR FREE 0 0 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 2009 NO NO YES DI 0 0 6 Endometrial A LIVING 125 2008 TCGA-DI-A1BY-01 TCGA-DI-A1BY-01A-31-A18Q-20 F17216D8-4293-45BC-8FA3-73C8A69EA573 TCGA-DI-A1BY-01 4d54cfbb-2bb7-4a45-b870-7ac7c87cae5e TCGA-DI-A1BY-01A-21D-A134-01 TCGA-DI-A1BY-01A-21D-A134-01 TCGA-DI-A1BY-01 TCGA-DI-A1BY-01 TCGA-DI-A1BY-01A-21D-A138-05 4d54cfbb-2bb7-4a45-b870-7ac7c87cae5e TCGA-DI-A1C3-01 MSS TCGA-DI-A1C3-01 Quiet UCEC non-CIMP c3 cluster 4 miRNA cluster 13 cluster 4 TCGA-DI-A1C3 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 38 TCGA-DI-A1C3-F20968 TCGA-DI-A1C3 TCGA-DI-A1C3-01A Never Used Stage IB NO -13885 755 0 739 YES Scheduled Follow-up Submission 2012-1-25 FEMALE 171 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES polyp removal Other method, specify: 170 NO G2 NO false No TCGA-DI-A1C3.63A6706E-823B-456E-A3BC-65755C07CF62.pdf A1C3 8.6 TUMOR FREE 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 2009 NO NO YES DI 0 0 Endometrial A LIVING 144 2008 016f584a-453b-4e91-a311-0c0120e127d0 TCGA-DI-A1C3-01 016f584a-453b-4e91-a311-0c0120e127d0 016f584a-453b-4e91-a311-0c0120e127d0 016f584a-453b-4e91-a311-0c0120e127d0 TCGA-DI-A1C3-01 TCGA-DI-A1C3-01A-41D-A134-01 TCGA-DI-A1C3-01A-41D-A134-01 TCGA-DI-A1C3-01 TCGA-DI-A1C3-01 TCGA-DI-A1C3-01A-41D-A138-05 TCGA-DI-A1NN-01 MSS TCGA-DI-A1NN-01 High C6-UCEC OV-like c1 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-DI-A1NN TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO YES Complete Response 63 0 2 TCGA-DI-A1NN-F19104 TCGA-DI-A1NN TCGA-DI-A1NN-01A Stage IIIC NO 1023 -23026 813 0 1076 1023 NO Scheduled Follow-up Submission 2011-12-2 FEMALE 173 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 300 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Metastatic vagina YES false No TCGA-DI-A1NN.EBBDE504-29C9-4662-8D06-44E8CBAD0741.pdf A1NN 3 WITH TUMOR 0 0 2 Complete Remission/Response Never Used NO Excisional Biopsy R2 R0 Primary Tumor 01 Minimally Invasive 1988 YES NO YES DI 2 9 0 10 Endometrial A LIVING 71 2008 TCGA-DI-A1NN-01 TCGA-DI-A1NN-01A-21-A18Q-20 CF1A7C5B-632B-4792-AA34-E10E967EC882 TCGA-DI-A1NN-01A-11D-A16D-09 TCGA-DI-A1NN-01A-11D-A16D-09 TCGA-DI-A1NN-01A-11D-A16D-09 TCGA-DI-A1NN-01 1857cddd-76d1-403b-a14e-f14d0781f68b TCGA-DI-A1NN-01A-11D-A16C-01 TCGA-DI-A1NN-01A-11D-A16C-01 TCGA-DI-A1NN-01 TCGA-DI-A1NN-01 TCGA-DI-A1NN-01A-11D-A16G-05 1857cddd-76d1-403b-a14e-f14d0781f68b TCGA-DI-A1NN-11 MSS TCGA-DI-A1NN-11 C6-UCEC mutation cluster 5 TCGA-DI-A1NN TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO YES Complete Response 63 0 2 TCGA-DI-A1NN-F19104 TCGA-DI-A1NN TCGA-DI-A1NN-11A Stage IIIC NO 1023 -23026 813 0 1076 1023 NO Scheduled Follow-up Submission 2011-12-2 FEMALE 173 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 100 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Metastatic vagina YES false No A1NN 3 WITH TUMOR 0 0 2 Complete Remission/Response Never Used NO Excisional Biopsy R2 R0 Solid Tissue Normal 11 Minimally Invasive 1988 YES NO YES DI 2 9 0 10 Endometrial A LIVING 71 2008 TCGA-DI-A1NN-11A-21D-A16G-05 TCGA-DI-A1NO-01 MSS TCGA-DI-A1NO-01 Squamous C6-UCEC OV-like c1 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 TCGA-DI-A1NO TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 68 0 0 TCGA-DI-A1NO-F20801 TCGA-DI-A1NO TCGA-DI-A1NO-01A Never Used Stage IIIA NO -24996 688 285 0 YES Scheduled Follow-up Submission 2012-1-23 FEMALE 166 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 270 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-DI-A1NO.11CEAAB6-3853-48EB-94CE-1B11FEF45B4C.pdf A1NO 1.03 WITH TUMOR 0 0 1 Complete Remission/Response Never Used NO RX Primary Tumor 01 Minimally Invasive 2009 NO NO YES DI 0 0 0 2 Endometrial A DECEASED 122 2009 TCGA-DI-A1NO-01 TCGA-DI-A1NO-01A-21-A18Q-20 6DFFF5AA-3B22-4F41-9A2F-4F6E84237EF6 TCGA-DI-A1NO-01 272f94bc-ce8b-46ff-b13f-827bba6071d5 TCGA-DI-A1NO-01A-31D-A160-01 TCGA-DI-A1NO-01A-31D-A160-01 TCGA-DI-A1NO-01 TCGA-DI-A1NO-01 TCGA-DI-A1NO-01A-31D-A161-05 272f94bc-ce8b-46ff-b13f-827bba6071d5 TCGA-DI-A1NO-11 MSS TCGA-DI-A1NO-11 C6-UCEC TCGA-DI-A1NO TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 68 0 0 TCGA-DI-A1NO-F20801 TCGA-DI-A1NO TCGA-DI-A1NO-11A Never Used Stage IIIA NO -24996 688 285 0 YES Scheduled Follow-up Submission 2012-1-23 FEMALE 166 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 240 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No A1NO 1.03 WITH TUMOR 0 0 1 Complete Remission/Response Never Used NO RX Solid Tissue Normal 11 Minimally Invasive 2009 NO NO YES DI 0 0 0 2 Endometrial A DECEASED 122 2009 TCGA-DI-A1NO-11A-11D-A161-05 TCGA-DI-A2QT-01 MSS TCGA-DI-A2QT-01 BRCA-LUAD+ UCEC Serous c4 squamous c3 miRNA cluster 14 TCGA-DI-A2QT TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 51 0 10 TCGA-DI-A2QT TCGA-DI-A2QT-01A Stage IIIC -18835 1186 377 0 2011-8-26 FEMALE 156 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Dilation and curettage procedure 280 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-DI-A2QT.416DF035-67B0-4461-9523-EB4A4A1FBA5B.pdf A2QT 96 WITH TUMOR 0 7 R2 Primary Tumor 01 Minimally Invasive 1988 NO YES DI 10 10 7 15 Endometrial A DECEASED 62 2008 859fec54-ae79-44fa-8021-b6dd66d529da TCGA-DI-A2QT-01 859fec54-ae79-44fa-8021-b6dd66d529da TCGA-DI-A2QT-01A-21-A23Z-20 155C8C74-6540-4D84-B87D-F7619D143457 859fec54-ae79-44fa-8021-b6dd66d529da 859fec54-ae79-44fa-8021-b6dd66d529da TCGA-DI-A2QT-01 TCGA-DI-A2QT-01A-12D-A19X-01 TCGA-DI-A2QT-01A-12D-A19X-01 TCGA-DI-A2QT-01 TCGA-DI-A2QT-01 TCGA-DI-A2QT-01A-12D-A19Z-05 TCGA-DI-A2QU-01 MSS TCGA-DI-A2QU-01 Squamous C6-UCEC UCEC Serous c4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 TCGA-DI-A2QU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 67 TCGA-DI-A2QU TCGA-DI-A2QU-01A Stage IVB -24488 2296 946 0 2011-8-26 FEMALE 160 Endometrioid endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 240 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-DI-A2QU.43F1EE09-6F10-4BCE-A55C-147084A26999.pdf A2QU 0 WITH TUMOR 0 0 RX Primary Tumor 01 Minimally Invasive 1988 NO YES DI 0 0 6 Endometrial A DECEASED 93 2005 TCGA-DI-A2QU-01 TCGA-DI-A2QU-01A-21-A23Z-20 051E4CE2-ABE2-443D-B2A6-E030EF7A01BF TCGA-DI-A2QU-01 94746e57-a703-4b53-bcdc-11107424eb23 TCGA-DI-A2QU-01A-11D-A18N-01 TCGA-DI-A2QU-01A-11D-A18N-01 TCGA-DI-A2QU-01 TCGA-DI-A2QU-01 TCGA-DI-A2QU-01A-11D-A18O-05 94746e57-a703-4b53-bcdc-11107424eb23 TCGA-DI-A2QU-11 MSS TCGA-DI-A2QU-11 C6-UCEC TCGA-DI-A2QU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 67 TCGA-DI-A2QU TCGA-DI-A2QU-11A Stage IVB -24488 2296 946 0 2011-8-26 FEMALE 160 Endometrioid endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 230 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No A2QU 0 WITH TUMOR 0 0 RX Solid Tissue Normal 11 Minimally Invasive 1988 NO YES DI 0 0 6 Endometrial A DECEASED 93 2005 TCGA-DI-A2QU-11 8fefb116-ef42-4566-a5e3-8793ca8b7cda TCGA-DI-A2QU-11 TCGA-DI-A2QU-11A-11D-A18O-05 8fefb116-ef42-4566-a5e3-8793ca8b7cda TCGA-DI-A2QY-01 MSS TCGA-DI-A2QY-01 High UCEC Serous c4 UCEC-like c5 miRNA c1uster 10 TCGA-DI-A2QY TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 0 TCGA-DI-A2QY-F60669 TCGA-DI-A2QY TCGA-DI-A2QY-01A Never Used Stage IIB NO -23398 2957 3349 0 2797 NO 2014-6-13 FEMALE 160 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES endocervical smear Other method, specify: 120 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-DI-A2QY.C78D0C27-34C3-44C4-9814-94EEE8A8AB95.pdf A2QY 50 positive TUMOR FREE 0 0 YES 2 Complete Remission/Response Never Used YES RX Primary Tumor 01 Minimally Invasive 1988 NO YES DI 0 3 0 6 Endometrial A DECEASED 85 2003 ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927 TCGA-DI-A2QY-01 ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927 TCGA-DI-A2QY-01A-21-A23Z-20 3DD87696-1FE4-464E-8359-535C2AD8A78D ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927 ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927 TCGA-DI-A2QY-01 TCGA-DI-A2QY-01A-12D-A19X-01 TCGA-DI-A2QY-01A-12D-A19X-01 TCGA-DI-A2QY-01 TCGA-DI-A2QY-01 TCGA-DI-A2QY-01A-12D-A19Z-05 TCGA-DI-A2QY-11 MSS TCGA-DI-A2QY-11 TCGA-DI-A2QY TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 0 TCGA-DI-A2QY-F60669 TCGA-DI-A2QY TCGA-DI-A2QY-11A Never Used Stage IIB NO -23398 2957 3349 0 2797 NO 2014-6-13 FEMALE 160 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES endocervical smear Other method, specify: 110 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No A2QY 50 positive TUMOR FREE 0 0 YES 2 Complete Remission/Response Never Used YES RX Solid Tissue Normal 11 Minimally Invasive 1988 NO YES DI 0 3 0 6 Endometrial A DECEASED 85 2003 9ba4d4d3-4640-40b7-8a67-72f384858b93 9ba4d4d3-4640-40b7-8a67-72f384858b93 9ba4d4d3-4640-40b7-8a67-72f384858b93 9ba4d4d3-4640-40b7-8a67-72f384858b93 TCGA-DI-A2QY-11 TCGA-DI-A2QY-11 TCGA-DI-A2QY-11A-11D-A19Z-05 TCGA-E6-A1LX-01 MSI-L TCGA-E6-A1LX-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 2 TCGA-E6-A1LX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 40 0 TCGA-E6-A1LX-F20265 TCGA-E6-A1LX TCGA-E6-A1LX-01A Never Used Stage IB NO -14731 1539 0 711 NO Scheduled Follow-up Submission 2011-12-28 FEMALE 163 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Tumor resection 190 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 NO false No TCGA-E6-A1LX.73CEBF93-0E7C-4EF9-A695-AF489AF3F0F0.pdf A1LX 14 negative TUMOR FREE 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1988 NO NO YES E6 0 3 0 Endometrial A LIVING 2006 TCGA-E6-A1LX-01 TCGA-E6-A1LX-01A-21-A18Q-20 88FC93D5-1A22-484D-9087-828750CCE453 TCGA-E6-A1LX-01 ca056af5-cdea-498c-adaf-9550e8fb4336 TCGA-E6-A1LX-01A-11D-A14F-01 TCGA-E6-A1LX-01A-11D-A14F-01 TCGA-E6-A1LX-01 TCGA-E6-A1LX-01 TCGA-E6-A1LX-01A-11D-A14H-05 ca056af5-cdea-498c-adaf-9550e8fb4336 TCGA-E6-A1LZ-01 MSS TCGA-E6-A1LZ-01 High C6-UCEC UCEC non-CIMP c3 cluster 4 BRCA basal-like c6 UCEC-like c11 miRNA cluster 14 cluster 2 mutation cluster 8 TCGA-E6-A1LZ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 76 0 TCGA-E6-A1LZ-F69830 TCGA-E6-A1LZ TCGA-E6-A1LZ-01A Never Used Stage IA NO -28054 1233 0 2406 NO Scheduled Follow-up Submission 2015-1-21 FEMALE Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Tumor resection 350 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-E6-A1LZ.55F7B7D0-D30A-4E78-B91A-CE794784CA3C.pdf A1LZ negative TUMOR FREE 0 YES 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 1988 YES NO YES E6 0 5 0 26 Endometrial A LIVING 65 2007 TCGA-E6-A1LZ-01 TCGA-E6-A1LZ-01A-21-A18Q-20 89C5BBA0-431E-4A89-9FC5-A03ABB721615 TCGA-E6-A1LZ-01A-11D-A142-09 TCGA-E6-A1LZ-01A-11D-A142-09 TCGA-E6-A1LZ-01A-11D-A142-09 TCGA-E6-A1LZ-01 4f4a8bd9-c07f-4930-8600-349ab60a37a7 TCGA-E6-A1LZ-01A-11D-A141-01 TCGA-E6-A1LZ-01A-11D-A141-01 TCGA-E6-A1LZ-01 TCGA-E6-A1LZ-01 TCGA-E6-A1LZ-01A-11D-A145-05 4f4a8bd9-c07f-4930-8600-349ab60a37a7 TCGA-E6-A1M0-01 MSS TCGA-E6-A1M0-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 TCGA-E6-A1M0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 0 TCGA-E6-A1M0-F69833 TCGA-E6-A1M0 TCGA-E6-A1M0-01A Never Used Stage IIIC NO -20629 360 0 1793 NO Scheduled Follow-up Submission 2015-1-21 FEMALE 174 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Tumor resection 160 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-E6-A1M0.F1AF61FE-BF05-49E2-85DA-F4CE37596DEA.pdf A1M0 90 negative TUMOR FREE 2 YES 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 YES NO YES E6 0 5 2 13 Endometrial A LIVING 114 2010 TCGA-E6-A1M0-01 TCGA-E6-A1M0-01A-21-A18Q-20 95236C17-EA65-447B-A665-5EA84796E305 TCGA-E6-A1M0-01 e527020e-6b3f-4837-87d1-8f7ba68c19d6 TCGA-E6-A1M0-01A-11D-A141-01 TCGA-E6-A1M0-01A-11D-A141-01 TCGA-E6-A1M0-01 TCGA-E6-A1M0-01 TCGA-E6-A1M0-01A-11D-A145-05 e527020e-6b3f-4837-87d1-8f7ba68c19d6 TCGA-E6-A1M0-11 MSS TCGA-E6-A1M0-11 C6-UCEC TCGA-E6-A1M0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 0 TCGA-E6-A1M0-F69833 TCGA-E6-A1M0 Never Used Stage IIIC NO -20629 0 1793 NO Scheduled Follow-up Submission 2015-1-21 FEMALE 174 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Tumor resection NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO No A1M0 90 negative TUMOR FREE 2 YES 3 Complete Remission/Response Never Used NO R0 Solid Tissue Normal 11 open 2009 YES NO YES E6 0 5 2 13 Endometrial LIVING 114 2010 TCGA-E6-A1M0-11 a0c84298-852b-454f-aab8-fb64656834dc TCGA-E6-A1M0-11 TCGA-E6-A1M0-11A-11D-A145-05 a0c84298-852b-454f-aab8-fb64656834dc TCGA-E6-A2P8-01 MSI-H TCGA-E6-A2P8-01 Quiet UCEC CIMP c18 UCEC-like c5 miRNA cluster 5 TCGA-E6-A2P8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO NO Progressive Disease 53 0 TCGA-E6-A2P8-F33518 TCGA-E6-A2P8 TCGA-E6-A2P8-01A Stage IV NO -19448 254 72 0 60 NO Scheduled Follow-up Submission 2012-6-29 FEMALE 156 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 100 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Lung Metastatic YES true No TCGA-E6-A2P8.B67CD692-73B4-4A61-A65B-65964AA3ACF4.pdf A2P8 89.1 negative WITH TUMOR 1 2 Progressive Disease NO Primary Tumor 01 Minimally Invasive 2009 NO NO YES E6 0 0 1 1 Endometrial A DECEASED 76 2010 db3429ba-32b0-40ef-bc81-ad0a8b097610 TCGA-E6-A2P8-01 db3429ba-32b0-40ef-bc81-ad0a8b097610 TCGA-E6-A2P8-01A-21-A23Z-20 10DEABF1-C72A-400C-9CDF-E2CE69F8E2CA db3429ba-32b0-40ef-bc81-ad0a8b097610 db3429ba-32b0-40ef-bc81-ad0a8b097610 TCGA-E6-A2P8-01 TCGA-E6-A2P8-01A-11D-A19X-01 TCGA-E6-A2P8-01A-11D-A19X-01 TCGA-E6-A2P8-01 TCGA-E6-A2P8-01 TCGA-E6-A2P8-01A-11D-A19Z-05 TCGA-E6-A2P9-01 MSI-H TCGA-E6-A2P9-01 Iq UCEC CIMP c18 UCEC-like c5 miRNA cluster 7 TCGA-E6-A2P9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 65 0 TCGA-E6-A2P9-F68580 TCGA-E6-A2P9 TCGA-E6-A2P9-01A Stage IA NO -24088 189 0 1386 NO Scheduled Follow-up Submission 2014-12-1 FEMALE 173 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 230 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-E6-A2P9.EF7B01C4-0952-4FE8-B128-2A43FA31E6F5.pdf A2P9 20 negative TUMOR FREE 0 NO 4+ Complete Remission/Response YES RX Primary Tumor 01 Minimally Invasive 2009 NO NO YES E6 0 1 0 7 Endometrial A LIVING 125 2011 08576085-2f37-41fc-82f6-39d396d75862 TCGA-E6-A2P9-01 08576085-2f37-41fc-82f6-39d396d75862 TCGA-E6-A2P9-01A-21-A23Z-20 EB9A5DA6-7AD0-44F1-83F5-9389E73B6319 08576085-2f37-41fc-82f6-39d396d75862 08576085-2f37-41fc-82f6-39d396d75862 TCGA-E6-A2P9-01 TCGA-E6-A2P9-01A-11D-A19X-01 TCGA-E6-A2P9-01A-11D-A19X-01 TCGA-E6-A2P9-01 TCGA-E6-A2P9-01 TCGA-E6-A2P9-01A-11D-A19Z-05 TCGA-E6-A8L9-01 MSS TCGA-E6-A8L9-01 TCGA-E6-A8L9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 61 0 TCGA-E6-A8L9-F69832 TCGA-E6-A8L9 TCGA-E6-A8L9-01A Never Used Stage IB NO -22333 657 0 1013 YES 2015-1-21 FEMALE 162 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 200 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true Yes TCGA-E6-A8L9.40CB57C1-7E8C-45B0-BEDD-DFE531C9201E.pdf A8L9 1.92 negative TUMOR FREE 0 YES 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO YES E6 0 5 0 15 Endometrial A LIVING 78 2012 916cf47a-0100-4e01-a912-2e884777186f TCGA-E6-A8L9-01 916cf47a-0100-4e01-a912-2e884777186f 9B18D6BD-ECE6-49B4-A70E-92E1B8BC3153 916cf47a-0100-4e01-a912-2e884777186f 916cf47a-0100-4e01-a912-2e884777186f TCGA-E6-A8L9-01 TCGA-E6-A8L9-01A-21D-A37M-01 TCGA-E6-A8L9-01A-21D-A37M-01 TCGA-E6-A8L9-01 TCGA-E6-A8L9-01 TCGA-E6-A8L9-01A-21D-A37Q-05 TCGA-EC-A1NJ-01 MSI-H TCGA-EC-A1NJ-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-EC-A1NJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 73 TCGA-EC-A1NJ-F55852 TCGA-EC-A1NJ TCGA-EC-A1NJ-01A Never Used Stage IA NO -27002 60 0 488 NO Scheduled Follow-up Submission 2014-2-18 FEMALE 153 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Tumor resection 620 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-EC-A1NJ.8E02F7D6-EBE4-46CB-B05C-B41FDCDC1141.pdf A1NJ 33 negative TUMOR FREE 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO YES NO EC 0 0 Endometrial A LIVING 62 2010 TCGA-EC-A1NJ-01 TCGA-EC-A1NJ-01A-21-A18Q-20 42820F72-E240-43CF-B375-31A1021BB55A TCGA-EC-A1NJ-01 838b151f-4608-4981-89f3-0cba9ec540fb TCGA-EC-A1NJ-01A-31D-A14F-01 TCGA-EC-A1NJ-01A-31D-A14F-01 TCGA-EC-A1NJ-01 TCGA-EC-A1NJ-01 TCGA-EC-A1NJ-01A-31D-A14H-05 838b151f-4608-4981-89f3-0cba9ec540fb TCGA-EC-A1QX-01 MSI-H TCGA-EC-A1QX-01 Iq C6-UCEC UCEC CIMP c18 cluster 2 squamous c3 UCEC-like c11 miRNA cluster 4 cluster 2 TCGA-EC-A1QX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO YES Complete Response 71 TCGA-EC-A1QX-F48708 TCGA-EC-A1QX TCGA-EC-A1QX-01A Never Used Stage IB NO 219 -26259 81 0 224 219 YES Scheduled Follow-up Submission 2013-9-19 FEMALE 161 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 560 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 YES true No TCGA-EC-A1QX.0C3EABFA-0F72-47C9-9A8B-6B14F2CD2D12.pdf A1QX negative TUMOR FREE 2 Progressive Disease Never Used YES Surgical Resection RX R0 Primary Tumor 01 2009 YES YES NO EC 0 0 Endometrial A LIVING 90 2010 TCGA-EC-A1QX-01 TCGA-EC-A1QX-01A-21-A18Q-20 F29B5B7A-0EA1-4AE8-B1FD-5D48D671F757 TCGA-EC-A1QX-01 bfa1d102-0917-407f-a158-3125d4219c6c TCGA-EC-A1QX-01A-31D-A16C-01 TCGA-EC-A1QX-01A-31D-A16C-01 TCGA-EC-A1QX-01 TCGA-EC-A1QX-01 TCGA-EC-A1QX-01A-31D-A16G-05 bfa1d102-0917-407f-a158-3125d4219c6c TCGA-EC-A24G-01 MSI-H TCGA-EC-A24G-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 TCGA-EC-A24G TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 0 0 TCGA-EC-A24G-F40428 TCGA-EC-A24G TCGA-EC-A24G-01A Never Used Stage II NO -20857 78 0 511 NO Scheduled Follow-up Submission 2013-2-20 FEMALE 148 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 410 NO YES Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 NO true No TCGA-EC-A24G.5DE142C5-7A0D-4C5E-8EF6-2809B10378C4.pdf A24G 50 TUMOR FREE 0 0 YES 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 2009 YES YES NO EC 0 0 0 15 Endometrial A LIVING 93 2011 TCGA-EC-A24G-01 TCGA-EC-A24G-01A-21-A18R-20 98AB1F54-6633-42A9-B751-785CD6E9260C TCGA-EC-A24G-01 92f1d13e-3dbb-4a41-aac4-5887b50bc19f TCGA-EC-A24G-01A-11D-A16C-01 TCGA-EC-A24G-01A-11D-A16C-01 TCGA-EC-A24G-01 TCGA-EC-A24G-01 TCGA-EC-A24G-01A-11D-A16G-05 92f1d13e-3dbb-4a41-aac4-5887b50bc19f TCGA-EO-A1Y5-01 MSS TCGA-EO-A1Y5-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 2 cluster 2 mutation cluster 13 TCGA-EO-A1Y5 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 1 TCGA-EO-A1Y5-F56547 TCGA-EO-A1Y5 TCGA-EO-A1Y5-01A Never Used Stage IIIC2 NO -23251 223 0 327 NO 2014-2-12 FEMALE 161 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Dilation and curettage procedure 110 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A1Y5.B3A96371-1CD6-4B08-BDA5-C8CD7C7DE81F.pdf A1Y5 100 TUMOR FREE 8 YES 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO YES EO 1 1 8 17 Endometrial A LIVING 79 2010 TCGA-EO-A1Y5-01 TCGA-EO-A1Y5-01A-21-A18Q-20 C19E3960-24A6-4C23-8543-E58F9FD8338B TCGA-EO-A1Y5-01A-11D-A159-09 TCGA-EO-A1Y5-01A-11D-A159-09 TCGA-EO-A1Y5-01A-11D-A159-09 TCGA-EO-A1Y5-01 fd13e02a-4bfb-4aaa-bbf7-488660106a31 TCGA-EO-A1Y5-01A-11D-A160-01 TCGA-EO-A1Y5-01A-11D-A160-01 TCGA-EO-A1Y5-01 TCGA-EO-A1Y5-01 TCGA-EO-A1Y5-01A-11D-A161-05 fd13e02a-4bfb-4aaa-bbf7-488660106a31 TCGA-EO-A1Y7-01 MSS TCGA-EO-A1Y7-01 High UCEC non-CIMP c3 cluster 4 UCEC-like c5 miRNA cluster 12 cluster 5 TCGA-EO-A1Y7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES Stable Disease 65 0 TCGA-EO-A1Y7-F68567 TCGA-EO-A1Y7 TCGA-EO-A1Y7-01A Never Used Stage IB NO -24085 196 0 1495 880 NO 2014-11-26 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 140 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Lung Distant Metastasis NO YES false No TCGA-EO-A1Y7.88AABD4B-ECB4-4748-B59F-BD4AE0621BFB.pdf A1Y7 60 WITH TUMOR 0 YES 4+ Stable Disease Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES EO 0 8 0 3 Endometrial A LIVING 95 2010 4da7543e-f58a-46f1-bf94-834d4ce4cbff TCGA-EO-A1Y7-01 4da7543e-f58a-46f1-bf94-834d4ce4cbff TCGA-EO-A1Y7-01A-21-A18Q-20 F45FB2AE-1B5C-4470-8986-8E69124A46F2 4da7543e-f58a-46f1-bf94-834d4ce4cbff 4da7543e-f58a-46f1-bf94-834d4ce4cbff TCGA-EO-A1Y7-01 TCGA-EO-A1Y7-01A-11D-A160-01 TCGA-EO-A1Y7-01A-11D-A160-01 TCGA-EO-A1Y7-01 TCGA-EO-A1Y7-01 TCGA-EO-A1Y7-01A-11D-A161-05 TCGA-EO-A1Y8-01 MSS TCGA-EO-A1Y8-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 mutation cluster 3 TCGA-EO-A1Y8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 87 TCGA-EO-A1Y8-F56552 TCGA-EO-A1Y8 TCGA-EO-A1Y8-01A Never Used Stage IA NO -31971 204 0 1147 NO 2014-2-12 FEMALE 146 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 170 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A1Y8.61143E14-52BD-499F-901C-4BD1EA83DAC1.pdf A1Y8 40 TUMOR FREE 0 NO 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES EO 0 0 16 Endometrial A LIVING 58 2010 TCGA-EO-A1Y8-01 TCGA-EO-A1Y8-01A-21-A18Q-20 838C4AC7-EF01-4F07-A1BC-A8165A744583 TCGA-EO-A1Y8-01A-11D-A159-09 TCGA-EO-A1Y8-01A-11D-A159-09 TCGA-EO-A1Y8-01A-11D-A159-09 TCGA-EO-A1Y8-01 a1d4b9ef-6fe5-49b5-9bb5-686d253baa4c TCGA-EO-A1Y8-01A-11D-A160-01 TCGA-EO-A1Y8-01A-11D-A160-01 TCGA-EO-A1Y8-01 TCGA-EO-A1Y8-01 TCGA-EO-A1Y8-01A-11D-A161-05 a1d4b9ef-6fe5-49b5-9bb5-686d253baa4c TCGA-EO-A22R-01 MSI-L TCGA-EO-A22R-01 Kirc+ C6-UCEC UCEC CIMP c18 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 TCGA-EO-A22R TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 TCGA-EO-A22R-F62603 TCGA-EO-A22R TCGA-EO-A22R-01A Stage IB NO -20604 925 0 1878 YES 2014-9-25 FEMALE 168 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 130 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A22R.5B97D87A-5D28-417F-A942-21775156B46C.pdf A22R 51 negative TUMOR FREE 0 NO 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO YES EO 0 18 Endometrial A LIVING 88 2008 TCGA-EO-A22R-01 TCGA-EO-A22R-01A-21-A23Z-20 F7096155-7582-491D-BC2C-4C28A7AC90B3 TCGA-EO-A22R-01 21aa44a9-e23e-4ab9-aa35-6942b118b066 TCGA-EO-A22R-01A-11D-A18N-01 TCGA-EO-A22R-01A-11D-A18N-01 TCGA-EO-A22R-01 TCGA-EO-A22R-01 TCGA-EO-A22R-01A-11D-A18O-05 21aa44a9-e23e-4ab9-aa35-6942b118b066 TCGA-EO-A22R-11 MSI-L TCGA-EO-A22R-11 C6-UCEC TCGA-EO-A22R TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 TCGA-EO-A22R-F62603 TCGA-EO-A22R TCGA-EO-A22R-11A Stage IB NO -20604 1058 0 1878 YES 2014-9-25 FEMALE 168 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 70 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No A22R 51 negative TUMOR FREE 0 NO 4+ Complete Remission/Response Never Used YES R0 Solid Tissue Normal 11 open 2009 NO YES EO 0 18 Endometrial A LIVING 88 2008 TCGA-EO-A22R-11A-11D-A18O-05 TCGA-EO-A22S-01 MSI-H TCGA-EO-A22S-01 Quiet C6-UCEC UCEC CIMP c18 squamous c3 UCEC-like c11 miRNA cluster 12 TCGA-EO-A22S TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 0 TCGA-EO-A22S-F62595 TCGA-EO-A22S TCGA-EO-A22S-01A Stage IB NO -21328 919 0 1872 NO 2014-8-13 FEMALE 156 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 100 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A22S.DB26485C-BE5C-4874-B79D-7FCFFFF70C4E.pdf A22S 51 TUMOR FREE 0 NO 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO YES EO 5 25 Endometrial A LIVING 84 2008 TCGA-EO-A22S-01 TCGA-EO-A22S-01A-21-A23Z-20 A71C8254-A31B-460C-8920-65EA0E6BE583 TCGA-EO-A22S-01 b8177a01-9ec3-47dc-a776-1794f693d9e7 TCGA-EO-A22S-01A-11D-A18N-01 TCGA-EO-A22S-01A-11D-A18N-01 TCGA-EO-A22S-01 TCGA-EO-A22S-01 TCGA-EO-A22S-01A-11D-A18O-05 b8177a01-9ec3-47dc-a776-1794f693d9e7 TCGA-EO-A22S-11 MSI-H TCGA-EO-A22S-11 C6-UCEC TCGA-EO-A22S TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 58 0 TCGA-EO-A22S-F62595 TCGA-EO-A22S TCGA-EO-A22S-11A Stage IB NO -21328 1052 0 1872 NO 2014-8-13 FEMALE 156 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 80 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No A22S 51 TUMOR FREE 0 NO 2 Complete Remission/Response Never Used YES R0 Solid Tissue Normal 11 open 2009 NO YES EO 5 25 Endometrial A LIVING 84 2008 TCGA-EO-A22S-11A-11D-A18O-05 TCGA-EO-A22T-01 MSI-H TCGA-EO-A22T-01 Kirc+ C6-UCEC UCEC CIMP c18 UCEC-like c5 UCEC-like c11 miRNA cluster 5 TCGA-EO-A22T TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 0 TCGA-EO-A22T-F62605 TCGA-EO-A22T TCGA-EO-A22T-01A Stage II NO -20608 916 0 2035 NO 2014-9-25 FEMALE 152 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 140 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A22T.1D5567D9-3015-452E-9888-2E67F91D6B20.pdf A22T 49 TUMOR FREE 0 NO 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO YES EO 11 0 19 Endometrial A LIVING 53 2008 TCGA-EO-A22T-01 TCGA-EO-A22T-01A-11-A23Z-20 DFC6F069-E4BA-4BD0-BBB4-4A40A3C98A0E TCGA-EO-A22T-01 fe8a344f-fc0b-415c-b388-c71e82b64703 TCGA-EO-A22T-01A-21D-A18N-01 TCGA-EO-A22T-01A-21D-A18N-01 TCGA-EO-A22T-01 TCGA-EO-A22T-01 TCGA-EO-A22T-01A-21D-A18O-05 fe8a344f-fc0b-415c-b388-c71e82b64703 TCGA-EO-A22T-11 MSI-H TCGA-EO-A22T-11 C6-UCEC TCGA-EO-A22T TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 0 TCGA-EO-A22T-F62605 TCGA-EO-A22T TCGA-EO-A22T-11A Stage II NO -20608 1049 0 2035 NO 2014-9-25 FEMALE 152 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 180 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No A22T 49 TUMOR FREE 0 NO 2 Complete Remission/Response Never Used YES R0 Solid Tissue Normal 11 open 2009 NO YES EO 11 0 19 Endometrial A LIVING 53 2008 TCGA-EO-A22T-11A-11D-A18O-05 TCGA-EO-A22U-01 MSI-H TCGA-EO-A22U-01 Quiet UCEC CIMP c18 UCEC-like c5 miRNA cluster 12 cluster 4 TCGA-EO-A22U TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 83 TCGA-EO-A22U-F62597 TCGA-EO-A22U TCGA-EO-A22U-01A Former User Stage IB NO -30557 758 0 1407 NO 2014-9-25 FEMALE 150 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 110 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A22U.DB7D72BC-F9C7-4726-98F4-A4F642B125C6.pdf A22U 51 negative TUMOR FREE NO 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES EO 0 0 Endometrial A LIVING 59 2009 3513c95d-9ea0-4c3b-9e8e-0f148231bc83 TCGA-EO-A22U-01 3513c95d-9ea0-4c3b-9e8e-0f148231bc83 TCGA-EO-A22U-01A-21-A18R-20 451C5655-3310-4746-895F-9038D36FE619 3513c95d-9ea0-4c3b-9e8e-0f148231bc83 3513c95d-9ea0-4c3b-9e8e-0f148231bc83 TCGA-EO-A22U-01 TCGA-EO-A22U-01A-11D-A17U-01 TCGA-EO-A22U-01A-11D-A17U-01 TCGA-EO-A22U-01 TCGA-EO-A22U-01 TCGA-EO-A22U-01A-11D-A17Z-05 TCGA-EO-A22X-01 MSS TCGA-EO-A22X-01 Kirc+ UCEC non-CIMP c3 UCEC-like c5 miRNA cluster 5 cluster 4 TCGA-EO-A22X TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 36 0 TCGA-EO-A22X-F56587 TCGA-EO-A22X TCGA-EO-A22X-01A Never Used Stage IIIA NO -13245 842 0 1752 2014-2-13 FEMALE 152 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 110 NO NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 NO false No TCGA-EO-A22X.4D919902-FBCE-4AAC-ACD2-38A2F1D8E901.pdf A22X 100 negative TUMOR FREE 0 YES Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO YES EO 0 10 0 26 Endometrial A LIVING 56 2008 ca6bff3c-e95e-42e6-8eff-76d66e8031b0 TCGA-EO-A22X-01 ca6bff3c-e95e-42e6-8eff-76d66e8031b0 TCGA-EO-A22X-01A-21-A18R-20 38F062A0-F499-4E30-A858-EC1133DD37E4 ca6bff3c-e95e-42e6-8eff-76d66e8031b0 ca6bff3c-e95e-42e6-8eff-76d66e8031b0 TCGA-EO-A22X-01 TCGA-EO-A22X-01A-11D-A17U-01 TCGA-EO-A22X-01A-11D-A17U-01 TCGA-EO-A22X-01 TCGA-EO-A22X-01 TCGA-EO-A22X-01A-11D-A17Z-05 TCGA-EO-A22Y-01 MSS TCGA-EO-A22Y-01 BRCA-LUAD+ UCEC CIMP c18 UCEC-like c5 miRNA cluster 5 cluster 4 TCGA-EO-A22Y TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 TCGA-EO-A22Y-F56824 TCGA-EO-A22Y TCGA-EO-A22Y-01A Never Used Stage IA NO -25127 692 0 1567 NO 2014-2-24 FEMALE Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 110 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A22Y.44F2A17C-265B-4C2A-9AA0-42C55A23B592.pdf A22Y 51 negative TUMOR FREE 0 NO 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO NO YES EO 0 33 Endometrial A LIVING 2009 24ee58d3-60c9-4808-b35a-2767594b83f8 TCGA-EO-A22Y-01 24ee58d3-60c9-4808-b35a-2767594b83f8 TCGA-EO-A22Y-01A-21-A18R-20 90125C27-8268-4C34-B4B1-3CA0B40FD3A5 24ee58d3-60c9-4808-b35a-2767594b83f8 24ee58d3-60c9-4808-b35a-2767594b83f8 TCGA-EO-A22Y-01 TCGA-EO-A22Y-01A-11D-A17U-01 TCGA-EO-A22Y-01A-11D-A17U-01 TCGA-EO-A22Y-01 TCGA-EO-A22Y-01 TCGA-EO-A22Y-01A-11D-A17Z-05 TCGA-EO-A2CG-01 MSS TCGA-EO-A2CG-01 High OV-like c1 UCEC-like c11 miRNA cluster 5 TCGA-EO-A2CG TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 69 0 TCGA-EO-A2CG-F56877 TCGA-EO-A2CG TCGA-EO-A2CG-01A Never Used Stage IA NO -25279 643 0 1564 NO 2014-2-25 FEMALE 152 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 60 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A2CG.CAF671DB-2DD1-43D5-99C8-185253775B37.pdf A2CG 49 negative TUMOR FREE 0 YES 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 YES YES EO 0 11 0 8 Endometrial A LIVING 68 2009 TCGA-EO-A2CG-01 TCGA-EO-A2CG-01 5f65a8b5-2460-4544-be71-5e7b7347b0fa TCGA-EO-A2CG-01A-12D-A17U-01 TCGA-EO-A2CG-01A-12D-A17U-01 TCGA-EO-A2CG-01 TCGA-EO-A2CG-01 TCGA-EO-A2CG-01A-12D-A17Z-05 5f65a8b5-2460-4544-be71-5e7b7347b0fa TCGA-EO-A2CH-01 MSS TCGA-EO-A2CH-01 Squamous C6-UCEC UCEC non-CIMP c3 UCEC-like c5 UCEC-like c11 miRNA cluster 1 TCGA-EO-A2CH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES NO Progressive Disease 73 TCGA-EO-A2CH-F70417 TCGA-EO-A2CH TCGA-EO-A2CH-01A Never Used Stage IVB NO -26966 802 590 0 413 YES 2015-2-12 FEMALE 152 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 80 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Lung Distant Metastasis NO YES false No TCGA-EO-A2CH.B4A5577E-C043-4D25-8D53-77A43C5EC0CC.pdf A2CH 51 WITH TUMOR YES 1 Progressive Disease Never Used NO R2 Primary Tumor 01 open 2009 YES NO YES EO 0 0 Endometrial A DECEASED 66 2009 TCGA-EO-A2CH-01 TCGA-EO-A2CH-01A-21-A18R-20 3CF90784-6646-4288-8671-ACE67B983808 TCGA-EO-A2CH-01 f9814b3c-60f3-4d83-885e-1e1a88e520a9 TCGA-EO-A2CH-01A-11D-A17U-01 TCGA-EO-A2CH-01A-11D-A17U-01 TCGA-EO-A2CH-01 TCGA-EO-A2CH-01 TCGA-EO-A2CH-01A-11D-A17Z-05 f9814b3c-60f3-4d83-885e-1e1a88e520a9 TCGA-EO-A3AS-01 MSS TCGA-EO-A3AS-01 Squamous UCEC non-CIMP c3 miRNA cluster 4 TCGA-EO-A3AS TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 86 TCGA-EO-A3AS-F38250 TCGA-EO-A3AS TCGA-EO-A3AS-01A Never Used Stage IA NO -31450 850 0 1046 NO 2013-1-31 FEMALE 147 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 70 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A3AS.844799B1-4C96-473A-8ECB-71ACB080F95E.pdf A3AS 49 TUMOR FREE NO 3 Complete Remission/Response Never Used NO Primary Tumor 01 open 2009 YES EO 0 0 Endometrial A LIVING 58 2009 0ce294d7-8111-474c-be3a-19195f5d49ab TCGA-EO-A3AS-01 0ce294d7-8111-474c-be3a-19195f5d49ab 0ce294d7-8111-474c-be3a-19195f5d49ab 0ce294d7-8111-474c-be3a-19195f5d49ab TCGA-EO-A3AS-01 TCGA-EO-A3AS-01A-11D-A19X-01 TCGA-EO-A3AS-01A-11D-A19X-01 TCGA-EO-A3AS-01 TCGA-EO-A3AS-01 TCGA-EO-A3AS-01A-11D-A19Z-05 TCGA-EO-A3AU-01 MSI-H TCGA-EO-A3AU-01 Quiet UCEC CIMP c18 UCEC-like c5 miRNA cluster 11 TCGA-EO-A3AU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO Complete Response 72 0 TCGA-EO-A3AU-F71141 TCGA-EO-A3AU TCGA-EO-A3AU-01A Stage II NO -26406 393 0 1543 1178 1178 YES 2015-3-18 FEMALE 150 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Endocervical curettage Other method, specify: 130 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Lung New Primary Tumor YES YES false No TCGA-EO-A3AU.B1D13355-6346-4FA4-950A-84114901515C.pdf A3AU 51 negative TUMOR FREE 1 YES 4+ Complete Remission/Response Never Used YES Surgical Resection R0 Primary Tumor 01 Minimally Invasive 2009 YES EO 1 14 Endometrial A LIVING 78 2010 f6c13e4d-5a10-48cc-8ce1-a535565b6006 TCGA-EO-A3AU-01 f6c13e4d-5a10-48cc-8ce1-a535565b6006 TCGA-EO-A3AU-01A-11-A23Z-20 6DB1614D-F39D-4DF2-9293-232B3CA6A975 f6c13e4d-5a10-48cc-8ce1-a535565b6006 f6c13e4d-5a10-48cc-8ce1-a535565b6006 TCGA-EO-A3AU-01 TCGA-EO-A3AU-01A-21D-A19X-01 TCGA-EO-A3AU-01A-21D-A19X-01 TCGA-EO-A3AU-01 TCGA-EO-A3AU-01 TCGA-EO-A3AU-01A-21D-A19Z-05 TCGA-EO-A3AV-01 MSS TCGA-EO-A3AV-01 Kirc+ UCEC non-CIMP c3 BRCA basal-like c6 miRNA cluster 4 TCGA-EO-A3AV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 51 0 TCGA-EO-A3AV-F48634 TCGA-EO-A3AV TCGA-EO-A3AV-01A Stage IIIC1 NO -18713 407 0 1069 NO 2013-9-18 FEMALE 158 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 130 NO NO Peri (6-12 months since last menstrual period) G3 NO false No TCGA-EO-A3AV.9FF6FADC-4F38-41A2-8B96-24CB1EB2010E.pdf A3AV 51 negative TUMOR FREE 6 YES Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES EO 3 6 33 Endometrial A LIVING 45 2010 ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f TCGA-EO-A3AV-01 ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f TCGA-EO-A3AV-01A-21-A23Z-20 CAEF23A5-BEC8-4033-9A45-A2620497D282 ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f TCGA-EO-A3AV-01 TCGA-EO-A3AV-01A-12D-A19X-01 TCGA-EO-A3AV-01A-12D-A19X-01 TCGA-EO-A3AV-01 TCGA-EO-A3AV-01 TCGA-EO-A3AV-01A-12D-A19Z-05 TCGA-EO-A3AY-01 MSS TCGA-EO-A3AY-01 Quiet UCEC CIMP c18 UCEC-like c5 miRNA cluster 4 TCGA-EO-A3AY TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 58 TCGA-EO-A3AY-F71142 TCGA-EO-A3AY TCGA-EO-A3AY-01A Stage IB NO -21291 227 0 1158 1163 NO 2015-3-18 FEMALE 164 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 150 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Vaginal Vault YES false No TCGA-EO-A3AY.330AEFE0-D564-4799-8928-B05280BACA91.pdf A3AY 50 negative WITH TUMOR 0 NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES EO 0 25 Endometrial A LIVING 76 2011 8025c2b5-a137-4c88-9ac4-cc4be43e4f25 TCGA-EO-A3AY-01 8025c2b5-a137-4c88-9ac4-cc4be43e4f25 TCGA-EO-A3AY-01A-21-A23Z-20 018AE6E3-62FC-46D9-95F5-F114322C89D4 8025c2b5-a137-4c88-9ac4-cc4be43e4f25 8025c2b5-a137-4c88-9ac4-cc4be43e4f25 TCGA-EO-A3AY-01 TCGA-EO-A3AY-01A-12D-A19X-01 TCGA-EO-A3AY-01A-12D-A19X-01 TCGA-EO-A3AY-01 TCGA-EO-A3AY-01 TCGA-EO-A3AY-01A-12D-A19Z-05 TCGA-EO-A3AZ-01 MSI-H TCGA-EO-A3AZ-01 Squamous UCEC non-CIMP c3 UCEC-like c5 miRNA cluster 5 TCGA-EO-A3AZ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 80 TCGA-EO-A3AZ-F48635 TCGA-EO-A3AZ TCGA-EO-A3AZ-01A Never Used Stage IB NO -29234 241 0 826 NO 2013-9-18 FEMALE 140 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Dilation and curettage procedure 120 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A3AZ.EA5D2C1C-703B-46BE-8B16-C40CE4BA0B46.pdf A3AZ 51 negative TUMOR FREE NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO YES EO 0 0 Endometrial A LIVING 78 2011 78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f TCGA-EO-A3AZ-01 78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f TCGA-EO-A3AZ-01A-21-A23Z-20 FBF232C4-9838-4991-8623-DC86F7A60FC8 78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f 78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f TCGA-EO-A3AZ-01 TCGA-EO-A3AZ-01A-12D-A19X-01 TCGA-EO-A3AZ-01A-12D-A19X-01 TCGA-EO-A3AZ-01 TCGA-EO-A3AZ-01 TCGA-EO-A3AZ-01A-12D-A19Z-05 TCGA-EO-A3B0-01 MSS TCGA-EO-A3B0-01 Kirc+ UCEC CIMP c18 UCEC-like c5 miRNA cluster 5 TCGA-EO-A3B0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 43 2 TCGA-EO-A3B0-F71143 TCGA-EO-A3B0 TCGA-EO-A3B0-01A Former User Stage IIIC2 NO -15954 196 0 1412 NO 2015-3-18 FEMALE 152 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 160 NO NO Indeterminate (neither Pre or Postmenopausal) G3 NO false No TCGA-EO-A3B0.5B8CD9C0-148B-4421-AA68-C1F2DF7F9B28.pdf A3B0 TUMOR FREE 5 NO 2 [Discrepancy] Never Used NO RX Primary Tumor 01 open 2009 YES EO 3 7 Endometrial A LIVING 53 2011 cad7a685-cb28-44bf-ad8e-e4528a73f0b6 TCGA-EO-A3B0-01 cad7a685-cb28-44bf-ad8e-e4528a73f0b6 TCGA-EO-A3B0-01A-21-A23Z-20 31CAA926-B4B8-4574-A03C-893D2ED156B5 cad7a685-cb28-44bf-ad8e-e4528a73f0b6 cad7a685-cb28-44bf-ad8e-e4528a73f0b6 TCGA-EO-A3B0-01 TCGA-EO-A3B0-01A-12D-A19X-01 TCGA-EO-A3B0-01A-12D-A19X-01 TCGA-EO-A3B0-01 TCGA-EO-A3B0-01 TCGA-EO-A3B0-01A-12D-A19Z-05 TCGA-EO-A3B1-01 MSS TCGA-EO-A3B1-01 High UCEC Serous c4 squamous c3 miRNA cluster 4 TCGA-EO-A3B1 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 TCGA-EO-A3B1-F48637 TCGA-EO-A3B1 TCGA-EO-A3B1-01A Never Used Stage IB NO -23162 163 0 820 NO 2013-9-18 FEMALE 170 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 90 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A3B1.D3309430-5427-4FAD-BDD6-A6E9BABE29D2.pdf A3B1 51 TUMOR FREE 0 YES Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES EO 0 13 Endometrial A LIVING 93 2011 2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f TCGA-EO-A3B1-01 2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f TCGA-EO-A3B1-01A-21-A23Z-20 266FC9A2-C102-471E-B05A-2A596507E0FB 2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f 2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f TCGA-EO-A3B1-01 TCGA-EO-A3B1-01A-12D-A19X-01 TCGA-EO-A3B1-01A-12D-A19X-01 TCGA-EO-A3B1-01 TCGA-EO-A3B1-01 TCGA-EO-A3B1-01A-12D-A19Z-05 TCGA-EO-A3KU-01 MSS TCGA-EO-A3KU-01 High UCEC Serous c4 UCEC-like c5 miRNA c1uster 10 TCGA-EO-A3KU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 0 TCGA-EO-A3KU-F48646 TCGA-EO-A3KU TCGA-EO-A3KU-01A Never Used Stage II NO -25116 93 0 677 2013-9-18 FEMALE 163 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 110 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A3KU.B6945BE4-FA4A-4ED4-9233-B32123F41C95.pdf A3KU 0 TUMOR FREE 0 YES 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES EO 9 6 Endometrial A LIVING 65 2011 91238210-9f8d-4c09-8016-fd0a7d135023 TCGA-EO-A3KU-01 91238210-9f8d-4c09-8016-fd0a7d135023 TCGA-EO-A3KU-01A-21-A23Z-20 9615A8B1-9358-4C26-A89B-10112848D993 91238210-9f8d-4c09-8016-fd0a7d135023 91238210-9f8d-4c09-8016-fd0a7d135023 TCGA-EO-A3KU-01 TCGA-EO-A3KU-01A-11D-A227-01 TCGA-EO-A3KU-01A-11D-A227-01 TCGA-EO-A3KU-01 TCGA-EO-A3KU-01 TCGA-EO-A3KU-01A-11D-A22B-05 TCGA-EO-A3KW-01 MSS TCGA-EO-A3KW-01 High UCEC Serous c4 UCEC-like c5 miRNA cluster 4 TCGA-EO-A3KW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 72 TCGA-EO-A3KW-F39967 TCGA-EO-A3KW TCGA-EO-A3KW-01A Stage IA NO -26492 205 0 497 NO 2013-2-7 FEMALE 153 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 150 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A3KW.C1CFE3DE-628B-4C0F-881B-588C613498DA.pdf A3KW TUMOR FREE 0 YES 2 Complete Remission/Response YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES EO 0 21 Endometrial A LIVING 62 2011 eb279337-8251-4442-905c-8a4be743f057 TCGA-EO-A3KW-01 eb279337-8251-4442-905c-8a4be743f057 TCGA-EO-A3KW-01A-21-A23Z-20 E6BEBDFC-AE99-42FA-A673-C64C518F0EEA eb279337-8251-4442-905c-8a4be743f057 eb279337-8251-4442-905c-8a4be743f057 TCGA-EO-A3KW-01 TCGA-EO-A3KW-01A-11D-A227-01 TCGA-EO-A3KW-01A-11D-A227-01 TCGA-EO-A3KW-01 TCGA-EO-A3KW-01 TCGA-EO-A3KW-01A-11D-A22B-05 TCGA-EO-A3KX-01 MSI-H TCGA-EO-A3KX-01 Quiet UCEC CIMP c18 UCEC-like c5 miRNA cluster 12 TCGA-EO-A3KX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 80 TCGA-EO-A3KX-F71144 TCGA-EO-A3KX TCGA-EO-A3KX-01A Stage IA -29260 184 0 1170 YES 2015-3-18 FEMALE 145 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 150 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A3KX.BB1CD473-0D98-414E-801B-09037E1BF43E.pdf A3KX TUMOR FREE 0 NO Complete Remission/Response YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES EO 0 3 Endometrial A LIVING 44 2011 babc3b9e-a99f-490b-a277-ab4e6f6b5449 TCGA-EO-A3KX-01 babc3b9e-a99f-490b-a277-ab4e6f6b5449 TCGA-EO-A3KX-01A-21-A23Z-20 B61C7ED5-D259-4A39-BA2A-4E31ECB0BFB7 babc3b9e-a99f-490b-a277-ab4e6f6b5449 babc3b9e-a99f-490b-a277-ab4e6f6b5449 TCGA-EO-A3KX-01 TCGA-EO-A3KX-01A-11D-A227-01 TCGA-EO-A3KX-01A-11D-A227-01 TCGA-EO-A3KX-01 TCGA-EO-A3KX-01 TCGA-EO-A3KX-01A-11D-A22B-05 TCGA-EO-A3L0-01 MSS TCGA-EO-A3L0-01 Kirc+ UCEC CIMP c18 squamous c3 miRNA c1uster 10 TCGA-EO-A3L0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 76 0 TCGA-EO-A3L0-F71161 TCGA-EO-A3L0 TCGA-EO-A3L0-01A Stage IA NO -28003 422 0 1554 2015-3-19 FEMALE 159 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 110 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EO-A3L0.AD1F0EEC-20B6-416B-9728-BC103D2B3B87.pdf A3L0 49 TUMOR FREE 0 NO 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO YES EO 2 11 Endometrial A LIVING 110 2010 4383201e-ca97-4192-8e89-c63b10caaa0c TCGA-EO-A3L0-01 4383201e-ca97-4192-8e89-c63b10caaa0c TCGA-EO-A3L0-01A-21-A23Z-20 BA066AC9-3E99-41B7-913A-E6E05347406E 4383201e-ca97-4192-8e89-c63b10caaa0c 4383201e-ca97-4192-8e89-c63b10caaa0c TCGA-EO-A3L0-01 TCGA-EO-A3L0-01A-11D-A227-01 TCGA-EO-A3L0-01A-11D-A227-01 TCGA-EO-A3L0-01 TCGA-EO-A3L0-01 TCGA-EO-A3L0-01A-11D-A22B-05 TCGA-EY-A1G7-01 MSS TCGA-EY-A1G7-01 BRCA-LUAD+ C6-UCEC UCEC CIMP c18 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 TCGA-EY-A1G7 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO YES NO Partial Response 86 TCGA-EY-A1G7-F10982 TCGA-EY-A1G7 TCGA-EY-A1G7-01A Never Used Stage II NO -31603 1002 189 0 95 NO 2011-5-2 FEMALE 151 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Tumor resection 140 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 false Yes TCGA-EY-A1G7.2803014E-7E68-463F-BF3C-C5E4DF9FA421.pdf A1G7 96 negative WITH TUMOR 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 1988 NO NO YES EY 0 0 Endometrial A DECEASED 85 2008 TCGA-EY-A1G7-01 TCGA-EY-A1G7-01A-21-A18Q-20 73D5F538-13D4-4E09-B7EF-0746A72B4BC0 c3c8ccb3-db16-4cc6-b790-204473be0f25 TCGA-EY-A1G7-01A-11D-A13J-01 TCGA-EY-A1G7-01A-11D-A13J-01 TCGA-EY-A1G7-01 TCGA-EY-A1G7-01A-11D-A13K-05 c3c8ccb3-db16-4cc6-b790-204473be0f25 TCGA-EY-A1G8-01 MSS TCGA-EY-A1G8-01 Kirc+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 6 TCGA-EY-A1G8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 83 TCGA-EY-A1G8-F10562 TCGA-EY-A1G8 TCGA-EY-A1G8-01A Stage IB NO -30517 771 456 0 NO 2011-4-21 FEMALE 160 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Tumor resection 100 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-EY-A1G8.2454950F-8B3D-4690-98CA-B94C79F99552.pdf A1G8 38 negative TUMOR FREE 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES EY 0 40 Endometrial A DECEASED 49 2008 TCGA-EY-A1G8-01 TCGA-EY-A1G8-01A-21-A18Q-20 70FDD3EE-9591-401A-8AE0-EACA0BDE0FFA d653b50c-d568-48a1-bbed-5e36fbf525ac TCGA-EY-A1G8-01A-11D-A13J-01 TCGA-EY-A1G8-01A-11D-A13J-01 TCGA-EY-A1G8-01 TCGA-EY-A1G8-01A-11D-A13K-05 d653b50c-d568-48a1-bbed-5e36fbf525ac TCGA-EY-A1GC-01 MSS TCGA-EY-A1GC-01 High C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA cluster 14 cluster 3 TCGA-EY-A1GC TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 62 TCGA-EY-A1GC-F70253 TCGA-EY-A1GC TCGA-EY-A1GC-01A Stage IB NO -22656 519 0 1647 NO Scheduled Follow-up Submission 2015-2-2 FEMALE 167 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Tumor resection 290 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A1GC.62D18250-0D82-43AB-AADE-E152D6FF74BB.pdf A1GC 5 negative TUMOR FREE 0 NO 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES EY 0 0 24 Endometrial A LIVING 96 2009 TCGA-EY-A1GC-01 TCGA-EY-A1GC-01A-21-A18Q-20 58118A63-3A3A-4625-A75E-D8EDA915269A TCGA-EY-A1GC-01 b408b777-f98b-4660-b01b-89fa0c607c3b TCGA-EY-A1GC-01A-11D-A13J-01 TCGA-EY-A1GC-01A-11D-A13J-01 TCGA-EY-A1GC-01 TCGA-EY-A1GC-01 TCGA-EY-A1GC-01A-11D-A13K-05 b408b777-f98b-4660-b01b-89fa0c607c3b TCGA-EY-A1GD-01 MSS TCGA-EY-A1GD-01 Iq C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 3 TCGA-EY-A1GD TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 51 0 TCGA-EY-A1GD-F70252 TCGA-EY-A1GD TCGA-EY-A1GD-01A Former User Stage IA NO -18638 511 0 1639 NO Scheduled Follow-up Submission 2015-2-2 FEMALE 157 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Tumor resection 230 NO NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G1 NO false No TCGA-EY-A1GD.65C636F7-B24D-479C-A607-FEFEE7D7E30D.pdf A1GD 0 negative TUMOR FREE 0 NO 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES EY 0 3 0 20 Endometrial A LIVING 79 2009 TCGA-EY-A1GD-01 TCGA-EY-A1GD-01A-21-A18Q-20 482B940B-57EA-48B1-97D5-1F5F105A5829 TCGA-EY-A1GD-01 5d109d0e-7bc8-4d3e-898b-a48ab288a5ee TCGA-EY-A1GD-01A-11D-A13J-01 TCGA-EY-A1GD-01A-11D-A13J-01 TCGA-EY-A1GD-01 TCGA-EY-A1GD-01 TCGA-EY-A1GD-01A-11D-A13K-05 5d109d0e-7bc8-4d3e-898b-a48ab288a5ee TCGA-EY-A1GE-01 MSS TCGA-EY-A1GE-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 4 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 1 TCGA-EY-A1GE TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 0 TCGA-EY-A1GE-F19724 TCGA-EY-A1GE TCGA-EY-A1GE-01A Never Used Stage IA NO -24667 506 0 741 NO Scheduled Follow-up Submission 2011-12-21 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 410 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-EY-A1GE.432813D0-4B52-4941-940C-5725BCE4211A.pdf A1GE 0 negative TUMOR FREE 0 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES EY 0 10 0 27 Endometrial A LIVING 103 2009 TCGA-EY-A1GE-01 TCGA-EY-A1GE-01A-21-A18Q-20 D3FF0165-3783-4EA1-83CF-9A312E3A8EC0 TCGA-EY-A1GE-01 d2a5585a-76fe-4e69-bf8a-36553bf282fb TCGA-EY-A1GE-01A-11D-A13J-01 TCGA-EY-A1GE-01A-11D-A13J-01 TCGA-EY-A1GE-01 TCGA-EY-A1GE-01 TCGA-EY-A1GE-01A-11D-A13K-05 d2a5585a-76fe-4e69-bf8a-36553bf282fb TCGA-EY-A1GF-01 MSI-H TCGA-EY-A1GF-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-EY-A1GF TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 75 0 TCGA-EY-A1GF-F19725 TCGA-EY-A1GF TCGA-EY-A1GF-01A Never Used Stage IA NO -27450 504 0 826 NO Scheduled Follow-up Submission 2011-12-21 FEMALE 165 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 160 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-EY-A1GF.0C63BAC2-FD3E-49CB-A352-0B1653B78BDD.pdf A1GF 11 negative TUMOR FREE 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES EY 0 9 0 16 Endometrial A LIVING 71 2009 TCGA-EY-A1GF-01 TCGA-EY-A1GF-01A-21-A18Q-20 EE015F30-256C-40B7-9FEF-3545593179BB TCGA-EY-A1GF-01 e8d79b43-6ed3-40f4-854e-5fd23204381f TCGA-EY-A1GF-01A-11D-A13J-01 TCGA-EY-A1GF-01A-11D-A13J-01 TCGA-EY-A1GF-01 TCGA-EY-A1GF-01 TCGA-EY-A1GF-01A-11D-A13K-05 e8d79b43-6ed3-40f4-854e-5fd23204381f TCGA-EY-A1GH-01 MSS TCGA-EY-A1GH-01 BRCA-LUAD+ C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 3 TCGA-EY-A1GH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 70 TCGA-EY-A1GH-F19726 TCGA-EY-A1GH TCGA-EY-A1GH-01A Never Used Stage IA NO -25802 452 0 710 NO Scheduled Follow-up Submission 2011-12-21 FEMALE 170 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 280 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-EY-A1GH.29D738E9-2F8D-4909-A427-7C056859B89A.pdf A1GH 33 negative TUMOR FREE 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO NO YES EY 0 Endometrial A LIVING 117 2009 TCGA-EY-A1GH-01 TCGA-EY-A1GH-01A-21-A18Q-20 18E9DF4D-A21E-449E-8EE8-C2AD19BD4491 TCGA-EY-A1GH-01 55f89e0e-bb6b-40e0-bc85-602a011c764b TCGA-EY-A1GH-01A-11D-A13J-01 TCGA-EY-A1GH-01A-11D-A13J-01 TCGA-EY-A1GH-01 TCGA-EY-A1GH-01 TCGA-EY-A1GH-01A-11D-A13K-05 55f89e0e-bb6b-40e0-bc85-602a011c764b TCGA-EY-A1GI-01 MSS TCGA-EY-A1GI-01 Quiet C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA cluster 13 cluster 4 TCGA-EY-A1GI TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 52 TCGA-EY-A1GI-F19727 TCGA-EY-A1GI TCGA-EY-A1GI-01A Never Used Stage IB NO -19117 444 0 710 NO Scheduled Follow-up Submission 2011-12-21 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Excisional Biopsy 150 NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G2 NO false No TCGA-EY-A1GI.1D56F7CA-A3F0-4078-B8E3-A10CD97873D4.pdf A1GI 76 negative TUMOR FREE 0 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO NO YES EY 0 0 23 Endometrial A LIVING 69 2009 TCGA-EY-A1GI-01 TCGA-EY-A1GI-01A-21-A18Q-20 27280176-FA3E-4547-BC14-810694C91270 TCGA-EY-A1GI-01 e505cac9-a568-42db-bc67-d90af57e5265 TCGA-EY-A1GI-01A-11D-A13J-01 TCGA-EY-A1GI-01A-11D-A13J-01 TCGA-EY-A1GI-01 TCGA-EY-A1GI-01 TCGA-EY-A1GI-01A-11D-A13K-05 e505cac9-a568-42db-bc67-d90af57e5265 TCGA-EY-A1GJ-01 MSS TCGA-EY-A1GJ-01 High UCEC Serous c4 cluster 3 UCEC-like c5 miRNA cluster 13 cluster 6 TCGA-EY-A1GJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 73 0 TCGA-EY-A1GJ-F19728 TCGA-EY-A1GJ TCGA-EY-A1GJ-01A Never Used Stage IA NO -26715 434 0 727 YES Scheduled Follow-up Submission 2011-12-21 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 300 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A1GJ.505FE0B0-068C-4B2A-AA40-4657FB2E0425.pdf A1GJ 0 negative TUMOR FREE 0 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES NO EY 0 10 0 15 Endometrial A LIVING 85 2009 TCGA-EY-A1GJ-01A-21-A18Q-20 FC904AB6-4B55-45A7-896A-02CAD12E1C69 TCGA-EY-A1GJ-01 TCGA-EY-A1GJ-01A-12D-A141-01 TCGA-EY-A1GJ-01A-12D-A141-01 TCGA-EY-A1GJ-01 TCGA-EY-A1GJ-01A-12D-A145-05 TCGA-EY-A1GK-01 MSI-H TCGA-EY-A1GK-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 4 TCGA-EY-A1GK TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 74 0 TCGA-EY-A1GK-F19756 TCGA-EY-A1GK TCGA-EY-A1GK-01A Never Used Stage IB NO -27127 409 0 693 NO Scheduled Follow-up Submission 2011-12-22 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 120 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes TCGA-EY-A1GK.B5024D10-E23D-4B3B-8C54-13EBAA423A04.pdf A1GK 58 negative TUMOR FREE 0 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES NO EY 0 12 0 14 Endometrial A LIVING 105 2009 TCGA-EY-A1GK-01 TCGA-EY-A1GK-01A-21-A18Q-20 FE0AC1DE-B750-4B82-9B56-EE722A7064F0 TCGA-EY-A1GK-01 bfbb3c82-87b0-44b2-bf2c-5c9bdc318460 TCGA-EY-A1GK-01A-11D-A13J-01 TCGA-EY-A1GK-01A-11D-A13J-01 TCGA-EY-A1GK-01 TCGA-EY-A1GK-01 TCGA-EY-A1GK-01A-11D-A13K-05 bfbb3c82-87b0-44b2-bf2c-5c9bdc318460 TCGA-EY-A1GL-01 MSS TCGA-EY-A1GL-01 Kirc+ UCEC CIMP c18 cluster 1 UCEC-like c5 miRNA cluster 11 cluster 2 TCGA-EY-A1GL TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 51 0 TCGA-EY-A1GL-F70250 TCGA-EY-A1GL TCGA-EY-A1GL-01A Never Used Stage II NO -18761 366 0 1014 NO Scheduled Follow-up Submission 2015-2-2 FEMALE 173 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 300 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-EY-A1GL.449C1D9F-6A1F-4523-8C86-AFED911D95D4.pdf A1GL 83 negative TUMOR FREE 0 NO 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO YES NO EY 0 6 0 13 Endometrial A LIVING 73 2010 94120972-002e-4dbd-8bb1-7f41f05f2b0f TCGA-EY-A1GL-01 94120972-002e-4dbd-8bb1-7f41f05f2b0f TCGA-EY-A1GL-01A-21-A18Q-20 C3D4EF49-BDA0-4723-90CB-311EDDE0C900 94120972-002e-4dbd-8bb1-7f41f05f2b0f 94120972-002e-4dbd-8bb1-7f41f05f2b0f TCGA-EY-A1GL-01 TCGA-EY-A1GL-01A-11D-A13J-01 TCGA-EY-A1GL-01A-11D-A13J-01 TCGA-EY-A1GL-01 TCGA-EY-A1GL-01 TCGA-EY-A1GL-01A-11D-A13K-05 TCGA-EY-A1GM-01 MSS TCGA-EY-A1GM-01 COAD-READ C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 TCGA-EY-A1GM TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO Progressive Disease 60 0 TCGA-EY-A1GM-F70249 TCGA-EY-A1GM TCGA-EY-A1GM-01A Never Used Stage IIIA NO -22010 323 995 0 210 791 NO Scheduled Follow-up Submission 2015-2-2 FEMALE 157 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 140 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Locoregional Recurrence NO YES false No TCGA-EY-A1GM.C3599CB9-3B69-4083-AA2E-5BB52CF1ED93.pdf A1GM 33 positive WITH TUMOR 0 YES 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES YES NO EY 0 13 0 11 Endometrial A DECEASED 71 2010 TCGA-EY-A1GM-01 TCGA-EY-A1GM-01A-21-A18Q-20 2C36E07A-174A-4CBC-8CCD-AD830A4BB1DF TCGA-EY-A1GM-01 9713963c-c7c7-47a0-ba01-6710bd4e9fea TCGA-EY-A1GM-01A-12D-A14F-01 TCGA-EY-A1GM-01A-12D-A14F-01 TCGA-EY-A1GM-01 TCGA-EY-A1GM-01 TCGA-EY-A1GM-01A-12D-A14H-05 9713963c-c7c7-47a0-ba01-6710bd4e9fea TCGA-EY-A1GO-01 MSI-H TCGA-EY-A1GO-01 Squamous UCEC Serous c4 cluster 4 UCEC-like c5 miRNA c1uster 10 cluster 3 TCGA-EY-A1GO TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO YES Progressive Disease 65 0 TCGA-EY-A1GO-F19759 TCGA-EY-A1GO TCGA-EY-A1GO-01A Former User Stage IIIC1 NO 517 -23853 259 0 586 517 NO Scheduled Follow-up Submission 2011-12-22 FEMALE 156 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8380/3 C54.1 YES Tumor resection 100 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 Lung Metastatic YES false No TCGA-EY-A1GO.82216372-E1EF-47F2-B57A-25C1DCB24E5E.pdf A1GO 98 negative WITH TUMOR 1 2 Complete Remission/Response Never Used YES Other Method, Specify Below VATS Wedge resection RX R0 Primary Tumor 01 Minimally Invasive 2009 YES YES NO EY 0 6 1 17 Endometrial A LIVING 76 2010 8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7 TCGA-EY-A1GO-01 8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7 TCGA-EY-A1GO-01A-21-A18Q-20 DFCAEDA6-D463-4CE3-B9BD-66CC4B3F2C82 8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7 8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7 TCGA-EY-A1GO-01 TCGA-EY-A1GO-01A-11D-A14F-01 TCGA-EY-A1GO-01A-11D-A14F-01 TCGA-EY-A1GO-01 TCGA-EY-A1GO-01 TCGA-EY-A1GO-01A-11D-A14H-05 TCGA-EY-A1GP-01 MSS TCGA-EY-A1GP-01 BRCA-LUAD+ UCEC Serous c4 cluster 3 UCEC-like c5 miRNA cluster 13 cluster 6 TCGA-EY-A1GP TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 54 TCGA-EY-A1GP-F19766 TCGA-EY-A1GP TCGA-EY-A1GP-01A Never Used Stage IA NO -20011 262 0 573 YES Scheduled Follow-up Submission 2011-12-22 FEMALE 158 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 90 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-EY-A1GP.D9933BA3-3D3B-4B93-AD6C-22ED47C4DBB1.pdf A1GP 32 negative TUMOR FREE 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO YES NO EY 0 0 Endometrial A LIVING 72 2010 c3740105-aee5-42ef-94e9-50f6b242b7c8 TCGA-EY-A1GP-01 c3740105-aee5-42ef-94e9-50f6b242b7c8 TCGA-EY-A1GP-01A-21-A18Q-20 24AA478A-20A3-4B5D-BC07-A92892908608 c3740105-aee5-42ef-94e9-50f6b242b7c8 c3740105-aee5-42ef-94e9-50f6b242b7c8 TCGA-EY-A1GP-01 TCGA-EY-A1GP-01A-11D-A13J-01 TCGA-EY-A1GP-01A-11D-A13J-01 TCGA-EY-A1GP-01 TCGA-EY-A1GP-01 TCGA-EY-A1GP-01A-11D-A13K-05 TCGA-EY-A1GQ-01 MSI-H TCGA-EY-A1GQ-01 BRCA-LUAD+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 5 cluster 4 TCGA-EY-A1GQ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Partial Response 76 TCGA-EY-A1GQ-F13192 TCGA-EY-A1GQ TCGA-EY-A1GQ-01A Stage IB NO -27905 274 0 544 334 NO Additional New Tumor Event 2011-12-22 FEMALE 165 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 160 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Metastatic R external iliac node, presacral peritoneal implant, ascitic fluid YES false Yes TCGA-EY-A1GQ.9A8D1D19-18D8-483B-BD87-B686D25C617F.pdf A1GQ 98 negative WITH TUMOR 0 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES NO EY 0 0 29 Endometrial A LIVING 81 2010 TCGA-EY-A1GQ-01 TCGA-EY-A1GQ-01A-11-A18Q-20 9901D7A2-131B-47A0-A143-80885513AFF8 TCGA-EY-A1GQ-01 afceaea6-337b-4ac4-a7fb-773c98d95547 TCGA-EY-A1GQ-01A-21D-A13J-01 TCGA-EY-A1GQ-01A-21D-A13J-01 TCGA-EY-A1GQ-01 TCGA-EY-A1GQ-01 TCGA-EY-A1GQ-01A-21D-A13K-05 afceaea6-337b-4ac4-a7fb-773c98d95547 TCGA-EY-A1GR-01 MSS TCGA-EY-A1GR-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-EY-A1GR TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 0 TCGA-EY-A1GR-F19769 TCGA-EY-A1GR TCGA-EY-A1GR-01A Never Used Stage IA NO -24784 263 0 536 YES Scheduled Follow-up Submission 2011-12-22 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 410 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A1GR.1C53C957-1A0A-46AF-A53B-0287683D52F6.pdf A1GR 33 negative TUMOR FREE 0 3 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO YES NO EY 0 9 0 16 Endometrial A LIVING 93 2010 TCGA-EY-A1GR-01 TCGA-EY-A1GR-01A-21-A18Q-20 8F1450F5-22BC-4D32-AB5E-5D64396EB05D TCGA-EY-A1GR-01 64b366d1-dfb2-4488-9fd1-e6b26998bb9d TCGA-EY-A1GR-01A-11D-A13J-01 TCGA-EY-A1GR-01A-11D-A13J-01 TCGA-EY-A1GR-01 TCGA-EY-A1GR-01 TCGA-EY-A1GR-01A-11D-A13K-05 64b366d1-dfb2-4488-9fd1-e6b26998bb9d TCGA-EY-A1GS-01 MSS TCGA-EY-A1GS-01 High C6-UCEC BRCA CIMP c7 cluster 2 BRCA basal-like c6 UCEC-like c11 miRNA c1uster 10 cluster 2 mutation cluster 2 TCGA-EY-A1GS TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Stable Disease 71 TCGA-EY-A1GS-F70247 TCGA-EY-A1GS TCGA-EY-A1GS-01A Stage IVB -26012 211 670 0 459 NO Scheduled Follow-up Submission 2015-2-2 FEMALE 161 Serous endometrial adenocarcinoma No YES C54.1 8441/3 C54.1 YES Tumor resection 270 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A1GS.3F953015-45DC-4678-A8B3-DC55339DE717.pdf A1GS 50 WITH TUMOR 7 YES 0 Stable Disease NO R2 Primary Tumor 01 open 2009 YES YES NO EY 0 7 9 Endometrial A DECEASED 62 2010 TCGA-EY-A1GS-01 TCGA-EY-A1GS-01A-21-A18Q-20 D6E48E59-4576-413C-B2EB-6EE828E54AB1 TCGA-EY-A1GS-01A-11D-A13L-09 TCGA-EY-A1GS-01A-11D-A13L-09 TCGA-EY-A1GS-01 7348f1f9-8bcf-41e2-bcb0-743823cac926 TCGA-EY-A1GS-01A-11D-A13J-01 TCGA-EY-A1GS-01A-11D-A13J-01 TCGA-EY-A1GS-01 TCGA-EY-A1GS-01 TCGA-EY-A1GS-01A-11D-A13K-05 7348f1f9-8bcf-41e2-bcb0-743823cac926 TCGA-EY-A1GT-01 MSS TCGA-EY-A1GT-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 2 TCGA-EY-A1GT TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 TCGA-EY-A1GT-F19877 TCGA-EY-A1GT TCGA-EY-A1GT-01A Former User Stage IIIA NO -25151 225 0 490 NO Scheduled Follow-up Submission 2012-1-3 FEMALE 168 Endometrioid endometrial adenocarcinoma No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 380 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-EY-A1GT.2F5AE4E7-9411-461D-ACD9-EB7D51CEF872.pdf A1GT 10 positive TUMOR FREE 0 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES YES NO EY 0 0 25 Endometrial A LIVING 70 2010 TCGA-EY-A1GT-01 TCGA-EY-A1GT-01A-21-A18Q-20 ECED1752-B536-431E-AB4E-255B1046711A TCGA-EY-A1GT-01 654f3e2f-00c7-4db6-b092-e2d0d50845da TCGA-EY-A1GT-01A-11D-A13J-01 TCGA-EY-A1GT-01A-11D-A13J-01 TCGA-EY-A1GT-01 TCGA-EY-A1GT-01 TCGA-EY-A1GT-01A-11D-A13K-05 654f3e2f-00c7-4db6-b092-e2d0d50845da TCGA-EY-A1GU-01 MSI-H TCGA-EY-A1GU-01 Iq C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 7 cluster 1 TCGA-EY-A1GU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 66 0 TCGA-EY-A1GU-F70245 TCGA-EY-A1GU TCGA-EY-A1GU-01A Never Used Stage IB NO -24304 189 997 0 378 YES Scheduled Follow-up Submission 2015-2-2 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 380 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-EY-A1GU.7A06A8F8-416F-41CD-B546-95DEA06996D0.pdf A1GU 94 negative TUMOR FREE 0 NO 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES NO EY 0 5 0 11 Endometrial A DECEASED 90 2010 TCGA-EY-A1GU-01 TCGA-EY-A1GU-01A-21-A18Q-20 1B18AB0C-DC27-4B01-8E6A-7E890F1207DE TCGA-EY-A1GU-01 02302c44-fe54-4b39-9bef-c56db229c2ac TCGA-EY-A1GU-01A-11D-A13J-01 TCGA-EY-A1GU-01A-11D-A13J-01 TCGA-EY-A1GU-01 TCGA-EY-A1GU-01 TCGA-EY-A1GU-01A-11D-A13K-05 02302c44-fe54-4b39-9bef-c56db229c2ac TCGA-EY-A1GV-01 MSS TCGA-EY-A1GV-01 High C6-UCEC OV-like c1 cluster 3 BRCA basal-like c6 UCEC-like c11 miRNA cluster 13 cluster 2 TCGA-EY-A1GV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 75 0 TCGA-EY-A1GV-F19882 TCGA-EY-A1GV TCGA-EY-A1GV-01A Stage IIIC1 NO -27581 156 0 481 YES Scheduled Follow-up Submission 2012-1-3 FEMALE 165 Mixed serous and endometrioid No YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 300 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A1GV.87A6A698-71B7-41D8-AE28-C2FCC92F9A94.pdf A1GV 59 negative TUMOR FREE 1 4+ Complete Remission/Response YES R0 Primary Tumor 01 Minimally Invasive 2009 YES YES NO EY 0 11 1 17 Endometrial A LIVING 79 2010 TCGA-EY-A1GV-01 TCGA-EY-A1GV-01A-21-A18Q-20 BE92B05E-43B1-4ED5-AEE9-E7781D431237 TCGA-EY-A1GV-01 2b56219d-b0d0-4107-acdf-b2ad9c18f090 TCGA-EY-A1GV-01A-11D-A13J-01 TCGA-EY-A1GV-01A-11D-A13J-01 TCGA-EY-A1GV-01 TCGA-EY-A1GV-01 TCGA-EY-A1GV-01A-11D-A13K-05 2b56219d-b0d0-4107-acdf-b2ad9c18f090 TCGA-EY-A1GW-01 MSS TCGA-EY-A1GW-01 Squamous C6-UCEC UCEC non-CIMP c3 cluster 2 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-EY-A1GW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO NO Progressive Disease 73 TCGA-EY-A1GW-F12151 TCGA-EY-A1GW TCGA-EY-A1GW-01A Never Used Stage IVB NO -26979 155 337 0 260 190 NO Additional New Tumor Event 2012-1-3 FEMALE 149 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 410 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Liver Metastatic YES false No TCGA-EY-A1GW.52C26330-540E-4409-ACDF-4D56EA1E7D7F.pdf A1GW 62 positive WITH TUMOR 2 Progressive Disease Never Used NO R1 Primary Tumor 01 open 2009 YES YES NO EY 0 0 Endometrial A DECEASED 81 2010 TCGA-EY-A1GW-01 TCGA-EY-A1GW-01A-11-A18Q-20 F4D2FE5C-7742-4751-B59D-E7907F5F90A2 TCGA-EY-A1GW-01 4e6ddf28-1fb2-4527-b415-30c714ecde09 TCGA-EY-A1GW-01A-22D-A13J-01 TCGA-EY-A1GW-01A-22D-A13J-01 TCGA-EY-A1GW-01 TCGA-EY-A1GW-01 TCGA-EY-A1GW-01A-22D-A13K-05 4e6ddf28-1fb2-4527-b415-30c714ecde09 TCGA-EY-A1GX-01 MSS TCGA-EY-A1GX-01 BRCA-LUAD+ UCEC CIMP c18 cluster 1 UCEC-like c5 miRNA c1uster 10 cluster 1 TCGA-EY-A1GX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES Progressive Disease 76 0 TCGA-EY-A1GX-F70244 TCGA-EY-A1GX TCGA-EY-A1GX-01A Stage IIIA NO -27962 172 1127 0 197 743 NO Scheduled Follow-up Submission 2015-2-2 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 370 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 Other, specify Locoregional Recurrence pelvic mass NO YES false No TCGA-EY-A1GX.4AD600AE-7CE0-4BBA-B4FC-0EB8C460502B.pdf A1GX 25 negative TUMOR FREE 0 NO 2 Complete Remission/Response NO R0 Primary Tumor 01 Minimally Invasive 2009 NO YES NO EY 0 6 0 8 Endometrial A DECEASED 69 2010 253d79e4-6505-4704-8cd4-aafa5d36b4a4 TCGA-EY-A1GX-01 253d79e4-6505-4704-8cd4-aafa5d36b4a4 TCGA-EY-A1GX-01A-21-A18Q-20 E64F4415-7FA9-481E-8BD3-89FE5AB640D9 253d79e4-6505-4704-8cd4-aafa5d36b4a4 253d79e4-6505-4704-8cd4-aafa5d36b4a4 TCGA-EY-A1GX-01 TCGA-EY-A1GX-01A-12D-A13J-01 TCGA-EY-A1GX-01A-12D-A13J-01 TCGA-EY-A1GX-01 TCGA-EY-A1GX-01 TCGA-EY-A1GX-01A-12D-A13K-05 TCGA-EY-A1H0-01 MSI-H TCGA-EY-A1H0-01 Kirc+ C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 UCEC-like c11 miRNA cluster 12 cluster 5 TCGA-EY-A1H0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Stable Disease 57 1 TCGA-EY-A1H0-F19894 TCGA-EY-A1H0 TCGA-EY-A1H0-01A Stage IIIC2 NO -20937 262 0 588 YES Scheduled Follow-up Submission 2012-1-3 FEMALE 163 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 330 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-EY-A1H0.CE7F1184-9FFC-4A30-926B-0008915893F2.pdf A1H0 23 negative WITH TUMOR 3 1 Partial Remission/Response YES R0 Primary Tumor 01 open 2009 YES YES NO EY 1 4 3 8 Endometrial A LIVING 90 2010 TCGA-EY-A1H0-01 TCGA-EY-A1H0-01A-21-A18Q-20 690B02E6-1CAD-4909-B674-32A3843EE797 TCGA-EY-A1H0-01 8b72e6e7-cac5-4b7f-8f6a-7abef8b24e01 TCGA-EY-A1H0-01A-11D-A13J-01 TCGA-EY-A1H0-01A-11D-A13J-01 TCGA-EY-A1H0-01 TCGA-EY-A1H0-01 TCGA-EY-A1H0-01A-11D-A13K-05 8b72e6e7-cac5-4b7f-8f6a-7abef8b24e01 TCGA-EY-A210-01 MSI-L TCGA-EY-A210-01 High UCEC non-CIMP c3 cluster 3 UCEC-like c5 miRNA cluster 12 cluster 5 TCGA-EY-A210 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 82 7 TCGA-EY-A210-F21703 TCGA-EY-A210 TCGA-EY-A210-01A Never Used Stage IIIC2 NO -30095 70 0 383 NO Scheduled Follow-up Submission 2012-2-17 FEMALE 155 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 840 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A210.51A98C43-6A6A-4027-8E92-B3B9AA1A63D4.pdf A210 38 positive TUMOR FREE 6 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 NO YES NO EY 7 8 6 20 Endometrial A LIVING 63 2011 4547d0d6-21ed-4128-9be9-34555bff3b83 TCGA-EY-A210-01 4547d0d6-21ed-4128-9be9-34555bff3b83 TCGA-EY-A210-01A-21-A18Q-20 CD95626D-05E0-4A37-A046-AFB888D11C6E 4547d0d6-21ed-4128-9be9-34555bff3b83 4547d0d6-21ed-4128-9be9-34555bff3b83 TCGA-EY-A210-01 TCGA-EY-A210-01A-11D-A160-01 TCGA-EY-A210-01A-11D-A160-01 TCGA-EY-A210-01 TCGA-EY-A210-01 TCGA-EY-A210-01A-11D-A161-05 TCGA-EY-A212-01 MSS TCGA-EY-A212-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 mutation cluster 5 TCGA-EY-A212 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Partial Response 83 0 TCGA-EY-A212-F21719 TCGA-EY-A212 TCGA-EY-A212-01A Stage IIIC1 YES -30680 112 310 0 110 YES Scheduled Follow-up Submission 2012-2-17 FEMALE 159 Serous endometrial adenocarcinoma No YES C54.1 8460/3 C54.1 YES Office Endometrial Biopsy 290 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes TCGA-EY-A212.3E8012E3-97F1-48A2-B1C0-5C814DF8EE01.pdf A212 45 positive WITH TUMOR 1 4+ Partial Remission/Response NO R0 Primary Tumor 01 Minimally Invasive 2009 NO YES NO EY 0 19 1 33 Endometrial A DECEASED 81 2010 TCGA-EY-A212-01 TCGA-EY-A212-01A-21-A18R-20 0AD26348-0444-4AA1-B64C-57F26CD91A94 TCGA-EY-A212-01A-11D-A14K-09 TCGA-EY-A212-01A-11D-A14K-09 TCGA-EY-A212-01 6c1a95ef-3b5a-49ac-aaeb-dcd8071bed23 TCGA-EY-A212-01A-11D-A14J-01 TCGA-EY-A212-01A-11D-A14J-01 TCGA-EY-A212-01 TCGA-EY-A212-01 TCGA-EY-A212-01A-11D-A14N-05 6c1a95ef-3b5a-49ac-aaeb-dcd8071bed23 TCGA-EY-A214-01 MSS TCGA-EY-A214-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-EY-A214 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 66 0 TCGA-EY-A214-F22091 TCGA-EY-A214 TCGA-EY-A214-01A Former User Stage IIIC1 NO -24136 160 0 438 NO Scheduled Follow-up Submission 2012-2-23 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 330 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes TCGA-EY-A214.90B0CBB0-3AC0-44F8-9C49-310CFFE0370C.pdf A214 72 negative TUMOR FREE 1 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 YES YES NO EY 0 19 1 31 Endometrial A LIVING 94 2010 TCGA-EY-A214-01 TCGA-EY-A214-01A-21-A18R-20 8BD01A29-72D8-46DD-BE1A-444403EB2F4C TCGA-EY-A214-01 32d0d293-ce07-487a-b914-062548072260 TCGA-EY-A214-01A-12D-A160-01 TCGA-EY-A214-01A-12D-A160-01 TCGA-EY-A214-01 TCGA-EY-A214-01 TCGA-EY-A214-01A-12D-A161-05 32d0d293-ce07-487a-b914-062548072260 TCGA-EY-A215-01 MSI-H TCGA-EY-A215-01 Quiet C6-UCEC UCEC CIMP c18 cluster 1 UCEC-like c5 COADREAD-like c15 miRNA c1uster 10 cluster 3 TCGA-EY-A215 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 0 TCGA-EY-A215-F21735 TCGA-EY-A215 TCGA-EY-A215-01A Stage IB NO -22076 293 0 574 NO Scheduled Follow-up Submission 2012-2-17 FEMALE 168 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 210 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes TCGA-EY-A215.C0F970E3-E534-4A34-B87A-4383FD261B53.pdf A215 50 negative TUMOR FREE 0 2 Complete Remission/Response YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES NO EY 0 14 0 7 Endometrial A LIVING 49 2010 TCGA-EY-A215-01 TCGA-EY-A215-01A-21-A18R-20 10A2C6D4-0F10-43F9-A5DD-9A61D34FA5B6 TCGA-EY-A215-01 9ea0e44d-a6c8-4e54-9e1f-ebdb82d0c5ab TCGA-EY-A215-01A-11D-A14J-01 TCGA-EY-A215-01A-11D-A14J-01 TCGA-EY-A215-01 TCGA-EY-A215-01 TCGA-EY-A215-01A-11D-A14N-05 9ea0e44d-a6c8-4e54-9e1f-ebdb82d0c5ab TCGA-EY-A2OM-01 MSI-H TCGA-EY-A2OM-01 Kirc+ C6-UCEC UCEC CIMP c18 UCEC-like c5 UCEC-like c11 miRNA cluster 12 TCGA-EY-A2OM TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 55 TCGA-EY-A2OM-F44823 TCGA-EY-A2OM TCGA-EY-A2OM-01A Stage IA -20398 176 0 694 2013-6-27 FEMALE 152 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 640 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A2OM.7C46CE28-FC96-47FD-A133-B95EA93E1D8B.pdf A2OM 20 negative TUMOR FREE 0 YES YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO EY 0 0 13 Endometrial A LIVING 110 2011 TCGA-EY-A2OM-01 TCGA-EY-A2OM-01A-21-A23Z-20 B6FE1435-A4DC-48E9-A92E-B7D599544F66 TCGA-EY-A2OM-01 0c622763-f905-4eaa-a05b-ea27dbd49888 TCGA-EY-A2OM-01A-11D-A18N-01 TCGA-EY-A2OM-01A-11D-A18N-01 TCGA-EY-A2OM-01 TCGA-EY-A2OM-01 TCGA-EY-A2OM-01A-11D-A18O-05 0c622763-f905-4eaa-a05b-ea27dbd49888 TCGA-EY-A2ON-01 MSS TCGA-EY-A2ON-01 High UCEC non-CIMP c3 BRCA basal-like c6 miRNA cluster 14 TCGA-EY-A2ON TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Progressive Disease 61 TCGA-EY-A2ON-F34164 TCGA-EY-A2ON TCGA-EY-A2ON-01A Stage IVB -22624 80 610 0 171 226 2013-6-20 FEMALE 165 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 650 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A2ON.AB1B272C-E1ED-4E7B-AAD2-F6B7E741E134.pdf A2ON positive WITH TUMOR YES Progressive Disease NO R2 Primary Tumor 01 Minimally Invasive 2009 YES NO EY 0 0 Endometrial A DECEASED 100 2011 10a6bc01-f811-400f-a205-caf7879008fe TCGA-EY-A2ON-01 10a6bc01-f811-400f-a205-caf7879008fe TCGA-EY-A2ON-01A-11-A23Z-20 D85F0679-8CFA-4EA3-B9DA-02CC32C4E01B 10a6bc01-f811-400f-a205-caf7879008fe 10a6bc01-f811-400f-a205-caf7879008fe TCGA-EY-A2ON-01 TCGA-EY-A2ON-01A-21D-A18N-01 TCGA-EY-A2ON-01A-21D-A18N-01 TCGA-EY-A2ON-01 TCGA-EY-A2ON-01 TCGA-EY-A2ON-01A-21D-A18O-05 TCGA-EY-A2OO-01 MSS TCGA-EY-A2OO-01 BRCA-LUAD+ UCEC CIMP c18 UCEC-like c5 miRNA cluster 13 TCGA-EY-A2OO TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 56 0 TCGA-EY-A2OO-F44827 TCGA-EY-A2OO TCGA-EY-A2OO-01A Stage IB -20797 715 0 1392 2013-6-27 FEMALE 175 Mixed serous and endometrioid No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 1 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A2OO.CC94C4BA-FBF6-4F0D-93DD-C2D98D965DF8.pdf A2OO 14 negative TUMOR FREE 0 YES YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES EY 0 3 0 21 Endometrial A LIVING 79 2009 060787cf-a4a0-402f-8534-742157bb4a2c TCGA-EY-A2OO-01 060787cf-a4a0-402f-8534-742157bb4a2c TCGA-EY-A2OO-01A-21-A23Z-20 71B9F996-932C-46AD-B6B1-C5ECEB19A332 060787cf-a4a0-402f-8534-742157bb4a2c 060787cf-a4a0-402f-8534-742157bb4a2c TCGA-EY-A2OO-01 TCGA-EY-A2OO-01A-11D-A19X-01 TCGA-EY-A2OO-01A-11D-A19X-01 TCGA-EY-A2OO-01 TCGA-EY-A2OO-01 TCGA-EY-A2OO-01A-11D-A19Z-05 TCGA-EY-A2OP-01 MSI-H TCGA-EY-A2OP-01 Iq UCEC CIMP c18 UCEC-like c5 miRNA cluster 12 TCGA-EY-A2OP TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 63 0 TCGA-EY-A2OP-F44831 TCGA-EY-A2OP TCGA-EY-A2OP-01A Stage IA -23090 521 0 944 2013-6-27 FEMALE 150 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 1 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A2OP.E16B08BE-7F2E-4F0E-9FC8-40FCC29F7BC7.pdf A2OP 10 negative TUMOR FREE 0 NO NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO EY 0 7 0 12 Endometrial A LIVING 57 2010 48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f TCGA-EY-A2OP-01 48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f TCGA-EY-A2OP-01A-21-A23Z-20 88434549-A691-4715-AD3D-4B3B7F2F6842 48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f 48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f TCGA-EY-A2OP-01 TCGA-EY-A2OP-01A-11D-A19X-01 TCGA-EY-A2OP-01A-11D-A19X-01 TCGA-EY-A2OP-01 TCGA-EY-A2OP-01 TCGA-EY-A2OP-01A-11D-A19Z-05 TCGA-EY-A2OQ-01 MSS TCGA-EY-A2OQ-01 Squamous UCEC Serous c4 UCEC-like c5 miRNA cluster 4 TCGA-EY-A2OQ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 61 0 TCGA-EY-A2OQ-F44835 TCGA-EY-A2OQ TCGA-EY-A2OQ-01A Stage IA -22309 217 0 885 2013-6-27 FEMALE 155 Endometrioid endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 1 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A2OQ.BD1FB0FF-176C-42D9-843E-2F2BF2EBCCC2.pdf A2OQ 29 negative TUMOR FREE 0 NO NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO EY 0 15 0 22 Endometrial A LIVING 79 2011 fe9055e4-f25c-4b7b-9479-a8468c36310f TCGA-EY-A2OQ-01 fe9055e4-f25c-4b7b-9479-a8468c36310f TCGA-EY-A2OQ-01A-21-A23Z-20 6075ABA3-3438-4ABE-9C56-BD9A57640AB8 fe9055e4-f25c-4b7b-9479-a8468c36310f fe9055e4-f25c-4b7b-9479-a8468c36310f TCGA-EY-A2OQ-01 TCGA-EY-A2OQ-01A-11D-A19X-01 TCGA-EY-A2OQ-01A-11D-A19X-01 TCGA-EY-A2OQ-01 TCGA-EY-A2OQ-01 TCGA-EY-A2OQ-01A-11D-A19Z-05 TCGA-EY-A3L3-01 MSS TCGA-EY-A3L3-01 High UCEC Serous c4 BRCA basal-like c6 miRNA c1uster 10 TCGA-EY-A3L3 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 82 0 TCGA-EY-A3L3-F50665 TCGA-EY-A3L3 TCGA-EY-A3L3-01A Stage IA -30138 198 0 832 2013-10-28 FEMALE 161 Serous endometrial adenocarcinoma No C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 1020 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A3L3.DBCC8E6F-3AB9-41B2-8266-341509A9FDB3.pdf A3L3 28 negative TUMOR FREE 0 YES Complete Remission/Response YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO EY 0 3 0 14 Endometrial A LIVING 92 2011 eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8 TCGA-EY-A3L3-01 eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8 TCGA-EY-A3L3-01A-21-A23Z-20 560982E6-96AF-414D-A20B-5F136CB71629 eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8 eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8 TCGA-EY-A3L3-01 TCGA-EY-A3L3-01A-11D-A227-01 TCGA-EY-A3L3-01A-11D-A227-01 TCGA-EY-A3L3-01 TCGA-EY-A3L3-01 TCGA-EY-A3L3-01A-11D-A22B-05 TCGA-EY-A3QX-01 MSS TCGA-EY-A3QX-01 Squamous UCEC non-CIMP c3 UCEC-like c5 miRNA cluster 4 TCGA-EY-A3QX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Progressive Disease 64 TCGA-EY-A3QX-F66590 TCGA-EY-A3QX TCGA-EY-A3QX-01A Stage IVB -23663 112 989 0 162 896 2014-10-21 FEMALE 168 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 659 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence Peritoneum NO YES false No TCGA-EY-A3QX.8AED036E-FB86-42D1-B840-FB4AD6E8D0EF.pdf A3QX 95 positive WITH TUMOR YES Complete Remission/Response NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO EY 0 0 Endometrial A DECEASED 63 2011 cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3 TCGA-EY-A3QX-01 cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3 TCGA-EY-A3QX-01A-21-A23Z-20 FCB39116-72F7-4722-B691-A8D39DC71BFE cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3 cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3 TCGA-EY-A3QX-01 TCGA-EY-A3QX-01A-11D-A227-01 TCGA-EY-A3QX-01A-11D-A227-01 TCGA-EY-A3QX-01 TCGA-EY-A3QX-01 TCGA-EY-A3QX-01A-11D-A22B-05 TCGA-EY-A4KR-01 MSS TCGA-EY-A4KR-01 TCGA-EY-A4KR TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 56 TCGA-EY-A4KR-F44431 TCGA-EY-A4KR TCGA-EY-A4KR-01A Stage IIIC1 NO -20669 147 346 0 196 NO 2013-6-19 FEMALE 164 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 610 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A4KR.D8669681-B1D2-4D39-B7BB-5207F901A937.pdf A4KR 99 positive WITH TUMOR 7 YES 2 Progressive Disease Never Used YES RX Primary Tumor 01 Minimally Invasive YES NO EY 0 7 9 Endometrial A DECEASED 114 2012 8bc81bd5-9814-4a83-b78d-6d5722a1a53d TCGA-EY-A4KR-01 8bc81bd5-9814-4a83-b78d-6d5722a1a53d 1B4E7519-3FE8-4F74-9497-D50B1985669F 8bc81bd5-9814-4a83-b78d-6d5722a1a53d 8bc81bd5-9814-4a83-b78d-6d5722a1a53d TCGA-EY-A4KR-01 TCGA-EY-A4KR-01A-11D-A27O-01 TCGA-EY-A4KR-01A-11D-A27O-01 TCGA-EY-A4KR-01 TCGA-EY-A4KR-01 TCGA-EY-A4KR-01A-11D-A27Y-05 TCGA-EY-A547-01 Indeterminate TCGA-EY-A547-01 TCGA-EY-A547 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 75 0 TCGA-EY-A547-F55805 TCGA-EY-A547 TCGA-EY-A547-01A Stage IA NO -27686 645 0 545 YES 2014-1-15 FEMALE 166 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 610 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes TCGA-EY-A547.59662419-D77B-4C25-A888-CE993D412FD1.pdf A547 14 negative TUMOR FREE 0 NO 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive YES NO EY 0 8 0 10 Endometrial A LIVING 108 2011 cc3bf52b-7b69-40c9-9358-f66cb7b1dd87 TCGA-EY-A547-01 cc3bf52b-7b69-40c9-9358-f66cb7b1dd87 C1DA4818-1742-461D-934C-4D1CFD051585 cc3bf52b-7b69-40c9-9358-f66cb7b1dd87 cc3bf52b-7b69-40c9-9358-f66cb7b1dd87 TCGA-EY-A547-01 TCGA-EY-A547-01A-11D-A27O-01 TCGA-EY-A547-01A-11D-A27O-01 TCGA-EY-A547-01 TCGA-EY-A547-01 TCGA-EY-A547-01A-11D-A27Y-05 TCGA-EY-A548-01 MSI-H TCGA-EY-A548-01 TCGA-EY-A548 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 83 TCGA-EY-A548-F55806 TCGA-EY-A548 TCGA-EY-A548-01A Never Used Stage IA NO -30544 169 0 430 NO 2014-1-15 FEMALE 157 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 850 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-EY-A548.A9ACF7BF-BB91-4B56-A398-C7A0FD473FC5.pdf A548 0 negative TUMOR FREE 0 NO 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive YES NO EY 0 0 12 Endometrial A LIVING 67 2012 32b29d34-5d28-4b68-9d64-61290448fca5 TCGA-EY-A548-01 32b29d34-5d28-4b68-9d64-61290448fca5 38F71989-9140-4D94-A813-CB38482A0CC3 32b29d34-5d28-4b68-9d64-61290448fca5 32b29d34-5d28-4b68-9d64-61290448fca5 TCGA-EY-A548-01 TCGA-EY-A548-01A-11D-A27O-01 TCGA-EY-A548-01A-11D-A27O-01 TCGA-EY-A548-01 TCGA-EY-A548-01 TCGA-EY-A548-01A-11D-A27Y-05 TCGA-EY-A549-01 MSI-H TCGA-EY-A549-01 TCGA-EY-A549 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 78 0 TCGA-EY-A549-F55760 TCGA-EY-A549 TCGA-EY-A549-01A Never Used Stage IA YES -28570 191 0 605 NO 2014-1-14 FEMALE 165 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.9 8380/3 C54.9 YES Office Endometrial Biopsy 370 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes TCGA-EY-A549.F6D1F090-C601-4212-951E-BEE086DDD24F.pdf A549 33 TUMOR FREE 0 NO 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive YES NO EY 0 18 0 22 Endometrial A LIVING 74 2012 4cbce4ad-3208-4463-a06d-75edce32ed3f TCGA-EY-A549-01 4cbce4ad-3208-4463-a06d-75edce32ed3f E18E8B7F-FB1D-4E71-99AF-81A632FC381A 4cbce4ad-3208-4463-a06d-75edce32ed3f 4cbce4ad-3208-4463-a06d-75edce32ed3f TCGA-EY-A549-01 TCGA-EY-A549-01A-11D-A27O-01 TCGA-EY-A549-01A-11D-A27O-01 TCGA-EY-A549-01 TCGA-EY-A549-01 TCGA-EY-A549-01A-11D-A27Y-05 TCGA-EY-A54A-01 Indeterminate TCGA-EY-A54A-01 TCGA-EY-A54A TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 67 1 TCGA-EY-A54A-F57555 TCGA-EY-A54A TCGA-EY-A54A-01A Former User Stage IIIC2 NO -24822 105 0 447 YES 2014-3-17 FEMALE 161 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.9 8380/3 C54.9 YES Office Endometrial Biopsy 500 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A54A.E3C3D3B8-550A-4652-9B17-122BC64A437A.pdf A54A 41 TUMOR FREE 4 YES 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO EY 1 8 4 16 Endometrial A LIVING 70 2012 a7c691a2-a91d-44d0-8e91-0234cddb1e92 TCGA-EY-A54A-01 a7c691a2-a91d-44d0-8e91-0234cddb1e92 2CD53475-9ADE-4981-95CF-286418DBBAF4 a7c691a2-a91d-44d0-8e91-0234cddb1e92 a7c691a2-a91d-44d0-8e91-0234cddb1e92 TCGA-EY-A54A-01 TCGA-EY-A54A-01A-11D-A27O-01 TCGA-EY-A54A-01A-11D-A27O-01 TCGA-EY-A54A-01 TCGA-EY-A54A-01 TCGA-EY-A54A-01A-11D-A27Y-05 TCGA-EY-A5W2-01 MSI-H TCGA-EY-A5W2-01 TCGA-EY-A5W2 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 72 0 TCGA-EY-A5W2-F58696 TCGA-EY-A5W2 TCGA-EY-A5W2-01A Stage IB NO -26498 105 0 516 NO 2014-4-22 FEMALE 161 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 870 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-EY-A5W2.C09EED3C-50CC-47CB-BA81-96D05E53D9F0.pdf A5W2 52 negative TUMOR FREE 0 NO 4+ Complete Remission/Response YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO EY 0 7 0 16 Endometrial A LIVING 83 2012 894b867a-591d-4d05-b008-db1a90b18a60 TCGA-EY-A5W2-01 894b867a-591d-4d05-b008-db1a90b18a60 7F27E4E1-84E6-4CD1-A925-56A28A53D371 894b867a-591d-4d05-b008-db1a90b18a60 894b867a-591d-4d05-b008-db1a90b18a60 TCGA-EY-A5W2-01 TCGA-EY-A5W2-01A-11D-A31T-01 TCGA-EY-A5W2-01A-11D-A31T-01 TCGA-EY-A5W2-01 TCGA-EY-A5W2-01 TCGA-EY-A5W2-01A-11D-A31V-05 TCGA-EY-A72D-01 MSS TCGA-EY-A72D-01 TCGA-EY-A72D TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 87 TCGA-EY-A72D-F63789 TCGA-EY-A72D TCGA-EY-A72D-01A Never Used Stage II NO -31818 120 0 179 NO 2014-8-18 FEMALE 162 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 340 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false Yes TCGA-EY-A72D.6F2C081B-8D36-4DB4-9846-67DC1D3964E0.pdf A72D 22.5 TUMOR FREE NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 YES NO EY 0 0 Endometrial A LIVING 106 2013 051469db-cfa9-4907-ae54-13c060ad2958 TCGA-EY-A72D-01 051469db-cfa9-4907-ae54-13c060ad2958 C1F2DA4B-8F02-437C-9A58-E1E9E3362666 051469db-cfa9-4907-ae54-13c060ad2958 051469db-cfa9-4907-ae54-13c060ad2958 TCGA-EY-A72D-01 TCGA-EY-A72D-01A-12D-A34P-01 TCGA-EY-A72D-01A-12D-A34P-01 TCGA-EY-A72D-01 TCGA-EY-A72D-01 TCGA-EY-A72D-01A-12D-A34S-05 TCGA-FI-A2CX-01 MSS TCGA-FI-A2CX-01 Kirc+ OV-like c1 cluster 3 LAML-like c13 miRNA c1uster 9 cluster 2 TCGA-FI-A2CX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 82 0 0 TCGA-FI-A2CX-F71662 TCGA-FI-A2CX Never Used Stage IB NO -30224 0 2031 NO Scheduled Follow-up Submission 2015-3-27 FEMALE 155 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO Yes A2CX 33 TUMOR FREE 0 0 NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 1988 NO NO YES FI 0 3 0 7 Endometrial LIVING 52 2008 TCGA-FI-A2CX-01 TCGA-FI-A2CX-01 ab3e5a04-9d4c-4289-93ed-38dba3e619b2 TCGA-FI-A2CX-01A-11D-A17C-01 TCGA-FI-A2CX-01A-11D-A17C-01 TCGA-FI-A2CX-01 TCGA-FI-A2CX-01 TCGA-FI-A2CX-01A-11D-A17F-05 ab3e5a04-9d4c-4289-93ed-38dba3e619b2 TCGA-FI-A2CY-01 MSS TCGA-FI-A2CY-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 4 cluster 2 TCGA-FI-A2CY TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 60 0 0 TCGA-FI-A2CY-F71663 TCGA-FI-A2CY TCGA-FI-A2CY-01A Never Used Stage IA NO -22098 1067 0 2080 NO Scheduled Follow-up Submission 2015-3-27 FEMALE 145 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 110 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-FI-A2CY.2C4CE5F5-AD46-427E-A787-529DF9FA891A.pdf A2CY 0 negative TUMOR FREE 0 0 NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 YES NO YES FI 0 2 0 15 Endometrial A LIVING 100 2008 TCGA-FI-A2CY-01 TCGA-FI-A2CY-01A-21-A18R-20 40294F1C-B9EC-4486-87DB-8973840F9238 TCGA-FI-A2CY-01 4bcff10b-20ad-4635-bbcd-855826277b8a TCGA-FI-A2CY-01A-11D-A17C-01 TCGA-FI-A2CY-01A-11D-A17C-01 TCGA-FI-A2CY-01 TCGA-FI-A2CY-01 TCGA-FI-A2CY-01A-11D-A17F-05 4bcff10b-20ad-4635-bbcd-855826277b8a TCGA-FI-A2D0-01 MSI-H TCGA-FI-A2D0-01 Quiet UCEC non-CIMP c3 cluster 4 UCEC-like c11 miRNA cluster 12 cluster 2 TCGA-FI-A2D0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 55 0 0 TCGA-FI-A2D0-F71665 TCGA-FI-A2D0 Never Used Stage IA NO -20393 0 1023 NO Scheduled Follow-up Submission 2015-3-27 FEMALE 158 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy NO Peri (6-12 months since last menstrual period) G3 NO No A2D0 0 negative TUMOR FREE 0 0 NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES FI 0 7 0 21 Endometrial LIVING 135 2008 TCGA-FI-A2D0-01 TCGA-FI-A2D0-01 e8736e4d-6e9b-49b0-a321-0e42740a11c1 TCGA-FI-A2D0-01A-11D-A17C-01 TCGA-FI-A2D0-01A-11D-A17C-01 TCGA-FI-A2D0-01 TCGA-FI-A2D0-01 TCGA-FI-A2D0-01A-11D-A17F-05 e8736e4d-6e9b-49b0-a321-0e42740a11c1 TCGA-FI-A2D2-01 MSS TCGA-FI-A2D2-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c11 miRNA c1uster 10 cluster 2 mutation cluster 3 TCGA-FI-A2D2 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES Progressive Disease 66 TCGA-FI-A2D2-F71666 TCGA-FI-A2D2 TCGA-FI-A2D2-01A Stage IB NO -24260 975 2352 0 1215 1917 NO Scheduled Follow-up Submission 2015-3-27 FEMALE 168 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 70 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Lung Locoregional Recurrence Liver NO YES true No TCGA-FI-A2D2.75FB8F31-5C30-48C2-B4A5-2DA184DC039C.pdf A2D2 33 negative WITH TUMOR YES 2 [Discrepancy] Never Used NO R0 Primary Tumor 01 open 1988 YES NO YES FI 0 0 Endometrial A DECEASED 166 2008 TCGA-FI-A2D2-01 TCGA-FI-A2D2-01A-11D-A17D-09 TCGA-FI-A2D2-01A-11D-A17D-09 TCGA-FI-A2D2-01A-11D-A17D-09 TCGA-FI-A2D2-01 941d70e7-2ac8-4809-baa4-7752df3c2ee3 TCGA-FI-A2D2-01A-11D-A17C-01 TCGA-FI-A2D2-01A-11D-A17C-01 TCGA-FI-A2D2-01 TCGA-FI-A2D2-01 TCGA-FI-A2D2-01A-11D-A17F-05 941d70e7-2ac8-4809-baa4-7752df3c2ee3 TCGA-FI-A2D4-01 MSI-H TCGA-FI-A2D4-01 Kirc+ UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA cluster 12 cluster 5 TCGA-FI-A2D4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Partial Response 44 TCGA-FI-A2D4-F31734 TCGA-FI-A2D4 Stage IIIC NO -16163 243 0 NO Scheduled Follow-up Submission 2012-5-8 FEMALE 163 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) G3 NO No A2D4 100 WITH TUMOR 0 1 Partial Remission/Response Never Used NO R2 Primary Tumor 01 open 1988 YES NO YES FI 0 1 1 Endometrial DECEASED 112 2009 TCGA-FI-A2D4-01 TCGA-FI-A2D4-01 c3c9142f-d5c8-44ef-90c2-9ae69846dc60 TCGA-FI-A2D4-01A-12D-A17C-01 TCGA-FI-A2D4-01A-12D-A17C-01 TCGA-FI-A2D4-01 TCGA-FI-A2D4-01 TCGA-FI-A2D4-01A-12D-A17F-05 c3c9142f-d5c8-44ef-90c2-9ae69846dc60 TCGA-FI-A2D5-01 MSS TCGA-FI-A2D5-01 Quiet UCEC non-CIMP c3 cluster 4 UCEC-like c11 miRNA c1uster 9 cluster 4 TCGA-FI-A2D5 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES YES NO Progressive Disease 56 TCGA-FI-A2D5-F31743 TCGA-FI-A2D5 TCGA-FI-A2D5-01A Never Used Stage IVB NO -20666 702 421 0 280 NO Scheduled Follow-up Submission 2012-5-8 FEMALE 160 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8380/3 C54.1 YES Dilation and curettage procedure 60 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Metastatic vaginal cuff YES true Yes TCGA-FI-A2D5.A8F4B3DC-7B7D-4F1F-A909-E23DAE23E52C.pdf A2D5 100 positive WITH TUMOR 0 1 1 Partial Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 YES NO YES FI 0 1 2 Endometrial A DECEASED 92 2009 TCGA-FI-A2D5-01 TCGA-FI-A2D5-01 33655926-ef2e-4e77-8be7-3f9c921db77c TCGA-FI-A2D5-01A-11D-A17C-01 TCGA-FI-A2D5-01A-11D-A17C-01 TCGA-FI-A2D5-01 TCGA-FI-A2D5-01 TCGA-FI-A2D5-01A-11D-A17F-05 33655926-ef2e-4e77-8be7-3f9c921db77c TCGA-FI-A2D6-01 MSI-H TCGA-FI-A2D6-01 Kirc+ BRCA CIMP c7 cluster 1 GBM-like c6 miRNA cluster 13 cluster 6 TCGA-FI-A2D6 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 74 TCGA-FI-A2D6-F71667 TCGA-FI-A2D6 Stage IB NO -27060 767 0 263 NO Scheduled Follow-up Submission 2015-3-27 FEMALE 165 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO No A2D6 74 negative TUMOR FREE NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES FI 0 0 Endometrial DECEASED 95 2009 TCGA-FI-A2D6-01 TCGA-FI-A2D6-01 fffc5da3-ed33-4f8d-982e-e75b2d707c4b TCGA-FI-A2D6-01A-11D-A17C-01 TCGA-FI-A2D6-01A-11D-A17C-01 TCGA-FI-A2D6-01 TCGA-FI-A2D6-01 TCGA-FI-A2D6-01A-11D-A17F-05 fffc5da3-ed33-4f8d-982e-e75b2d707c4b TCGA-FI-A2EU-01 MSS TCGA-FI-A2EU-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA c1uster 10 cluster 2 TCGA-FI-A2EU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 0 0 TCGA-FI-A2EU-F31382 TCGA-FI-A2EU TCGA-FI-A2EU-01A Stage IA NO -24837 2779 0 2941 YES Scheduled Follow-up Submission 2012-5-1 FEMALE 168 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 110 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-FI-A2EU.95F8FB60-A533-4A37-8B4B-FC6811A77636.pdf A2EU 0 negative TUMOR FREE 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 YES NO YES FI 0 2 0 11 Endometrial A LIVING 93 2003 TCGA-FI-A2EU-01 TCGA-FI-A2EU-01A-21-A18Q-20 98F272A2-B83C-4E44-ACCC-BD15049DA4C3 TCGA-FI-A2EU-01 1d3ec463-a3c0-4aa5-8fc0-d221be3a0700 TCGA-FI-A2EU-01A-11D-A17C-01 TCGA-FI-A2EU-01A-11D-A17C-01 TCGA-FI-A2EU-01 TCGA-FI-A2EU-01 TCGA-FI-A2EU-01A-11D-A17F-05 1d3ec463-a3c0-4aa5-8fc0-d221be3a0700 TCGA-FI-A2EW-01 Indeterminate TCGA-FI-A2EW-01 High C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 14 cluster 2 mutation cluster 13 TCGA-FI-A2EW TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO [Discrepancy] 71 0 0 TCGA-FI-A2EW-F31518 TCGA-FI-A2EW TCGA-FI-A2EW-01A Never Used Stage IIB NO -26267 2321 0 1462 1169 NO Scheduled Follow-up Submission 2012-5-4 FEMALE 160 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 120 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Liver Metastatic YES true No TCGA-FI-A2EW.3DED6690-5A21-4EDC-B9D4-5E1F2F5A9CC1.pdf A2EW 75 negative TUMOR FREE 0 0 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 YES NO YES FI 0 8 0 29 Endometrial A LIVING 83 2005 TCGA-FI-A2EW-01 TCGA-FI-A2EW-01A-21-A18Q-20 2C665CF4-C3ED-4579-9050-4064E3AE281C TCGA-FI-A2EW-01A-11D-A17D-09 TCGA-FI-A2EW-01A-11D-A17D-09 TCGA-FI-A2EW-01A-11D-A17D-09 TCGA-FI-A2EW-01 e3abb7cf-945d-496f-8bf0-828ddfef6538 TCGA-FI-A2EW-01A-11D-A17C-01 TCGA-FI-A2EW-01A-11D-A17C-01 TCGA-FI-A2EW-01 TCGA-FI-A2EW-01 TCGA-FI-A2EW-01A-11D-A17F-05 e3abb7cf-945d-496f-8bf0-828ddfef6538 TCGA-FI-A2EX-01 MSS TCGA-FI-A2EX-01 High C6-UCEC UCEC non-CIMP c3 cluster 3 UCEC-like c5 UCEC-like c11 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-FI-A2EX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO NO Progressive Disease 58 0 0 TCGA-FI-A2EX-F31519 TCGA-FI-A2EX TCGA-FI-A2EX-01A Stage IIIA NO -21489 2201 0 284 213 NO Scheduled Follow-up Submission 2012-5-4 FEMALE 154 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Dilation and curettage procedure 110 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Metastatic YES true No TCGA-FI-A2EX.68355069-2D77-4C5C-9AA9-E93A0C3CFD94.pdf A2EX 13 positive WITH TUMOR 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 YES NO YES FI 0 6 0 28 Endometrial A LIVING 89 2005 TCGA-FI-A2EX-01 TCGA-FI-A2EX-01A-21-A18Q-20 10FFCFD0-5CD9-4530-AA2D-EB697F20CCA4 TCGA-FI-A2EX-01A-11D-A17D-09 TCGA-FI-A2EX-01A-11D-A17D-09 TCGA-FI-A2EX-01A-11D-A17D-09 TCGA-FI-A2EX-01 06745c8c-5e2b-4131-93a5-9023c32665ac TCGA-FI-A2EX-01A-11D-A17C-01 TCGA-FI-A2EX-01A-11D-A17C-01 TCGA-FI-A2EX-01 TCGA-FI-A2EX-01 TCGA-FI-A2EX-01A-11D-A17F-05 06745c8c-5e2b-4131-93a5-9023c32665ac TCGA-FI-A2EY-01 MSI-L TCGA-FI-A2EY-01 Squamous OV-like c1 squamous c3 miRNA cluster 14 TCGA-FI-A2EY TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium NO NO YES Complete Response 63 0 0 TCGA-FI-A2EY-F31521 TCGA-FI-A2EY TCGA-FI-A2EY-01A Stage IIIA NO 670 -23042 1866 880 0 577 NO Scheduled Follow-up Submission 2012-5-4 FEMALE 183 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Tumor resection 140 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Lung New Primary Tumor YES true No TCGA-FI-A2EY.D529A633-2FC9-4C28-BEA4-994BABD51A48.pdf A2EY 93 negative TUMOR FREE 0 0 3 Complete Remission/Response Never Used NO Surgical Resection R0 R0 Primary Tumor 01 open 1988 YES NO YES FI 0 0 0 0 Endometrial A DECEASED 96 2006 c23bc644-ff87-4c84-a156-686903524aaa TCGA-FI-A2EY-01 c23bc644-ff87-4c84-a156-686903524aaa TCGA-FI-A2EY-01A-21-A23Z-20 A57C3886-0CF2-40C1-9D4D-2F74B5D4F6F1 c23bc644-ff87-4c84-a156-686903524aaa c23bc644-ff87-4c84-a156-686903524aaa TCGA-FI-A2EY-01 TCGA-FI-A2EY-01A-12D-A18N-01 TCGA-FI-A2EY-01A-12D-A18N-01 TCGA-FI-A2EY-01 TCGA-FI-A2EY-01 TCGA-FI-A2EY-01A-12D-A18O-05 TCGA-FI-A2F4-01 MSI-H TCGA-FI-A2F4-01 Iq UCEC CIMP c18 cluster 1 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-FI-A2F4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 0 TCGA-FI-A2F4-F71670 TCGA-FI-A2F4 TCGA-FI-A2F4-01A Stage IC NO -23621 860 0 2230 YES Scheduled Follow-up Submission 2015-3-27 FEMALE 165 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 60 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true Yes TCGA-FI-A2F4.B57570A5-2AE1-4D8B-9284-AB5769DDFDA6.pdf A2F4 59 TUMOR FREE 0 0 NO 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 1988 NO NO YES FI 0 4 0 28 Endometrial A LIVING 74 2009 TCGA-FI-A2F4-01 TCGA-FI-A2F4-01 14198ecd-3508-4ece-8fea-8141d3e4b1e7 TCGA-FI-A2F4-01A-11D-A17C-01 TCGA-FI-A2F4-01A-11D-A17C-01 TCGA-FI-A2F4-01 TCGA-FI-A2F4-01 TCGA-FI-A2F4-01A-11D-A17F-05 14198ecd-3508-4ece-8fea-8141d3e4b1e7 TCGA-FI-A2F8-01 MSS TCGA-FI-A2F8-01 Squamous C6-UCEC UCEC Serous c4 cluster 3 UCEC-like c11 miRNA c1uster 10 cluster 3 mutation cluster 5 TCGA-FI-A2F8 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 0 TCGA-FI-A2F8-F31739 TCGA-FI-A2F8 TCGA-FI-A2F8-01A Former User Stage II NO -23649 679 0 933 NO Scheduled Follow-up Submission 2012-5-8 FEMALE 173 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 70 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-FI-A2F8.9445945A-A7AC-4C36-889B-68A50644D556.pdf A2F8 26 positive WITH TUMOR 0 0 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 YES NO YES FI 0 6 0 24 Endometrial A LIVING 99 2009 TCGA-FI-A2F8-01 TCGA-FI-A2F8-01A-12D-A17D-09 TCGA-FI-A2F8-01A-12D-A17D-09 TCGA-FI-A2F8-01A-12D-A17D-09 TCGA-FI-A2F8-01 1b38dbc6-5830-4514-9317-9dcb23e36b98 TCGA-FI-A2F8-01A-12D-A17C-01 TCGA-FI-A2F8-01A-12D-A17C-01 TCGA-FI-A2F8-01 TCGA-FI-A2F8-01 TCGA-FI-A2F8-01A-12D-A17F-05 1b38dbc6-5830-4514-9317-9dcb23e36b98 TCGA-FI-A2F9-01 MSS TCGA-FI-A2F9-01 Kirc+ UCEC Serous c4 cluster 3 UCEC-like c11 miRNA c1uster 10 cluster 3 TCGA-FI-A2F9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 79 0 0 TCGA-FI-A2F9-F71672 TCGA-FI-A2F9 TCGA-FI-A2F9-01A Never Used Stage IA NO -28886 709 0 1803 NO Scheduled Follow-up Submission 2015-3-27 FEMALE 175 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 60 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-FI-A2F9.5D03E085-0588-47A8-8B1C-E243D8127325.pdf A2F9 44 negative TUMOR FREE 0 0 NO 4+ Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO NO YES FI 0 3 0 35 Endometrial A LIVING 99 2009 TCGA-FI-A2F9-01 TCGA-FI-A2F9-01 2aef2acc-a065-4196-a278-1c1ce689e689 TCGA-FI-A2F9-01A-11D-A17C-01 TCGA-FI-A2F9-01A-11D-A17C-01 TCGA-FI-A2F9-01 TCGA-FI-A2F9-01 TCGA-FI-A2F9-01A-11D-A17F-05 2aef2acc-a065-4196-a278-1c1ce689e689 TCGA-FI-A3PV-01 MSS TCGA-FI-A3PV-01 Squamous UCEC Serous c4 miRNA c1uster 10 TCGA-FI-A3PV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 68 0 0 TCGA-FI-A3PV-F71674 TCGA-FI-A3PV Stage IA -24898 1264 0 2015-3-27 FEMALE 174 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Dilation and curettage procedure NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) High Grade No A3PV 0 negative WITH TUMOR 0 0 R0 Primary Tumor 01 open 2009 NO YES FI 0 6 0 10 Endometrial DECEASED 105 2003 af1f390e-abd4-4ed2-bc65-0b1080b786a9 TCGA-FI-A3PV-01 af1f390e-abd4-4ed2-bc65-0b1080b786a9 af1f390e-abd4-4ed2-bc65-0b1080b786a9 af1f390e-abd4-4ed2-bc65-0b1080b786a9 TCGA-FI-A3PV-01 TCGA-FI-A3PV-01A-11D-A227-01 TCGA-FI-A3PV-01A-11D-A227-01 TCGA-FI-A3PV-01 TCGA-FI-A3PV-01 TCGA-FI-A3PV-01A-11D-A22B-05 TCGA-FI-A3PX-01 MSS TCGA-FI-A3PX-01 High UCEC Serous c4 UCEC-like c5 miRNA cluster 14 TCGA-FI-A3PX TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 2 TCGA-FI-A3PX-F71661 TCGA-FI-A3PX TCGA-FI-A3PX-01A Stage IIIC2 -21063 1280 0 2384 2015-3-27 FEMALE 170 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Dilation and curettage procedure 130 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) High Grade NO true No TCGA-FI-A3PX.5E3FD49D-DE9B-4A5B-B4FC-2825CCB48B46.pdf A3PX 92 negative TUMOR FREE 4 NO Complete Remission/Response NO R0 Primary Tumor 01 open 2009 NO YES FI 2 5 4 10 Endometrial A LIVING 90 2008 773a978c-a52f-470b-b659-4c06de8a7e5b TCGA-FI-A3PX-01 773a978c-a52f-470b-b659-4c06de8a7e5b TCGA-FI-A3PX-01A-21-A23Z-20 219D9644-1FAC-4682-A1DC-37448FA3823A 773a978c-a52f-470b-b659-4c06de8a7e5b 773a978c-a52f-470b-b659-4c06de8a7e5b TCGA-FI-A3PX-01 TCGA-FI-A3PX-01A-11D-A227-01 TCGA-FI-A3PX-01A-11D-A227-01 TCGA-FI-A3PX-01 TCGA-FI-A3PX-01 TCGA-FI-A3PX-01A-11D-A22B-05 TCGA-FL-A1YF-11 TCGA-FL-A1YF-11 TCGA-FL-A1YF TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Solid Tissue Normal 11 b80bd803-b042-474e-864e-b2c6ee4708e5 b80bd803-b042-474e-864e-b2c6ee4708e5 b80bd803-b042-474e-864e-b2c6ee4708e5 b80bd803-b042-474e-864e-b2c6ee4708e5 TCGA-FL-A1YF-11 TCGA-FL-A1YF-11 TCGA-FL-A1YF-11A-12D-A16G-05 TCGA-FL-A1YG-11 TCGA-FL-A1YG-11 TCGA-FL-A1YG TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium TCGA-FL-A1YG-11A 170 NO false Solid Tissue Normal 11 A 88802e34-7269-4b5e-b552-a969281ab241 88802e34-7269-4b5e-b552-a969281ab241 88802e34-7269-4b5e-b552-a969281ab241 88802e34-7269-4b5e-b552-a969281ab241 TCGA-FL-A1YG-11 TCGA-FL-A1YG-11 TCGA-FL-A1YG-11A-12D-A16G-05 TCGA-FL-A1YH-11 TCGA-FL-A1YH-11 TCGA-FL-A1YH TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Solid Tissue Normal 11 ba70deb1-e8c2-4f74-9883-46e7095f677d ba70deb1-e8c2-4f74-9883-46e7095f677d ba70deb1-e8c2-4f74-9883-46e7095f677d ba70deb1-e8c2-4f74-9883-46e7095f677d TCGA-FL-A1YH-11 TCGA-FL-A1YH-11 TCGA-FL-A1YH-11A-11D-A16G-05 TCGA-FL-A1YI-11 TCGA-FL-A1YI-11 TCGA-FL-A1YI TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium TCGA-FL-A1YI-11A 120 NO false Solid Tissue Normal 11 A 0c5df2a7-417c-478d-9a7e-675a8777747c 0c5df2a7-417c-478d-9a7e-675a8777747c 0c5df2a7-417c-478d-9a7e-675a8777747c 0c5df2a7-417c-478d-9a7e-675a8777747c TCGA-FL-A1YI-11 TCGA-FL-A1YI-11 TCGA-FL-A1YI-11A-11D-A16G-05 TCGA-FL-A1YL-11 TCGA-FL-A1YL-11 TCGA-FL-A1YL TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium TCGA-FL-A1YL-11A 80 NO false Solid Tissue Normal 11 A 4ad4e642-d5fc-459e-8553-bb1c9795c09d 4ad4e642-d5fc-459e-8553-bb1c9795c09d 4ad4e642-d5fc-459e-8553-bb1c9795c09d 4ad4e642-d5fc-459e-8553-bb1c9795c09d TCGA-FL-A1YL-11 TCGA-FL-A1YL-11 TCGA-FL-A1YL-11A-11D-A16G-05 TCGA-FL-A1YM-11 TCGA-FL-A1YM-11 TCGA-FL-A1YM TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium TCGA-FL-A1YM-11A 80 NO false Solid Tissue Normal 11 A TCGA-FL-A1YM-11 3499b1ce-1d6d-423d-8509-77e3f6818b0c TCGA-FL-A1YM-11 TCGA-FL-A1YM-11A-12D-A17F-05 3499b1ce-1d6d-423d-8509-77e3f6818b0c TCGA-FL-A1YN-11 TCGA-FL-A1YN-11 TCGA-FL-A1YN TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium TCGA-FL-A1YN-11A 60 NO false Solid Tissue Normal 11 A 331785a5-59ba-441f-81dc-384d7f80905b 331785a5-59ba-441f-81dc-384d7f80905b 331785a5-59ba-441f-81dc-384d7f80905b 331785a5-59ba-441f-81dc-384d7f80905b TCGA-FL-A1YN-11 TCGA-FL-A1YN-11 TCGA-FL-A1YN-11A-11D-A17F-05 TCGA-FL-A1YQ-11 TCGA-FL-A1YQ-11 TCGA-FL-A1YQ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium TCGA-FL-A1YQ-11A 130 NO false Solid Tissue Normal 11 A 21a04fd6-500e-4d42-846b-b6b7783098fb 21a04fd6-500e-4d42-846b-b6b7783098fb 21a04fd6-500e-4d42-846b-b6b7783098fb 21a04fd6-500e-4d42-846b-b6b7783098fb TCGA-FL-A1YQ-11 TCGA-FL-A1YQ-11 TCGA-FL-A1YQ-11A-11D-A17F-05 TCGA-FL-A1YT-11 TCGA-FL-A1YT-11 TCGA-FL-A1YT TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium TCGA-FL-A1YT-11A 70 NO false Solid Tissue Normal 11 A 2532b16b-1217-43df-aa69-cdbb5f9c3778 2532b16b-1217-43df-aa69-cdbb5f9c3778 2532b16b-1217-43df-aa69-cdbb5f9c3778 2532b16b-1217-43df-aa69-cdbb5f9c3778 TCGA-FL-A1YT-11 TCGA-FL-A1YT-11 TCGA-FL-A1YT-11A-12D-A17F-05 TCGA-FL-A1YU-11 TCGA-FL-A1YU-11 TCGA-FL-A1YU TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Solid Tissue Normal 11 f0d6b561-bfd2-41b7-a43c-1006370eec8f f0d6b561-bfd2-41b7-a43c-1006370eec8f f0d6b561-bfd2-41b7-a43c-1006370eec8f f0d6b561-bfd2-41b7-a43c-1006370eec8f TCGA-FL-A1YU-11 TCGA-FL-A1YU-11 TCGA-FL-A1YU-11A-11D-A17F-05 TCGA-FL-A1YV-11 TCGA-FL-A1YV-11 TCGA-FL-A1YV TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium TCGA-FL-A1YV-11A 110 NO false Solid Tissue Normal 11 A da44c9b1-d38b-4b75-887c-ec1646969758 da44c9b1-d38b-4b75-887c-ec1646969758 da44c9b1-d38b-4b75-887c-ec1646969758 da44c9b1-d38b-4b75-887c-ec1646969758 TCGA-FL-A1YV-11A-12D-A17F-05 TCGA-FL-A3WE-11 TCGA-FL-A3WE-11 TCGA-FL-A3WE TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium TCGA-FL-A3WE-11A 80 NO true Solid Tissue Normal 11 A 6b961695-40e4-4c88-976a-8fb6c99b4f0f 6b961695-40e4-4c88-976a-8fb6c99b4f0f 6b961695-40e4-4c88-976a-8fb6c99b4f0f 6b961695-40e4-4c88-976a-8fb6c99b4f0f TCGA-FL-A3WE-11 TCGA-FL-A3WE-11 TCGA-FL-A3WE-11A-11D-A22B-05 TCGA-H5-A2HR-01 MSI-L TCGA-H5-A2HR-01 High UCEC Serous c4 UCEC-like c5 miRNA cluster 12 TCGA-H5-A2HR TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 71 TCGA-H5-A2HR-F37038 TCGA-H5-A2HR TCGA-H5-A2HR-01A Stage IB -25986 1627 0 39 NO 2012-11-21 FEMALE Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 110 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 false No TCGA-H5-A2HR.3747A4AC-811E-49A1-8459-93807BB363C6.pdf A2HR 18 negative TUMOR FREE 0 4+ R0 Primary Tumor 01 open 1988 NO YES H5 0 0 19 Endometrial A LIVING 95 2006 9ed0c69e-a7e6-4c99-8c93-541d7bde4be6 TCGA-H5-A2HR-01 9ed0c69e-a7e6-4c99-8c93-541d7bde4be6 TCGA-H5-A2HR-01A-21-A18R-20 FF5E27B1-C378-4BB7-9F66-BEF3E837F372 9ed0c69e-a7e6-4c99-8c93-541d7bde4be6 9ed0c69e-a7e6-4c99-8c93-541d7bde4be6 TCGA-H5-A2HR-01 TCGA-H5-A2HR-01A-11D-A17U-01 TCGA-H5-A2HR-01A-11D-A17U-01 TCGA-H5-A2HR-01 TCGA-H5-A2HR-01 TCGA-H5-A2HR-01A-11D-A17Z-05 TCGA-JU-AAVI-01 MSS TCGA-JU-AAVI-01 TCGA-JU-AAVI TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 61 TCGA-JU-AAVI-F69309 TCGA-JU-AAVI Stage IIIC1 NO -22289 540 0 236 505 NO 2015-1-20 FEMALE 150 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Incisional Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Distant Metastasis Porta Hepatis NO YES No AAVI 93 negative WITH TUMOR YES 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 1988 YES NO JU 0 2 2 16 Endometrial DECEASED 121 2013 e860c29e-5d8d-4aee-b631-f55664403bdc TCGA-JU-AAVI-01 e860c29e-5d8d-4aee-b631-f55664403bdc e860c29e-5d8d-4aee-b631-f55664403bdc e860c29e-5d8d-4aee-b631-f55664403bdc TCGA-JU-AAVI-01 TCGA-JU-AAVI-01A-11D-A402-01 TCGA-JU-AAVI-01A-11D-A402-01 TCGA-JU-AAVI-01 TCGA-JU-AAVI-01 TCGA-JU-AAVI-01A-11D-A409-05 TCGA-K6-A3WQ-01 MSS TCGA-K6-A3WQ-01 Squamous UCEC Serous c4 UCEC-like c5 miRNA cluster 12 TCGA-K6-A3WQ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES Progressive Disease 60 TCGA-K6-A3WQ-F59157 TCGA-K6-A3WQ TCGA-K6-A3WQ-01A Stage IVB -22092 63 427 0 400 351 2014-5-1 FEMALE 171 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 440 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 Other, specify Locoregional Recurrence uterine NO YES true No TCGA-K6-A3WQ.16F848AA-C14C-45F7-A756-414615853761.pdf A3WQ 95 positive WITH TUMOR 1 1 YES YES Primary Tumor 01 Minimally Invasive 2009 YES NO K6 0 1 2 Endometrial A DECEASED 99 2012 8fac215c-7172-42ed-af07-00b27c05d3a6 TCGA-K6-A3WQ-01 8fac215c-7172-42ed-af07-00b27c05d3a6 TCGA-K6-A3WQ-01A-21-A240-20 2F07DA77-7FFB-44F5-A741-FEFC6577AEDE 8fac215c-7172-42ed-af07-00b27c05d3a6 8fac215c-7172-42ed-af07-00b27c05d3a6 TCGA-K6-A3WQ-01 TCGA-K6-A3WQ-01A-11D-A227-01 TCGA-K6-A3WQ-01A-11D-A227-01 TCGA-K6-A3WQ-01 TCGA-K6-A3WQ-01 TCGA-K6-A3WQ-01A-11D-A22B-05 TCGA-KJ-A3U4-01 MSS TCGA-KJ-A3U4-01 Squamous UCEC Serous c4 UCEC-like c5 miRNA cluster 4 TCGA-KJ-A3U4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium YES NO Progressive Disease 55 0 TCGA-KJ-A3U4-F71041 TCGA-KJ-A3U4 TCGA-KJ-A3U4-01A Never Used Stage IA NO -20392 56 0 1095 306 306 NO 2015-3-15 FEMALE 165 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Tumor resection 420 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 Other, specify Locoregional Recurrence abdominal YES YES true Yes TCGA-KJ-A3U4.F0B04416-21FE-4DBC-84BB-7188131399B6.pdf A3U4 21 TUMOR FREE 0 YES 2 Progressive Disease NO Surgical Resection R0 R0 Primary Tumor 01 open 2009 YES NO KJ 0 1 0 11 Endometrial A LIVING 96 2012 ad229cea-5cac-422d-a773-370ed37152e9 TCGA-KJ-A3U4-01 ad229cea-5cac-422d-a773-370ed37152e9 TCGA-KJ-A3U4-01A-21-A23Z-20 99182DDF-D675-4FD2-9EB4-FE8D00804C93 ad229cea-5cac-422d-a773-370ed37152e9 ad229cea-5cac-422d-a773-370ed37152e9 TCGA-KJ-A3U4-01A-11D-A227-01 TCGA-KJ-A3U4-01A-11D-A227-01 TCGA-KJ-A3U4-01 TCGA-KJ-A3U4-01A-11D-A22B-05 TCGA-KP-A3VZ-01 MSS TCGA-KP-A3VZ-01 High OV-like c1 UCEC-like c5 miRNA cluster 13 TCGA-KP-A3VZ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 69 TCGA-KP-A3VZ TCGA-KP-A3VZ-01A Stage IV -25366 633 0 722 2012-7-16 FEMALE 163 Serous endometrial adenocarcinoma No C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 200 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) High Grade true Yes TCGA-KP-A3VZ.FF834E31-78F7-4A56-8EC0-E026BE940FD4.pdf A3VZ 75 positive WITH TUMOR 0 0 RX Primary Tumor 01 open 2009 NO YES KP 0 0 7 Endometrial A LIVING 55 2010 0f347f95-e4bc-480e-ab1a-84c9df4018c9 TCGA-KP-A3VZ-01 0f347f95-e4bc-480e-ab1a-84c9df4018c9 TCGA-KP-A3VZ-01A-21-A240-20 F48CD35C-BA90-4686-97F7-DCB03EF55CC2 0f347f95-e4bc-480e-ab1a-84c9df4018c9 0f347f95-e4bc-480e-ab1a-84c9df4018c9 TCGA-KP-A3VZ-01 TCGA-KP-A3VZ-01A-11D-A227-01 TCGA-KP-A3VZ-01A-11D-A227-01 TCGA-KP-A3VZ-01 TCGA-KP-A3VZ-01 TCGA-KP-A3VZ-01A-11D-A22B-05 TCGA-KP-A3W0-01 MSS TCGA-KP-A3W0-01 BRCA-LUAD+ OV-like c1 UCEC-like c5 miRNA cluster 5 TCGA-KP-A3W0 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 72 TCGA-KP-A3W0 TCGA-KP-A3W0-01A Never Used Stage IB NO -26378 351 0 404 NO 2012-7-19 FEMALE 162 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Dilation and curettage procedure 90 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-KP-A3W0.8623B627-C3E3-469B-A640-2F8BCFC0B711.pdf A3W0 75 positive TUMOR FREE YES 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES KP 0 0 Endometrial A LIVING 94 2011 0ed2207e-47d3-47aa-804f-abffb6f42e64 TCGA-KP-A3W0-01 0ed2207e-47d3-47aa-804f-abffb6f42e64 TCGA-KP-A3W0-01A-11-A240-20 516DD408-6008-4824-852D-77384BAD6142 0ed2207e-47d3-47aa-804f-abffb6f42e64 0ed2207e-47d3-47aa-804f-abffb6f42e64 TCGA-KP-A3W0-01 TCGA-KP-A3W0-01A-21D-A227-01 TCGA-KP-A3W0-01A-21D-A227-01 TCGA-KP-A3W0-01 TCGA-KP-A3W0-01 TCGA-KP-A3W0-01A-21D-A22B-05 TCGA-KP-A3W1-01 MSS TCGA-KP-A3W1-01 High UCEC non-CIMP c3 BRCA basal-like c6 miRNA cluster 14 TCGA-KP-A3W1 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 76 TCGA-KP-A3W1 TCGA-KP-A3W1-01A Never Used Stage IA NO -27902 198 0 288 NO 2012-7-19 FEMALE 170 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Dilation and curettage procedure 710 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-KP-A3W1.58145248-B111-463A-A1CC-32DA993F0B26.pdf A3W1 25 negative TUMOR FREE 0 0 YES 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES KP 0 0 5 Endometrial A LIVING 66 2011 b1ee7148-ddae-404a-b796-004539c02aa7 TCGA-KP-A3W1-01 b1ee7148-ddae-404a-b796-004539c02aa7 TCGA-KP-A3W1-01A-21-A240-20 23F4AE6E-5C55-4107-8B98-CE129078D051 b1ee7148-ddae-404a-b796-004539c02aa7 b1ee7148-ddae-404a-b796-004539c02aa7 TCGA-KP-A3W1-01 TCGA-KP-A3W1-01A-11D-A227-01 TCGA-KP-A3W1-01A-11D-A227-01 TCGA-KP-A3W1-01 TCGA-KP-A3W1-01 TCGA-KP-A3W1-01A-11D-A22B-05 TCGA-KP-A3W3-01 MSS TCGA-KP-A3W3-01 High UCEC Serous c4 UCEC-like c5 miRNA cluster 7 TCGA-KP-A3W3 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 72 TCGA-KP-A3W3 TCGA-KP-A3W3-01A Stage IB NO -26310 739 0 794 NO 2012-7-19 FEMALE 164 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 680 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 YES true No TCGA-KP-A3W3.9D8F170A-A4B1-463A-B92C-357870762EAD.pdf A3W3 75 positive WITH TUMOR YES 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES KP 0 0 Endometrial A LIVING 126 2010 b2d5d73b-6669-438a-b6fd-0e29b7bce645 TCGA-KP-A3W3-01 b2d5d73b-6669-438a-b6fd-0e29b7bce645 TCGA-KP-A3W3-01A-22-A240-20 D0D776F7-12A4-4219-A969-DB67B1908683 b2d5d73b-6669-438a-b6fd-0e29b7bce645 b2d5d73b-6669-438a-b6fd-0e29b7bce645 TCGA-KP-A3W3-01 TCGA-KP-A3W3-01A-11D-A227-01 TCGA-KP-A3W3-01A-11D-A227-01 TCGA-KP-A3W3-01 TCGA-KP-A3W3-01 TCGA-KP-A3W3-01A-11D-A22B-05 TCGA-KP-A3W4-01 MSS TCGA-KP-A3W4-01 Kirc+ UCEC Serous c4 UCEC-like c5 miRNA cluster 4 TCGA-KP-A3W4 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 63 TCGA-KP-A3W4 TCGA-KP-A3W4-01A Former User Stage IIIA NO -23200 688 554 0 NO 2012-7-19 FEMALE 151 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 540 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 YES true No TCGA-KP-A3W4.5B8C1B60-7046-4A3A-9D65-ECCB91BF9847.pdf A3W4 75 positive WITH TUMOR 0 0 YES 3 Partial Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO YES KP 0 0 19 Endometrial A DECEASED 61 2010 8488db37-440c-407d-a184-72ee19632c9f TCGA-KP-A3W4-01 8488db37-440c-407d-a184-72ee19632c9f TCGA-KP-A3W4-01A-21-A240-20 EBA5622C-234D-4AA9-B586-10F48DC05A17 8488db37-440c-407d-a184-72ee19632c9f 8488db37-440c-407d-a184-72ee19632c9f TCGA-KP-A3W4-01 TCGA-KP-A3W4-01A-11D-A227-01 TCGA-KP-A3W4-01A-11D-A227-01 TCGA-KP-A3W4-01 TCGA-KP-A3W4-01 TCGA-KP-A3W4-01A-11D-A22B-05 TCGA-PG-A5BC-01 MSS TCGA-PG-A5BC-01 TCGA-PG-A5BC TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 72 TCGA-PG-A5BC-F59222 TCGA-PG-A5BC TCGA-PG-A5BC-01A Stage II NO -26436 205 0 707 YES 2014-5-6 FEMALE 163 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 120 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-PG-A5BC.040F4583-2683-42A8-B185-56A08874F3A0.pdf A5BC TUMOR FREE NO 4+ Complete Remission/Response Never Used NO Primary Tumor 01 2009 NO YES PG Endometrial A LIVING 87 2012 47e8bbd2-fd10-4dc8-882e-cb88ca27338d TCGA-PG-A5BC-01 47e8bbd2-fd10-4dc8-882e-cb88ca27338d 19F3BEE7-5B36-4114-A3B4-47A3F1BC941E 47e8bbd2-fd10-4dc8-882e-cb88ca27338d 47e8bbd2-fd10-4dc8-882e-cb88ca27338d TCGA-PG-A5BC-01 TCGA-PG-A5BC-01A-12D-A27O-01 TCGA-PG-A5BC-01A-12D-A27O-01 TCGA-PG-A5BC-01 TCGA-PG-A5BC-01 TCGA-PG-A5BC-01A-12D-A27Y-05 TCGA-PG-A6IB-01 MSI-H TCGA-PG-A6IB-01 TCGA-PG-A6IB TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 68 TCGA-PG-A6IB-F66521 TCGA-PG-A6IB TCGA-PG-A6IB-01A Never Used Stage IA NO -24969 160 0 648 NO 2014-10-30 FEMALE Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 100 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-PG-A6IB.C975AE5D-7370-4D1D-81AE-D3ABE5364055.pdf A6IB 38 negative TUMOR FREE 2 Complete Remission/Response Never Used R0 Primary Tumor 01 open 2009 NO YES PG 0 0 Endometrial A LIVING 2012 55b5dd8f-9e80-4084-9cb2-c04ccf558802 TCGA-PG-A6IB-01 55b5dd8f-9e80-4084-9cb2-c04ccf558802 91F3B808-ED4A-4631-8FFC-37AB68EBEF9B 55b5dd8f-9e80-4084-9cb2-c04ccf558802 55b5dd8f-9e80-4084-9cb2-c04ccf558802 TCGA-PG-A6IB-01 TCGA-PG-A6IB-01A-21D-A31T-01 TCGA-PG-A6IB-01A-21D-A31T-01 TCGA-PG-A6IB-01 TCGA-PG-A6IB-01 TCGA-PG-A6IB-01A-21D-A31V-05 TCGA-PG-A7D5-01 MSS TCGA-PG-A7D5-01 TCGA-PG-A7D5 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 62 TCGA-PG-A7D5-F71179 TCGA-PG-A7D5 TCGA-PG-A7D5-01A Former User Stage IA NO -23006 618 0 1177 YES 2015-3-20 FEMALE 158 Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8441/3 C54.1 YES Office Endometrial Biopsy 100 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-PG-A7D5.2E996CFE-9F6E-432F-9B09-6FBC2A920B24.pdf A7D5 47 negative TUMOR FREE YES 4+ Stable Disease Never Used YES R0 Primary Tumor 01 open 2009 NO YES PG 0 0 Endometrial A LIVING 79 2011 460f0df0-00fb-43bf-9143-782a45ca490c TCGA-PG-A7D5-01 460f0df0-00fb-43bf-9143-782a45ca490c 3D9099E7-D773-46F2-BEB3-B0A53B6FEB5B 460f0df0-00fb-43bf-9143-782a45ca490c 460f0df0-00fb-43bf-9143-782a45ca490c TCGA-PG-A7D5-01 TCGA-PG-A7D5-01A-11D-A34P-01 TCGA-PG-A7D5-01A-11D-A34P-01 TCGA-PG-A7D5-01 TCGA-PG-A7D5-01 TCGA-PG-A7D5-01A-11D-A34S-05 TCGA-PG-A914-01 MSS TCGA-PG-A914-01 TCGA-PG-A914 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 73 TCGA-PG-A914-F71183 TCGA-PG-A914 TCGA-PG-A914-01A Never Used Stage IA NO -26992 263 0 687 NO 2015-3-20 FEMALE Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8461/3 C54.1 YES Cytology (e.g. Peritoneal or pleural fluid) 260 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-PG-A914.B073614D-A6E3-4A83-96C4-1F189F8D16B4.pdf A914 13 negative TUMOR FREE NO 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO YES PG 0 0 Endometrial A LIVING 2013 6e5ab8c9-03de-4a9d-ac92-37f28170c0a0 TCGA-PG-A914-01 6e5ab8c9-03de-4a9d-ac92-37f28170c0a0 95D3256E-1073-4BD1-8097-937B3CA2CDF7 6e5ab8c9-03de-4a9d-ac92-37f28170c0a0 6e5ab8c9-03de-4a9d-ac92-37f28170c0a0 TCGA-PG-A914-01 TCGA-PG-A914-01A-11D-A37M-01 TCGA-PG-A914-01A-11D-A37M-01 TCGA-PG-A914-01 TCGA-PG-A914-01 TCGA-PG-A914-01A-11D-A37Q-05 TCGA-PG-A915-01 MSS TCGA-PG-A915-01 TCGA-PG-A915 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 60 TCGA-PG-A915-F67387 TCGA-PG-A915 TCGA-PG-A915-01A Never Used Stage IA NO -22119 238 0 249 NO 2015-3-20 FEMALE Serous endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.1 8461/3 C54.1 YES Cytology (e.g. Peritoneal or pleural fluid) 410 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO true No TCGA-PG-A915.F2869E10-B5EB-4AB7-9CC9-A7B2E5DDBB7C.pdf A915 negative TUMOR FREE NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO YES PG 0 0 Endometrial A LIVING 2013 c590ff56-1d2d-40ea-9fba-0768d66ec12c TCGA-PG-A915-01 c590ff56-1d2d-40ea-9fba-0768d66ec12c 7629E5EF-DE9B-46C7-93BC-03D42328EC4A c590ff56-1d2d-40ea-9fba-0768d66ec12c c590ff56-1d2d-40ea-9fba-0768d66ec12c TCGA-PG-A915-01 TCGA-PG-A915-01A-11D-A37M-01 TCGA-PG-A915-01A-11D-A37M-01 TCGA-PG-A915-01 TCGA-PG-A915-01 TCGA-PG-A915-01A-11D-A37Q-05 TCGA-PG-A916-01 MSS TCGA-PG-A916-01 TCGA-PG-A916 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 70 TCGA-PG-A916-F71185 TCGA-PG-A916 TCGA-PG-A916-01A Former User Stage I NO -25617 224 0 522 NO 2015-3-20 FEMALE Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 220 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-PG-A916.3E66FA38-0D87-47CA-A72D-63C0619A2182.pdf A916 negative TUMOR FREE NO 1 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO YES PG 0 0 Endometrial A LIVING 2013 a9430dc8-38cf-4ef1-8442-e20582f6d893 TCGA-PG-A916-01 a9430dc8-38cf-4ef1-8442-e20582f6d893 577759B3-B76A-445B-84C7-DCA24C120A56 a9430dc8-38cf-4ef1-8442-e20582f6d893 a9430dc8-38cf-4ef1-8442-e20582f6d893 TCGA-PG-A916-01 TCGA-PG-A916-01A-11D-A37M-01 TCGA-PG-A916-01A-11D-A37M-01 TCGA-PG-A916-01 TCGA-PG-A916-01 TCGA-PG-A916-01A-11D-A37Q-05 TCGA-PG-A917-01 MSI-H TCGA-PG-A917-01 TCGA-PG-A917 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 74 TCGA-PG-A917-F67180 TCGA-PG-A917 TCGA-PG-A917-01A Former User Stage IA NO -27104 583 0 212 NO 2014-10-31 FEMALE Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Cytology (e.g. Peritoneal or pleural fluid) 390 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO true No TCGA-PG-A917.9836008F-81F7-4029-9A28-10AB6021DFEA.pdf A917 positive TUMOR FREE NO 2 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 NO YES PG 0 0 Endometrial A LIVING 2012 2dc0d41b-72fa-4514-889f-3c46507fd5e8 TCGA-PG-A917-01 2dc0d41b-72fa-4514-889f-3c46507fd5e8 2dc0d41b-72fa-4514-889f-3c46507fd5e8 2dc0d41b-72fa-4514-889f-3c46507fd5e8 TCGA-PG-A917-01 TCGA-PG-A917-01A-31D-A37M-01 TCGA-PG-A917-01A-31D-A37M-01 TCGA-PG-A917-01 TCGA-PG-A917-01 TCGA-PG-A917-01A-31D-A37Q-05 TCGA-QF-A5YS-01 MSS TCGA-QF-A5YS-01 TCGA-QF-A5YS TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 0 TCGA-QF-A5YS-F58613 TCGA-QF-A5YS TCGA-QF-A5YS-01A Never Used Stage II NO -20841 158 0 689 NO 2014-4-16 FEMALE 162 Mixed serous and endometrioid No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 120 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-QF-A5YS.2608B03E-0D29-49EF-BC3D-A26D5017C265.pdf A5YS 22 TUMOR FREE 0 YES 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES QF 0 5 0 2 Endometrial A LIVING 79 2012 646422f2-97e3-43e4-bb4f-260277cff6f4 TCGA-QF-A5YS-01 646422f2-97e3-43e4-bb4f-260277cff6f4 AD17002A-950C-42A0-8590-3A491D5621A1 646422f2-97e3-43e4-bb4f-260277cff6f4 646422f2-97e3-43e4-bb4f-260277cff6f4 TCGA-QF-A5YS-01 TCGA-QF-A5YS-01A-11D-A31T-01 TCGA-QF-A5YS-01A-11D-A31T-01 TCGA-QF-A5YS-01 TCGA-QF-A5YS-01 TCGA-QF-A5YS-01A-11D-A31V-05 TCGA-QF-A5YT-01 MSS TCGA-QF-A5YT-01 TCGA-QF-A5YT TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 57 TCGA-QF-A5YT-F58612 TCGA-QF-A5YT TCGA-QF-A5YT-01A Never Used Stage II NO -20981 804 0 1215 NO 2014-4-16 FEMALE 170 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. NO C54.0 8380/3 C54.0 YES Office Endometrial Biopsy 40 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-QF-A5YT.1CCA2D47-BA5D-46A9-89F9-681C58EFC10D.pdf A5YT 50 TUMOR FREE NO 0 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES QF 0 0 Endometrial A LIVING 146 2010 86ae75e5-6460-45a3-89f0-aaeba2462268 TCGA-QF-A5YT-01 86ae75e5-6460-45a3-89f0-aaeba2462268 86ae75e5-6460-45a3-89f0-aaeba2462268 86ae75e5-6460-45a3-89f0-aaeba2462268 TCGA-QF-A5YT-01 TCGA-QF-A5YT-01A-11D-A31T-01 TCGA-QF-A5YT-01A-11D-A31T-01 TCGA-QF-A5YT-01 TCGA-QF-A5YT-01 TCGA-QF-A5YT-01A-11D-A31V-05 TCGA-QS-A5YQ-01 MSS TCGA-QS-A5YQ-01 TCGA-QS-A5YQ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 55 TCGA-QS-A5YQ-F59570 TCGA-QS-A5YQ TCGA-QS-A5YQ-01A Stage IIIA NO -20425 43 0 759 NO 2014-5-15 FEMALE 160 Endometrioid endometrial adenocarcinoma No NO C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 370 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G1 NO false No TCGA-QS-A5YQ.D1631D6F-F055-4D35-A6DD-FE7A251BD4C2.pdf A5YQ 10 TUMOR FREE 0 0 YES 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO QS 0 0 7 Endometrial A LIVING 83 2013 618b52e3-9797-4c61-a0dd-1ffa8ea6d321 TCGA-QS-A5YQ-01 618b52e3-9797-4c61-a0dd-1ffa8ea6d321 E9379320-2726-431E-B512-78858CEA26C3 618b52e3-9797-4c61-a0dd-1ffa8ea6d321 618b52e3-9797-4c61-a0dd-1ffa8ea6d321 TCGA-QS-A5YQ-01 TCGA-QS-A5YQ-01A-11D-A31T-01 TCGA-QS-A5YQ-01A-11D-A31T-01 TCGA-QS-A5YQ-01 TCGA-QS-A5YQ-01 TCGA-QS-A5YQ-01A-11D-A31V-05 TCGA-QS-A5YR-01 MSI-H TCGA-QS-A5YR-01 TCGA-QS-A5YR TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Stable Disease 61 TCGA-QS-A5YR-F58590 TCGA-QS-A5YR TCGA-QS-A5YR-01A Never Used Stage IIIB NO -22372 118 0 719 YES 2014-4-15 FEMALE 168 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Dilation and curettage procedure 280 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-QS-A5YR.D9417AEE-FD30-42FA-986E-26C98E29C428.pdf A5YR 13 WITH TUMOR 0 0 NO 4+ Stable Disease Never Used NO RX Primary Tumor 01 Minimally Invasive 2009 YES NO QS 0 0 5 Endometrial A LIVING 100 2012 0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63 TCGA-QS-A5YR-01 0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63 E55BD3ED-96B6-4277-A869-A47B08840653 0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63 0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63 TCGA-QS-A5YR-01 TCGA-QS-A5YR-01A-31D-A31T-01 TCGA-QS-A5YR-01A-31D-A31T-01 TCGA-QS-A5YR-01 TCGA-QS-A5YR-01 TCGA-QS-A5YR-01A-31D-A31V-05 TCGA-QS-A744-01 MSS TCGA-QS-A744-01 TCGA-QS-A744 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 86 TCGA-QS-A744-F64971 TCGA-QS-A744 TCGA-QS-A744-01A Stage IIIB NO -31520 44 0 451 NO 2014-9-16 FEMALE 163 Endometrioid endometrial adenocarcinoma No YES C54.0 8380/3 C54.0 YES Office Endometrial Biopsy 310 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-QS-A744.F37C9C5C-8AAA-47FB-8BAD-AE2EB0F70B4F.pdf A744 86 TUMOR FREE YES 4+ Never Used NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO QS 0 0 Endometrial A LIVING 76 2013 2eede096-06aa-4026-9c23-2a2d1d9015c1 TCGA-QS-A744-01 2eede096-06aa-4026-9c23-2a2d1d9015c1 59780BBC-3B71-437F-9C0F-2FD11DA2AA92 2eede096-06aa-4026-9c23-2a2d1d9015c1 2eede096-06aa-4026-9c23-2a2d1d9015c1 TCGA-QS-A744-01 TCGA-QS-A744-01A-11D-A34P-01 TCGA-QS-A744-01A-11D-A34P-01 TCGA-QS-A744-01 TCGA-QS-A744-01 TCGA-QS-A744-01A-11D-A34S-05 TCGA-QS-A8F1-01 MSS TCGA-QS-A8F1-01 TCGA-QS-A8F1 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Progressive Disease 85 TCGA-QS-A8F1-F66552 TCGA-QS-A8F1 TCGA-QS-A8F1-01A Never Used Stage IIIA NO -31386 29 135 0 125 NO 2014-10-20 FEMALE 168 Serous endometrial adenocarcinoma No NO C54.3 8441/3 C54.3 YES Tumor resection 250 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 NO false No TCGA-QS-A8F1.563BDC27-AFA6-4DE0-AB17-8CFD93D1CA81.pdf A8F1 50 negative WITH TUMOR YES 0 Progressive Disease Never Used NO Primary Tumor 01 Minimally Invasive 2009 YES NO QS 0 0 Other Specify A DECEASED 75 2013 d05ea5d7-8d21-4fd6-9199-fdc606a9843c TCGA-QS-A8F1-01 d05ea5d7-8d21-4fd6-9199-fdc606a9843c F4063512-BBF4-4CB1-B21E-E63FC0753FD0 d05ea5d7-8d21-4fd6-9199-fdc606a9843c d05ea5d7-8d21-4fd6-9199-fdc606a9843c TCGA-QS-A8F1-01 TCGA-QS-A8F1-01A-21D-A37M-01 TCGA-QS-A8F1-01A-21D-A37M-01 TCGA-QS-A8F1-01 TCGA-QS-A8F1-01 TCGA-QS-A8F1-01A-21D-A37Q-05 TCGA-SJ-A6ZI-01 MSI-H TCGA-SJ-A6ZI-01 TCGA-SJ-A6ZI TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 64 0 0 TCGA-SJ-A6ZI-F70447 TCGA-SJ-A6ZI TCGA-SJ-A6ZI-01A Never Used Stage IB NO -23653 88 0 631 NO 2015-2-26 FEMALE 66 Endometrioid endometrial adenocarcinoma No No, I have never taken menopausal hormone therapy. YES C54.1 8380/3 C54.1 YES Radical hysterectomy, bilateral salpingo-oophorectomy Other method, specify: 880 NO NO G1 NO false No TCGA-SJ-A6ZI.2CA0FD3F-7635-4395-A13B-C3BB9D3FF0D8.pdf A6ZI 75 negative TUMOR FREE 0 0 NO 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO SJ 0 9 0 18 Endometrial A LIVING 93 2013 0d5a9a1e-e473-4b9a-bc27-60147dca9fe6 TCGA-SJ-A6ZI-01 0d5a9a1e-e473-4b9a-bc27-60147dca9fe6 43EBE86A-68BA-46A4-A4B9-A6AD5E615BFE 0d5a9a1e-e473-4b9a-bc27-60147dca9fe6 0d5a9a1e-e473-4b9a-bc27-60147dca9fe6 TCGA-SJ-A6ZI-01 TCGA-SJ-A6ZI-01A-12D-A34P-01 TCGA-SJ-A6ZI-01A-12D-A34P-01 TCGA-SJ-A6ZI-01 TCGA-SJ-A6ZI-01 TCGA-SJ-A6ZI-01A-12D-A34S-05 TCGA-SJ-A6ZJ-01 MSS TCGA-SJ-A6ZJ-01 TCGA-SJ-A6ZJ TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium Complete Response 61 TCGA-SJ-A6ZJ-F67768 TCGA-SJ-A6ZJ TCGA-SJ-A6ZJ-01A Former User Stage IB NO -22597 216 0 556 NO 2014-11-11 FEMALE 168 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Office Endometrial Biopsy 580 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G2 NO false No TCGA-SJ-A6ZJ.B7C3C4EC-E494-4290-AFDA-FEFEBA8A3BA5.pdf A6ZJ 62.5 negative TUMOR FREE 0 0 NO 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO SJ 0 28 Endometrial A LIVING 132 2012 d3473471-b625-4f56-8300-590324d48002 TCGA-SJ-A6ZJ-01 d3473471-b625-4f56-8300-590324d48002 272FE29A-16A0-4E92-8B02-84FCC35D8BF4 d3473471-b625-4f56-8300-590324d48002 d3473471-b625-4f56-8300-590324d48002 TCGA-SJ-A6ZJ-01 TCGA-SJ-A6ZJ-01A-12D-A34P-01 TCGA-SJ-A6ZJ-01A-12D-A34P-01 TCGA-SJ-A6ZJ-01 TCGA-SJ-A6ZJ-01 TCGA-SJ-A6ZJ-01A-12D-A34S-05 TCGA-SL-A6J9-01 MSS TCGA-SL-A6J9-01 TCGA-SL-A6J9 TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 73 0 0 TCGA-SL-A6J9-F68332 TCGA-SL-A6J9 TCGA-SL-A6J9-01A Stage IB NO -26701 86 0 2 NO 2014-11-14 FEMALE 167 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Tumor resection 280 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true No TCGA-SL-A6J9.DFD43EFD-E91F-487F-A737-93C57C065A49.pdf A6J9 50 negative 0 0 2 RX Primary Tumor 01 open 2009 NO YES SL 0 2 0 9 Endometrial A LIVING 88 2013 55477806-1928-4281-8ee4-69da5b60c6a8 TCGA-SL-A6J9-01 55477806-1928-4281-8ee4-69da5b60c6a8 D703CF4D-5D96-4B15-8944-2EDD5BECA5A0 55477806-1928-4281-8ee4-69da5b60c6a8 55477806-1928-4281-8ee4-69da5b60c6a8 TCGA-SL-A6J9-01 TCGA-SL-A6J9-01A-11D-A31T-01 TCGA-SL-A6J9-01A-11D-A31T-01 TCGA-SL-A6J9-01 TCGA-SL-A6J9-01 TCGA-SL-A6J9-01A-11D-A31V-05 TCGA-SL-A6JA-01 MSI-H TCGA-SL-A6JA-01 TCGA-SL-A6JA TCGA Endometrioid Cancer (UCEC) uterine corpus endometrioid carcinoma Endometrium 77 0 0 TCGA-SL-A6JA-F68333 TCGA-SL-A6JA TCGA-SL-A6JA-01A Stage IB NO -28401 45 0 7 NO 2014-11-14 FEMALE 167 Endometrioid endometrial adenocarcinoma No YES C54.1 8380/3 C54.1 YES Tumor resection 200 NO YES Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) G3 true No TCGA-SL-A6JA.60CDA761-5DF1-4580-AD84-1CE9A15F31F8.pdf A6JA 50 TUMOR FREE 0 0 NO 4+ Complete Remission/Response NO Primary Tumor 01 open 2009 NO YES SL 0 1 0 11 Endometrial A LIVING 129 2013 1be5c0c6-8645-4894-8573-05ece1839689 TCGA-SL-A6JA-01 1be5c0c6-8645-4894-8573-05ece1839689 8D9E4270-BBA4-483C-82D0-88CD5FF6DA4C 1be5c0c6-8645-4894-8573-05ece1839689 1be5c0c6-8645-4894-8573-05ece1839689 TCGA-SL-A6JA-01 TCGA-SL-A6JA-01A-11D-A31T-01 TCGA-SL-A6JA-01A-11D-A31T-01 TCGA-SL-A6JA-01 TCGA-SL-A6JA-01 TCGA-SL-A6JA-01A-11D-A31V-05